Microglia in the developing nervous system by Rezaie, Payam
This electronic thesis or dissertation has been 











The copyright of this thesis rests with the author and no quotation from it or information derived from it 
may be published without proper acknowledgement. 
 
Take down policy 
If you believe that this document breaches copyright please contact librarypure@kcl.ac.uk providing 
details, and we will remove access to the work immediately and investigate your claim. 
END USER LICENCE AGREEMENT                                                                         
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 
International licence. https://creativecommons.org/licenses/by-nc-nd/4.0/ 
You are free to: 
 Share: to copy, distribute and transmit the work  
 
Under the following conditions: 
 Attribution: You must attribute the work in the manner specified by the author (but not in any 
way that suggests that they endorse you or your use of the work).  
 Non Commercial: You may not use this work for commercial purposes. 
 No Derivative Works - You may not alter, transform, or build upon this work. 
 
Any of these conditions can be waived if you receive permission from the author. Your fair dealings and 








Microglia in the developing nervous system
Rezaie, Payam
Download date: 06. Nov. 2017
TM `THIRD' ELE*NT 
Microglia In The Developing Nervous System 
DOCTORAL RESEARCH THESIS 
by 
Payam Rezaie 
Department of Neuropathology, Institute of Psychiatry, King's College London, 
DeCrespigny Park, London SE5 8AF, United Kingdom 
Thesis submitted in accordance with the requirements for a doctoral degree in 
Neuropathology & Neuroimmunology, Faculty of Medicine, 





The central nervous system (CNS) contains several populations of mononuclear phagocytes 
whose functional roles as `immune sentinels' involve host defence and tissue repair. Microglia 
are the principal mononuclear phagocytes residing within the CNS, and represent a 
heterogeneous population of cells in the adult and neonate. The origin of these cells was a 
subject of contention for most of the 20`h century, a topic which is presented within this work. 
The consensus opinion regards the origin of microglia as derived from circulating 
haematopoietic progenitors that initially colonise the developing nervous system around the 
time of birth in rodents. There is additional indication that microglial progenitors may arise 
prior to vascularisation of the CNS, principally from the surrounding mesenchymal tissue. 
Subsequently, these progenitors disperse ubiquitously throughout the CNS, undergo 
progressive differentiation and establish distinct non-overlapping territories during postnatal 
development. 
The aims of this investigation were to determine (i) the phasing and patterns of microglial 
invasion, (ii) mechanisms by which microglial progenitors colonise the brain and spinal cord 
during embryogenesis and early neonatal life, (iii) signals which may direct the migration of 
these precursor cells and affect their distribution primarily in man, and to a lesser extent in 
murine development. The following protocols were adapted for use in this study: single and 
dual-label immuno- and lectin-histochemistry on fresh-frozen, paraffin-embedded and 
vibratomed sections, assessed using light, fluorescence and confocal microscopy; Stamper- 
Woodruff adhesion assay with THP-1 human monocytic cell line; in situ hybridisation and 
TUNEL assay of apoptosis on cryostat sections; human foetal astrocyte and microglial co- 
cultures; time-lapse video microscopy and computerised image analysis; migration assays 
using a modified Dunn chemotaxis chamber, and electrophysiological characterisation of 
mixed glial cultures. Microglial progenitors were identified in situ in the human foetal brain 
and spinal cord and in culture using a panel of markers directed at monocytes and 
macrophages: CDllb/CD18 (Mac-1, C3bi receptor), CD45 (LCA), CD64 (FcyRI), CD68 
(PG-M I /KP-1), HAM-56, and lectins RCA-1, TL and GSB-4. Human and murine foetal CNS 
tissues were screened for the expression of (i) adhesion molecules: ICAM-1, ICAM-2, 
VCAM-1, PECAM, E- and P-selectins; (ii) chemokines: MIP-la, MIM P, MCP-1, MCP-3, 
IL-8, RANTES, IP-10, SDF-1, fractalkine, and (iii) chemokine receptors: CCR2, CCR5, 
CXCRI, CXCR4. 
Microglial colonisation of the developing nervous system, which commences around 12 
gestational weeks (12GW) in man and from embryonic day 15 (E15) onwards in mice, 
proceeds in a well co-ordinated manner. Microglial differentiation corresponds with highly 
vascularised regions of the CNS, and these cells co-localise temporally and spatially with 
differentiating GFAP-positive astrocytes. The interchangeable, morphological continuum and 
motility of microglia have been demonstrated clearly by time-lapse analysis in co-culture with 
astrocytes. Developmental expression of ICAM-2 on CNS endothelium, together with the 
spatio-temporal expression of chemokines such as MCP-1, MIP-la, IL-8, RANTES and 
fractalkine, have been identified as potential signals directing microglial colonisation within 
the human foetal CNS. Questions related to the origin of microglia, potential signals driving 
their distribution. differentiation and ramification within the CNS, and their possible roles 
during development, are comprehensively discussed. 
2 
IN MEMORY OF THE DISTINGUISHED NEUROHISTOLOGISTS & EMBRYOLOGISTS, 
WHOSE PIONEERING EFFORTS HAVE CONTRIBUTED TOWARDS 
OUR PRESENT WEALTH OF KNOWLEDGE 
DEDICATED 
to my parents and to my wife and sons 
to my mentor, Professor David Male 
for allowing me to pursue my independent research 
for his invaluable guidance, patience, enthusiasm and advice 
for his example of excellence in academic pursuits 
to Professor Peter Lantos 
for his unfailing professional and personal support 
and for enabling the work to be undertaken in his Department 
to my students 
Komal Patel, Jasvinder Jeetle, Charlie Pontikis, Shiyam Mohamed 
Nigel Tong, Nisha Parihar, Vanessa Corbisiero, Susan Shams, Rachel Harry-Olatoke 
for their keen enthusiasm and fruitful efforts 
to colleagues, past and present within the Department of Neuropathology, 
Institute of Psychiatry, London, within the UK and worldwide, 
for their ongoing collaborations, encouragement and support 
3 
"According to classical ideas, nerve tissue is formed of two kinds of cells which differ in form and function- 
namely, nerve cells and neuroglia cells. It has been necessary to admit, in addition, the existence of a third group 
of cells which I have called microglia. " 
"The microglia, or third element, although it is not a part of the fundamental architecture of the central nervous 
system, is always present in nerve tissue; indeed it is intimately associated with its elements for the auxiliary, but 
nevertheless necessary, task of taking up, transforming and removing the products of normal metabolism and 
abnormal disintegration of neurons. " 
"Which are the elements of the pia-mater that, on entering the nerve tissue, give rise to microglia I do not know 
with certainty. Present histological methods do not detect the initial stages of transformation of microglioblasts. 
Nevertheless in the pia and adventitial connective tissue nuclei resembling lymphocytes are present in large 
numbers in those places where the microglia is formed, and I am inclined to believe that those nuclei are the 
mother elements of microglia. The lymphocyte-like bodies corresponding to the polyblasts of connective tissue, 
immigrate into the nerve tissue, and this might explain why microglial cells are able to develop migratory activities 
and amoeboid and pseudopodial movements, and may be converted into macrophages. " 
"These are, in brief, my observations on the normal characters of microglia. They have been amply confirmed, 
although some authors have been slow to accept my ideas. It is always difficult to replace deeply rooted ideas, and 
some fundamental conceptions such as the mesodermic origin of microglia, are still under discussion. 
Embryological observations, however, demonstrate its mesenchymatous nature and they are supported by the 
physiological observation that it behaves as a mesodermal element ... " 
"These ideas have been developed in my papers from 1919 to 1921, and though they have been discussed in many 
subsequent papers by other workers, almost nothing new has been added to our knowledge of this subject. Today 
these ideas are widely accepted. " 
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For the past two decades, microglia have been widely regarded to originate from circulating 
blood-derived bone marrow elements which appear in the nervous system prior to and shortly 
after birth, migrate to all constituent parts of the CNS, and remain in these localities in an 
`inactive' or `resting' state until the advent of some disease. Furthermore, it is recognised that 
one of the first noticeable signs in any form of pathology affecting the nervous system is a 
tremendous increase in the activity of microglia, which proliferate and migrate to the site of 
damage and phagocytose cellular and other debris. Once the affected area is cleared of 
potentially harmful matter, astrocytes have the opportunity to lay down a scar in place of the 
destroyed tissue. These descriptions have held true to a great extent until now. Nevertheless, 
evidence that has recently emerged from several independent sources, including the present 
work, indicates possible differences in the lineage of microglia which arise during the foetal 
period (derived from foetal macrophages or of mesenchymalmyeloid origin) from those that 
may populate the nervous system in the neonate and in the adult (derived from circulating 
bone marrow progenitors). The chapters that follow will focus primarily on studies on the 
colonisation of the developing human and murine nervous systems by microglia in situ 
(Chapter II & III), characterisation of human foetal microglia and astrocytes in vitro, and the 
interaction between these two cell types in tissue culture (Chapter IV). The thesis will close 
with a discussion of the findings with respect to current hypotheses on the origin of microglia, 
and their potential roles within the developing nervous system (Chapter V). 
Several main concepts will be discussed within the context of this work: 
1. Microglia initially arise from progenitors located in the mesenchymal tissue surrounding the 
embryonic CNS, and concurrently from circulating mononuclear progenitors (foetal macrophages) that 
access the CNS via the bloodstream and vascular endothelium, at early stages of foetal life. 
2. The precise route of invasion into the CNS (i. e. vascular or meningeal/connective tissue associated) 
is dependent upon (i) the specific period in embryonic/foetal or postnatal development; (ii) the specific 
location within the central nervous system, and (iii) the particular species under investigation. 
3. Dissemination of microglia throughout the CNS is a progressive, co-ordinated event that appears to 
be temporally and spatially regulated by a variety of signals derived from the CNS tissue itself, but not 
specifically restricted to neuronal apoptosis (naturally occurring programmed cell death). 
4. During development, the transformation of `naive' microglial progenitors, into the `mature' ramified 
forms is most probably under the direction of diffusible, as well as contact-mediated factors derived 
from within the CNS, including the extracellular matrix components with which these cells come into 
contact. However, in vitro experiments indicate that the various morphological states of microglia are 
interchangeable, and the same cell may undergo rapid and reversible transformation from one state to 
the other, with transitional (intermediate) morphologies frequently encountered. 
5. Experiments which manipulate the influx, differentiation and distribution of foetal mononuclear 
phagocytes into various embryonic organs (including the skin, liver, lymph nodes, and lungs), with 
particular focus on the CNS (for example through knockout and transgenic technology using myeloid 
transcription factors) will help to further clarify the origins, biological functions and potential 
involvements of these different subpopulations in the histogenesis and modelling of tissues during 
development. 
6. The findings of the present work have direct bearing for the clinical therapy of a number of 
hereditary paediatric neurological disorders (hereditary lipidoses, Gaucher's disease, Krabbe's disease) 
which are associated with a deficiency in certain key enzymes within the CNS, as well as defective 
mononuclear phagocytes. Transplantation using bone marrow and cord blood (rich in haematopoietic 
progenitors) has proven partially successful as a form of clinical treatment. The use of microglial 
progenitors as a tool for gene therapy to target the CNS in such disorders is now conceivable. This 
study has shown that an effective window for such therapy exists during the second trimester of intra- 
uterine human life, commencing with the infiltration of progenitors around the twelfth week of 
gestation. 
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Chapter I INTRODUCTION & OVERVIEW 
A brief synopsis of the history behind the discovery and origin of microglia 
Prior to the twentieth century, the nervous system was considered to be composed of two 
types of cell, which differed in form and function. namely nerve cells and neuroglia 
(interstitial cells of the nervous system). Following the discovery of neuroglia by Virchow in 
1846, numerous attempts were made to demonstrate these cells in situ. However, belief had 
been prevalent for some time that mesodermic elements also penetrated the nervous tissue 
both during embryonic development and under pathological conditions, and could 
subsequently transform to a population of neuroglia (see Rezaie and Male, 2002b for 
references). Scholars of the late 19th century generally adhered to three principal theories 
regarding the origin of `neuroglia' as being derived: (i) solely from ectoderm, or otherwise 
from the primitive medullary canal, (ii) in equal part from mesoderm and ectoderm, or (iii) 
from the mesoderm. The idea that neuroglia in man could be derived from mesodermal tissue 
was further emphasised by Eichhorst in 1875. He noted that -neuroglia' were absent from the 
white matter of the spinal cord until the fourth month of foetal human life, when extravasating 
leukocytes began to migrate and ramify, and became immobile upon reaching their final 
destinations. The terms `mesoglia' and later `third element of the nervous system' were first 
introduced by W. Ford Robertson (1900) and Santiago Ramon y Cajal (1913a, b) respectively, 
to define such phagocytic mesoderm-derived elements within the nervous system, taking into 
account their separate origins from neurons and neuroglia (a term predominantly designating 
astrocytes). This was later amended by del Rio-Hortega between 1919 and 1921, to 
`microglia' in order to further discriminate between true mesodermal elements and 
oligodendrocytes, previously regarded as a component of 'mesoglia'. This particular 
contention sparked much controversy among del Rio-Hortega's peers and resulted in an 
escalation of fruitful research throughout Europe that eventually declined up to the outbreak of 
the Second World War. The post-war years were a period during which the very' existence and 
nature of microglia were cast in doubt until, in the 1960s, a new cohort of investigators 
realised the potential that is now commonly ascribed to microglia as 'intrinsic immune 
effector cells of the CNS'. 
The discoveries of Pio del Rio-Hortega 
Although del Rio-Hortega's original descriptions of the morphology and function of microglia 
have been confirmed time and again, the origin of these cells has proved more controversial. 
Based on his studies in laboratory animals, del Rio-Hortega stated that 'according to all 
indications, the microglia i. s formc'd through the migration of'embryonic corpuscles from the 
pia into the nerve centres' and additionally from other related elements, chiefly the blood 
mononuclears'. He also defined the time-frame for colonisation of the mammalian nervous 
system, to occur late during embryonic development and after birth (coinciding with vascular 
and meningeal organisation). del Rio-Hortega noted that there was unequal distribution in the 
quantity of microglia at different stages of development, with cells in some areas forming 
large masses (in the deeper portions of the hemispheres, along the path of vessels and 
spreading under the ependyma), but entirely absent in others. He defined the major sources of 
microglia within the interhemispheric commissure, related to the meningeal fold entering the 
brain via the fissure of Bichat and ascending towards the lateral ventricles, as originating from 
[i] the superior tela choroidea and [ii] pia covering the cerebral peduncles and cerebellum. He 
further defined pial adventitiae of large and medium-sized blood vessels as additional foci. 
"Within a few days all these regions supply the brain with very numerous microglial elements 
that migrate through the nervous interstices and spread in diverse directions. As the migration 
radiates towards the convolutions, the microgliocytes soon invade areas far removed from 
their source: the cells which originated in the superior tela choroidea enter the corpus 
callosum above and the cerebral trigonum and optic thalami below spreading throughout the 
ammonic cortex. They migrate towards the walls of the ventricles and later penetrate the 
white matter of the hemispheres finally reaching the cerebral cortex. The microglia entering 
through the region of the peduncles, where it appears at first as a dense marginal layer, 
rapidly ascends to the region of the internal capsule and is distributed throughout the 
hemispheres. In its migration it follows, more or less closely, the direction of the vessels. " (del 
Rio-Hortega, 1932). These significant observations have been overlooked by many authors 
who have referred to del Rio-Hortega's work in the past. 
Del Rio-Hortega also described the various morphological forms of microglia, and introduced 
the concept that the degree of motility of these cells was related to alterations in their shape. 
He described early rounded forms of microglia which occurred in loosely-packed structural 
zones (for example in the white matter of cerebral hemispheres and in the `interammonic' 
region between the hippocampi. where they either formed dense masses, were scattered or 
arranged in rows along blood vessels. Numerous processes of various length and calibre 
projected from their cell body, and these became more elongated and finely branched as they 
encountered the dense framework of the cortical plate (future neocortical grey matter) with 
more narrow interstices. Upon reaching their final destinations microglia adopted even finer 
and longer processes. later to be divided into secondary and tertiary branches with retractile 
spines which fit into the interstitial space. On passing along closely-packed fibers such as the 
corpus callosum, in perivascular or perineuronal spaces, and in other neuronal tract regions 
(such as the corpus callosum, fimbria, cerebral peduncles and ascending nerve fibers). 
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microglia often appeared as elongated, bipolar and lamellar cells. Their colonisation and 
distribution was almost complete by a few days after birth. although 'microgliocytes' 
(precursor cells) could still be found in larger numbers in the white matter, where amoeboid 
and less ramified varieties remained for a longer period. These gradually subsided as 
myelination neared completion. Microglia were noted to be heterogeneous in their 
morphology, their shapes showing variability and possessing usually three to four. but also up 
to six or more, primary processes. On the whole however, microglia were typically arranged 
according to the general cytoarchitecture within each region of the central nervous system. 
Those cells located within the grey matter soon assumed multipolar branched shapes of great 
complexity and uniform distribution. The capability of these cells to function as phagocytes 
and migrate to sites of injury within the CNS under pathological conditions was a 
phenomenon that had already been convincingly demonstrated in the 1920s and 1930s by 
experiments particularly carried out by Wilder Penfield and del Rio-Hortega (see Rezaie and 
Male, 2002b). Most pathologists were willing to accept the notion that phagocytes in the CNS 
originated primarily from resting microglia (for example Cone, 1928) and secondarily from 
cells associated with the connective tissue surrounding blood vessels (most likely the 
perivascular macrophages) or from circulating blood monocytes (Gozzano, 1931 a, b, c; Testa, 
1929). 
Histogenesis, related distribution and turnover of microglia within the CNS 
Various centres of microglial proliferation were denoted as `fountains' by del Rio-Hortega 
(1919a, 1921 a, 1921b, 1932). Such sites included the interpeduncular fossa (the point where 
the invaginated pia forms the tela choroidea of the third ventricle) and a region located 
beneath the tela of the fourth ventricle. Microglial progenitors (often termed `microglioblasts' 
or `microgliocytes') made their appearance immediately below the pia mater, and migrated 
from these areas into the brain tissue. Further studies mainly in rodents, led other authors to 
propose that microglia were also derived from perivascular tissues in addition to elements in 
the pia mater (von Säntha, 1932; Winkler-Junius, 1926). In 1939 Kershman, who had been 
studying the human foetal brain and spinal cord, noted that the earliest influx of microglia- 
forming cells was concomitant with the earliest vascularisation of the developing human 
nervous system. At early stages of embryonic development in particular, microglial 
progenitors were found to migrate from these 'fountains' into the CNS along branches of 
choroidal and pial blood vessels (Belezky, 1932: del Rio-Hortega, 1919a, 1921a, 1921b). 
Progenitors located in the leptomeninges and adventitial connective tissue of blood vessels 
were referred to as 'polyblasts' or `histiocytes' of the connective tissue by del Rio-Hortega, 
and their nuclei reported to resemble that of lynmphocytes. 
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Gozzano's extensive studies between 1929 and 1932 on the histogenesis of microglia in 
newborn rabbits, confirmed del Rio-Hortega's descriptions, the areas of invasion of 
mesenchymal cells corroborating del Rio-Hortega's fountains. von Sdntha (1932) made 
similar observations in the brains of cat, dog and rat embryos. Significantly. he noted that 
microglia could be demonstrated much earlier in development than a few days before birth. 
Prior to mid-gestation, he observed the presence of mature microglial cells in the nerve 
parenchyma, usually intimately associated with blood vessels, and their occurrence 
corresponded to the general development of the particular site. The following year, von Sdntha 
and Juba (1933) demonstrated the earliest appearance of microglia in the rhombencephalon 
and diencephalon of 15mg rat embryos to coincide with the onset of vascularisation in these 
areas. Juba (1933,1934) additionally found microglia in the brain of a human foetus 23mm in 
length and fowl embryo 5 days old. Dunning and Furth (1935) observed `many mature 
microglia cells with fully developed processes' in the brains of chicken and guinea pig 
embryos, close to capillaries and located below the pia mater and the ependyma. These 
observations (also confirmed by Bolsi, 1936) led the authors to believe that microglia could be 
derived from vessel-associated connective tissue and probably from circulating blood 
monocytes, at a considerably earlier period of time than shortly before birth. 
Two controversial questions arose from the derivation of microglial progenitors from pial 
elements. The first addressed the exact composition of cells forming the pia mater, and the 
second whether pial cells could give rise to macrophages. In his study on foetal rats, 
Dougherty (1944) showed that microglial progenitors spread laterally from where the pia was 
in contact with the corpus callosum and fimbria fornix. The areas of greatest proliferation 
were located to the borders of the dorsal lateral wall of the lateral ventricles, intermingled with 
oligodendroglial progenitors and ependymal cells. Microglia dispersed from these sites along 
the length of fibers of the corpus callosum dorsally and around bundles of fibres ventrally, and 
acquired various bipolar or spindle morphologies along the direction of the fibres. In 
tangentially cut fibres, microglia were found intermixed with oligodendroglia and formed 
rings about bundles of developing neurons. Based on nuclear morphology and structural 
characteristics, Dougherty noted that cells within the pia mater were similar to those present in 
fountains, and furthermore, that amoeboid macrophages of a similar variety could also be 
found in the cerebrospinal fluid (CSF) and ventricles of 17 and 18 day-old foetal rats, but not 
in newborn animals. Microglia within the CNS ý ere further found to share morphological 
characteristics with tissue macrophages found in other parts of the body. Macrophages laden 
with lipid were located , ithin the pia mater and around pial vessels in foetal animals, but were 
for the most part located to deeper structures within the brain of newborn rodents. Pia-forming 
cells had been shown to take up vital dyes, bacteria, carbon particles as well as lipids that were 
14 
found normally in newborn rats and other species. In the 17 and 18-day old foetal rats, the pial 
zone was filled with macrophages. However, perivascular accumulations of cells or large 
numbers of cells within blood vessels were not common occurrences, and could not 
substantiate the view that microglial progenitors present in the pia and tela choroidea were 
blood-derived (Dougherty, 1944; Gozzano 1930). During the course of these early studies, it 
was also found that pial cells which entered the brain of newborn rats were not predominantly 
phagocytic. Apparently, many became phagocytes following invasion of the nervous tissue. 
del Rio-Hortega was well aware that arguments sparked by the controversy surrounding the 
origin of microglia were in part due to the difficulties in identifying microglia, and that 
progress in this area was limited to the techniques available at the time: The elements present 
in the pia, its folds and the vascular adventitial layers that, after entering the nervous system 
are transformed into microglia are at present unknown" and furthermore "the main difficulty 
in the study of this important detail is due to the imperfections of the (silver impregnation) 
technique since only two fundamentally opposite methods are available, namely, the nuclear 
technique and the protoplasmic staining method... none of the present-day techniques stains 
simultaneously and successively the protoplasm and the nuclei of the superficial elements. " 
This controversy was still rife nigh on half a century after the discovery of microglia, even 
with the introduction of electron microscopy to such studies. Microglial progenitors were once 
again located to developing vessels and the sub-pial border by Vaughn and Peters (1968) and 
Vaughn (1969). These authors however, rejected a mesodermal origin for microglia. Fujita 
(1965) argued that cells inside the embryonic pia mater differentiated from sub-pial glioblasts 
and did not migrate into the neuropil from the pia mater, but later agreed (Fujita & Kitamura, 
1975) that resting microglia could be derived from mesenchyme. Reactive (that is, activated as 
opposed to normal resting) microglia were thought more likely to be derived from monocytes. 
Others considered microglia to derive intrinsically from progenitors within the CNS, from 
perivascular cells (Miyagawa, 1933) (now referred to as perivascular macrophages), or 
exclusively from blood monocytes (Kitamura, 1973; Fujita and Kitamura 1975,1976). 
Differences inherent between species were considered as a possibility for causing the largely 
contradictory findings of this period (Cammermeyer. 1970; Feigin, 1969; Hain, 1963). During 
the 1960s however, many authors tended to agree that `resting' microglia represented a 
uniform cell population identifiable by light microscopy (Cammermeyer, 1966; Feigin, 1969: 
Glees, 1955; Hommes & Leblond, 1967: Ibrahim et al., 1968,1974; Kreutzberg, 1966,1968b; 
Lewis, 1968; Naoumenko & Feigin, 1963; Niessing, 1952; Scheibe] & Scheibel, 1958; 
Sjöstrand, 1966a, b; Tsujiyama. 1963). Approximately 5-10% of all non-neuronal cell nuclei in 
the neuropil were estimated to represent microglia in the cerebral cortex (Brownson, 1956) the 
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corpus callosum (Mori & Leblond, 1969), and optic nerve (Stensaas. 1977: Vaughn & Peters, 
1968). 
In 1968, Roessman and Friede first addressed the question concerning the turnover and origin 
of microglia in vivo, by injecting labelled bone marrow cells into rodents. They found isolated 
labelled cells in the neuropil of normal and traumatised recipient animals to be indicative of a 
haematogenous origin for microglia. Manfred Oehmichen (1980) separately conducted a 
series of transfusion experiments in the 1970s. By labelling blood cells from a donor animal 
and transfusion into an irradiated recipient animals, he could identify labelled cells within the 
neuropil of a few normal adult animals, but could not determine whether the migrated 
mononuclear cells transformed into resting microglia. Radioactively labelled monocytes 
injected intravenously into healthy, brain-damaged or nerve-damaged rabbits yielded 
inconsistent results with very few occasional cells in the neuropil. In the late 1970s, Eng-Ang 
Ling (1978) also found blood-derived mononuclear cells within the brain of neonatal rats, 
following intravenous injection of colloidal carbon. It was further proposed (mainly through 
autoradiographic studies) that the majority of mononuclear cells invading the CNS could also 
proliferate locally (Adrian & Smothermon, 1970; Fujita & Kitamura, 1975,1976; Kitamura et 
al., 1972; Konigsmark & Sidman, 1963; Smith & Adrian, 1972). Nevertheless, this view was 
not shared unanimously. Oehmichen (1980) estimated the labelling index for microglia to be 
quite poor (between 0.2-0.3%) in contrast to that for monocytes and macrophages of other 
organs (for example, mouse blood monocytes: 2.9%, mouse peritoneal macrophages 1.3%; 
mouse liver macrophages 1.5%; mouse alveolar macrophages 2%). It appeared that the 
frequency of division in mononuclear phagocytes from various sites in the body was up to ten 
times greater than for comparable elements within the CNS. A distinct increase of between 1- 
3% labelling index could however, be established in proliferating mononuclear phagocytes of 
the CNS under pathological conditions. Kitamura and colleagues (Fujita & Kitamura, 1975, 
1976; Kitamura et al., 1972) in particular, maintained that microglia were derived exclusively 
from blood monocytes that had invaded the CNS. These could en passage, arbitrarily lie 
inside the basement membrane sheaths during migration (and could be distinguished from 
pericytes which were not derived from monocytes). 
Still the issue regarding the origin of microglia remained unresolved. Oehmichen (1980) did 
not support a migration of blood cells into the undamaged neuropil. He noted that labelled 
migratory cells within other organs were similarly encountered only rarely under non- 
pathological conditions (for example in non-irritated peritoneal cavities and in the undamaged 
liver). The idea that transformation of migrating blood cells and intrinsic local division of 
CNS-resident mesodermal phagocytes were concurrent events, was one that had already been 
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voiced earlier in the 20th century (Achücarro, 1904; Forster, 1908; Marchand, 1909, 
Merzbacher, 1910). By the 1970s, it became established that mononuclear invasion of the 
CNS occurred in response to inflammatory or traumatic stimuli. On the other hand. evidence 
for mononuclear invasion was absent in models of Wallerian (Friede & Johnstone, 1967: 
Skoff & Vaughn, 1971) or retrograde degeneration (Adrian & Smothermon, 1970. Berner et 
al., 1973; Kreutzberg, 1967,1968a, 1968b; Sjöstrand. 1965,1966a, 1966b: Stenwig, 1972). 
Instead, under these circumstances, a local proliferation of activated mononuclear phagocytes 
was indicated. Most of the locally proliferating cells could be demonstrated between the 
second and fifth days post-lesioning. Thus emerged the hypothesis that under normal 
conditions, the relatively slow turnover of microglia in the postnatal and adult nervous system 
resulted mainly from local cell division. 
Since the 1970s, numerous studies have identified morphological, phenotypical and functional 
similarities between microglia and cells of the mononuclear phagocyte system (van Furth et al. 
1972). Ultrastructural studies using transmission electron microscopy confirmed the earlier 
light microscopic descriptions that microglia and blood monocytes shared similarities in their 
morphologies (Anker, 1975; Blakemore, 1975: Das, 1976; Das & Ptaffenroth, 1976; Gonatas 
et al., 1964; Lampert & Carpenter, 1965; Persson, 1976; Schultz & Pease, 1959). Microglia 
were later shown to share phenotypic characteristics (cell surface markers) with monocytes 
and macrophages, but not with astrocytes and oligodendrocytes (Miyake et al., 1984; Murabe 
& Sano, 1983; Perry et al., 1985; Valentino & Jones, 1980; reviewed in Streit et al., 1988). 
Sophisticated bone marrow chimera studies in rodents demonstrated that perivascular 
microglia were replenished from bone marrow progenitors (deGroot et al., 1992; Flügel et al. 
2001; Hickey, 1991; Hickey & Kimura, 1988; Hickey et al., 1992; Matsumoto & Fujiwara, 
1987). Curiously, there were no clear indications from these studies that perivascular 
microglia could transform to parenchymal ramified microglia. This evidence, together with 
the observation that there is no perivascular infiltration of mononuclear cells in adult rodents 
following transection of facial motor neurons (Graeber et al., 1988), and in addition to the 
thymidine incorporation experiments highlighted above, has substantiated the idea that 
parenchymal microglia have a very low turnover in the adult CNS (Hickey et at.. 1992; 
Lassmann et al., 1993; Lawson et al., 1992; Perry, 1994; Perry & Gordon, 1991). This 
contrasts with perivascular cells, which possess higher rates of turnover and occur in a more 
phenotypically and morphologically activated state at rest. It has been reaffirmed that the 
microglial population is maintained through an equal share of in situ division of resident cells 
and migration of monocytes, and estimated that it would take the lifetime of a mouse for the 
entire microglial population in the steady state to be replaced by immigration of monocv'tes 
alone (Kennedy & Abkowitz. 1997: Lawson et al., 1992, Yeager et al., 1992). The most 
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plausible explanation for all these findings would be to consider that the influx of microglial 
precursor cells is confined to a brief perinatal `time-window', and any subsequent increase in 
the adult microglial population is predominantly a result of the proliferation of pre-existing 
parenchymal microglia (reviewed in Rezaie & Male, 1999). It is this perinatal window in time 
that will be the subject of comprehensive analysis in the present work which investigates both 
the human and murine CNS. 
Phagocytes within the CNS and their relationship with microglia 
There are at least four compartments within the central nervous system in which phagocytic 
cells can be found. Apart from microglia within the parenchyma of nervous tissue, there are 
also (i) the population of perivascular cells already mentioned, that are located between the 
glial and endothelial basement membranes, (ii) subarachnoidal cells and those detected within 
the cerebrospinal fluid (CSF), and (iii) epiplexus cells of the choroid plexus. Only the intrinsic 
microglia have been discussed so far. Two questions arise that require further consideration of 
mononuclear phagocytes within other compartments. The first relates to the extent that other 
cell types contribute towards microglial histogenesis within the CNS during development. The 
second addresses the origin of phagocytes in these other compartments: Do all mononuclear 
phagocytes associated with the CNS originate from circulating progenitors derived from the 
blood, or is there an intrinsic mesenchymatous/ adventitial origin for some populations (for 
example, subarachnoid `free' cells and parenchymal microglia) ? 
microglia derived from perivascular cells (? ) 
A clear distinction between pericytes located around capillaries, perivascular phagocytic cells 
(probably macrophages) and perivascular parenchymal microglia is very rarely made in the 
literature. This has gained considerable attention recently (Thomas, 1999), particularly with 
respect to repopulation of resident microglia from blood-derived progenitors. The relationship 
between these cell types will have a strong influence on current concepts of microglial origin, 
and a clarification between perivascular microglia and perivascular macrophages is necessary 
to avoid confusion (Graeber et al., 1989,1990,1992; Perry & Gordon, 1997). This is 
particularly important when considering the earlier views proposed by some authors that 
microglia could be derived from perivascular cells located on the external surface of vascular 
basement membranes belonging to small arteries, capillaries, venules and small veins 
(Baldwin et al.. 1969, Cammermeyer, 1965-1970, Dunning & Stevenson, 1934; Field, 1955: 
Jones, 1970; Juba, 1934: Kershman. 1939; Miyagawa, 1934. Mori and Leblond 1969; 
Schaltenbrand & Bailey. 1928. von Säntha, 1932, Vaughn, 1965). Whether populations of 
microglia can indeed originate from perivascular macrophages is as an issue that is yet 
unresolved. 
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microglia derived from subarachnoid cells (? ) 
The subarachnoid space is an extension of the intraparenchymal perivascular space. The pial 
surface layer of the CNS has fenestrations or openings that allow continuity between the 
subarachnoid and endoneural spaces. The leptomeninges (pia-arachnoid and invading vessels) 
have been considered by the majority of investigators to derive from mesoderm. and we have 
already noted del Rio-Hortega's view that microglial progenitors within the brain were 
derived from perivascular and pial connective tissue (mesenchyme) during the embryonic 
period, which following invasion of the cerebral parenchyma, transformed to microglia. In 
1972, Morse and Low noted that mesenchymal cells possessing the morphological 
characteristics of macrophages, could frequently be observed below the pial cell layer 
(between the pia and glial membrane). The majority of these mesenchymal cells (both on the 
surface of the brain and along cerebral vessels) could undergo transformation from a quiescent 
to an active phase, contained lipid vacuoles and resembled microglia from a morphological 
sense. Migration of these cells from the edges of vessels and the leptomeninges into the 
neuropil along with their morphological transformation could explain these findings (Belezky, 
1932; Gozzano, 1931a-c; Kershman, 1939). In a similar manner, Herrlinger and colleagues 
(1977) noted peroxidase-positive derivatives of monocytes located at juxtavascular ('satellite') 
positions within the neuropil and in the subarachnoid space. 
microglia derived from ventricular macrophages and epiplexus cells of the choroid (? ) 
Macrophage-like cells were originally noted on the surface epithelium of the choroid plexus 
by Goldmann in 1913 and Kolmer in 1921, who believed these elements to derive from the 
blood. Kolmer described the motile and phagocytic ability of these `wandering cells'. Biondi 
(1934) later described them in man. The term `Kolmer cell' was adopted for use until the 
suggestion by Kappers (1953,1958) of `epiplexus cell', to reflect the observation that these 
cells remained in direct contact with plexus epithelium over long periods. It was assumed that 
epiplexus cells originated from connective tissue of the tela choroidea and proliferated locally 
prior to migration into the ventricular cavity (Biondi, 1934, Vialli, 1930). Other authors 
described similar cells on the surface of ependymal walls, referred to as 'supraependymal 
cells' (Allen, 1975; Coates, 1972,1973a, 1973b, 1975: Hosoya & Fujita,, 1973; Peters, 1974. 
Walsh et al., 1978). It was suggested that blood monocytes reached the ventricle by migrating 
through choroidal vessels and epithelium of the choroid plexus. 
From an early period, it was noted that large numbers of microglia were located within the 
subependymal region (Dewy ulf. 1937, del Rio-Hortega. 1921 ab. Wislocki & Leduc, 1952). 
They were also known as 'macrophage-like; cells' (Oksche, 1956) or 'hypoependymal cells' 
(Talanti. 1926). Some authors noted that microglia in this region actively proliferated and 
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suggested that they were derived from ectodermal matrix (Jakob, 1927; Lewis, 1968; Metz & 
Spatz, 1924; Paterson et al. 1973; Pruijs, 1927: Rydberg, 1932. Schaltenbrand & Bailey. 
1928). Investigations by other authors comparing the morphology of microglia with glial cells 
yielded contradictory results. 
It is evident that these early studies, spanning over 60 years since the initial proposals of Rio- 
Hortega between 1919 and 1921, introduced many of the basic concepts regarding microglia 
with which we are familiar today. However, they were clearly limited through relying almost 
exclusively on morphological investigations and without recourse to the vast array of more 
sophisticated investigative techniques that have only been developed over the past two 
decades. For example, fluorescence- and light microscopic immunohistochemical detection of 
cell surface markers was not possible prior to the late 1970s and early 1980s, and immunogold 
electron microscopic studies as well as tissue culture methodologies were in their infancy 
during the 1960s-1970s. Moreover, these earlier investigators had at best, only a partial 
understanding of the lineage of mononuclear phagocytes or their functions, and a poor 
theoretical framework of the immune system and conditions affecting the nervous system. 
Contemporary views on the morphology, phenotype, origin and functions of microglia 
Much of our present understanding of microglial cell biology has stemmed from studies 
carried out principally in rodents. It has been estimated that microglia constitute between 5- 
15% of the total cellular composition of the CNS in adult rodents (Lawson et al. 1992). We 
now know that microglia, in addition to their role as phagocytes when activated, are capable 
of expressing MHC class II molecules and presenting antigen to T lymphocytes, and of 
production and response to a plethora of cytokines. In this respect, they represent (together 
with brain endothelium, perivascular cells and to a lesser extent, astrocytes) the primary line 
of immune defence within the adult CNS (Davis et al. 1994; Fujita et al. 1981; Ling and Wong 
1993; Moore and Thanos, 1996; Perry and Gordon, 1991). Microglia can adapt to the CNS 
microenvironment and can change their location, morphology and functional status. This 
property of microglia is reflected by their differential expression of surface antigens. 
Studies in rodents have shown that microglia are amoeboid, highly phagocytic, motile and 
immune active cells during foetal and neonatal development, capable of responding to 
multiple events involved with the structuring of the CNS, and formation of the neuronal-glial 
environment (Fujita et al. 1981; Ling and Wong 1993: Perry et al. 1985; Perry and Gordon, 
1991). In the adult, microglia appear as highly ramified cells at rest, with finely-branched 
processes and a small oval cell body. Adult microglia occupy and monitor distinct non- 
overlapping territories and are evenly distributed spatially. In particular, their distribution is 
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not related to original sites of entry of microglial progenitors (Lawson et al. 1990). These 
quiescent `resting' cells appear to downregulate both the expression of their surface 
molecules, and their capacity for phagocytosis, cytokine production and antigen presentation 
(Oehmichen et al. 1979; Perry and Gordon, 1991; Wood et al. 1979). Such recognised 
phenomena are in keeping with a need to protect the CNS from immune-mediated cellular 
damage. As a consequence however, microglia have been found notoriously difficult to 
visualise using conventional immunohistochemistry. Furthermore, a lack of specific 
microglial markers has, in the past, confounded attempts to follow the proposed 
developmental stages of transition between amoeboid and ramified microglial forms (Moore 
and Thanos, 1996). 
Although microglia share a repertoire of cell surface markers found on other mononuclear 
phagocytes (specifically monocytes and macrophages), including CD 11 b/CD 18 (Mac-1, 
CR3), CD45 (leukocyte common antigen), CD64 (FcyRI), CD68 (macrosialin, PG-M1, KP-1, 
EBM-11), and F4/80 (a marker of mature macrophages and monocyte-derived dendritic cells 
in rodents) (Perry and Gordon, 1991), these antigens are differentially expressed by 
subpopulations of microglia, according to their stage of development and functional activity 
(Hutchins et al. 1990, Rezaie and Male 1999, Rezaie et al. 1999). Histochemical staining with 
lectins such as ricinus communis agglutinin-] (RCA-1), griffonia bandeiraea simplicifolia 
isolectin-B4 (GSB4) or lycopersicon esculentum (tomato lectin) has proved very useful in 
detecting all subpopulations of microglia, including the resting forms in the adult CNS 
(Mannoji et al. 1986; Streit and Kreutzberg 1987; Suzuki et al. 1988). 
These functional and phenotypic characteristics of microglia indicate that they belong to the 
mononuclear phagocyte lineage. Such cells migrate into foetal tissues prior to and during 
formation of the blood-brain barrier and differentiate into tissue macrophages. Evidence also 
considers these cells at least in part, to be derived from circulating bone marrow progenitors: 
initial experiments by Ling and colleagues (reviewed in Ling and Wong, 1993). It now 
appears that some cells derived from the bone marrow can enter the developing and adult CNS 
in rodents and transform to macrophages in the choroid plexus, meninges and the perivascular 
space (Hickey and Kimura 1988, Hickey et al. 1992; Krall et al. 1994; Flügel et al. 2001). 
Furthermore, electrophysiological studies have shown that microglia share a similar in ard- 
rectifying potassium channel with a population of progenitor cells found in the bone marrow. 
but absent on peripheral macrophages (Kettenmann et al. 1993). 
Nevertheless, the origin of parenchymal microglia is still a point for contention. While 
suggestions have been made that microglia arise from neuroectodermal progenitors (Fedoroff, 
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1995; Richardson et al. 1993), or from an intrinsic population of pluripotential haematopoietic 
progenitors (of the CFU-GM lineage) (Alliot et al. 1991), other views have considered these 
parenchymal cells to derive from mesenchymal precursors (mesodermal elements/foetal 
macrophages) in addition to that from circulating blood mononuclear progenitors (monocytes) 
that penetrate the nervous tissues in man, primarily during the latter half of intrauterine life 
(Rezaie, 2003; Rezaie and Male, 1999,2002a). Despite their similarities with macrophages, 
microglia of the CNS differ from tissue-specific macrophages found throughout the body, by- 
their characteristic morphology, their capacity to proliferate and by their distinct pattern of ion 
channels (Boucsein et al. 2000; Eder et al. 1999). They appear to 'lose' or 'downregulate' 
their phenotypic characteristics and enzymatic markers, typical of monocytes and 
macrophages, upon taking up residence within the CNS compartment (Flaris et al. 1993; Perry 
and Gordon, 1989). They also undergo a morphological transformation to become 
progressively ramified cells with the maturation of the nervous system. These characteristics 
are believed to be conferred on microglia as a result of their unique environment (Wilms et al. 
1997). Within the adult nervous system, microglia which usually occupy distinct non- 
overlapping territories in their ramified conformations, are capable of rapidly 'de- 
differentiating' to their activated amoeboid morphological states in response to inflammatory 
or pathological stimuli. 
Mechanisms of migration and patterns of distribution of microglia in development 
The mechanisms by which microglial progenitors enter the developing CNS are currently not 
known. The first hypotheses to explain microglial migration during development proposed 
that the cells were moving towards signals from dying neurons (Ashwell 1990; Hume et al. 
1983; Pearson et al. 1993; Perry 1987; Perry et al. 1985; Perry and Gordon, 1988,1991; 
Schnitzer 1989). It is true that debris from dying neurons are internalised by mononuclear 
phagocytes and that microglia can migrate towards these dying cells (Bodeutsch and Thanos, 
2000; Witting et al. 2000). However. microglial progenitors arrive in the developing nervous 
system, before neuronal death is prevalent (Ashwell, 1989; Ashwell et al. 1989; Diaz-Araya et 
al. 1995), and they are absent from certain areas of the brain where cell death is present 
(Milligan et al. 1991; Rakic and Zecevic, 1998). 
It is well-recognised that the migration of leukocytes to particular sites of inflammation is 
governed by tissue-specific production of integrins, adhesion molecules, selectins and 
chemotactic cytokines (chemokines). Integrins are transmembrane glvcoproteins that mediate 
cell-cell adhesion and cell-substrate interactions (Haas and Plo«v, 1994) Table 1.01 and ß2 
integrins are constitutively expressed on the surface of leukocytes (in an inactive state) and 
integrate the intracellular cy-toskeleton with the extracellular matrix (when activated). 
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Structurally, they are heterodimeric and consist of noncovalently associated a and ß subunits, 
of which the ß subunits are highly conserved. Integrins are constitutively expressed but do not 
bind to their ligand unless activated to a favourable conformational state. A consensus 
tripeptide RGD sequence (Arg-Gly-Asp) is necessary for integrin-ligand interactions. This 
tripeptide sequence is recognised by several integrins (a5ß 1, cdIlbß3, and most av ß integrins). 
Other integrins recognise different sequences (KQAGDV, DGEA, EILDV, GPRP), and the N- 
terminal domains of a and ß subunits combine to form a ligand-binding head on each region. 
Ligands for integrins include intercellular cell adhesion molecules (ICAMs), vascular cell 
adhesion molecules (VCAMs), CD3 1, complement proteins, and bacterial or viral proteins. 
Table 1. The integrins, their component subunits and ligands 
Integrin ... 
VLA family 
VLA-l 01 (CD29) al (CD49a) Laminin, collagen 
VLA-2 01 a2 (CD49b) Collagen, laminin 
VLA-3 ßl a3 (CD49c) Fibronectin, laminin, collagen 
VLA-4 ßl a4 (CD49d) VCAM-I, fibronectin 
VLA-5 ßl a5 (CD49e) Fibronectin 
VLA-6 ßl a6 (CD49f) Laminin 
ß1 a7 ßl a7 Laminin 
ß1a8 ß1 0 
ßl av ß1 av (CD51) Fibronectin 
LeuCAM family 
LFA-1 (32c (CD18) aL (CD11a) ICAM-1, ICAM-2, ICAM-3 
Mac-1 ßi2 aM (CDI Ib) ICAM-1 (ICAM-2), Fibrinogen, ON 
P150,95 ß2 aX (CD] lc) ON, Fibrinogen 
ad(32 ß2 ad ICAM-3 
Cytoadhesin family ß3 (CD61) 
CD41a glib (CD41) Fibrinogen, fibronectin, vitronectin, vWf 
Vitronectin receptor av (CD51) Vitronectin, fibrinogen, vWf, laminin, 
thrombospondin, fibronectin, PECAM (CD31) 
ß4a6 ß4 (CD104) a6 (CD49f) Laminin 
ß5av ß5 av (CD51) Vitronectin, fibronectin 
'ß6av 06 av (CD51) Fibronectin 
ß7a4, LPAM-1 ß7 a4 (CD49d) Fibronectin, VCAM-l, MadCAM-1 
Integrins are recognised as important in many processes including inflammation, 
angiogenesis, cellular gowth and differentiation, and for their involvement in directing cell 
migration and neunte outgrowth during development (DeSimone, 1994). Table 1 lists some 
important integrins and their ligands. Cellular adhesion molecules including ICAM-1. ICAM- 
2, VCAM-l and PECAM, which act as ligands for integrins. are members of the 
immunoglobulin superfamily. Selectins (P-. S- and I. -) are a family of calcium-dependent 
carbohydrate-binding proteins that enable initial adhesion of leukocytes to the gall of blood 
vessels during inflammation (Bevilacqua 1993). They bind to sialy lated and fucosv lated 
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carbohydrate ligands and permit leukocytes to roll along the endothelial lumenal surface, prior 
to anchoring at sites downstream. Thus, the role of selectins is restricted to directing leukocyte 
interactions with vascular endothelium. 
The binding of integrins on leukocytes to cell adhesion molecules (CAMs), either 
constitutively expressed or induced on the endothelium, lead to interactions with the 
cytoskeleton that allow the migration of cells into lymphoid, non-lymphoid and inflamed 
tissues (Male et al. 1994). This process consists of at least two events, of which the first 
directs migration of circulating cells across vascular endothelium, the second involves 
localisation to particular zones within tissues. By analogy with the migration of leukocytes 
into other tissues, the expression of certain adhesion molecules during embryonic 
development and in the early postnatal period could play an important role in the recruitment 
of haematogenous progenitors of microglial cells. If these progenitors do indeed derive from 
the circulation, at least three steps could be potentially involved in their migration through 
cerebral endothelium: (i) circulating cells are slowed down by interaction between their 
carbohydrate residues and selectins (e. g. E-, L- or P-selectin) expressed on the lumenal aspect 
of the cerebral endothelium, (ii) arrested cells may be triggered by cytokines (such as MCP-1 
or IL-8) held on the endothelial surface, and/or through homotypic interaction between 
PECAM-1 (CD31) on the endothelium and leukocyte surfaces, (iii) triggering causes 
activation of leukocyte integrins which subsequently interact with adhesion molecules (e. g. 
ICAM-1, ICAM-2, VCAM-1) expressed on vascular endothelium (Ebnet et al. 1996; Male et 
al. 1994). According to this scenario, it is possible that some populations of microglial 
progenitors use combinations of well-defined adhesion molecules to enter the developing 
CNS. Alternatively the process may be controlled by adhesion molecule(s) that are expressed 
at particular times on CNS endothelium during development. 
Table 2. Some important chemokines and their receptors 
Chemokine Family Receptor Ligand 
CC chemokines CCRI RANTES, MIP-1 a, MCP-2, MCP-3 
CCR2 MCP-1, MCP-2, MCP-3, MCP-4 
CCR3 Eotaxin, RANTES. MCP-3, MCP-4 
CCR4 RANTES, MIP-la, MCP-1 
CCR5 RANTES, MIP-la, MIP-lß 
CXC chemokines CXCRI IL-8 
CXCR2 IL-8, GRO-aJß/y, NAP-2, ENA78, GCP-2 
CXCR3 IP-l0, Mig 
CXCR4 SDF-1 
CX3C chemokine CX3CR I Fractalkine 
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Equally important is the role of chemokines in directing this migratory phenomenon (refer to 
Rezaie and Male, 1999; Rezaie et al. 2002a). Chemokines are a group of chemotactic 
cytokines that activate leukocytes and are essential for directing the migration of these cells 
under normal circumstances, and particularly in inflammation (Bacon and Oppenheim, 1998; 
Ransohoff and Tani, 1998; Sozzani et al. 1996; Zlotnik and Yoshie 2000). More than 75 
chemokines have now been described, the majority of which belong to two distinct families: 
CXC (or (x-) chemokines and CC (or ß-) chemokines Table 2. They can be distinguished 
according to the position of cysteine residues forming disulphide bonds that are either adjacent 
(CC) or separated by an amino acid (CXC) in the N-terminal region. Their corresponding 
genes are located on chromosomes 4 (CXC) and 17 (CC) respectively. All are secreted, with 
the exception of fractalkine (a CX3C chemokine), which has both transmembrane and 
cytoplasmic domains. The ß-chemokines are potent chemoattractants for monocytes (but not 
neutrophils) in vitro. With few exceptions (Mig and PF4), a-chemokines preferentially 
chemoattract neutrophils. CXC and CC chemokines can form symmetrical homodimers as 
quaternary structures. At high concentrations (> 100µM), they adopt a dimeric form. At 
physiologically active concentrations (> 100µM) they generally occur as monomers, and 
chemokines elicit biological activities at nanomolar concentrations in vivo (Paolini et al. 
1994). Fractalkine (also referred to as neurotactin) is constitutively expressed at high levels 
within the normal adult CNS and upregulated in pathology (Bazan et al. 1997; Harrison et al. 
1998; Imai et al. 1997; Maciejewski-Lenoir et al. 1999; Nishiyori et al. 1998). 
By sequence comparison, fractalkine is most closely related to the ß-chemokine MCP-1 (Pan 
et al. 1997). Chemokines have overlapping functions and display affinity for more than one 
receptor. Their receptors are coupled to G-proteins via the intracytoplasmic and carboxy 
terminals. These receptors possess seven transmembrane domains and belong to the serpentine 
superfamily of receptors, 18 of which have been identified (CCR1-11, CXCRI-5, XCR1, 
CX3CR1: Murphy et al. 2000 for review). Competition binding and cross-desensitisation 
studies have shown CCR2. CCR4 and CCR5 to be expressed on human monocytes. Both 
CCR5 and CXCR4 have been detected on perivascular mononuclear cells of the brain and on 
macrophages. CXCR4 has further been reported on subpopulations of neurons in situ and in 
culture. 
Interest in the chemokines and their receptors has been at the heart of research into 
neuroinflammation over the past few years (Bacon and Harrison 2000; Bacon and Oppenheim 
1998: Glabinski and Ransohoff, 1999; Hesselgesser and Hork, 1999: Leung et al. 1997; Locati 
and Murphy,, 1999; Meda et al. 1996; Mennicken et al. 1999: Sanders et al. 1998; Woodroofe 
et al. 1999; Xia and Hyman, 1999: Zhang et al. 2000). Chemokines now appear to possess 
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multiple biological activities in addition to their known roles in mobilising inflammatory cells. 
These include roles in development, growth and migration of cells. angiogenesis. 
haematopoiesis. phagocytosis. free radical production, apoptosis. T-cell activation. neoplasia. 
inflammatory regulation in response to injury. wvound healing. tissue repair and macrophage 
recruitment, as well as interactions with pathogens including viruses (Bacon and Harrison. 
2000; Baggiolini et al. 1997: DiPietro et al. 1995. Engelhardt et al. 1998: Gibran et al. 1997: 
Glabinski and Ransohoff, 1999: Hesselgesser and Horuk. 1999: Jackman et al. 2000; Locati 
and Murphy. 1999; Schall and Bacon, 1994). 
A wide variety of cells produce chemokines. Endothelial cells in particular, not only 
synthesise chemokines, but possess the ability to transport these molecules from the 
ablumenal to the lumenal surface. The leukocyte migratory response is co-ordinated with the 
expression of relevant adhesion molecules, cytokines and proteases (Proost et al. 1996). 
Chemokines appear to be particularly important for activating leukocytes and inducing the 
transition from rolling to firm adhesion to the endothelium. Cells are likely to encounter 
several chemokine gradients as they move throughout tissues. and there is further evidence for 
the presence of hierarchies of chemokines that direct migration to particular sites (Foxman et 
al. 1997). Those with a higher specific activity are active c% en at lo\ý concentrations at 
invariably greater distances from the site of production. Less potent chemokines require a 
higher concentration and are active closer to the site of production. BN example, in rat lungs, 
RANTES and MCP-1 (as well as GM-CSF) produced by alveolar epithelial cells, control the 
distribution of alveolar macrophages through the creation of local chemotactic gradients 
(O'Brien et al. 1998). Diapedesis and migration towards a site of infection is similarly 
controlled by chemokine gradients (Schall, 1994, Miller and Krangel, 1992). The binding of 
chemokines to extracellular matrix components and cell surface molecules (for example % is 
heparan sulphate proteoglycans) can confine or immobilise chemokines to the sites of 
production and thus help to establish hierarchical gradients of chemokines that direct site- 
specific migration of leukocytes (Baggiolini et al. 1997, Cuff et al. 2000: Foxman et al. 1997: 
Hesselgesser and Iloruk, 1999, Locati and Murphy, 1999, O'Brien et al. 1998, Rot, 1992: 
Tanaka et al. 1993, Webb eßt al. 19933, Witt and Lander, 1994). 
l'here are expanding roles for chemokines in the development, and signalling of embrvo`, enic 
events. l'hesc include the positioning of cells within appropriate subcompartments of tissues 
(e. g. foetal liver, bone marrow and thymus). lineage de\ elopment, the recruitment of bone 
marrow pi-genitors to tioctal tissues (e. g. lungs. kidney and epidermis ). and the patterning and 
development of organs (Forster et al. 1996: Gunn et al. 1999: Jazin et at. V)97- Jotereau Ct at. 
1997, Kukita et al. 1997. on l . ucttichau et al. 
1996. Ma et al. 1999: McGrath et al. 1999: 
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Nakamura et al. 1995; O'Brien et al. 1998; Volejnikova et al. 1997; Votta et al. 2000; 
Wilkinson et al. 1999). Recent data suggest additional roles for chemokines in the 
maintenance of CNS homeostasis and neuronal patterning during development (Hesselgesser 
and Horuk, 1999; Horuk 1998; Ma et al. 1998; Mennicken et al. 1999; Zou et al. 1998). 
Specifically, microglia are known to express chemokine receptors (CCR1, CCR2, CCR3. 
CCR5, CCR10, CXCR4, CX3C) and migrate in response to a variety of chemokines (MIP-I(x, 
MIP-1ß, MIP-3, MCP1-5, RANTES, SDF-1 and fractalkine) (Cross and Woodroofe, 1999). It 
is therefore possible that the migration of microglial progenitors to the CNS during 
development, is initiated by intracerebral gradients of chemotactic agents such as chemokines. 
Why investigate colonisation of the developing CNS by microglia? 
Studies in rodents have shown that microglia colonise the nervous system in the period just 
before birth, but mainly throughout the postnatal period (Miyake et al. 1984; Perry et al. 1985; 
Dalmau et al. 1997). Microglial resting morphology, growth and adult numbers are attained 
within several days following birth, and these cells have been shown to distribute within the 
first two postnatal weeks (Perry, 1987-1997). As a result, the postnatal period has been the 
primary focus for studying the differentiation of amoeboid microglia to ramified cells, a 
transformation which is gradually accompanied by the disappearance of amoeboid cells, 
which are no longer detectable in the mature brain (Ling and Wong, 1993). Our knowledge of 
these perinatal and postnatal events in rodents is significant. However, by comparison, less is 
known about the routes and mechanisms of migration during the foetal period in these species. 
Considerably less is known about such events in the developing human nervous system. 
Elucidating the phasing, patterns and mechanisms of microglial colonisation of the human 
CNS in situ are not only important from a developmental point of view. Knowledge of these 
events will be of direct significance to studies that address somatic gene therapy of human 
disease (for example the hereditary lipidoses), in which microglial progenitors may be used as 
potential gene carriers into the CNS. Transplantation studies indicate that some progenitor 
populations for microglia exist within umbilical cord blood (Krivit et al. 1995.1998; Unger et 
al. 1993) and that genetic defects can be partly corrected by the transplantation of bone 
marrow or umbilical cord blood. Conceivably, microglial progenitors can be engineered to 
carry normal genes into the CNS. The main underlying purpose for this investigation will 
therefore be to understand the timing and mechanisms by which the human central nervous 
system is colonised by microglia. This information is critical from a clinical approach, in its 
potential application to gene therapy for a number of paediatric neurological disorders, 
including the hereditary lipidoses. The mouse has emerged over the last two decades, as a 
most useful experimental model for a wide variety of neurological disorders. In order to 
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consider practical approaches towards this aim in the clinic, one would also need to 
investigate colonisation of the murine CNS in situ during the foetal period prior to birth, if this 
species is to be used as a valid experimental model that will faithfully replicate both disease 
and its treatment stratagem. 
Microglia in tissue culture 
The morphological transformations and motile behaviour of microglia have been best 
characterised from studies in tissue culture. Del Rio-Hortega's original descriptions of 
microglia between 1919 and 1921 were soon followed by the first accounts of these cells in 
culture, dating back to 1925. The transformation of various morphological 'transitory' states 
of microglia were observed in these culture studies, and there was general agreement at the 
time that similar changes took place in vivo: the amoeboid and pseudopodic cells were 
recognised as the motile, migratory forms, while the branched cells were more stable forms 
(Costero 1930a, 1930b, 1930c, 1931; Dunning and Furth 1935, del Rio-Hortega, 1932; 
Kershman 1939; Penfield, 1928, Wells and Carmichael 1930). We now know that the 
procedure of isolating microglia inadvertently results in the activation of these cells, 
characterised by their amoeboid morphology, expression of adhesion molecules and 
production of large amounts of free radicals (Heppner et al. 1998). However, the deactivation 
and accompanying ramification of microglia are precipitated by cellular interactions within 
the CNS microenvironment. Microglial cultures have been produced either pure (i. e. >90%) or 
in co-culture with astrocytes. Specifically, experiments in vitro have emphasised the 
importance of astrocytes in regulating microglial transformation (Noble et al. 1994; 
Schmidtmayer et al. 1994; Sievers et al. 1994). Although the majority of the more recent in 
vitro studies have concentrated on microglia isolated from the rodent CNS, methods for 
isolating human foetal microglia have also been developed (Hassan et al. 1991; Lauro et al. 
1997; Lee et al. 1992; Peudenier et al. 1991), and several reports have highlighted the 
differentiation of human foetal microglia in co-culture with astrocytes (Hassan et al. 1991; 
Lauro et al. 1995; Lee et al. 1994; Liu et al. 1994). In such preparations, ramified cells are 
usually located above or under astrocyte monolayers, whereas amoeboid cells occur more 
frequently overlying astrocytes (Tanaka et at. 1999). Ramified microglia have also been 
described in slice preparations (Hailer et al. 1996) and dissociated cultures obtained from 
rodent CNS (Booth and Thomas, 1991). Notably. these cells possess a high level of pinocytic 
activity (determined from sequestration of dyes in pinocytic vesicles). but little or no 
phagocytic activity (Ransom and Thomas, 1991; Ward et at. 1991). A few studies have 
investigated microglia using time-lapse video microscopy (Booth and Thomas, 1991; 
Brockhaus et al. 1993; Nolte et at. 1996; Schiefer et al. 1999; Stence et at. 2001; Thomas 
1990, Turley et al. 1994: Ward et al. 1991). Only two of these reports have directly analysed 
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microglial motility using cellular recordings in relation to morphology . and these A ere carried 
out in CNS slice preparations (Brockhaus et al. 1993; Stence et al. 2001). The main focus for 
these studies has been directed at the deramification and activation of microglia following 
culture. 
Given the regulatory influence of astrocytes on microglial morphology and function ,N hich are 
indicated in these in vitro studies, it is important to determine the temporal and spatial 
relationship between these two cell types in situ in the developing nervous system and the 
interaction between these cell types in tissue culture with respect to the differentiation of 
human foetal microglia, and their production of and response to chemokines that may be 
involved in directing microglial dispersion throughout the nervous system during 
development. 
Aims and Objectives 
The main purpose of this investigation was to understand the temporo-spatial phasing and 
mechanisms by which the nervous system is colonised by microglial progenitors. These data 
are of particular application to potential therapies for a number of paediatric disorders 
affecting the brain, including hereditary lipidoses (Niemann-Pick disease, Gaucher's disease, 
Krabbe disease and metachromatic leukodystrophy) (Scriver et al. 1989), which are caused by 
single enzyme deficiencies that may lead to the accumulation of lipids within mononuclear 
phagocytes and subsequently to progressive neuropathological damage of variable severity. 
These defects may be partly corrected by transplantation of normal bone marrow or cord 
blood, rich in haematopoietic progenitors. 
Therefore the objectives of this investigation were to determine (i) the phasing and patterns of 
microglial colonisation of the developing human and murine nervous system. (ii) mechanisms 
by which microglial progenitors colonise the brain and spinal cord during foetal development 
including their interaction with astrocytes, and (iii) to investigate possible signals that may 
direct the migration of these precursor cells and affect their distribution primarily in the 
developing human nervous system. 
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Chapter II MICROGLIA IN THE DEVELOPING HUMAN CNS 
In this Chapter we shall first determine the location, morphology and phenotype of microglia 
in the human foetal brain and spinal cord, and progress to the expression of potential signals 
driving the recruitment and differentiation of microglial progenitors: (i) vascular adhesion 
molecules, (ii) chemokines, and (iii) regional apoptosis. Expression of defined adhesion 
molecules and chemokines and the distribution of astrocytes will be examined for correlation 
with areas colonised by foetal microglia. The following questions «- ill be addressed: 
" What are the phases of colonisation and regional distribution patterns of microglial 
progenitors within the human foetal brain and spinal cord during the second trimester? 
" It is known that microglia in tissue culture interact with astrocytes and that signals 
received from these cells can cause microglia to differentiate. Does a temporo-spatial 
relationship hold between microglial progenitors and astrocytes in situ, within human 
foetal CNS? 
" Are microglial progenitors recruited via blood vessels, and which defined adhesion 
molecules are expressed on cerebral vessels as potential signals for recruiting these cells? 
" Which chemokines are expressed within the human foetal brain during the second 
trimester? How are they distributed, and do microglial progenitors possess the 
corresponding chemokine receptors that they may use to migrate towards sources of these 
chemoattractants? 
" Do microglial progenitors specifically accumulate within areas undergoing 





Human tissue samples 
Frozen and formalin-fixed paraffin-embedded CNS tissues from foetal and adult human 
postmortem cases were obtained for this study from the MRC Brain Bank, Institute of 
Psychiatry, King's College London (courtesy of Dr. Nigel Cairns and Nadeem Khan, co- 
ordinators), and the MRC Tissue Bank, Hammersmith Hospital, London, UK (courtesy of Dr. 
L. Wong, Honorary Consultant and Director). Tables 3-5. All materials were acquired with 
prior informed consent and approval of the local ethical committees of the Institute of 
Psychiatry and the Bethiem, Maudlsey and King's Healthcare NHS Trusts. Gestational age of 
foetal material is given in weeks (gestational weeks or GW) and was estimated according to 
the following criteria in order of preference: anatomically by crown-to-rump length, head 
circumference, foot length, hand measurements, or calculated from the last menstrual period. 
There was no evidence of intracranial pathology or germinal layer haemorrhage in foetal 
material included in these studies. Where indicated, tissue had previously been snap frozen by 
contact with a brass plate at -70°C and stored at this temperature until use. Frozen sections 20- 
60µm thick, were cut from each block of tissue onto silane-coated slides using a cryostat and 
stored at -70°C for histological analysis. Cryostat sections from adult human brain 
(pathological and non-pathological tissues), a normal infant brain and paraffin-embedded 
sections of human tonsil were used as controls. Serial paraffin-embedded sections (7-10µm 
thick) taken from five normal foetal brains (19-23GW) were also used for this study. In 
addition, a further four paraffin-embedded, mercuric-chloride fixed tissue blocks from 
postnatal human CNS [NP 106-83 (1 day); NP 101-83 (6 weeks): NP3-83 (3 months); NP55-83 
(5 months)] were obtained from Dr. Brian Harding, Department of Histopathology, Great 
Ormonds Street Childrens Hospital NHS Trust, London. Sections from these cases were 
treated with Lugol"s iodine (10 minutes) and sodium hyposulphite (2 minutes) in order to 
remove the residual mercuric precipitate, prior to use. 
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Table 4. Details of human foetal spinal cord tissues used in this investigation 
Specimen No. M enstrual Age/weeks Con ception Age/weeks Orientation 
*13853 9.7 7-8 longitudinal 
14065 10.4 8-9 transverse 
13616 10.8 8-9 transverse 
13580 11.0 9 transverse 
13374 11.5 9-10 transverse 
13400 12.4 10-11 transverse 
14167 12.9 10-11 transverse 
13945 14.6 12-13 transverse 
13966 16.3 14-15 transverse 
[*J menstrual age determined anatomically by hand measurements, 
in all other cases, menstrual age was determined by a number of parameters including crown-rump 
measurement, anatomically by foot length, or by history of the last menstrual period. Conception age was 
estimated as menstrual age less two weeks. All samples were from thoraco-lumbar regions. 
Table 5. Details of adult human tissue samples used in this investigation 
F 63 >24 myocardial infarction normal aged brain 
F 71 30 pulmonary embolism normal aged brain 
M 83 >24 myocardial infarction normal aged brain 
F 80 9 bronchopneumonia, dementia Alzheimer's disease 
F 81 31 bronchopneumonia Alzheimer's disease 
M 73 6 bronchopneumonia diffuse Lewy body disease 
M 78 7 bronchopneumonia diffuse Lewy body disease 
M 41 <24 pulmonary infection HIV encephalitis and CMVI 
M 48 --- AIDS HIV encephalitis (subacute) 
M 53 <48 terminal dementia, MND frontal-type dementia, MND 
F 69 24 motor neuron disease motor neurone disease 
M 47 7 bronchopneumonia multiple sclerosis 
F 54 32 pulmonary embolism multiple sclerosis 
F 63 92 bronchopneumonia normal spinal cord 
F 64 60 carcinoma of bladder normal spinal cord 
M 76 41 bronchopneumonia normal spinal cord 
M 80 6 carcinoma of prostate normal spinal cord 
M 86 70 peritonitis normal spinal cord 
Abbreviations: AIDS: acquired immunodeficiency syndrome; 
HIV: human immunodeficienc y virus; 
CMVI: cyt omegalovirus infection; 
MND: motor neurone disease. 
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Protocol I. IMMI NOHISTOCHEMISTRY 
A modified streptavidin-biotin-HRP (ABC) method (Dako, UK) was used for single and dual- 
label immunohistochemistry. A list of all immunoreagents used and their dilutions is given in 
Table 6 and Table 7. All antibodies were routinely tested to determine optimal dilutions. 
Frozen sections were thawed at room temperature and air-dried for two hours, prior to 
immersion in a solution of methanol containing 2.5% of a 30% hydrogen peroxide solution for 
90 minutes. Sections embedded in paraffin wax were first dewaxed in xylene, rehydrated in 
100% alcohol (2 x5 minutes) prior to immersion in the methanol hydrogen peroxide solution. 
Sections were next rinsed with deionised water, then washed twice in phosphate buffered 
saline solution (PBS, pH7.6) (comprising 8g NaCl [0.14M], 0.2g KCl [2.7mM], 0.2g KH2PO4 
[1.5mM] and 1.15g Na2HPO4 [8. lmM] made up in 1 litre of deionised water). They were 
preincubated with Hanks Balanced Saline Solution (HBSS, Sigma UK) containing 1% of each 
of the following: [1M] MgCl2, [1M] CaCI, Tween 20, and bovine serum albumin (BSA, 
Sigma UK) for 2 hours at room temperature and pressure (rtp). The solution was drained off 
the slides and they were incubated for a further 2 hours in normal serum (rabbit serum for 
monoclonal antibodies raised in mice, rabbit serum for antibodies raised in goats, swine serum 
for polyclonal antibodies raised in rabbits, DAKO, UK) diluted 1: 10 with PBS to block non- 
specific binding. The solution was drained off the slides and sections were incubated 
overnight either at 4°C or at room temperature with the primary antibody made up in 1: 100 
dilution of the respective normal serum. Sections were then washed twice in PBS and reacted 
with biotinylated rabbit anti-mouse IgG (for mouse monoclonal antibodies), rabbit anti-goat 
IgG (for goat polyclonal antibodies), or swine anti-rabbit lgG (for rabbit polyclonal 
antibodies) (DAKO, UK), diluted 1: 100-200 in PBS, for 2 hours at room temperature. Two 
subsequent washes with PBS were followed by a2 hour incubation with streptavidin-biotin- 
horseradish peroxidase complex (ABC-HRP kit, DAKO UK) prepared 30 minutes prior to 
application, and a further two washes with PBS. 3,3'-diaminobenzidine tetrachloride (DAB, 
0.25 or 0.5mg/ml made up in PBS) and 0.05% hydrogen peroxide «ere used as substrate for 
the HRP, to visualise the bound primary antibody (brown reaction product). 
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Table 7. Antibodies directed against human chemokines and chemokine receptors 
Clone/lot Dilution Source 
mAbs to human chemokines 
MIP-1 a Cat 500-M74 1: 100 PeproTech EC Ltd, UK 
MIP-la 11A3 1: 500 Srotec, UK 
MCP-l/MCAFa Lot056LO22 1: 100 PeproTech EC Ltd., UK 
MCP-1/MCAF 10F7 1: 100 Serotec, UK 
MCP-3 36320.11 1: 100 R&D systems, Europe 
IL-8 Lot 026Y031 1: 500 PeproTech EC Ltd., UK 
pAbs to human chemokines 
MIP-1 ß (rabbit) Lot 047E361 1: 10-1000 PeproTech EC Ltd. UK 
RANTES (rabbit) Cat 500-P78 1: 500 PeproTech EC Ltd. UK 
IP-10 (rabbit) Lot Ol7E391 1: 1000 PeproTech EC Ltd. UK 
SDF-1/PBSF (goat) Lot AKU02 1: 10-100 R&D systems, Europe 
Fractalkine (rabbit) Cat 500-P98 1: 1000 PeproTech EC Ltd. UK 
mAbs to human chemokine receptors 
CCR2b 48607.121 1: 100-250 R&D systems, Europe 
CCR5 2D7 1: 20-50 Becton Dickinson Ltd., UK 
CCR5` 45549.111 1: 20 R&D systems, Europe 
CXCR 1 42705.1 11 1: 25 R&D systems, Europe 
CXCR4 I2G5 1: 20-50 Becton Dickinson Ltd., UK 
CXCR4d 44716.111 1: 50 R&D systems, Europe 
mAb (monoclonal antibodies); pAh (polyclonal antibody) 
ano cross-reactivity with other MCP or structutally related chemokine epitopes 
hno cross-reactivity with CCR5 
`no cross-reactivity with CCR 1 /2/3 
dno cross-reactivity with other chemokine receptors 
Following development of the first immune bound enzyme complex with DAB, sections were 
rinsed with deionised water, then preblocked with the appropriate normal serum (swine serum 
for polyclonal antibodies raised in rabbits), incubated with primary and secondary antibodies, 
and ABC-HRP according to the protocol described. The reaction was visualised using VIP 
(Vector Laboratories, UK) to obtain a violet reaction product. Alternatively, after the 
secondary antibody incubation step, sections were incubated with streptavidin-biotin complex 
bound to alkaline phosphatase. and the activity of this enzyme was demonstrated by 
incubating sections with Vector Red substrate (Vector Laboratories, UK) or overnight (in the 
dark, at room temperature) in nitroblue tetrazolium (NBT) and 5-bromo-4-chloro-3-indolyl- 
phosphate (BCIP) substrate (containing 1µl/ml levamisole to inhibit endogenous alkaline 
phosphatase activity. Vector Laboratories. UK). Sections were washed under running tap 
water, nuclei were lighly counterstained with haematoxylin or methyl green, and sections were 
differentiated, dehydrated in a series of graded alcohols, cleared in Xylene and mounted using 
Permount, or DPX (VWR-Merck International. UK) for light microscopic analysis. For 
methyl green counterstaining, the solution was first preheated to 60°C, slides were incubated 
for 1-5 minutes, then rinsed for 1 minute with deionised water. Excess water was drained and 
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slides were dipped 5-10 times in acetone containing 0.05% (v/ v) acetic acid. Sections were 
dehydrated immediately in 95% alcohol, and two changes of 100% alcohol. cleared in xylene 
and mounted. Alternatively, the acetone/acetic acid step was eliminated and slides processed 
as per usual in graded alcohols (70-100%). All single and double-immunostaining procedures 
were performed on batches of slides on the same occasion to limit randomisation of intensity 
or conditions. Adjacent sections were stained with haematoxylin and eosin, to identify 
structural morphology. 
For optimising the immunoreactive protocol, the original diluent buffer routinely used within 
the Departmental protocols (Tris-buffered saline solution, pH7.6: TBS containing 60.45g 
Trizma base, 85g NaCl per liter of water to which is added 32mis of concentrated HCI, and 
pH adjusted to 7.6), was replaced with PBS, as this buffer appeared to produce consistently 
less background immunoreactivity. Likewise Triton-X100 detergent used routinely for 
permeabilising the tissues was substituted with Tween 20, as this similarly reduced 
background immunoreactivity, particularly on frozen tissue sections for dual-label 
immunohistochemistry. Negative control sections were included, where the primary 
antibodies were omitted or replaced with control IgG (isotype mouse, rabbit or goat IgG, 
Vector Laboratories, UK). 
Protocol 2. LECTIN HISTOCHEMISTRY 
Background: Lectins were discovered in the l9 `h century, when it was found that extracts 
from certain plants could agglutinate red blood cells (Liener et al. 1986). The term `lectin' was 
given to agglutinins that could discriminate between red blood cell types. This term now 
includes proteins that can bind to defined sugars (glycoconjugates) in plants, microorganisms, 
viruses and animals. The majority of lectins consist of multimeric non-covalently associated 
subunits. Each lectin demonstrates preferential binding to a particular carbohydrate substrate, 
allowing discrimination between mannose, glucose, lactose and galactose residues Table 8. 
Some of these lectins require the particular sugar to be located at a terminal (non-reducing) 
position in the oligosaccharide, whereas others can bind within the oligosaccharide chain. The 
a- and (3-isomeric structure of sugars is a separate factor that determines lectin binding. 
Practically all biological membranes and cell walls contain glv coconjugates that can be 
analysed using lectins. Occasionally. lectins have been found to induce mitosis in cells which 
do not normally divide, although the exact mechanism underlying this is unclear (Liencr et al. 
1986). 
;7 
Table 8. Specifcity of some commonly used lectins 
Sugar recognised Lectin 
Fucose AAL, LTL, UEA I 
Glucose Con A, LCA, PSA 
Galactose ACL, ECL, EEL, GSL I, GSL I-B4, MAL I. PNA, RCAh(,. RCA120, SBA 
Mannose Con A, GNL, HHL, LCA, NPL, PSA 
N-acetylglucosamine DSL, LEL, STL, WGA 
N-acetyl gal actosami ne BPL, DBA, GSL 1, MPL, PTL, SJA, RCA60, RCA120, SBA. VVA. WFA 
Sialic acid MAL II, SNA 
Abbreviations: 
AAL: Aleuria aurantia; ACL: Amaranthus caudatus; PNA: Arachis hypogea (peanut lectin); Jacalin: Arlocarpus integrifolia 
(Jackfruit lectin); BPL: Bauinia purpurea alba (Camels foot tree lectin); ConA: Canavalia ensiformis (Jack bean lectin); 
DSL: 
Datura stramonium (Thom apple/jimson weed lectin); DBA: Dolichos b Torus (Horse gram lectin); ECL: F_rvthrina crvstagalli 
(coral tree lectin); EEL: Euonymus europaeus (spindle tree lectin); GNL: Galanthus nivalis (snowdrop lectin); SBA: glycine max 
(soybean lectin); GSL: Gr Tonia (Bandeiraea) simplicifolia; HHL: Hippeastrum hybrid (Amaryllis lectin); LCA: Lens culinaris 
(lentil lectin); LTL: Lotus letragonolobus (winged pea lectin)/Tetragonolobus purpurea (asparagus pea lectin); LEL: 
Lycopersicon esculentum (tomato lectin); MAL: Maackia amurensis; MPL: . 
%1aclura pomifera (Osage orange lectin); NPL: 
Narcissus pseudonarcissus (daffodil lectin); PSA: Pisum sativum; PTL: Psophocarpus letragonolobus (Winged bean lectin); 
RCA: Ricinus communis (castor bean lectin); SNA: Sambucus nigra (elderberry lectin); STL: Solanum tuberosum (Potato lectin); 
SJA: Sophorajaponica (Japanese pagoda tree lectin); WGA: Trticum vulgaris (wheat germ lectin); UEA: Ulex europaeus (Furze 
gorse lectin); VVA: Vicia villosa (Hairy Vetch lectin); ffisteria floribunda (Japanese Wisteria lectin). 
Lectins such as RCA-l, GSB-4, mistletoe and tomato lectin have gained considerable 
popularity for their use in reliably detecting microglia, irrespective of their morphological or 
immunophenotypical states (Hewicker-trautwein et al. 1996; Rezaie et al. 1997,1999; Suzuki 
et al. 1988; Wierzba-Bobrowicz et al. 1995). They are especially valuable for studies on 
macrophage precursors and foetal and embryonic macrophages, since they identify these cells 
when only a limited number of anti-macrophage antibody markers are useful, and before cells 
can be distinguished by their high lysosomal enzyme activities (Kaur et al. 1990; Sorokin et 
al. 1994). By contrast, immunohistochemistry appears to be more varied in identifying 
microglia, due to the differential expression of surface antigens (refer to Chapter V). These 
lectins specifically stain lactose and galactose (RCA-1, GSB4) and N-acetylglucosamine 
(tomato lectin) residues on the surface of macrophages and microglia as a well as a large 
proportion of cerebral vascular endothelium (Mannoji et al. 1997). Expression of surface 
galactopyronasyl residues is thought to precede cellular activation and is clearly upregulated 
on microglia in diseases of the CNS such as HIV and Alzheimer's disease (personal 
observations). 
The lectins used in this study were RCA-1, GSB4 and tomato lectin. Ricinus communis 
agglutinin-1 (RCA-1, RCA120), isolated from castor bean seeds, is a glycoprotein with a 
molecular weight of 120KD, consisting of two subunits. RCA-1 preferentially binds to 
oligosaccharides ending in galactose (ß-D-galactose, a common constituent), but may also 
interact with N-acetyl-a-D-galactosamine. Desialylation is occasionally necessary, since most 
glycoproteins possess terminal sialic acid residues that can block lectin binding. The 
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inhibitory sugar for RCA-1 is lactose or glactose. Griffonia (Bandeiraea) Simplicifolia 
Lectin-I isolectin B4 (GSB4/BSB4) belongs to a family of glycoproteins with a MW of 
-115Kd. There are two types of subunit (A and B) that combine to form tetrameric structures. 
The A-rich lectin preferentially agglutinates blood group A erythrocytes (specific for a-N- 
acetylgalactosamine residues), whereas the B-subunit preferentially agglutinates blood group 
B cells and is specific for a-galactose residues. GSB4 isolectin only contains the B subunits 
and is reported as a useful marker for endothelial cells and microglia from non-primate 
(mouse, rat, rabbit and goat) species. The inhibitory sugar for GSB4 is galactose. 
Lycopersicon esculentum (tomato lectin) is a stable glycoprotein containing 50% arabinose 
and glactose. It is composed of a single polypeptide of lOOKd that can form aggregates in 
solution. Tomato lectin preferentially binds to trimers and teramers of N-acetylglucosamine, 
and to a number of glycoproteins including glycophorin. 
Protocol: Lectin histochemistry protocols were modified from a method previously described 
by Mannoji et al. (1986). Frozen sections were thawed at room temperature and air-dried for 
two hours, prior to immersion in a solution of methanol containing 2.5% of 30% hydrogen 
peroxide for one hour. Sections embedded in paraffin wax were first dewaxed in xylene, 
rehydrated in 100% alcohol (2 x5 minutes) prior to immersion in the methanol/hydrogen 
peroxide solution. Fixed tissue sections were incubated with lysis buffer (Hanks balanced 
saline solution (HBSS) containing 1% of each of the following: BSA, Tween 20, [1M] CaC12, 
[I M] MgC12) for 90-120 minutes at room temperature, and incubated overnight at 4°C with 
1: 250-500 biotinylated RCA-1, GSB-4 or 1: 100-250 dilution of tomato lectin solution (Vector 
laboratories) made up in lysis buffer. Biotinylated lectins require calcium and magnesium ions 
for maximum activity, and HBSS was used as diluent, since PBS proved to have an adverse 
effect resulting in much weaker staining (personal observations). Following three 5-minute 
washes in PBS, sections were incubated with ABC-HRP (Dako, UK) for 90-120 minutes. 
After three final washes with PBS, lectin reactivity was visualised using peroxidase substrates: 
DAB or Vector VIP (Vector Laboratories, UK). Slides were dehydrated, cleared and 
coverslipped in the usual manner. Negative controls were included where the lectin was 
preincubated with its inhibitory sugar (400mM galactose/lactose/N-acetylgalactosamine/N- 
acetylglucosamine, I hour at 37°C) in solution prior to incubating with sections. 
Protocol a. SILVER IMPREGNATION 
Modified method after del Rio-Hortega: Vibratome-sectioned formalin-fixed tissues (20 
40µm thick) were received in 25ml of deionised water to which 2 drops of ammonia were 
added and left for 20 minutes. following a rapid wash "ith deionised water, the free-floating 
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sections were immersed for ten minutes at room temperature in a solution containing 5ml of 
10% silver nitrate, 20m1 of 5% sodium carbonate and 15m1 of ammonia (sufficient to dissolve 
the resultant precipitate). Tissue sections were washed with deionised water, reduced in 20% 
non-neutralised formalin in deionised water for 1 minute, before a further wash with deionised 
water and toned in yellow gold choride for 1-5 minutes. They were air-dried, cleared and 
mounted with a glass coverslip in the usual manner. Microglia stained black against a beige- 
brown background. Weil-Davenport method: 20-40µm thick formalin-fixed cryostat or 
vibratomed sections were manipulated through the following solutions: (i) silver solution 
(18ml freshly prepared silver nitrate titrated with approximately 2ml of 30% ammonia, to 
dissolve the resultant preceipiate), for 20 seconds at room temperature, and following a rinse 
in deionised water, (ii) sections were reduced in 15% non-neutralised formalin in deionised 
water for approximately one minute (until sections were beige-brown in colour). Next, they 
were washed with deionised water, mounted onto slides, air-dried, cleared and mounted with a 
glass coverslip in the usual manner. Microglia stained black against a beige-brown 
background. 
Protocol 4. IN SITU HYBRIDISATION 
1. Selection of RNA primers and oligonucleotide probes 
Complete sequences encoding mRNA for GFAP (control), and the chemokines MCP-l and 
MIP-la were accessed from the NIH GenBank and SwissProt databases: - 
GFAP GenBank ID (Accession numbers: J04569 [GDB: G00-118-799]; 
Protein Id [AAA52528.1]; PID: g183075; GI: 183075. 
MCP-1 GenBank ID (Accession): M31626; M24545; (NM 002982); NID: g4506840; 
Protein Id: NP 002973.1 (P13500- Swiss-Prot); PID: g4506841 (g307163); 
GI: 4506841 (307163). 
MIP-la GenBank ID (Accession): M23452 (NM 002983); NID: g4506843; GI: 4506843; 
NP 002974.1; PID: P 10147 (Swiss-Prot) 
Possible sequences that could act as primers, or had been previously used as primers in the 
literature, were identified within the encoding region. A 30 oligomer was selected within this 
encoding region encompassed by the primer sequences: - 





ACT CAA TGC TGG CTT CAA GGA 
CCC GCA ACG CGG AGC TGC TCC 
Selected sequence GCA GAT GAA GCC ACC CTG GCC CGT CTG GAT 529-558 
Oligonucleotide Probe 
Specification of Probe 
ATC CAG ACG GGC CAG GGT GGC TTC ATC TGC 






ATG AAA GTC TCT GCC GCC CTT 





GTG CAG AGG CTC GCG AGC TAT AGA AGA ATC 202-231 
GAT TCT TCT ATA GCT CGC GAG CCT CTG CAC 




ATG CAG GTC TCC ACT GCT GCC 
GAC CTG GAG CTG AGT GCC TGA 
84-104 
342-362 
Selected sequence CGG CAG ATT CCA CAG AAT TTC ATA GCT GAC 201-230 
Oligonucleotide Probe 
Specification of Probe 
GTC AGC TAT GAA ATT CTG TGG AAT CTG CCG 
Tm 61.5°C; MW 9208; OD/ml (@260nm) 3.00; 99.00µg/ml; 9.2pmol/µl 
Oligonucleotide probes have been used to detect genes, short sequences and RNA. The above 
probes were synthesised and purchased from Perkin-Elmer Applied Biosystems, UK, supplied 
ready to use in 20% acetonitrile/water. The melting temperature (Tm) of the probe (the 
temperature at which one half of the duplex molecules become dissociated into single strands) 
can be estimated from the constituent bases (A+T: 2 OH bonds; G+C: 3 OH bonds). Tm is 
known to be influenced by the salt concentration, the percentage of formamide (a destabilising 
molecule that disrupts hydrogen bonds) in the hybridisation solution, the probe length and GC 
content of the probe. As a simple rule, Tm (°C) _2x (number of AT base pairs) +4x 
(number of GC base pairs). Low salt and high formamide concentrations assist further in 
producing high stringency (refer to procedure below). 30-base oligonucleotide probes were 
selected with high Tm. Formamide used in the protocol decreased the melting temperature by 
breaking OH bonds, reducing Tm to -50°C. 
Position in Database Entry 
Position in Database Entry 
Position in Database Entry 
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A Basic Local Alignment Search Tool (BLAST) engine was used to explore similarities 
between the selected mRNA sense sequences (against which the oligonucleotide probes were 
developed) and all available formats on the databases. This search was accessed via the 
National Center for Biotechnology and Information web site (NCBI, NIH, Betheseda, USA: 
http: //www. ncbi. nlm. nih. gov/UniGene/). The specificity of the probes for their respective 
proteins was assessed in this manner. The 30-base mRNA sequence selected for GFAP 
[request ID: 941101040-21140-27537] was 100% homologous with records of human GFAP 
sequences. The MCP-1 mRNA sequence [request ID: 941190920-20286-11027] was 100% 
homologous with recorded MCP-1 sequences. The MIP-1 a mRNA sequence [request ID: 
941190665-18743-13384] showed 95-100% homology with human MIP-la sequences. 
IN SITU HYBRIDISATION: Protocol for frozen sections [light microscopy] 
In situ hybridisation was performed on frozen sections of foetal and adult human CNS, using 
the non-radioactive in situ hybridisation oligo colour kit from Amersham International Plc, 
UK (catalogue #RPN 3400). This method detects fluoresceinated oligonucleotide probes using 
a secondary antibody reagent targeted to fluorescein, conjugated with alkaline phosphatase, 
and binding subsequently detected using nitroblue tetrazolium (NBT) and 5-bromo-4-chloro- 
3-indolyl-phosphate (BCIP) as substrate, according to standardised protocols (Wisden and 
Morris, 1994). All solutions were prepared in RNAse-free autoclaved water (18.2MS , 
endotoxin-free, ultrapure filtered, Millipore, UK). The kit comprised the following: (i) 50µ1 
fluorescein- ll -dUTP, (ii) 200 units of terminal transferase in 100µl of buffer, pH7.0, (iii) 
l00µ1 of lOx concentrated buffer containing sodium cacodylate, pH7.2, (iv) lml of sterile 
deionised water, (v) control unlabelled probe: 300ng/30µ1 M13 forward sequencing primer, 
(vi) anti-fluorescein alkaline phosphatase (AP) conjugate: 40µl of a 1000x concentrated stock 
of sheep anti-fluorescein antibody conjugated to alkaline phosphatase, (vii) 5ml of 
hybridisation buffer (1.2m1 sterile water; I ml of 20x SSC (see below), 0.5g dextran sulphate 
(a polymer which accelerates the rate of hybridisation reaction by up to 3 times, by forming a 
matrix in the hybridisation mixture which concentrates the probe without affecting the 
stringency: an estimate of the approximate percentage of nucleotides that are correctly 
matched between probe and target sequences), l00µ1 of 50x Denhardt's solution (2g Ficoll, 2g 
polyvinyl pyrollidone, 2g bovine serum albumin, fraction V dissolved in 100ml sterile water 
and aliquoted), 2.5m1 deionised formamide (regulates stringency and lowers Tm), 400m1 of a 
stock [1 Ong/ml] solution of denatured/sonicated salmon sperm DNA (unlabelled blocking 
DNA to block probe hybridisation to non-specific sites), (viii) lOg of blocking agent. (ix) 
500µI of BCIP solution in dimethv lformamide. (x) 500m1 of NBT solution in 70% 
dimethv Iformamide. 
42 
Preparation of fluorescein-labelled probe: The following protocol ' vas employed for single- 
stranded oligonucleotides bearing 3'-OH group. Original stock concentrations of the probes 
were: [9.0 pmoles/µl] MCP-1, [9.2pmoles/µl] MIP-1 a, [8.9pmoles/µl] GFAP. The 
fluorescein-labelling reaction was catalysed by terminal deoxinucleotidyl transferase (TdT), 
which introduces a tail of fluorescein-dUTP onto the 3' end of an oligonucleotide. 
Components of the kit were first thawed on ice. The following were added to a 1.5m1 tube: 
100 pmoles of the oligonucleotide probe, 10µI of fluorescein-11-dUTP. 16µl of the cacodylate 
buffer, 16µl of terminal transferase, and deionised water supplied to obtain a final total 
volume of 160µ1. The solution was mixed gently by pipetting, and the reaction mixture 
incubated at 37°C for 60-90 minutes. Labelled probes were stored on ice or at -20°C for long- 
term storage (stable up to six months). The optimised reaction protocol was considered to 
yield a tail length sufficient to ensure high sensitivity in hybridisation without compromising 
the stringency of the specific probe sequence. An incubation time of 1 hour was typically 
sufficient to label 25-250pmoles of probe, and there was no need to purify unincorporated 
fluorescein-dUTP from labelled oligonucleotide. 
Procedure: Frozen sections previously cut -20µm thickness onto extra-clean RNAse-free 
positively-charged slides (VWR international Ltd. ), were thawed to room temperature, and 
fixed in freshly prepared 4% paraformaldehyde solution in TBS. Sections were next rinsed in 
TBS and treated as follows. Pretreatment: They were rinsed in ultrapure water, placed in 
TBS for 2 minutes, and permeabilised with 0.1-0.5mg/ml of Proteinase K (made up in Tris- 
EDTA buffer, comprising l OmM Tris-HC1,1 mM EDTA, pH 8.0, prewarmed at 37°C for 10 
minutes, 100-200µl per slide). Sections were incubated in this solution for 20-30 minutes at 
37°C. Digestion was terminated by rinsing sections twice with ultrapure water and washing 
with a solution of glycine (2mg/ml) in TBS for 5 minutes. Next, sections were washed in cold 
20% acetic acid (stored in the refrigerator) for approximately 15-20 seconds to remove 
endogenous alkaline phosphatase, and rinsed twice (5 minutes per wash) with TBS. 
Hybridisation: Sections were allowed to air-dry for twenty minutes before proceeding with 
hybridisation. Briefly, the hybridisation buffer was prewarmed at 37°C for 5 minutes, and 
carefully mixed 1: 1 with deionised formamide. The labelled probe solution [50ngiml] was 
added to 1 ml of hybridisation buffer. and 20-40µ1 of the mixture placed onto tissue sections. A 
parafilm cover was applied to ensure even coverage of the section b\ the hybridisation 
mixture, and slides were placed on a hotplate at 90°C for ten minutes, following which they 
were incubated at 37°C for 16-24 hours. The parafilm was removed with care and sections 
placed in TBS containing 0.10,, o Triton X-100 trn ice, three minutes per ww ash. Stringency: 
Sections were next rinsed twice (5 minutes per wash) in 1x SSC (diluted from a 20x stock 
comprising 3M NaCl, 0.3M trisodium citrate, pH7.0 with HCI, which was filtered and 
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autoclaved), and 0.1% (w/v) SDS (lauryl sulphate sodium salt/sodium dodec'Yl sulphate, 
molecular biology grade, Sigma. UK). Sections were washed thoroughly with TBS to remove 
the SDS. Detection: Sections were then incubated with blocking solution (1: 5 normal rabbit 
serum (Dako, UK) made up in TBS containing 3% BSA and 0.1% Triton X-100) for 30 mins. 
The blocking solution was discarded, sections rinsed briefly with TBS, and incubated with 
rabbit F(ab) anti FITC conjugated to alkaline phosphatase (Dako, UK: diluted 1: 100 in TBS 
containing 3% BSA, 0.1% Triton X-100) for one hour. Sections were then washed twice in 
TBS (3 minutes per wash), and rinsed for 5 minutes in optimised detection buffer (100 mM 
Tris-HC1; 50 mM MgC12; 100 mM NaCl; pH 9.0). Alkaline phosphatase activity was 
demonstrated by incubating sections overnight (in the dark, at room temperature) in 
NBT/BCIP substrate (45µl NBT, 35µl BCIP added to 10ml detection buffer, containing 40% 
dimethylformamide solution and 1 µWml levamisole which inhibit endogenous alkaline 
phosphatase activity). Sections were next washed in running tap water. air-dried and mounted 
in permount from microclear (Raymond Lamb, UK) or with PBS/glycerol mountant. 
Controls: Negative controls were included where (i) sections were incubated with 
hybridisation buffer lacking probe, (ii) the mRNA binding site was hybridised with an 
unlabelled probe, or (iii) the M13 forward sequencing primer (30µ1 of a lOng/ml stock) 
replaced the oligonucleotide probe in the hybridisation buffer. An oligonucleotide probe to 
GFAP mRNA sequence was used as a positive control for the procedure. 
Protocol 5. IN SITU CELL DEATH DETECTION 
TdT-mediated dUTP end labelling: The modes of cell death: apoptosis or necrosis, can be 
distinguished according to morphological, biochemical and molecular criteria. Programmed 
cell death (apoptosis) represents an apparently natural mechanism in tissue turnover and 
during development. Apoptosis occurs without accompanying inflammatory consequences, 
which are usually associated with necrotic events. Instead, cells undergoing apoptosis appear 
to disassemble nuclear and cytoplasmic components in an organised manner. Endonucleolysis, 
which results in the unravelling and cleavage of nuclear DNA into oligonucleosome-sized 
fragments, is considered as a central event in programmed cell death or apoptosis. This 
process can be detected as a `DNA ladder' on agarose gels during electrophoresis. The in situ 
labelling of aooptosis-induced breaks in the DNA strand is useful for identifying apoptosis in 
individual cells and to determine their histological localisation. DNA polymerase and terminal 
dcoxv ribonucleotide transferase (TdT) have been widely used for the incorporation of labelled 
nucleotides to DNA strand breaks in situ. This 'tailing' reaction using Cdi (also described as 
ISFL: in situ end labelling; or TUNEL: TdT-mediated dUTP nick end labelling) has been used 
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here, as outlined in the instruction manual of the In Situ Cell Death Detection Peorxidase Kit 
(Roche Diagnostics, GmbH, Cat No. 1 684 817). 
The test principle is relatively simple: cleavage of genomic DNA during apoptosis may yield 
double-stranded, low molecular weight DNA fragments (mono- and oligo- nucleosomes) as 
well as single-strand breaks (`nicks') in high molecular weight DNA. These breaks in DNA 
strands can be identified by labelling free 3'-OH termini with modified nucleotides in an 
enzymatic reaction. TdT catalyses polymerisation of nucleotides to free 3'-OH termini of 
DNA in a template-independent manner, and labels DNA strand breaks. The incorporated 
fluorescein is detected by an antibody Fab fragment (from sheep) raised against fluorescein, 
and conjugated with horseradish peroxidase (HRP). 
The reagents consisten of the following: (i) 250µ1 of enzyme solution (TdT from calf thymus 
in lOx concentrate storage buffer), (ii) 2,750µ1 of label solution (fluorescein-labeled 
nucleotide mixture in reaction buffer, (iii) peroxidase-conjugated sheep anti-fluorescein 
antibody, (iv) pre-treatment: 0.5% pepsin made up in PBS. Negative controls included 
incubation with label solution alone. Positive controls included incubating tissue sections with 
100µg/ml deoxyribonuclease- 1 (from bovine pancreas) (Sigma, UK), for 30 minutes at room 
temperature, to induce breaks in the DNA strand. Positive control tissue from cases with 
motor neuron disease and multiple sclerosis were also used, which possessed a high index of 
apoptosis. 
Procedure: Frozen sections (20µm thick) were thawed at room temperature and air-dried, 
prior to immersion in a solution of methanol containing 2.5% of 30% hydrogen peroxide for 
one hour. Sections emebedded in paraffin wax (10-20µm thick) were first dewaxed in xylene 
and placed in 100% alcohol (2 x5 minutes), prior to immersion in the methanol/hydrogen 
peroxide solution. Following this, tissue sections were rinsed in deionised water for 5 minutes, 
and pretreated in a humidity chamber with 0.5% pepsin in PBS for one hour at 37°C. Non- 
specific binding was blocked by incubating sections with 1% bovine serum albumin made up 
in HBSS, and 1: 10 dilution of normal sheep serum (Vector laboratories, UK). Positive control 
slides were incubated at this stage with 100µg/ml DNAse-1 (Sigma, UK) for 30 minutes at 
room temperature. Negative control and test sections were incubated for a further 30 minutes 
with the blocking solution. Next, the sections were rinsed twice in PBS (5 minutes per wash) 
during which the TUNEL reaction mixture was prepared on ice by adding 50µl of the enzyme 
to 500µl of the label solution. 501il of the TUNE! mixture was applied to each section, and 
these were overlaid with parafilm to ensure even coverage, and incubated for 1-2 hours at 
37°C in a humidity chamber. Negative control slides were incubated with 50µ1 of label 
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solution alone. The parafiim was gently removed from slides and sections washed three times 
(5 minutes per wash) in PBS, prior to incubation with the peroxidase-conjugated sheep anti- 
fluorescein antibody (50µl per section, 1: 5 dilution) for one hour at 37°C in a humidity 
chamber. Next, tissue sections were rinsed three times with PBS (3 x5 minute washes) and 
developed with DAB solution, dehydrated, cleared and mounted with a glass coverslip as per 
immunohistochemical protocols. 
Protocol 6. THE STAMPER-WOODRUFF ASSAY 
The method devised by Stamper and Woodruff in 1976, modified after Vora et al. (1995), was 
adapted in this investigation to assess the adhesion of monocytes to sections of human foetal 
and adult CNS. In their original studies, Stamper and Woodruff (1977) showed the selective 
binding of leukocytes to high endothelial venules in frozen sections of rodent lymphoid 
tissues. This technique was later applied for studying leukocyte-endothelial interactions in 
murine choroid plexus (Steffen et al. 1996), in encephalitic brain sections from rhesus 
monkeys (Sasseville et al. 1994), in human lymphoid tissue (Pals et al. 1986), human skin in 
psoriasis (Sackstein et al. 1988) and human synovium in rheumatoid arthritis (Jalkanen et al. 
1986). Vora and colleagues (1995) further adapted the method to study the interaction of 
lymphocytes with cerebral vessels, when overlaid onto cryostat sections of the human brain. 
Cell Culture: The human leukaemic monocytic cell line THP-1 (Tsuchiya et al. 1980), was 
obtained from the European Collection of Cell Cultures, Centre for Applied Microbiology and 
Research, Porton Down, Salisbury, Wiltshire, UK. This cell line was derived from the blood 
of a boy with acute monocytic leukaemia, and following characterisation demonstrated Fc and 
C3bi receptors, but lacked surface or cytoplasmic immunoglobulins. The HLA haplotype was 
HLA-A2, A9, B5, DRW 1 and DRW2. The monocytic nature of this cell line was further 
supported by the ablity of THP-1 cells to phagocytose latex particles and sensitised 
erythrocytes, their production of lysozyme and alpha-naphthyl butyrate activities, and by their 
abilities to sensitise T-lymphocytes. Importantly. these cells were found to maintain their 
monocytic characteristics for over 14 months when maintained in culture (Tsuchiva et al. 
1980). THP-1 cells were cultured in 75cm3 flasks with RPMI-1640 medium (Gibco. UK) 
supplemented with 5% foetal calf serum, 100 units/ml penicillin, 100 µg/ml streptomycin, 
2mM glutamine, and 2x 10-5M ß-mercaptoethanol, in an incubator at 37"C, with 5% CO2. 
THP-1 cells were grown in suspension to a density of Ix 106 cells/ml prior to use. 
In situ adherence assay: Cell suspensions were harvested by centrifugation at 4"C (12,500 
rpm, for 5 minutes), washed twice with vv ith modified HBSS (without calcium or magnesium). 
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before being resuspended in HBSS at a density of 2x 106 cells/ml for the Stamper-Woodruff 
assay. Fresh-frozen cryostat sections were allowed to thaw at room temperature for 20 
minutes, before being overlaid with 200µl of cell suspension (4 x 105 THP-1 cells), and 
incubated for one hour at 37°C. Through varying the cell densities (1 x 106 down to 1x 104 
cells per section), temperature (4°C in the refrigerator, 19-21 °C at room temperature, and in 
the incubator at 37°C) and duration of incubation (10-90 minutes), the conditions selected 
were optimised to result in reproducible binding patterns of THP-1 cells to the tissue sections. 
Following the incubation, sections were washed carefully with HBSS (with calcium and 
magnesium) to remove non-adherent cells, and fixed either with I% paraformaldehyde or pure 
methanol solution containing 2.5% of a 30% hydrogen peroxide solution for 90 minutes, and 
processed for light microscopic evaluation of cells bound to the tissue. Sections were checked 
under the light microscope at each of the above stages, in order to determine the extent of 
possible detachment of bound cells. There was no appreciable loss of bound THP-1 cells when 
following this procedure. In order to determine the specificity of binding, control tissue 
sections were incubated with the following prior to being overlaid with THP-1 cells: (i) 
normal HBSS, (ii) modified HBSS (calcium and magnesium-free) with 1-5mM EDTA (a 
calcium chelating agent which inhibits integrin adhesion), or (iii) a cocktail of inhibitory 
synthetic proteins targeting integrins (200µg/ml): RGD (targeting collagen/laminin, a3ß1 
integrin), EILDV (targeting fibronectin, (API integrin), QIDSP (targeting fibronectin, a5ß 1 
integrin). Sections of the brain from normal adults and multiple sclerosis cases were used as 
controls. 
Lectin Histochemistry: Fixed tissue sections were incubated with lysis buffer (HBSS 
containing 1% of each of the following: BSA, Tween 20. [IM] CaC12, D MI M] MgCl2) for 90 
minutes at room temperature, and incubated with 1: 500 biotinylated RCA-1 solution made up 
in lysis buffer (Vector Laboratory, UK) for 4 hours. Following three 5-minute washes in 
HBSS, sections were incubated with ABC-HRP (Dako, UK) for a further 90 minutes. After 
three washes with PBS, RCA-1 reactivity was visualised using the peroxidase substrate: 
Vector VIP (Vector Laboratories, UK). Slides were dehydrated, cleared and coverslipped in 
the usual manner. Negative controls were included where the lectin was preincubated with its 
inhibitory sugar (400mM galactose. 1 hour at 37°C) in solution prior to pipetting onto sections. 
Immunohistochemistry: Single and dual-label immunohistochemistry was performed to 
identify mononuclear phagocytes and adhesion molecules as previously outlined. For dual- 
label studies. the standard protocol was adhered to. with the following exception: sections 
NN ere first incubated with antibodies to C D45, CD64. CD68 or with a cocktail of these 
monoclonal antibodies (CD45: CD64: CD68, all at 1: 20) for 4 hours at room temperature, and 
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developed using DAB as chromogen to give a brown reaction product. Subsequently, sections 
were incubated with antibodies to detect adhesion molecules (Table 6) for 4 hours at room 
temperature, and developed using Vector VIP (Vector Laboratories, UK) to give a violet 
reaction product. If required, sections were lightly counterstained with methyl green. 
4 
RESULTS 
I. Distribution, phenotype and morphology of microglia in the human brain during the 
second trimester 
The structural integrity of tissue sections was well-preserved despite the rigorous procedures 
that were followed. Anatomical localisation and terminology were determined from a standard 
reference atlas of the human foetal brain (Feess-Higgins and Larroche, 1979), and through the 
assistance of a resident paediatric neuropathologist (Dr. Andrew Dean), within the Department 
of Neuropathology, Institute of Psychiatry. During development, the cerebral cortex 
(telencephalon) is characterised by five histological layers that develop by the third month of 
foetal life (8-10 weeks) see Figure 1 (please refer also to Figure 5, Figure 6 and Figure 21). 
The germinal layer, lining the ventricles is composed of a densely nucleated ventricular zone 
(VZ) and overlying subventricular zones (SVZ), and represents the major site for gliogenesis 
and neurogenesis. Overlying these is the intermediate zone (IZ), a transitory structure, which 
in the future forms the white matter, through which glial and neuronal progenitors migrate to 
reach the cortical plate (CP). The marginal layer (ML), containing the Cajal-Retzius cells 
which direct the laminar distribution of neurons in the CP. is placed between the CP and the 
pial surface. The subplate (SP) is another transient structure located immediately below the 
CP, which harbours thalamo-cortical fibers, as these develop and make their appropriate 
connections within the laminae of the CP. 
Operational criteria used to define populations of microglia in the developing brain 
According to the observations discussed below, several characteristic morphologies and 
phenotypes of microglia could be defined , ithin the developing brain. (i) CD68+/RCA-1+1" 
and CD68++/RCA-1+ cells with morphologies more typical of macrophages (large, rounded or 
amoeboid vesicle-laden cells with an uneven or `ruffled' surface membrane) were referred to 
as -amoeboid' microglia. These were typically found in the meningeal and marginal layers and 
confined in limited numbers immediately subjacent to the cortical plate of the telencephalon, 
within white matter tracts and close to cerebral blood vessels deeper areas of the brain. (ii) A 
population of RCA-1+/CD68- cells smaller in size and of rounded (undifferentiated) 
appearance which mainly resided in the marginal layer, the cortical plate and subplate at the 
outset of the second trimester were referred to as -microglial progenitors' or `precursor cells'. 
"These cells were freely lying in the marginal layer, closel\ associated with the ablumenal wall 
of cortical blood vessels, and only occasionally detected in the corpus callosum and «ithin 
deeper regions of the developing brain, again in association with small blood vessels. 






A Nissl-stained section taken through the 
telencephalon at 13GW to show the five 
characteristic histological layers 
The germinal layer, lining the ventricles is composed of 
a densely nucleated ventricular zone (VZ) and overlying 
subventricular zones (SVZ), and represents the major 
site for gliogenesis and neurogenesis. Overlying these is 
the intermediate zone (IZ), a transitory structure, which 
in the future forms the white matter, through which glial 
and neuronal progenitors migrate to reach the cortical 
plate (CP). The marginal layer (ML), containing the 
Cajal-Retzius cells which direct the laminar distribution 
of neurons in the CP, is interposed between the CP and 
the pial surface. The subplate (SP) is another transient 
structure located immediately below the CP, which 
harbours thalamo-cortical fibers, as these develop and 
make their appropriate connections within the laminae of 
the CP. 
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(iii) The terms `transforming', `transitional' and 'early ramified' microglia refer to RCA- 
1+/CD68+, RCA-l+/CD68", RCA-1'/CD68- cells that had begun to differentiate (ramify) and 
more closely resembled the adult ramified microglia in morphology (see also Figure 21). The 








EARLY RAMIFIED MICROGLIA 
RCA-1+/CD68- 
RCA-1 **/rn6? - 
The precise relationship between amoeboid cells and early ramified microglia is difficult to 
determine from the studies in situ. As discussed below, the amoeboid 'state' appears to be 
bypassed at least during the first phase of colonisation of the developing telencephalon that 
takes place before 16GW, where by far the majority of microglial progenitor cells begin to 
differentiate morphologically and ramify without apparently passing through an amoeboid 
stage. 
12-14 gestational weeks 
Telencephalon 
Immunohistochemsitry with the macrophage marker CD68 revealed weak-to-moderate 
expression on an early population of mononuclear phagocytes residing within the marginal 
layer and subplate of the telencephalon (Figure 2). Some cells were interspersed throughout 
the cortical plate, particularly within the lower aspect of this layer. Immunoreactivity with 
CD68 was more intense on round cells located within the upper marginal layer, underlying the 
meninges at 13GW. Corresponding higher power photographs of CD68 positive cells located 
within the marginal/pial layers and the subplate are presented in Figure 2 and Figure 3 
respectively. The majority of CD68 positive cells located within the upper aspect of the 
marginal layer (underlying the pial surface) were of round shape, up to 25-3011m in diameter 
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CD68 positive cells in the human foetal telencephalon at 13GW 
CD68-immunoreactive cells are located within the marginal layer (ML) below the pial 
layer of the meninges, interspersed throughout the cortical plate (CP) with particular 
preference for lower cortical layers, and within the subplate (SP) of the telencephalon 
(A). CD68 positive cells are conspicuously absent within other layers of the 
telencephalon. (B, C) Higher power photos of CD68-immunoreactive cells located within 
the ML. The majority of these rounded mononuclear phagocytes resemble 
monocytes/macrophages in their morphology (C, inset). They are frequently detected 
around small meningeal vessels, particularly overlying the marginal layer. Occasionally, 
more differentiated, CD68-immunoreactive cells of smaller amoeboid morphology can 
be seen within the marginal layer itself (C, arrows) and within the upper layers of the 
cortical plate. Nuclei counterstained with haematoxylin or methyl green. 
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FIGURE 3 
CD68 positive cells in the subplate of human foetal telencephalon at 13GW 
Higher power photos of CD68-immunoreactive cells confined within the subplate. These 
cells are clearly amoeboid in morphology (A-F), associate with radial blood vessels (BV) 
passing through the cortical plate and subplate (B, C), and occasionally appear more 
ramified, extending processes several micrometers away from the cell body (D). 
Expression of CD68 is both at the cell surface and of a vesicular pattern within the 
cytoplasm (E-F), in keeping with previous descriptions of macrophages. Nuclei 
counterstained with haematoxylin. 
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FIGURE 4 
CD68 positive cells in human foetal choroid plexus at 13GW 
CD68 immunoreactive cells located within the choroid plexus demonstrate 
heterogeneous morphologies, which include round, unipolar and bipolar varieties (A-D). 
Cells resembling macrophages (E) with granular cytoplasm and rough membrane are 
common within the choroid at this gestational age. Occasionally, cells are encountered 
that express CD68 only at their periphery (F), and usually possess displaced nuclei. 
These morphological characteristics are more typical of mononuclear phagocytes 
undergoing cell death, a phenomenon which will be further elaborated in Chapter IV. 
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Many of these were located around (but not usually within) delicate, small-diameter and thin- 
walled meningeal vessels. With progression further into the marginal layer, and within the 
upper limits of the cortical plate, a more differentiated morphology of CD68 positive cells was 
evident, and these smaller cells adopted an amoeboid morphology more characteristic of 
amoeboid microglia according to previous descriptions (Figure 2C, arrowheads). CD68 
immunoreactive cells located within the subplate (Figure 3) were clearly amoeboid in 
morphology, and showed surface and cytoplasmic reactivity with this marker. Some of these 
cells were also located around blood vessels penetrating the cortical plate. a few cells 
appeared in pairs and very rarely cells could be seen with a more ramified morphology, 
extending two or more processes several micrometers in distance. The cells within these 
regions were not immunoreactive for CD 1lb or CD64, and only very weakly reactive with 
CD45 (not shown). CD68-immunoreactive cells were distinctly absent elsewhere within the 
developing telencephalon. However, positivity for this marker was clearly demonstrated on 
mononuclear phagocytes within the choroid plexus (Figure 4). Within the choroid, a 
morphologically heterogeneous population of cells coexisted, with round, unipolar, bipolar 
and amoeboid shapes. Cells with morphological characteristics typical of macrophages (rough 
membrane, cytoplasmic granules), were frequent. Occasionally a cell was encountered that 
expressed CD68 only at the periphery and whose nucleus was displaced to one side of the 
membrane. These were more typical signs associated with a form of cell death in mononuclear 
phagocytes, a phenomemon which will be further elaborated upon in Chapters IV and V. 
Lectin histochemistry with RCA-1 highlighted a population of progenitor cells within the 
marginal layer, cortical plate and subplate of the telencephalon, which could be distinguished 
morphologically from the CD68-immunoreactive cells already described (Figures 5-8). 
Figure 5 and Figure 6 show lower power composite photomicrographs of the entire expanse 
of the telencephalon between 13-14 GW, histochemically reacted with RCA-l. From these 
figures, it is clear that the accumulation of cells within the lower cortical layer and subplate 
(indicated by arrowheads) represent the first microglial colony within the telencephalon. 
Microglia, which are at various stages of differentiation in the subplate, could be clearly and 
readily discriminated from blood vessels which were also stained with the lectin. At this stage, 
the ventricular, subventricular and intermediate zones are largely devoid of microglial 
progenitors. There was a greater density of transforming RCA-1 positive cells within the 
subplate and upper aspect of the intermediate zone by 14GW (Figure 6). RCA-1 positive cells 
in the marginal layer and cortical plate were small in diameter, and round or ovoid within the 
marginal layer. occasionally occurring as paired cells, and associated NN ith the parenchymal 
























RCA-1 histochemistry within the human foetal telencephalon 13-14GW 
Lectin histochemistry with RCA-1 identifies blood vessels and microglial progenitors 
within the telencephalon between 13-14 GW (see also figure 6). Microglial progenitors 
and early transforming ramified microglia can be found in the lower cortical plate and 
subplate (arrowheads, see Figures 8-10), whereas the intermediate zone, subventricular 
and ventricular areas are largely devoid of microglia or their progenitor cells during this 
period. (ML) marginal layer, (CP) cortical plate, (SP) subplate, (IZ) intermediate zone, 
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Composite figure to show RCA-1 histochemistry in human 
foetal telencephalon at 14GW 
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FIGURE 7 
RCA-1 positive microglial progenitors in the marginal layer and cortical plate of 
human foetal telencephalon at 13GW 
Lectin histochemistry identified blood vessels (A, C, D, I-L) and populations of microglial 
progenitors (B-L) within the marginal layer and cortical plate of the telencephalon 
between 12-14 weeks of gestation. Cells located within the marginal layer were smaller 
in diameter (15-20µm) and more rounded or ovoid in appearance than their CD68- 
immunoreactive compatriots. These cells were occasionally found in pairs (B, E), 
occurred preferentially within the marginal layer (B-D), and were clearly associated with 
the parenchymal aspect of blood vessels that penetrated the cortical plate (I-L). RCA-1 
positive cells located within blood vessels could not be clearly demonstrated at this 
gestational age, but instead appeared to attach to the ablumenal surface of blood 
vessels (C, l arrowheads) and progressively detached from radial vessels (J-L). 
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FIGURE 8 
Morphology of RCA-1 positive microglial progenitors in the lower cortical plate, 
subplate and intermediate zone of human foetal telencephalon, 13-14GW 
Examples are presented here of the morphological varieties of RCA-1 lectin-positive 
cells located within the cortical plate (A-0), subplate (P-S) and the upper aspect of the 
intermediate zone (T-W) of the developing telencephalon. RCA-1 positive cells can be 
occasionally identified within radial vessels that penetrate the cortical plate (A-C). Cells 
lying freely within the cortical plate are round or ovoid in shape (D, F-I). There is a clear 
morphological differentiation of these cell types in advancing from the cortical plate 
(rounded cells) to the subplate (transforming unipolar/bipolar) and upper aspect of the 
intermediate zone (early ramifying cells). A population of these cells is clearly dividing 
within the upper and (more frequently) lower cortical plate (E, M-0), prior to their 
differentiation within the subplate and intermediate zones (P-W). RCA-1 positive cells 
appear at more advanced stages of differentiation by 14GW within the subplate and 
upper aspect of the intermediate zone. They usually emit 2-3 (or more) delicate and long 
processes at various sites along the cell body and each of these in turn sprouts tributary 
processes along its length at various angles. These early ramified cells (T-W) have 
begun to resemble adult microglia more closely in their morphoplogy. Methyl green 
counterstain. 
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Lectin-labelled cells could not be detected with any clarity, within blood vessels during this 
period of gestation (12-13GW), but were frequently seen at various stages of 'detachment' 
from radial vessels within the lower aspect of the cortical plate (Figure 71-L). Cells with 
progressively more ramified morphologies could be discerned when progressing from the 
marginal layer through the cortical plate (Figure 8A-O) to the subplate and immediately 
upper aspect of the intermediate zone (Figure 8P-W), indicating a progressive early 
colonisation, migration and differentiation of microglial progenitors within this region. 
Between 13 and 14GW, a few RCA-1 positive progenitors could be seen within as well as 
attached to the parenchymal surface of radial vessels in the cortical plate (Figure 8A-C). 
Again, those lying freely within the cortical plate were round or ovoid (Figure 8D, F-I), and 
could not be detected using conventional immunohistochemistry with markers directed against 
CD 11 b or CD64. A small percentage of these RCA-1 positive cells were in the process of 
dividing, whereas those which were encountered within the lower cortical plate and subplate 
had begun to extend fine processes (unipolar, bipolar and multipolar varieties), as they 
differentiated (Figure 8P-S). By 14GW, cells located within the subplate and upper aspect of 
the intermediate zones were found to be in more advanced stages of morphological 
differentiation, emitting progressively more delicate and elongated processes with angular 
side-branches (Figure 8T-W). 
Elsewhere within the human foetal brain between 12 and 14GW, mononuclear phagocytes 
could be detected within the ganglionic eminence, germinal matrix and at the boundary of the 
matrix with the caudate (Figure 9), within the caudate and thalamus (Figure 10), and internal 
capsule (Figure 11, Figure 12). 
Ganglionic eminence/Germinal matrix 
RCA-1 positive cells were found in small numbers within the germinal matrix, but were 
particularly prevalent at the boundary between the ganglionic eminence and the caudate 
(Figure 9A, B). An occasional round cell was detected closely adherent to a blood vessel 
(Figure 9C), and there was also some indication that these cells were dividing within this 
region (Figure 9F). However, the majority of these lectin-positive cells were robust (up to 30- 
40µm in diameter), and showed cytoplasmic granules characteristic of macrophages (Figure 
9D, E, G-J). Immunoreactivity with CD68 detected a smaller population of cells than with 
RCA-I, at the boundary between the ganglionic eminence and caudate. Nevertheless, CD68- 
positivc cells located within the germinal matrix (of the ganglionic eminence) were more 
conspicuously evident than shown with RCA-1. and the majority of these were in the vicinity 
of vessels within the interior of the ganglionic eminence, rather than associated with the 
periphery (Figure 9K-O). 
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FIGURE 9 
Morphology of RCA-1 and CD68 positive microglia in the human foetal 
ganglionic eminence and germinal matrix at 13GW 
The majority of RCA-1 positive cells (A-J) in the ganglionic eminence and germinal 
matrix showed morphological characteristics typical of macrophages (D- J). They were 
particularly prevalent around blood vessels and at the border between the ganglionic 
eminence/germinal matrix (GM) and caudate (CAU), (A: arrowheads, B). Only an 
occasional rounded cell could be detected (C). CD68 positive cells (K-O) were more 
easily identified within the centre of the GM (K, L), in the vicinity of blood vessels (BV) 
(M-O). 
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Caudate and Thalamus 
Likewise, within the caudate and thalamus, RCA-1 positive amoeboid cells could be seen 
focally distributed and associated closely with the vasculature (Figure 10). Their numbers 
were much higher within the caudate, and morphologically, those within the caudate (Figure 
1OA-G) were more robust in comparison to that found in the thalamus (Figure 1OH-L). Not 
only were there fewer cells present in the vicinity of blood vessels within the thalamus, but 
large lectin-positive cells could be clearly identified en passage through thalamic blood 
vessels (Figure 10J-L). Cells passing within vessels were already morphologically similar to 
those that had emerged in the caudate. These observations suggest that the signals within the 
caudate, that preferentially recruit mononuclear phagocytes (amoeboid microglia) to this site, 
are already in operation at 13GW, whereas by comparison, such signals within the thalamus 
may be delayed. 
Internal Capsule 
Within the internal capsule, RCA-1 positive cells were located pasted along and within 
cellular columns, and closely associated with blood vessels in this region (Figure 11). 
Morphologically, most of these cells were smaller and more rounded than the amoeboid 
microglia (particularly those that were adhering to blood vessels, Figure 11D) found within 
the caudate or thalamus, although distinctly macrophage-like amoeboid cells could also be 
seen in some areas (Figure 11F, G). CD68 imunoreactivity within the same region (Figure 
12) revealed an abundant population of vesicle-laden amoeboid cells, the majority of which 
remained close to small diameter vessels (capillaries) (Figure 12C, E). By evidence of their 
morphological characteristics and their expression of CD68, these amoeboid cells could be 
considered to participate in structural remodelling within the internal capsule. 
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RCA-1 histochemistry to demonstrate the distribution of amoeboid 
microglia/macrophages and their relationship with blood vessels in the 
human caudate and thalamus at 13GW 
(A-G) caudate, (H-L) thalamus. RCA-1 positive cells are found focally within the 
caudate, in the vicinity of blood vessels (A-C). These 'amoeboid' microglial cells show 
the characteristic morphology of macrophages, displaying numerous cytoplasmic 
granules (D-G). Within the thalamus, lectin-positive amoeboid cells are fewer in 
numbers within the parenchyma (H, I). In addition to these amoeboid cells, several 
intravascular RCA-1 labelled cells can be detected within the thalamus (J-K), and these 
already possess morphological characteristics (vesicle-laden cytoplasm) similar to those 
found resident within the caudate. 
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RCA-1 positive mononuclear phagocytes within the internal capsule at 13GW 
RCA-1 positive cells within the internal capsule, are located along and within cellular 
columns (A). (B, C) show higher power photos of the respective regions designated by 
an asterix in (A). The majority of these cells are small and round, and several can be 
found pasted along vessels (D). Nevertheless, amoeboid macrophage-like cells laden 
with cytoplasmic vesicles, and resembling those within the caudate, can also be found 
lying freely within this transitory structure (E-G). Methyl green counterstain. 
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CD68 positive mononuclear phagocytes within the internal capsule at 13GW 
Immunoreactivity with CD68 demonstrated an abundant population of amoeboid 
macrophage-like cells already present within the internal capsule. The majority of these 
were aggregated densely around blood vessels (BV) and finer capillaries (CAP). These 
cells closely resembled CD68 positive amoeboid cells found within the caudate. Nuclei 
counterstained with haematoxylin. 
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16-23 gestational weeks 
The influx of microglial precursors was observed to be closely associated with (i) the 
development and maturation of the cerebrovasculature. (ii) the developing subplate. (iii) 
intermediate zone, (iv) ventricular zone and (v) within the corpus callosum of the 
telencephalon between 16 and 23GW. Colonisation, which was found to commence from the 
beginning of the second trimester (12-14 weeks of gestation) as shown above, continued to 
proceed in a co-ordinated manner, and by 22GW, foetal microglia were already widely 
distributed throughout the developing brain, with the exception of the cortical plate. Foetal 
microglia located below the cortical plate (within the subplate), adopted a more ramified 
morphology and downregulated phenotype, resembling adult forms more closely than in other 
areas. 
The distribution of RCA-l lectin positive microglia in the telencephalon between 16 and 
22GW is indicated on the schematic diagrams shown in Figure 13. Original annotations that 
accompany this representation are shown in Figure 14. The distribution profiles for foetal 
microglia in these drawings represent actual regional profiles in the corresponding serial 
sections taken at each level per time point. Figure 15 shows the regional distribution of foetal 
microglia immunolabelled with a cocktail of mononuclear phagocyte markers 
(CD1 1 b: CD45: CD64: CD68) in one entire hemisphere from a foetus at 19GW. The general 
distribution of microglia has been plotted on representative sagittal sections (shaded in blue) 
and presented here, progressing from the medial to lateral aspect. 
RCA-1 intensely labelled blood vessels, amoeboid microglia and macrophages in the choroid 
plexus and foetal microglia in the parenchyma between 16 and 23GW. However, the intensity 
in staining of foetal microglia toward the end of this period gradually decreased, particularly 
within the intermediate zone, where these cells were already sprouting finely-branched 
processes, as they matured (Figure 16). At all stages examined between 16-23GW, RCA-I 
labelled microglia were more closely associated with either blood vessels or the germinal 
layers (VZ, SVZ) (Figure 17). These cells usually occurred along or within the ventricular 
layer, or adjacent to small-diameter blood vessels. heavily-stained amoehoid cells ere 
frequently observed at ventricular junctions of the choroid plexus (Figure 17A, B), and within 
transitory structures such as the internal capsule, the corpus callosum and other extensions of 
developing white matter (Figures 13-15). Microglia NN ere less frequently detected within the 
marginal laver or associated within the meninges 
from 16-2 3GW. 
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FIGURE 13 
Distribution of RCA-1 positive microglia in the human foetal brain 
between 16 and 22GW 
Schematic representations of data gathered from adjacent 20-40. imm 
sections. Coronal sections (16,17,18 weeks); horizontal sections (19,20,22 
weeks). Distribution is indicated by hatched areas: (a) blood vessel 
associated, (b) ventricular associated, (c) meninges associated. (I) heavily 
stained amoeboid cells, (!! ) lighter stained ramified cells, (! i! ) layered 
arrangement, (+) major sites of influx, (") corresponds to the anterior 
corpus callosum. 
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FIGURE 14 
Distribution of RCA-1 positive microglia in the human foetal brain 
between 16 and 22GW 
Original annotated illustrations from sections of the telencephalon 
corresponding to the schematic representation shown in Figure 13. 
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FIGURE 15 (continued) 
Distribution of microglia in the human brain at 19GW (sagittal view) 
Plots indicated by blue shading, represent major dispersion of microglia (there are very scarce cells 
in areas outside that indicated). Microglia are (i) amoeboid in the ventricular and subventricular 
zones, midbrain, diencephalon (thalamus), where they are often found as aggregates of cells, (ii) 
arranged perpendicular to the cerebral wall, in parallel arrays (associated with vimentin, CD31 and 
laminin immunoreactive blood vessels), (iii) evenly dispersed early ramified cells in the 
intermediate zone and subplate of the telencephalon. Amoeboid microglia follow tracts within the 
optic chiasm, olfactory tract, thalamus, crus cerebri, crus fornicis, the extent of the corpus callosum 
and are clearly associated with blood vessels. Amoeboid and transforming early ramified microglia 
are abundant at the border between the germinal matrix and the caudate (surrounding the tip of the 
caudate) and in the internal capsule. Vimentin positive radial glial processes and vessels appear 
most intensely immunoreactive in the sub-cortical plate, intermediate zone as well as within the 
caudate and thalamus. Microglia are clearly evident surrounding deep grey structures: basal ganglia, 
thalamic nuclei, habenula and within the internal capsule. They form boundaries between caudate, 
putamen and thalamus. However, microglial progenitors are rarely detected extravasating from 
I6(1W onwards. Bipolar and tripolar varieties of microglia are the most common transitional 
morphological forms during development. Microglia identified by immunoreactivity to 
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FIGURE 16 
Microglia in the intermediate zone and sub-plate, 16-22GW 
(A, B) CD11b positive microglia within the intermediate zone. (C-D) RCA-1 positive 
microglia in the subplate region, (E, F) Higher power figures to show the transforming 
early ramified morphology of RCA-1 positive foetal microglia within the subplate region. 
(G-I) CD68 (PG-MI) immunoreactive microglia in the intermediate zone at 22GW appear 
to downregulate this phenotypic marker when closer to the cortical plate (G, to the right 
of figure, cells indicated by arrowheads). (H) Examples of PGM-1 positive cells in the 
intermediate zone closer to the subventricular zone. (I) Examples of PGM-1 positive 
cells within the intermediate zone closer to the subplate/cortical plate. 
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FIGURE 17 
RCA-1-labelled microglia in human foetal cortex 16-22GW 
Foetal microglia predominate within the following sites: (i) junctions of the choroid plexus 
(CHP) with ependyma lining the ventricles (A, B): (A) densely stained amoeboid cells in 
CNS tissue adjoining the choroid plexus at 16GW, (B) note the heavily stained 
amoeboid cells in the lining of the ventricular surface of the ependyma at 22GW where it 
joins with the cihoroid plexus. Cells within the CNS proper appear less amoeboid and 
may be migrating away from the site of origin. (ii) small-diameter blood vessels, 
particularly at transitory sites such as the corpus caliosum (C, D). (C) arrows indicate 
amoeboid microglia associated with a small-diameter vessel in the corpus callosum at 
16GW; note the adjacent larger diameter vessels, (D) arrows indicate amoeboid 
microglia associated with a small-diameter blood vessel in the intermediate zone at 
19GW. (iii) subependymal zones (ventricular zone, VZ) underlying the ependymal layer 
of the lateral ventricles (E, F): (E) relatively few cells are stained at 19GW, (F) there is 
abundant cellular staining within the same region at 22GW. In both instances, RCA-1 
labelled cells appear to migrate outwards from these original sites. 
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Lectin-labelled cells were also identified within and surrounding nucleated areas such as the 
thalamus, basal ganglia (putamen and globus pallidus) and the cavum and lamina septum 
pellucidum (Figures 13-15). RCA-1 positive cells were observed encapsulating the putamen 
and globus pallidus at 17GW, extending out into the internal capsule, and abundant at the apex 
of the junction interposed between the putamen and the germinal matrix, associated with 
vessels within these areas. Transforming early ramified microglia were already detectable 
throughout the intermediate zone at 16GW, although few in numbers. By 18-20GW, foetal 
microglia appeared to populate the IZ more extensively. transforming from amoeboid to early 
ramified forms (Figure 16A-F). This arrangement of foetal microglia was well-defined by 
18GW and by 22GW, amoeboid cells were largely confined to the ventricular zone, 
subventricular zone and corpus callosum. The corpus callosum in particular, was a major site 
for intensely RCA-1 stained and immunoreactive amoeboid cells throughout this period. The 
transforming early-ramified microglia on the other hand, were distributed throughout the 
intermediate zone, and began to penetrate the cortical plate at various sites, undergoing 
maturation to adult forms. Those residing within the subplate appeared to be in a more 
advanced state of differentiation than cells newly recuited from the subventricular and 
ventricular zones. The numbers of these sub-cortical plate cells had increased by 23GW. 
It was noted earlier that with transition from the ventricular zone to the cortical plate, foetal 
microglia were found to downregulate their immunophenotype for practically all markers 
examined towards the end of the second trimester, but particularly notable with CD68 (Figure 
16G-I). In this respect, cells located closer to the SVZ were expressing these markers more 
heavily, whereas those situated in the intermediate zone and subplate were only weakly 
immunoreactive. This led to a comparison between the densities of RCA-1 and CD68 labelled 
microglia within the telencephalon, shown graphically in Figure 18. On initial inspection, 
CD68 and RCA-1 appeared to label different populations of foetal microglia. CD68-positive 
microglia were unevenly distributed up to 19 weeks, with highest densities within the 
ependyma and mid-intermediate zone (Figure 18A). By 22 weeks, CD68-positive cells were 
more evenly distributed. However, a new surge of RCA-1 positive cells appeared at this time, 
with greater densities emerging towards the ependymalventricular zone (Figure 18B). This 
observation could reflect either (i) the migration outwards from the ventricular and 
subventricular zones of a freshly-recruited population of cells towards the cortical plate, (ii) 
the merger of two populations of foetal microglia (those which colonise the subplate and IZ 
initially with cells which subsequently arrive in the VZ and SVZ), (iii) the existence of 
differing sub-populations of foetal microglia which differentiate regionally within the 
telencephalon, or (iv) the regional and transient proliferation of foetal microglia (within the 
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FIGURE 18 
Distribution of microglia in the human foetal telencephalon at 19 and 22GW 
Immunohistochemistry (CD68) and lectin histochemistry (RCA-1) were performed on 30-40µm 
serial cryostat sections from normal non-pathological frontal blocks, and processed for light 
microscopy (Rezaie et al. 1997). Control sections were taken from adult brain and stained for 
microglia using the Weil-Davenport silver method. All quantitative analysis was performed with a 
light microscope using a x20 objective, from serial RCA-1 and CD68 stained sections lightly 
counterstained with haematoxylin to define nuclei. Microglia were visualised using DAB (brown) or 
Vector-VIP (violet), and defined as positively stained cells with a distinct cell body (with/without 
processes). RCA-1 positive microglia were readily distinguished morphologically from cortical 
vessels at the section thickness employed. Data are presented as the mean density (±SEM) of 
foetal microglia per 0.25mm2 area (non-overlapping fields) in 8-10 systematic parallel sweeps from 
the ependymal/germinal matrix layer (EP) to the cortical plate (CX). Due to the dense nature of 
closely-packed cells within the ependymal layer, values indicated with and asterix (') for this area, 
represent the minimum number of identifiable microglia. Consecutive fields within the intermediate 
zone are represented as zones (Z1-Z7/Z9). Control data (+) indicate the mean density of microglia 
(iSEM) in 9-10 non-overlapping fields of normal adult white matter using the same defined areas 
and objective. Microglia were more evenly distributed within the adult brain. A: 19 gestational 
weeks. CD68 and RCA-1 labelled foetal microglia were unevenly distributed between the 
ependyma and cortex, with a greater density in the ependymal layer/mid-intermediate zone and 
minimal numbers within the cortical plate. The median values for the two distributions were 
significantly different (Wilcoxon signed-rank test: n=8, w=0, p<0.05). B. 22 gestational weeks. 
CD68 positive cells were more evenly distributed across the tissue sections. There was no 
significant difference in the mean density of CD68-labelled cells in fields Z1-Z7 of the intermediate 
zone. RCA-1 labelled a greater number of cells in what appeared to be a secondary `wave' of 
migration outwards from the ependyma. 
















Dual immunolabelling of microglia (brown) and proliferating cell nuclear antigen 
(violet) in human foetal brain at 16GW and 22GW 
A population of foetal microglia are actively dividing. (A) within the intermediate zone (IZ) 
at 16GW, microglia are the predominant cell population that appear to express PCNA. 
As one would perhaps expect, there are PCNA-immunoreactive cells within the cortical 
plate (CP) of developing neocortex (probably neurons). (B) At 22 gestational weeks, 
double-labelled cells are also localised to sub-ependymal (ventricular zone, VZ) and 
subventricular (SVZ) sites. A population of macrophages within the choroid plexus (CP) 
are also proliferating. (C-E) Higher magnification of double-labelled, dividing cells within 
the intermediate zone at 16GW. A: CD68 (KP-1)/PCNA, B: CD45 (LCA)/PCNA, C-E: 
CD68 (KP-1)/PCNA. 
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With respect to the latter hypothesis, an immunohistochemical assessment of proliferating cell 
nuclear antigen (PCNA, a co-factor of DNA polymerase-8) expression showed that a 
significant proportion of foetal microglia within the intermediate zone and ventricular zones 
were proliferating (Figure 19). 
RCA-I appeared to identify all populations of mononuclear phagocytes indiscriminately 
throughout the period of development under study, and this phenomenon confirmed previous 
reports endorsing the use of this marker as a useful indicator for resting and activated 
microglial cell populations as well as a tool for following their development (Mannoji et al. 
1986, Sreit and Kreutzberg, 1987; Suzuki et al. 1988). By comparison, foetal microglia 
showed a decreased level of immunoreactivity for the markers CD 1 lb, CD45. CD64 and 
CD68, progressively at distances away from the ventricular zone. This progression was clear 
both on single and dual immunolabelling of these cells Figure 16G-I, Figure 20. Foetal 
microglia within the ventricular and subventricular zones and in the corpus callosum 
demonstrated intense expression of these markers. In the intermediate zone and subplate, 
expression of CD64 and CD68 was highly downregulated on cells which had begun to ramify 
(transitional morphological varieties). Instead, these cells expressed lower levels of CD45 or 
CD1lb alone (according to the intensity of staining) Figure 20F, G. The phenotype of these 
foetal microglia therefore appeared to be downregulated in keeping with their morphological 
transformation. The process of colonisation of the human foetal telencephalon by microglia 
during the second trimester is summarised in the schematic illustrations shown in Figure 21. 
In view of the immunophenotypic variation of foetal microglia, a procedure was sought that 
would identify all immunophenotypic subpopulations, for the purpose of direct comparison 
with the lectin histochemical findings. The most direct approach was to identify foetal 
microglia using a cocktail of monoclonal (mouse anti-human) antibodies that recognise 
mononuclear phagocytes. Monoclonal mouse anti-human antibodies to CD1 lb, CD45, CD64, 
and CD68 were combined in solution at a dilution of 1: 20-50 per reagent and applied to the 
tissue sections, following the standard immunohistochemical protocol described under 
methods. The results were impressive (Figure 22, Figure 23A-D), and the technique has 
subsequently been used successfully in the laboratory for identifying all subpopulations of 
microglia in a variety of neuropathological disorders, as well as within the developing brain. 
The combined immunolabelling technique revealed a similar distribution of foetal microglia to 
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FIGURE 22 
Microglia in human foetal tellencephallon at 19GW 
Combined immunoreactivity with CD1 1 b: CD45: CD64: CD68 identifies foetal microglia 
clearly within the intermediate zone (A, B). In the ventricular and subventricular zones 
(C, D) foetal microglia occur as dense aggregates (corresponding to Del Rio-Hortega's 
'fountains') and below the ventricular zone, supraependymal macrophages (E), can be 
detected, which are found attached to the ventricular lining of the lateral ventricles. A 
higher power figure of a transforming microglial cell (early ramified microglia) typical of 
those found within the intermediate zone and subplate, is shown in (F). 
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FIGURE 23 
Microglia in the internal capsule, septum pellucidum, SVZ and CC at 19GW 
(A-D) Combined immunoreactivity with CD11 b: CD45: CD64: CD68 (brown) identifies 
foetal microglia clearly associated with cell columns within the internal capsule (A, B), 
cavum septum pellucidum (C) and subventricular zone (D) at 19 weeks. Double 
immunolabelling reveals the spatial relationship between microglia (brown) and 
laminin-immunoreactive blood vessels (violet) in the internal capsule (E, F) and corpus 
callosum/CC (G, H). Foetal microglia clearly associate with certain medium-large sized 
blood vessels in the internal capsule. Their relationship with blood vessels in the 
corpus callosum is not exclusive however. 
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In addition to more clearly identifying the populations of foetal microglia within the 
telencephalon (Figure 22, Figure 23), amoeboid cells were identified with supreme clarity 
elsewhere in the brain: particularly within the internal capsule and the cavum septum 
pellucidum, where these cells associated specifically with cell columns in linear arrangements, 
as already described between 12-14GW (Figure 11A-C), but with much greater densities 
(Figure 23A). This technique was employed to map the distribution of microglia in the entire 
hemisphere at 19GW, presented in Figure 15 Amoeboid microglia were found to follow tracts 
within the optic chiasm, olfactory tract, crus cerebri, crus fornicis, and throughout the extent 
of the corpus callosum at 19GW. Amoeboid and transforming foetal microglia were abundant 
at the border between the germinal matrix and the caudate (surrounding the tip of the caudate) 
and in the internal capsule, indicating the expansion of populations seeding these areas 
between 12 and 14GW. Foetal microglia were clearly evident surrounding the basal ganglia, 
thalamic nuclei, habenula, and formed boundaries between the caudate, putamen and 
thalamus. The most frequent morphological subtypes of foetal microglia within these regions 
were amoeboid, bipolar or tripolar varieties at 19GW. 
II. The spatial relationship between microglia, blood vessels and vimentin- 
immunoreactive radial glial processes 
A close association between foetal microglia and lectin-stained cerebral blood vessels was 
observed within different regions of the central nervous system from the earliest stages of 
colonisation by microglia. A property of blood vessels in the developing human brain is their 
high expression of laminin, a component of the extracellular matrix, which is mainly confined 
to the cerebral endothelium during the second trimester (Rezaie and Male, 1999). In order to 
clearly ascertain a region-specific relationship between foetal microglia and blood vessels, 
dual label immunohistochemistry was performed using the combined markers for microglia 
and laminin to detect cerebral vessels (Figure 23E-H. Figure 24). 
As shown in the figures, foetal microglia obviously associated with blood vessels in a region- 
specific manner. Within the internal capsule, amoeboid cells were profoundly accumulated 
around certain medium-to-large sized vessels (these may be tributaries of the middle cerebral 
artery) (Figure 23 E, F) whereas they were distinctly less numerous or absent from 
neighbouring vessels (Figure 23F). Clearly some signal from these vessels stimulated 
microglial adherence. migration and proliferation that was not available elsewhere on cerebral 
endothelium. Likewise within the corpus callosum. amoeboid microglia showed a high degree 
of association with some vvessels, but this was not exclusive, since blood vessels on either side 
of the corpus callosum were devoid of these clustered cells. These observations suggested that 
81 
additional factors within this transitory structure (possibly associated with neuronal fibers), 
further to cues from blood vessels. were responsible for governing the highly restricted 
distribution of foetal microglia within the corpus callosum. The idea that foetal microglia are 
involved with modelling the corpus callosum, as suggested by several authors, has certain 
appeal. Alternatively, an equally plausible explanation could be that the corpus callosum 
provides a route or highway for the migration and dispersion of foetal microglia subsequent to 
their emigration from blood vessels. Higher magnification photomicrographs are shown in 
Figure 24, of foetal microglia and laminin-immunoreactive blood vessels within the corpus 
callosum. Here we can see more clearly, the close interaction between amoeboid microglia 
and blood vessels (Figure 24A-C). Occasionally, putative microglial progenitors can also be 
detected within the corpus callosum at 19GW (Figure 24 D-H). These cells are frequently 
detected attached to the outer wall of blood vessels, and rarely seen within. Foetal microglia 
do indeed appear to be dividing, as indicated (Figure 24H) and through immunoreactivity 
with PCNA (not shown). 
Initial work had found vimentin to be expressed on radial glia and a small proportion of 
cerebral blood vessels (that penetrated the cortical plate) within the human foetal CNS (Rezaie 
and Male, 1999). Further investigation confirmed that immunoreactivity to vimentin was 
mostly confined to radial glial processes, and some cortical blood vessels within the 
telencephalon (Figure 25A-C). The most notable expression was that found in the subplate 
and intermediate zone, and there was a comparable lack of vimentin-positive fibers in the 
cortical plate. The subplate represented an area dense with a meshwork of radial glial fibers, 
through which passed small-diameter vimentin-positive vessels. Specifically, microglia within 
the subplate were intimately associated with vimentin-positive fibers, and notably lacking 
from neighbouring areas devoid of these processes (Figure 25D, E). Within the cavum septum 
pellucidum, parallel columnar arrangements of fibers (Figure 25F) likewise provided routes 
for the attachment of amoeboid microglia (see Figure 23C). Both cellular profiles and fine 
cellular processes could be identified within the thalamus (Figure 25G) and caudate (not 
shown), but these regions clearly lacked the structural organisation observed in the subplate 
and the cavum. These findings in situ, supported the concept of a close physico-anatomic 
relationship between foetal microglia and vimentin-positive radial glia and their processes in 






s "ý .ý*ta 1ý y 
A t' 
x100 x100 







A- "VAU 0 
tký 






x400 H x400 
FIGURE 24 
The relationship between microglia and laminin-immunoreactive blood vessels 
in the corpus callosum at 19GW 
Combined immunoreactivity with CD11 b: CD45: CD64: CD68 identifies foetal microglia 
in association with blood vessels that express laminin (A-C). Putative microglial 
progenitors can also be detected (D-G), including some amoeboid cells that are 
dividing (H). Microglia (brown), vessels (violet). 
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FIGURE 25 
Expression of vimentin in human foetal brain at 19GW 
(A-G) Immunoreactivity with vimentin (violet) identifies radial glial fibers within the 
intermediate zone of the telencephalon, in the septum pellucidum and thalamus as well 
as blood vessels that penetrate the cortical plate. The subplate is an area particulaly rich 
in vimentin-positive fibers (B, C), and these are arranged as undulating and tortuous 
forms, rather than the classic linear arrangement one encounters in other regions of the 
intermediate zone. Note the comparative lack of investment of the cortical plate (CP) with 
vimentin-immunoreactive fibers (A, B). Double-immunolabelling indicates microglia 
(brown) to be in close contact with vimentin-positive fibers (violet) in the subplate and 
distinctly lacking in areas devoid of these fibers (D, E). Likewise, radial glial fibers within 
the septum pellucidum are preferential sites for the accumulation of amoeboid microglia 
(see also figure 23C). Nuclei counterstained with methyl green. 
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III. Distribution of GFAP positive astrocytes in the human brain at second trimester 
Having defined the temporo-spatial distribution, phenotype and morphology of foetal 
microglia in the human foetal brain, and their relationship with cerebral vessels and vimentin- 
positive radial glial fibers, the question remained as to how this distribution related to that of 
glial fibrillary acidic protein (GFAP)-immunoreactive astrocytes during the same period of 
development. A close physical and functional relationship has been established for these two 
cell types from studies in tissue culture and experimental work in vivo (Rezaie and Male, 
2002). During development, the synthesis and accumulation of GFAP is considered to 
correspond with the morphological and functional maturation of astrocyte progenitors 
(including radial glia which transform into astrocytes), which also takes place within the 
second trimester. Thus, the expression of GFAP was next examined in a series of human 
foetal brains from 19 to 23GW. 
The morphology of GFAP-positive cells in these normal human brains is presented in Figures 
26-31. GFAP-positive cells in a case of hypoxic-ischeamic injury at 26-27GW, are shown in 
Figure 32, for comparison as a pathological control. GFAP was detected on progenitor cells 
within the ventricular and subventricular zone, where they were closely apposed to blood 
vessels in these germinal layers, on radial glial fibers and on tanycytes lining the ventricles at 
19GW (Figure 26). Radial fibers and columnar arrangements of fibers and GFAP positive cell 
columns were identified within the cavum septum pellucidum between 19 and 20GW (Figure 
27A-C). GFAP positive cells within the thalamus had begun to resemble more mature 
astrocytes morphologically, by this time, and there was clear indication that they associated 
with blood vessels (Figure 27D-F). By 21 GW, cells expressing GFAP were evident 
interspersed throughout the intermediate zone, and those that resided within the subplate 
demonstrated more intense expression of this protein (Figure 28). Polarised cells that 
extended fine processes (radial glia) from the SVZ through the IZ were frequently detected, 
and immature GFAP positive astrocyte progenitors were common in the caudate (Figure 
28D). Within the intermediate zone, astrocyte progenitors were found in various 
morphological states from round immature progenitors to cells which sprouted three or more 
processes and those that extended fine processes from either end of the cell body (Figure 29). 
These latter types (see Figure 29C) resembled transforming radial glial progenitors described 
by others to occur in this region. By 23GW, GFAP positive cells in the intermediate zone were 
undergoing morphological transformation from rounded progenitors to immature astroc} tes 
(Figure 30). Surprisingly, many cells within the subplate remained in a less differentiated 
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Expression of GFAP in the normal human telencephalon at 19GW 
GFAP was expressed by tanycytes lining the ventricles (A, B, D), and by progenitors 
within the germinal layers (VZ and SVZ) (A-C). Delicate radial glial fibers extending 
from the germinal layers (A, arrowheads), could also be identified within the 
intermediate zone (IZ). Closer inspection of the germinal layers, revealed that the 
majority of differentiating astrocyte progenitors that expressed GFAP were located in 
the vicinity of blood vessels (BV) onto which their processes terminated (C). Nuclei 
counterstained with haematoxylin. 
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FIGURE 27 
Expression of GFAP in the normal human brain, 19-20GW 
Columnar arrangement of GFAP positive fibers were clearly visible within the cavum 
septum pellucidum, spanning this transient site (A-C). Intense GFAP immunoreactivity 
was also detected within the ventricular zone of this region, which gave rise to these 
fibers, and large-calibre vessels (BV) were found embedded within the VZ. At this time, 
GFAP positive cells in the thalamus took on more differentiated morphologies (D), and 
a significant number of these cells were clearly investing blood vessels with their 
processes (E, F). Nuclei counterstained with haematoxylin. 
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FIGURE 28 
Expression of GFAP in the normal human brain, 20-21GW 
There was continued expression of GFAP within the VZ and SVZ between 20-21GW 
(A). However, GFAP-positive cells could now be found interspersed throughout the 
intermediate zone, subplate and extending into the cortical plate (A, B). Focally, cells 
located in the subplate showed higher GFAP expression (B). Those within the upper 
aspect of the germinal layers took on a more polarised morphology, extending their 
processes unidirectionally toward the IZ from the SVZ (C), and these continued 
through the expanse of the cortex as thin, almost non-detectable (radial glial) fibers. In 
the caudate, GFAP positive astrocyte progenitors were also common (D). Nuclei 
counterstained with haematoxy! lin. 























Morphology of GFAP positive cells in the intermediate zone of normal 
human telencephalon between 20 and 21GW 
GFAP-positive astrocyte progenitors were encountered at different stages of 
differentiation within the intermediate zone. Isolated cells with three or more processes 
emitting from their cell body region (A, B), cells that extended delicate, thin processes 
in a bipolar fashion (C), those that were clearly associating with cortical blood vessels 
(D) as well as more immature varieties (H- J) were all readily identified. Nuclei 








































Morphology of GFAP positive cells in the subplate and intermediate 
zone of normal human brain at 23GW 
The majority of GFAP positive cells in the subplate tended to remain in a more 
undifferentiated and immature morphology even at this more advanced stage 
in development (A-F). By contrast, GFAP positive cells were clearly in the 
process of transformation in the intermediate zone by 23 weeks (G-Q). There 
were fewer cells of the immature morphological forms (G-L) and higher 
numbers of cells possessing more mature astrocyte morphologies (M-Q). 
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FIGURE 31 
Expression of GFAP in the normal human brain at 23GW 
Further examples of cells expressing GFAP in the subplate (A-C) of a separate case at 
23 weeks. GFAP positive cells within the internal capsule (D) and intermediate zone 
(E) are frequently encountered clearly associating with blood vessels. Tanycytes lining 
the ventricles (F) and more asteriform immature astrocytes within the internal capsule 
(G), are also common. Nuclei counterstained with haematoxylin. 
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FIGURE 32 
boa 
Pathological morphology of cells expressing GFAP in the human brain 
diagnosed with hypoxic-ischaemic injury at 26-27GW 
The morphology of GFAP positive cells in foetal hypoxic-ischaemia was profoundly 
different from that of normal foetal control cases. Reactive changes in these cells had 
taken place throughout all layers of the telencephalon (A), and particularly on cells 
within white matter tracts (B), and in the vicinity of, or adherent to blood vessels (C, D). 
A vesicular/foamy appearance and rounded, hypertrophied morphology was the 
prevalent reactive change in these GFAP-expressing cells (E). Nuclei counterstained 
with haematoxylin. 
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Immature astrocytes could be seen within the internal capsule, GFAP positive tan,, cytes were 
still evident and regionally within the brain, astrocytes had begun to associate intimately with 
blood vessels, as they continued to differentiate (Figure 31). By comparison. in the 
pathological hypoxic-ischaemic state, GFAP positive cells were found to adopt marked 
reactive changes both in their morphology and in their intense reactivity with GFAP (Figure 
32). Reactive changes in these transformed cells could be detected throughout the brain, and 
particularly notable around blood vessels. The majority resembled 'gemistocytic astrocytes' in 
form, similar to that described in various disturbances affecting the CNS. Clearly these 
changes were distinct from that presented within the normal human foetal brain. 
The distribution of GFAP positive cells in the human foetal brain between 19 and 23GW, is 
shown in Figures 33-37. At the earlier time points examined, between 19 and 20GW (Figure 
33, Figure 34), GFAP positive cells were found in small numbers dispersed throughout the 
intermediate zone. By 20GW, these cells were frequently found closely associated with blood 
vessels, extending several fine processes onto the endothelium. GFAP could also be detected 
in tanycytes lining the ventricles, focally at the pial surface (particularly covering midline 
structures), and on cells within the internal capsule, cavum septum pellucidum (where GFAP 
could be detected in linear columnar arrangements and parallel fibres), the thalamus, but most 
abundantly within the ventricular and subventricular zones by 20GW. Between 20 and 21GW 
(Figure 35), there was a noticeable increase in the density of cells expressing GFAP within 
ventricular and subventricular zones, corpus callosum and intermediate zones. There was a 
concomittant increase in the number of GFAP positive astrocytic fibers investing radiating 
blood vessels within the telencephalon. The internal capsule and claustrum were major foci for 
these cells. At 23GW (Figure 36, Figure 37), there were appreciably higher densities of these 
cells within the intermediate zone. The ventricular and subventricular zones still maintained a 
substantial population of cells newly expressing GFAP. The most striking distribution 
however, was that observed at boundaries between the putamen and globus pallidus, at the 
border between the caudate and the germinal matrix, surrounding the caudate, and within the 
internal capsule. GFAP positive cells were distinct within dorsal projections of the corpus 
callosum, and blood vessels in the dorsal aspect of the telencephalon (fronto-parietal regions) 
were considerably more heavily invested with GFAP positive cells and their processes. The 
fact that differentiating or recently differentiated GFAP-positive astrocytes co-localised within 
the same regions of the brain as microglia, was immediately identifiable. Their distribution at 
boundaries bet een nucleated areas, where microglia likewise tend to aggregate, albeit at an 
earlier stage in development (this phenomenon is already detectable for microglia at 17GW, 
rather than 23GW for astrocytes) is particularly significant. 
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Distribution of GFAP positive astrocytes in human foetal brain at 19GW 
The distribution of cells expressing GFAP were plotted onto scanned images 
corresponding to coronal sections taken at different levels through the foetal brain 
(progressing from the frontal pole to the occipital pole). Nissi-stained sections to the left of 
the figure are annotated to show the major anatomical regions. The plots to the right of the 
figure represent data gathered from three consecutive sections at each level. Both 
hemispheres are indicated. Solid lines represent dense astrocytic investment at the pial 
and ependymal (tanycytes) surfaces. Note that these are discontinuous (i. e. they do not 
extend continually around the surface of the brain, or the ependyma lining the ventricles). 
Areas where GFAP-immunoreactive astrocytes are distributed are indicated by dots. 
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FIGURE 34 
Distribution of GFAP positive astrocytes in human foetal brain 19-20GW 
The distribution of cells expressing GFAP were plotted onto scanned images 
corresponding to coronal sections taken at different levels through the foetal brain 
(progressing from the frontal pole to the occipital pole). Nissl-stained sections to the left of 
the figure are annotated to show the major anatomical regions. The plots to the right of the 
figure represent data gathered from three consecutive sections at each level. One 
hemisphere is indicated. Solid lines represent dense astrocytic investment at the pial and 
ependymal surfaces or within the subventricular zone. Areas where GFAP-immunoreactive 
astrocytes are distributed are indicated by dots. Dashed and short solid lines indicate 
GFAP-positive astrocytes associated with cerebral blood vessels. A similar scheme has 
been adopted for Figures 35-37. 
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FIGURE 36 






























Distribution of GFAP positive astrocytes in human foetal brain 23GW (case 2) 
NUCLEUS CAUDATUS 







Similarly, the distribution of GFAP-positive cells within the internal capsule, ventricular and 
subventricular zones corresponds closely with that of microglia in the same regions. 
Moreover, astrocytes within the intermediate zone, like microglia, were typically found as 
isolated cells which were undergoing morphological differentiation during this period. At 
23GW, GFAP positive cells further tended to accumulate in the subplate laterally within the 
telencephalon (frontal and temporal poles), as indicated on Figure 36. The observation that 
certain blood vessels are preferentially invested with these differentiating astrocytes may attest 
to a differential gradient for the development of blood-brain-barrier properties, that takes place 
regionally within the human foetal brain at second trimester. 
From these observations, it can be seen that the regional prevalence of astrocyte progenitors 
and differentiation of astrocytes coincide well with that of microglia. However, there is a 
discrepancy in the timing of these changes, since microglia appear to differentiate (within the 
intermediate zone and subplate), earlier than GFAP positive astrocytes. This most interesting 
finding will require additional investigation, particularly with respect to whether microglia can 
themselves exert more direct influence over the regional differentiation of astrocytes with 
which they co-localise. 
I V. Signals associated with the recruitment, dispersion and differentiation of microglial 
progenitors within the human foetal brain 
The studies presented so far clearly show that microglial colonisation of the CNS is taking 
place within the second trimester of human development, and their distribution corresponds 
regionally with vascularisation, glial fibers and correlates well both spatially and temporally 
with the differentiation of astrocytes. The next aim was to decipher possible signals that could 
be responsible for recruiting these cells and that could determine their regional prevalence and 
patterns of differentiation. The focus of these efforts was directed at the expression of 
adhesion molecules by cerebral vessels, the expression of chemokines and their receptors 
within the CNS, and an assessment of the levels and extent of apoptosis in the developing 
brain. These studies were carried out on tissues obtained toward the latter half of the second 
trimester (16-23GW) 
Vascular adhesion molecules 
Sections of the human foetal CNS were screened for expression of CD31 (PECAM-l), CD54 
(1CAM-1), CD102 (ICAM-2), CD106 (VCAM-1), 1. - and P-selectin. 1 arlier, it was noted that 
cerebral vessels invariably expressed laminin throughout the second trimester. Furthermore, 
microglial 'fountains' within the germinal layers co-localised with capillaries in these regions 
99 
(Figure 38). The majority of cerebral vessels were also found to express PECAM-1, and 
expression of this adhesion molecule was particularly found on radiating cortical vessels and 
within capillaries in the germinal layers throughout this period (Figure 38). 
The corpus callosum at 16GW and intermediate zone at 22GW are presented in Figure 39 for 
comparing expression of adhesion molecules. In contrast to PECAM-1, ICAM-1 displayed 
minimal, weak and patchy staining, and VCAM-1 could not be detected (not shown). There 
was no change in the staining intensity or distribution of PECAM or ICAM-1 between 16 and 
22GW. In contrast, ICAM-2 appeared to stain vessels more specifically and particularly 
within the corpus callosum at 16GW. Vessels stained with ICAM-2 were more widely 
distributed throughout the cortex at 22GW. Dual-labelling with markers against macrophages 
showed microglia to be more closely associated with ICAM-2-labelled blood vessels in the 
corpus callosum and on radiating cortical vessels at 22GW Figure 39. 
Although E-selectin was absent on vessels in the telencephalon, a scant number of foetal 
cerebral vessels were labelled with CD62-P (P-selectin) Figure 40. Curiously, a few non- 
endothelial cells (numbering no more than nine per section) were also stained with P-selectin. 
These cells co-expressed CD68 (Figure 40), particularly on their processes, whereas CD62-P 
was more or less confined to the cell body. Most of these cells were of rounded morphology, 
and on occasion, more amoeboid cells could also be identified. They were not associated with 


































Expression of adhesion molecules in human foetal cerebral cortex, 16-22GW 
(A, C, E) Blood vessels invariably expressed laminin throughout the second trimester. 
Therefore, laminin clearly defined the vascular arrangement of the human foetal brain. 
(G-H) Microglial 'fountains' wthin the germinal layer were found to co-localise with 
capillaries in this region. (A) laminin (violet) on cerebral vessels, 19GW; (B) PECAM-1 
(violet) on vessels, CD45 (brown) identifies microglia; (C) Laminin (violet) expression on 
vessels within the ventricular and subventricular zones, CD68 identifies foetal microglia 
at 19GW; (D) ICAM-2 on a radiating cortical vessels, CD45 (brown) identifies associated 
mononuclear phagocytes at 22GW; (E) Higher power micrograph of (C) to show 
microglia (brown) and laminin (violet) in the subventricular zone at 19GW; (F) IL-8 
(violet) on a cortical vessel, CD45 (brown) on microglia at 22GW; (G, H) PECAM-1 
(violet) on capillaries in the germinal layer, CD68 (brown) identifies microglial 'fountains'. 
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Expression of adhesion molecules in the telencephalon, 16-22GW 
Double immunolabelling to demonstrate microglia and adhesion molecules on cerebral 
endothelium 16-22GW. Microglia are stained brown and blood vessels violet in each 
case. PECAM-1 (CD31) stained the majority of cerebral vessels (A). By comparison, 
ICAM-1-immunoreactive vessels were very sparse (C), whereas ICAM-2 expressing 
vessels (E) were frequently associated with microglial precursors within the corpus 
callosum (F) and intermediate zone (G, H). A-F: Human foetal corpus callosum at 16GW; 
G, H: radiating vessels in IZ at 22GW; A, B: PG-M1/PECAM; C, D: CD11b/ICAM-1; E-H: 
















Expression of CD62-P (P-selectin) in human foetal cortex 
Double immunolabelling with CD68 (PG-M1, brown)/CD62-P (violet) on cerebral cortex 
at 16GW. (A) Blood vessel stained with CD62-P and adjacent rounded CD62-P positive 
cells (arrows). Note the CD68 positive foetal microglia to the lower right of the vessel 
distinctly lacks CD62-P. (B, C) Dual-labelled spherical cells of varying size, found in 
nucleated areas. (D) Dual-labelled cell resembling a foetal microglia, with processes 
surrounding an adjacent cell. 
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Chemokines and chemokine receptors 
Several potential chemotactic factors, including chemokines, are known to activate integrin 
adhesion molecules on leukocytes and macrophages, causing associated reorganisation of the 
cytoskeleton and triggering migration of these cells (Glabinski et al. 1996). In order to 
ascertain whether such signals and their receptors were expressed during the second trimester. 
sections of the human foetal brains (16-22GW) were screened for the ß-chemokines: MIP-1 a, 
MlP-1 P, MCP-1, MCP-3, RANTES, the a-chemokines: IL-8, IP-l0, SDF-1 and their 
receptors: CCR2, CCR5, CXCR1 and CXCR4. The expression of the CX3C chemokine 
Fractalkine was also assessed. 
Of the chemokines examined, MCP-1 in particular was noted to label a band of cells diffusely 
within the subplate and predominantly lower aspect of the cortical plate (Figure 41). 
Additional immunoreactivity was noted within the corpus callosum, the ventricular and 
subventricular zones and in the choroid plexus (Figure 41). Specifically, expression of MCP-1 
localised to the subplate, was limited to the lateral aspect of the developing telencephalon 
from 19GW onwards, and notably absent from dorsal, ventral or medial regions. Although 
astrocytes are capable of producing MCP-1 in tissue culture, as shown in this study (see 
Chapter 4) and by others (Glabinski et al. 1996; Hayashi et al. 1995), MCP-1 expression was 
more widely distributed within the subplate and did not co-localise solely with with GFAP- 
positive cells in situ within the human foetal brain. 
MIP-1 a was not expressed appreciably within the cortical plate or sub-plate. Instead, this 
chemokine specifically labelled cells within the ventricular zone (not shown) and the 
intermediate zone (Figure 42). Double-labelling with an antibody to CD68 revealed that MIP- 
1a positive cells in the intermediate zone were foetal microglia. Notably, these cells 
commonly appeared in pairs, suggesting that they had recently divided. Paired cells in this 
zone expressed PCNA, also implying recent division (Figure 19). Within the ventricular zone, 
it was likely that both MIP-Ia and MCP-1 were labelling blood vessels as well as neuronal or 
glial progenitors. These observations show that microglia may be responding to differential 
chemokine gradients of MCP- I expression, which may account for their migration throughout 






Iý. 'e. 4s. -I-I 





x100 B x100 
VL cc 
ý+ 
X100 D ~ý , X1 00 
FIGURE 41 
MCP-1 expression in human foetal telencephalon at 22GW 
(A) an area of cortex lacks expression of MCP-1. (B) adjacent area of cortex shows 
expression of MCP-1 immunohistochemistry (light haematoxylin nuclear counterstain). 
(C) MCP-1 is also expressed by cells within the ventricular zone (VZ) and projections of 
the corpus callosum (CC). (D) heavily CD68 (brown) and MCP-1 (violet) immunostained 
cells confined to the ventricular/subventricular zones and the choroid plexus. 
Abbreviations: (CP) cortical plate, (SP) subplate, (VZ) ventricular zone, (SVZ) 
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Dual immunohistochemical labelling with MIP-la and CD68 (PG-MI) within the 
intermediate zone at 22GW 
(A) Double-labelled cells within the transitory white matter (intermediate zone). The 
cortical plate is to the top of the figure. (B-D) Higher magnification of double-labelled 
cells within the intermediate zone. The majority of these double-stained cells appear in 
pairs and may have recently divided. CD68: brown, MIP-la: violet. 
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Fractalkine was diffusely expressed by radiating cortical vessels passing through the 
intermediate zone, within the corpus callosum, and in patches on discrete cell clusters within 
the intermediate zone and subventricular zone from 19GW (Figure 43). RANTES was 
dispersed on cells in the intermediate zone and more specifically within the subplate and to a 
lesser extent in the cortical plate as early as 16GW (Figure 44). This chemokine was also 
expressed on cells in the choroid plexus. Therefore, expression of RANTES was another 
candidate for recruiting foetal microglia to the cortical plate and subplate. Immunoreactivity 
with IL-8 was mainly associated with radial blood vessels within the intermediate zone. and 
occasionally on cells at perivascular sites (Figure 44, refer also to Figure 38F). IL-8 was 
further expressed within the ventricular zone, although this chemokine was distinctly absent 
on some populations of foetal microglia (Figure 44). Neither MIP-1 ß, IP-10, or SDF-1 were 
expressed within the human foetal brain, and MCP-3 showed very weak and diffuse 
immunoreactivity confined to the ventricular zone and occasionally associated with tanycytes 
(not shown). 
Dual-label immunohistochemistry revealed that foetal microglia within the intermediate zone 
and subplate expressed CCR2 (Figure 45). However, immunoreactivity with CCR2 was not 
confined solely to microglia and by 23GW, expression of this receptor was more widespread 
within the intermediate zone, subplate and cortical plate, more intense within the subplate and 
lower cortical plates (Figure 46). CCR2 was also expressed on a proportion of cells within the 
SVZ and corpus callosum, and intensely within the ventricular zone (Figure 45). CCR5 was 
found within the corpus callosum and subventricular zone at 22GW and on dispersed cells 
within the intermediate zone by 23GW (Figure 46). Expression of CXCR4 was intense within 
the same regions as CCR5 (Figure 47A, B), and with dual-label immunohistochemistry, 
identified on foetal microglia within the ventricular zone (Figure 45E, F). Focal expression of 
this chemokine receptor was also localised to the human foetal spinal cord at 9GW (Figure 47 
C, D). Convincing expression of CXCRI could not be determined within the human foetal 
nervous system using conventional immunohistochemistry. 
By comparison, the chemokines MCP-1, MIP-la and RANTES and the chemokine receptors 
CCR2, CCR5 and CXCR4 were all found to be associated with blood vessels in sections from 
the frontal cortex of a normal infant (Figure 48 and Figure 49). Unlike MIP-1 a, the 
immunoreactive expression pattern for MCP-1 and RANTES (patchy and discontinuous) may 
have been associated with perivascular cells that reside around blood vessels, rather than 
vascular endothelium per se. Likewise the pattern of immunoreactivity seen with CCR2. 
CCR5 and CXCR4 may have been associated to some extent with perivascular cells, and in 
the case of CCR5 NN-ere also related to cells in the vicinity of blood vessels (Figure 49). 
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FIGURE 43 
Expression of Fractalkine in human telencephalon at 19GW 
Fractalkine was expressed diffusely on cerebral endothelium of radial cortical vessels 
(A) and within the ventricular zone. Strong expression was found on cells within the 
splenium of the corpus callosum (co-localising with microglia and astrocyte progenitors) 
(B). Expression of this chemokines was also found in patches or clusters of cells located 
within the intermediate zone (C), and the subventricular zone (D). In positive control 
tissue from a case with multiple sclerosis, fractalkine was intensely immunoreactive on 
perivascular infiltrating cells within the demyelinating plaque (E). Nuclei counterstained 
with methyl green. 
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Expression of RANTES and IL-8 in human foetal telencephalon 
(A) RANTES (violet) is expressed in the intermediate zone (IZ), subplate (SP) and to 
some extent within the cortical plate (CP) at 16GW. (B) RANTES is also widely 
expressed by cells within the choroid plexus. (C-F) IL-8 immunoreactivity is largely 
associated with radial blood vessels within the intermediate zone, and occasionally 
expressed on cells in perivascular sites (E), at 23GW. (G, H) Although IL-8 is also 
expressed within the ventricular zone (violet), this chemokine is not present on some 
populations of microglia (brown), see also (F) (arrowhead). A-F haematoxylin 
counterstain, G, H: methyl green counterstain. 
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Expression of CCR2 and CXCR4 in human telencephalon, 17-22GW 
Double immunolabelling of CCR2 with CD68 identified foetal microglia expressing CCR2 
within the intermediate zone and subplate (A, B). However, not all immunoreactivity 
within the intermediate zone (or the cortical plate) was accounted for by microglia alone 
(refer also to Figure 48). Similarly, only a proportion of microglia in the SVZ were 
expressing CCR2 (C). Expression of this chemokine receptor was more pronounced and 
widespread within the ventricular zone, where it also co-localised with foetal microglia 
(D). By contrast, the expression of CXCR4 within the ventricular zone (E, F) was more 
restricted to foetal microglia within this region. A-C: 19GW, D: 22GW, E, F: 17GW. 
Microglia: brown, CCR2/CXCR4: violet. Nuclei counterstained with methyl green. 
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FIGURE 46 
Expression of chemokine receptors in normal human telencephalon 23GW 
By 23GW, the expression of CCR2 was particularly pronounced within the lower 
cortical plate, subplate and intermediate zones (A-D). Cellular profiles within the 
subplate and lower cortical plate were particularly distinct at this stage of development 
(C) and were more likely to be neuronal progenitors/differentiating neurons rather than 
microglia. Distinct cellular profiles expressing CCR5 were also dispersed within the 
intermediate zone of the telencephalon around this period (E-F). CP: cortical plate; SP: 
subplate. 












Expression of CXCR4 and CCR5 in human foetal nervous system 
(A) CXCiR4 was expressed on cells within the subventricular zone and extensions of 
the corpus callosum in the cerebrum. (B) CCR5 was heavily expressed in the same 
region, and more widely distributed in the germinal layer and intermediate zone. (C, D) 
CXCR4 expression was more localised within the human foetal spinal cord in the first 
timester, and likely to coincide with waves of neuronal migration in these areas. 
Human foetal cerebrum. A: CXCR4 (brown) expression in the subventricular zone/ 
corpus callosum (the germinal layer is to the lower left of the figure), 22GW frontal 
cortex. B. CCR5 (brown) expression in the subventricular zone/corpus callosum 
(germinal layer to the lower left of figure), 22GW frontal cortex. Human foetal spinal 
cord. C: CXCR4 (brown/black) expression is localised in the spinal cord at 9GW, 
longitudinal section. D: higher magnification of (C) within the area of most intense 
CXCR4 expression (probably cervical/thoracic segment) at 9GW. Nuclei 
counterstained with methyl green. 30-40µm cryostat sections. 
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FIGURE 48 
Expression of MCP-1, MIP-1a and RANTES in normal infant brain 
In the normal infant brain, MCP-1, MIP-l a, and RANTES were all confined to cerebral 
vessels (A-F). Expression of MCP-1(B) and RANTES (F) appeared discontinuous and 
patchy by comparison with that seen for MIP-1a (D). Close examination of this type of 
immunoreactive pattern suggested that MCP-1 and RANTES were most likely 
expressed by perivascular-associated cells (i. e. perivascular macrophages), whereas 
that for MIP-1a was probably endothelial expression, although this needs to be 
confirmed. 
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FIGURE 49 
Expression of CCR2, CCR5 and CXCR4 in normal infant brain 
CCR2 (A, B) and CXCR4 (E, F) were also confined to cerebral vessels in the normal 
infant brain. By contrast, other cells in the vicinity of blood vessels were immunoreactive 
with CCR5 (C, D), although this chemokine receptor was additionally expressed in 
patches on endothelium. Here, once more, the nature of this pattern of immunoreactivity 
suggested that perivascular cells were being identified through their known expression 
of these chemokine receptors. This hypothesis remains to be confirmed. 
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Although microglia appeared morphologically and numerically diminuitive in two out of three 
cases of Down's syndrome examined, when compared regionally to normal foetal brains, they 
nevertheless did express CCR2 receptors and MIP-la similar to that which occured normally 
(personal observations). MIP-1 a in these brains however, was additionally but weakly 
immunoreactive on vessels within the intermediate zone (personal observations). Although 
these observations are important.. there was insufficient material to pursue this avenue of 
investigation further in cases of Downs syndrome. Our positive control material also included 
material from a neonate with acute-on chronic ventriculitis/encephalitis, and this case had 
remarkably elevated expression of chemokine receptors CCR2 and CXCR4 on a variety of 
cell types within the cortical grey matter (including neurons), as well as on cerebral 
endothelium, particularly upregulated on reactive cells that populated the ependymal lining 
(not shown). 
Since the earlier studies had highlighted the potential importance of MIP-la and MCP-1 in 
directing microglial colonisation, in situ hybridisation was performed on adjacent sections of 
frozen material, to demonstrate where, regionally these chemokines were being synthesised. 
Oligonucleotide probes directed at MCP-1 and MIP- l a, revealed expression of their 
respective mRNA within the ventricular zone (MCP-1, MIP-la), ganglionic eminence (MCP- 
1) and more diffusely within the cortical plate (MCP-1, MIP-1 a) between 17 and 22G W in the 
normal human foetal brain (Figure 50 and Figure 51). These findings supported the 
immunohistochemical studies indicating that the major sites of production of these 
chemokines were located within the ventricular zone/germinal layers (including the ganglionic 
eminence where neuroglial progenitors prevailed), and within the cortical plate (where 
neuronal progenitors where prevalent). There were insufficient materials and resources to 
pursue this most interesting finding further during the course of this investigation. However, 
since the results presented here have emphasised that the corresponding patterns of protein 
expression (determined immunohistochemically) for Fractalkine and RANTES, and the 
chemokine receptors CCR2, CCR5 and CXCR4, appear equally significant from the 
perspective of microglial colonisation, future work should determine where regionally, the 
mRNA for these and other chemokines and chemokine receptors are expressed within the 
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In situ hybridisation for MIP-1a and MCP-1 mRNA on frozen sections 
of the human foetal telencephalon 17-22GW 
(A) 17GW and adult multiple sclerosis (MS) control sections were incubated with 
hybridisation buffer lacking probe (top panel of duplicate sections) or incubated with 
unlabelled probe (lower panel of duplicate sections). The 19GW control section was 
incubated with hybridisation buffer lacking probe. The positive control MS sections were 
incubated with an oligonucleotide probe to GFAP. (B) Test sections of the human foetal 
brain incubated with MIP-1cx and MCP-1 oligonucleotide probes. Note the intense 
labelling of the ventricular zone with MIP-1a at 17GW, MCP-1 at 19GW and diffusely 
within the cortical plate at 17GW and 22GW with MCP-1. At 22GW, the ganglionic 
eminence (GE) is intensely labelled with MIP-1a and MCP-1 mRNA. (*) see Figure 
51A/B, (**) see Figure 51 D, (***) see Figure 51 F. No counterstain. 
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In situ hybridisation for MCP-1 and GFAP mRNA 
Images correspond to sections shown in Figure 50. (A, B) Sections of the CNS from a 
case with multiple sclerosis labelled with an oligonucleotide probe to GFAP as control. 
Note the intense labelling, particularly within the white matter (WM). (C, E) Negative 
control sections incubated with hybridisation buffer lacking probe. (D, F) Non-radioactive 
in situ hybridisation with an oligonucleotide probe to MCP-1 showing diffuse labelling 
within the cortical plate (CP) and more intense labelling within the ventricular zone (VZ) 
between 19 and 22GW. GM: grey matter; WM: white matter; CR cortical plate; SP: 
subplate; VZ: ventricular zone; SVZ: subventricular zone. No nuclear counterstain. 
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Apoptosis 
Human foetal brains were screened to determine the regional extent of apoptosis in the 
telencephalon using the TUNEL method (Gavrieli et al. 1992). The most significant finding 
was that TUNEL-labelled cells were predominantly interspersed within the ventricular zone 
and subventricular zones between 19 and 22GW where they inevitably co-localised with 
microglia (Figure 52). However. other regions of the telencephalon where microglia could 
also be located, lacked any appreciable labelling with TUNEL. These findings suggest that 
apoptotic cell death in the SVZ and VZ may be important for recruiting foetal microglia to 
these particular sites, but does not explain the more widespread and progressive dissemination 
of these cells throughout the brain. 
Stamper-Woodruff assay 
In attempting to pursue these lines of thought further, and to determine whether potential 
microglial progenitors (human monocytes) can bind to blood vessels within specific regions of 
the brain (i. e. points of entry for microglial progenitors), sections of human foetal brains were 
overlaid with cells derived from the human monocytic cell line THP-1, according to the 
procedure outlined under the methods section, modified from Stamper and Woodruff (1976). 
THP-1 cells could be identified in culture with markers directed against CDl lb, CD45, CD68 
or with RCA-1 (not shown). The results presented in Figure 53, Figure 54, and Figure 55 
were somewhat surprising and unexpected. THP-1 cells bound with a high degree of 
specificity to the subplate, lower cortical plate and intermediate zone, and to a region 
overlying the marginal layer (Figure 53C-F). Clearly this binding was dependent on 
interaction between integrins and extracellular matrix components since preincubation of 
sections with a cocktail of peptides blockng laminin, fibronectin and collagen binding sites, 
interfered with the binding of THP-1 cells (Figure 53A, B). The pattern of THP-1 cell binding 
to human foetal brains correlated closely with the expression of MCP-1 (and RANTES) within 
this site, and to the accumulation of foetal microglia and differentiating GFAP positive 
astrocytes presented earlier in this Chapter. Further analysis of THP-1 cell binding revealed 
them to interact specifically with the sub-pial granular layer (SGL) (Figure 54A, B), a 
transitory structure in man that is present in the latter half of the second trimester (H. Uylings, 
personal communication). The SGL consists of neurons (derived from the retrobulbar 
ventricle) and glia (derived from the neocortical ventricular zone). and is thought to be 
important for the proper migration of cortical neurons and their formation into layers, a 
phenomenon that cells of the SGL may co-ordinate through interaction with Cajal-Retzius 
cells (H. Uylings, personal communication). 
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FIGURE 52 
TUNEL reactivity in positive control tissues and within the human foetal 
subventricular zone 19-22GW 
(A, B) TUNEL reactivity in the cingulate cortex from an adult case with multiple 
sclerosis. (C, D) TUNEL reactivity in the cingulate cortex from a case with motor neuron 
disease. TUNEL labelling within the human foetal subventricular zone at 19GW (E, F) 
and 22GW (G, H), co-localised with microglia. A-D: TUNEL reaction alone, E-H. TUNEL 
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FIGURE 53 
Stamper-Woodruff assay of THP-1 cell binding to human foetal telencephalon (I) 
(A, B) Sections pretreated with inhibitory peptides, show no adherent THP-1 monocytes. 
In sharp contrast, THP-1 cells bound specifically to the sub-pial granular layer (SGL) as 
well as to the lower cortical plate and subplate regions at 18GW (C, D) and in even more 
significant numbers at 22GW (E-F). 
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Stamper-Woodruff assay of THP-1 cell binding to human foetal telencephalon (II) 
(A, B) A large number of of THP-1 cells adhered to the sub-pial granular layer (SGL) 
overlying the marginal layer of the telencephalon at 19GW. (C, D) Adherent cells were 
frequently detected within the choroid plexus (C, F) and attached to the ependymal layer 
lining the lateral ventricles (C-E). Few cells were found scattered throughout the 
parenchyma of the telencephalon (A, C, E). A, B: 19GW, C, E, F: 17GW, D. 22GW 
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Stamper-Woodruff assay of THP-1 cell binding to human foetal telencephalon (III) 
(A-D) THP-1 cells were found to adhere strongly to the parenchyma of the intermediate 
zone within the telencephalon at 23GW (A, B) less so at 19GW (C) or 20GW (D). Bound 
cells were frequently located to perivascular sites, but rarely adherent to cerebral 
endothelium of radiating cortical vessels. (E) Occasionally, adherent cells were identified 
closely associated with small capillaries in the intermediate zone at 19GW. These were 
spatially distributed along the length of the vessel, in a similar pattern to that seen with 
perivascular cell investment of cerebral blood vessels. (F) In positive control CNS tissue 
from a case with multiple sclerosis, THP-1 cells were clearly found to adhere to 
perivascular sites and both ablumenal and lumenal aspects of cerebral vessels, as 
shown. A, B: 23GW; C. 19GW, D: 20GW, E. 19GW; F: adult MS case 
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Adherent cells were also frequently detected within the choroid plexus and attached to the 
ependymal layer lining the lateral ventricles (Figure 54). Few cells could be seen scattered 
randomly throughout the rest of the CNS parenchyma prior to 22GW. By contrast, at 23GW. 
THP-1 cells were found to adhere strongly to the parenchyma of the intermediate zone 
(Figure 55A-D). Although bound cells were frequently located to perivascular sites, they were 
rarely adherent to cerebral endothelium of radiating cortical vessels. Very infrequently, 
adherent cells could be identified distributed along small capillaries (Figure 55E) in a similar 
array as seen for perivascular cells investing cerebral blood vessels (data not shown). 
However, these were few and far between and did not, on the whole, coincide closely with 
areas populated by microglia. THP-1 cells were clearly found to adhere not only at 
perivascular sites, but also to the lumenal and ablumenal aspects of cerebral vessels in CNS 
tissue from a case with multiple sclerosis (Figure 55F). 
VI. Microglia in the human foetal spinal cord 
Sections of the thoraco-lumbar region of the human foetal spinal cord derived between 9 and 
16 weeks menstrual age (here also referred to as GW) from nine foetuses, were assessed to 
determine the temporo-spatial patterns of colonisation by microglial progenitors (Table 4). 
Spinal cords from the lumbar region of five normal adults (negative controls) and two cases of 
motor neuron disease (positive controls) were also screened (Table 5). Between 9 and 16 
weeks, foetal microglia of the spinal cord presented as a heterogeneous population of cells, 
with subsets identifiable with monocyte/macrophage markers (Table 9). Differential 
expression of the other markers employed, are also indicated in this table for comparison. 
Table 9. Differential expression of markers in human foetal spinal cord 7-15 weeks* 
Marker : 1 12-13 14-15 MND Normal 
CD11b nd + - - + ++ - 
CD45 + t t - + ++ - 
CD64 nd - - - + +_ 
CD68 + + ++ ++ ++ +++ _ 
CD45: 68 ++ ++ +++ +++ +++ +++ 
HAM-56 nd - t - + +_ 
RCA-1 - - nd - + +_ 
GFAP ++ ++ nd ++ ++ ++ _ 
Vimentin ++ ++ nd ++ nd -- 
ICAM-2 - t ++ ++ ++ 
PECAM-1 ++ ++ ++ ++ ++ tt 
Kev: (-) no staining, (+) weak positive staining. (++) positive, (+++) intense staining: (nd) not determined 
A minimum of ten consecutive sections were analysed from each sample 
(*) Foetal age given in weeks from conception/fertilisation 
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At the earliest time point, microglial progenitors were preferentially located around the 
ependymal layer surrounding the neural cavity (Figure 56A, B). These associated with 
vimentin-immunoreactive radial glial processes within the same region and vimentin-positive 
radial glial fibers could be seen to extend outwards from the ventricular zone through the 
marginal layer of the cord to the periphery (Figure 56C, D). These initial foetal microglia were 
predominantly amoeboid and few in numbers (totalling between 10 and 20 CD45: CD68 
positive cells per 40-60µm section). Immunoreactivity with vimentin further demonstrated a 
dense meshwork of radial glial fibers oriented within the marginal layer, and a numerous 
network of vimentin-positive mesenchymal cells (the majority possessing bipolar and 
elongated morphologies, distinct from macrophages, also present within this region- refer to 
Figure 58 and Figure 59) in the connective tissue surrounding the spinal cord (Figure 57). 
Macrophages demonstrated using combined immunohistochemistry with CD45 and CD68, 
could be detected within the vertebral column and connective tissues surrounding the spinal 
cord from 11 weeks (Figure 58 and Figure 59). These samples were also screened for 
expression of adhesion molecules, chemokines and chemokine receptors as previously 
outlined. Of these, ICAM-1, ICAM-2 and VCAM-1 were not expressed at 9 weeks. At 12-13 
weeks, ICAM-2 was expressed on vessels at the periphery of the spinal cord, and co-localised 
with macrophages in the connective tissue (Figure 59). Neither ICAM-1 nor VCAM-1 
immunoreactivity were detectable. Within the spinal cord, CD45: CD68 positive cells were 
migrating inwards from the ventral (floor plate) and dorsal (roof plate) aspects of the cord into 
the ventral and dorsal funiculi respectively, between 14 and 16 weeks (Figure 60). Whereas 
PECAM-1 detected the majority of blood vessels within the spinal cord (Figure 60) much like 
that seen in the cerebrum, ICAM-2 showed the microvasculature of the cord clearly at 14 
weeks and was notably expressed on vessels situated at the periphery, which supplied both 
dorsal and ventral aspects of the thoraco-lumbar region (Figure 60). By 16 weeks, the 
colonisation of microglial progenitors was in full progress within the spinal cord, and the 
influx of cells dorsally and ventrally (with corresponding densities of 40-50 cells/mm2), was 
associated closely with delicate vessels that specifically expressed ICAM-2 within the same 
regions (Figure 61). Other regions of the spinal cord (dorso-lateral, medial and ventro-lateral) 
totalled between 5-30 CD68+ cells/mm2 at 16 weeks. Interestingly, the pattern of reactivity 
with GFAP at this time, demonstrated astrocytes and their processes preferentially localised to 
the marginal layer and their processes no longer spanning the breadth of the spinal cord (data 
not shown). This arrangement of fibers, appeared to preferentially favour the inward migration 
of microglial progenitors. With the exception of CXCR4 (shown in Figure 47C, D) somewhat 
surprisingly, and in sharp contrast to the human foetal brain, none of the chemokines or 
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FIGURE 56 
Foetal microglia and radial glia in human spinal cord, 9-10GW 
(A, B) Microglia are preferentially located around the ventricular layer surrounding the 
neural cavity at this stage in development (CD45: CD68); (C, D) Figures to demonstrate 
microglia (CD45: CD68, brown) and vimentin-positive radial glial processes (violet) 
arising from the ependymal layer (these radial glial fibers are arranged in parallel , and 
span the region between the ependymal layer and the marginal layer of the cord (refer 
to Figure 99 for anatomy of the foetal spinal cord). 
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Vimentin immunoreactivity associated with the human foetal spinal cord 
(A, B) Immunoreactivity with vimentin (violet) detects a dense meshwork of radial glial 
fibers in the marginal layer between 9-10GW. (C-F) Within the connective tissue 
surrounding the spinal cord, there are numerous vimentin-positive mesenchymal cells 
which form a network. The majority of these cells are elongated or bipolar in 
morphology, and quite distinct from mononuclear phagocytes. 











Macrophages surrounding the human foetal spinal cord, 12-13GW 
Photomicrographs demonstrating combined CD45. CD68 immunoreactive macro- 
phages (brown) within the vertebral column and connective tissues surrounding the 
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FIGURE 59 
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Macrophages associated with the spinal cord, 12-13GW 
(A-D) Distribution of combined CD45: CD68 positive macrophages in the connective 
tissues surrounding the spinal cord, 12-13GW. (E, F) At the periphery of the spinal cord, 
macrophages (brown) are associated with blood vessels expressing ICAM-2 (violet). 
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Macrophage distribution, PECAM-1 (CD31) and ICAM-2 expression in the 
human foetal spinal cord, 14-16GW 
(A, B) Low power (A) and higher power (B) figures showing the distribution of combined 
CD45: CD68 immunoreactive macrophages. Note the high density of immunolabelled cells 
surrounding the spinal cord and migrating inwards within the ventral aspect of the cord. 
(C-D) Immunoreactivity with CD45 shows a similar distribution of cells positioned around 
the cord (C) and within the region ventral to the neural cavity. (E, F) Immunoreactivity with 
PECAM-1 (CD31) demonstrates the majority of blood vessels within the spinal cord. 
(G, H) Immunoreactivity with ICAM-2 shows the microvasculature of the cord clearly 
(14GW), and ICAM-2 is particularly expressed on blood vessels situated at the periphery 
of the spinal cord, which supply both dorsal (H) and ventral aspects of the thoraco-lumbar 
region. 
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Microglial colonisation is associated with vessels expressing ICAM-2 in the 
ventral aspect of human foetal spinal cord 
(A, B) low power figures to show the preferential distribution of combined CD45: CD68 
immunoreactive foetal microglia within the ventral part of the thoraco-lumbar spinal cord 
at 16GW. This also occurred to a lesser extent within dorsal and peripheral regions of 
the cord (not shown). (C-F) Higher power dual-label photomicrographs demonstrate 
microglia (brown), associated closely with delicate vessels specifically expressing ICAM- 
2 within the region ventral to the neural cavity at 16GW. 
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Chapter III MICROGLIA IN THE FOETAL MOUSE BRAIN 
From the studies presented thus far, we know that microglial colonisation of the human CNS 
takes place essentially during the second trimester, and commences from the beginning (and 
shortly before) this period. By comparison, studies in rodents have shown that microglia 
colonise the nervous system in the period just before birth, but mainly throughout the 
postnatal period (Dalmau et al. 1997; Miyake et al. 1984; Perry et al. 1985). The primary aim 
of this chapter is to define the corresponding timing, phases and extent of microglial 
colonisation that takes place in the mouse during the foetal period (embryonic day 15 to birth). 
This is necessary in order to establish similarities (or differences) in the modality of 
colonisation with that which occurs in man. 
The phenotype of murine microglial progenitors and foetal microglia will be determined by 
lectin histochemistry using tomato lectin, RCA-I and GSB4, and by immunoistochemistry 
with markers against CD IIb, CD45, MOMA and F4/80 antigen. ICAM-2, MIP-1 a and MCP- 
I emerged among the potentially important factors regulating microglial colonisation in man. 
In order to compare these findings with the murine CNS, sections of foetal mouse brains were 
also screened for expression of vascular adhesion molecules PECAM-1, ICAM-1, ICAM-2, 
VCAM-1, and the chemokines MIP-1 a and MCP-1. 
The following points were addressed in relation to the developing murine CNS: 
0 What are the phases of colonisation and regional patterns of distribution of microglial 
progenitors within the foetal murine CNS between E 15 and birth? 
" Is ICAM-2 expressed in the murine foetal CNS as a potential signal for the recruitment of 
m icrogl ial progenitors? Are PECAM-1, ICAM-1 and VCAM-1 expressed on cerebral 
vessels during development in the mouse? 
" What are the patterns of expression of MIP-la and MCP-1 in the murine foetal CNS? 





Tissue samples and histological processing 
Time-mated female Balb/c mice were purchased from Harlan Olac, UK (delivered on the 13`h 
day of gestation) and sacrificed humanely by placement in a lethal chamber infused with 
carbon dioxide and chloroform, followed by rapid dislocation of cervical vertebrae. Care was 
taken when handling animals in order to avoid any unnecessary suffering. The abdominal 
cavity was incised and pups immediately removed, euthanised with chloroform, decapitated 
and entire heads placed immediately upon ice. Postnatal animals were injected 
intraperitoneally with a solution of sodium pentobarbital (180-200mgiml)/euthanised with 
chloroform, prior to decapitation as per embryos. The brain was carefully dissected from the 
cranial cavity with the aid of microdissection tools and a dissecting microscope. All 
procedures were conducted according to local guidelines under ethical committee approval. 
Brains from embryonic C57BL/6J mice were additionally obtained through a collaboration 
with Dr. Graham Hagger and colleagues (GlaxoSmithKline Laboratories, Hertfordshire). 
Some foetal and adult mouse brains were fixed with 4% paraformaldehyde solution, frozen in 
isopentane immersed in liquid nitrogen. and sectioned serially at 20-40µm using a cryostat. 
Surplus sections were stored in cryoprotectant (15% glucose, 30% ethylene glycol in PBS 
pH7.4: 75g sucrose, 150m1 ethylene glycol made up to 500m1 with PBS) at -20°C until further 
use. The majority of embryonic (2 litters at each time point from E15-birth), postnatal (P6, 
P 12 and P 19) and adult mouse brains were placed in either Bouin's fixative solution (made up 
as a solution containing 150m1 saturated aqueous picric acid solution, 50m1 of 40% 
formaldehyde solution, 10ml of glacial acetic acid) or neutral buffered formalin for 16-24 
hours. Bouin's picric acid fluid is widely recognised as the fixative of choice in order to 
preserve the structural integrity of embryonic and foetal tissues. However, excess time in this 
fixative was avoided, as it led to marked hardening and shrinkage of the tissue. Picric acid is 
known to react with histories and basic proteins, forming crystalline picrates with amino acids. 
It stains tissue yellow, but this can be removed by placing specimens in 70% alcohol, or 
through treatment with lithium carbonate. The yellow colouration of the material was also 
useful for structural identification and orientation of samples in paraffin blocks following 
processing. Tissue from the spleen and lymph nodes of adult mice were also taken, to serve as 
positive control materials. 
l'he processing schedule used routinely for human materials, was optimised for embryonic 
murine material, and was found to be equally suitable for tissues obtained from adult mice. 
following fixation. tissues were processed in cassettes on a Shandon H}percentre set to the 
132 
following schedule: (i) 50% alcohol for 30 minutes; (ii) 70% alcohol for 30 minutes: (iii) 96% 
alcohol for 30 minutes; (iv) 100% alcohol for 3 hours. (v) chloroform for 2 hours: (vi) paraffin 
wax, a mixture of dental wax and white wax, for 3 hours, prior to embedding into blocks and 
leaving to set on a cold plate. A total of 18 Bouin's-fixed foetal Balb/c and 36 C57BL/6J 
mouse brains (E15 to birth) were examined in this study. Each block of tissues contained 
foetal mouse brains from one litter at one time point. Blocks were presented with the rostral 
(olfactory) region to the uppermost (cutting) surface. Corona] blocks of tissue were sectioned 
serially at 15-40µm thickness on a base-sledge microtome, onto glass slides coated with 
aminopropyl silane for histological examination. Every tenth slide was selected for analysis, 
using immuno- and lectin histochemistry, essentially according to the protocols described for 
human tissues. The yellow colouration of Bouin's-fixed material was readily removed through 
the routine procedures of dewaxing and rehydration for sections on slides. Where necessary, a 
longer duration in 70% alcohol (a few hours or overnight, depending on thickness of sections) 
with continuous gentle agitation was sufficient to remove any residual yellow tincture from 
the sections. Adjacent slides were stained with haematoxylin and eosin for histological 
identification of brain areas. The list of reagents used is shown in Table 10. For 
immunohistochemistry, the secondary reagents used were biotinylated rabbit anti-rat IgG 
(1: 50 dilution, mouse preadsorbed, Vector Laboratories, UK), rabbit anti-goat IgG (1: 100 
dilution, Vector laboratories, UK) or swine anti-rabbit IgG (1: 100 dilution, Dako, UK). 
Sections were incubated with appropriate corresponding normal sera (rabbit or swine) for 
blocking steps prior to incubation with the primary antibody, as per protocol in Chapter 2. 
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Distribution, morphology and phenotype of microglial progenitors in foetal murine CNS 
Schematic, annotated outlines of coronal sections from the developing brain are indicated in 
Figure 62 and Figure 63, to show the regional anatomy of the developing mouse brain. These 
were compiled with reference to standard atlases (Jacobowitz et at. 1997; Schambra et al. 
1992). Section levels indicated on the figure progress in a rostra]-caudal direction. The 
regional distributions of tomato lectin and RCA-1 positive amoeboid and early ramifying 
microglia in the embryonic mouse brains are shown in Figure 64 and Figure 65 for 
comparison. Outlined sections correspond approximately to the section levels indicated in 
Figure 62 and Figure 63. Schematic plots represent cumulative data from three sections 
analysed per embryonic brain, at each level, per time point. Individual identified cells were 
initially plotted manually onto draft templates of the brain sections, prior to being collated and 
presented in the final digitised format. Amoeboid microglia were defined as morphologically 
amorphous or rounded cells with a defined nucleus (stained with haematoxylin). Early 
ramifying cells possessed a small nucleus and two or more elongating and delicate processes. 
Only cells that could conclusively be identified were used for plotting data. There were no 
clear strain differences between C57BL/6J or Balb/c mice in the distribution patterns of 
microglia during the embryonic period. In order to facilitate regional comparison between the 
distribution of the two morphological varieties, the left hemisphere was used to denote 
amoeboid microglia (blue), and the right hemisphere for early ramified cells (yellow). At all 
stages examined, amoeboid cells appeared to coexist regionally with progressively ramifying 
cells, with the exception that these early ramified microglia appeared to migrate and colonise 
the grey matter with ongoing development, whereas amoeboid cells tended to predominate 
within developing (white matter) tracts. 
The mononuclear phagocyte markers, CDI lb, CD45 and MOMA could not be identified on 
microglial progenitors, amoeboid cells or early ramifying throughout the embryonic period. 
These markers produced specific immunoreactivity within control tissues (spleen and lymph 
nodes). Only F4'80 antigen was found to be expressed to variable degrees on some 
populations of microglia during the period under study. GSB4 lectin was far less useful as a 
marker for microglia in the developing brain, than either tomato lectin or RCA-l, which 
reliably detected the majority of microglial forms. For this reason. the data accrued from 
analysis of sections reacted with these two lectins were used for the comparative 
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FIGURE 62 
Anatomical organisation of the foetal mouse brain at Embryonic Day 15 
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FIGURE 62: abbreviations 
Corresponding section levels are indicated (L1-L21) on the figure. 
a, accumbens nucleus; AA, amygdaloid area; abl, basal lateral amygdaloid nucleus; abm, basal 
medial amygdaloid nucleus; Aca, anterior commissure (anterior part); am, medial amygdaloid 
nucleus, AQ, aqueduct of Sylvius; arc, arcuate nucleus; BSC, brachium of superior colliculus; 
bsttl, bed nucleus of stria terminalis (lateral part); CC G, corpus callosum (genu); CCi, cingulate 
cortex; CC T, corpus callosum (trunk); CEn, entorhinal cortex; CFr, frontal cortex; Cl, cingulum; cl, 
claustrum; CPa, parietal cortex; CPd, cerebral peduncle; cp, caudate-putamen; cov, ventral 
cochlear nucleus; CTe, temporal (auditory) cortex; de, dorsal endopyriform nucleus; DG, dentate 
gyrus; dmt, dorso-medial thalamic nucleus; DSCbP, decussation of superior cerebellar peduncles; 
EC, external capsule; EML, external medullary lamina; F, fornix; GE, ganglionic eminence; gp, 
globus pallidus; hal, lateral habenula; hdb, horizontal nucleus of diagonal band of Broca; IC, 
internal capsule; ICj, islands of Calleja; III V, third ventricle; LH, lateral hypothalamic area, Ipo, 
lateral preoptic nucleus; LPOA, lateral preoptic area; LV, lateral ventricle; MFB, medial forebrain 
bundle; mgpo, magnocellular preoptic nucleus; ML, medial lemniscus, mm, medial mammillary 
nucleus; MT, mammillothalamic tract; MTg, mammillotegmental tract; OTU, olfactory tubercle; PC, 
posterior commissure; pnrt, pontine reticular nuclei; pot, posterior thalamic nucleus; prm d, 
premammillary nucleus (dorsal part); RPI sc, roof plate of superior colliculus; S, subiculum; sc, 
superior (anterior) colliculus; SCO, subcommissural organ; sm, supramammillary nucleus. STT, 
stria terminalis; SVZ, subventricular zone, T. tectum; Tg, tegmentum; vmh, ventromedial 
hypothalamic nucleus; vmt, ventromedial thalamic nucleus; VZ, ventricular zone. 
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FIGURE 63: abbreviations 
Corresponding section levels are indicated (L1-L20) on the figure. 
a, nucleus accumbens; AAA, anterior amygdaloid area, abm, basal medial amygdaloid nucleus; 
ac, central amygdaloid nucleus; AC a, anterior commissure (anterior part); ah, anterior 
hypothalamic nucleus; AH, anterior hypothalamic area, al, lateral amygdaloid nucleus; aom, 
anterior olfactory nucleus (medial part); AQ, aqueduct of Sylvius; bstt m, bed nucleus of stria 
terminalis (medial part); Cb, cerebellum; CC G, corpus callosum (genu)s CCI, cingulate cortex; CC 
R, corpus callosum (rostrum); CC T, corpus callosum (trunk); CFr, frontal cortex; ChPI, choroid 
plexus; Cl, cingulum; Cin, insular cortex; C'Ir, infralimbic cortex; cl, claustrum; cod, dorsal cochlear 
nucleus; cp, caudate-putamen; CPa, parietal cortex; DB, diagonal band of Broca; de, dorsal 
endopyriform nucleus; EC, external capsule; EML, external medullary lamina; EXC, extreme 
capsule; F, fornix; F C, column of the fornix; FR, fasciculus retroflexus (habenula-peducular tract); 
F VC, ventral commissure of the fornix (ventral hippocampal coram ssure); gp, globus pallidus; hal, 
lateral habenula; ham, medial habenula; hdb, horizontal nucleus of the diagonal band of Broca; 
HI, hippocampus; HIC, hippocampal commissure; ic, inferior (posterior) colliculus; ICbP, inferior 
cerebellar peduncle; III V, third ventricle; IV V, fourth ventricle; IC, internal capsule; IG, indusium 
griseum; II d, lateral lemniscus nucleus (dorsal part); Ipo, lateral preoptic nucleus; Is, lateral septal 
nucleus; LL, lateral lemniscus; LV, lateral ventricle; ME, medulla; MFB, medial forebrain bundle; 
mg, medial geniculate body; mgpo, magnocellular preoptic nucleus; ML, medial lemniscus; mipo, 
medial preoptic nucleus; MTg, mammillotegmental tract; mvb, medial vestibular nucleus; MZ, 
marginal zone; n III, oculomotor nucleus; nic, nucleus of inferior colliculus. np, nucleus proprius of 
posterior commissure; nVmes, mesencephalic nucleus of trigeminal nerve; n VII, nucleus of facial 
nerve; nVsp, spinal tract nucleus of trigeminal nerve; pI CPf, pyramidal layer of pyriform cortex; pi 
OTU, pyramidal layer of olfactory tubercle: PN, pons; pn, pontine nuclei; PNRF, pontine reticular 
formation; pnrt, pontine reticular nuclei, pre, pretectal nucleus; pot, posterior thalamic nucleus; 
prm d, premammillary nucleus (dorsal part); prm v, premammi'liary nucleus (ventral part); PT, 
pyramidal tract; pvh, paraventricular hypothalamic nucleus; pvt, paraventricular thalamic nucleus, 
rd (B7), dorsal raphe nucleus (serotonergic); ReF, reticular formation; rm (B3), nucleus raphe 
magnus (serotonergic); rmd (B8), nucleus raphe medianus (serotonergic); ro (B2), nucleus raphe 
obscurus (srotonergic); rt, reticular thalamic nucleus, S, subiculum; sc. superior (anterior) 
colliculus; SCbP, superior cerebellar peduncle; sch, suprachiasmatic nucleus; sdn, sexual 
dimorphic nucleus; SEP R, septum pellucidum (roof); sm, supramammillary nucleus; so, superior 
olivary nucleus; sot, solitary tract nucleus, son, supraoptic nucleus; STT, stria terminalis; SUT, 
subthalamus, SVZ, subventricular zone; tb, nucleus of trapezoid body; vdb, ventral nucleus of 
diagonal band of Broca; vig, ventral lateral geniculate body, vmh, ventromedial hypothalamic 
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Tomato lectin clearly identified microglial progenitors and amoeboid cells at E15. located 
mainly at perivascular sites and associated with infolding of the meninges (Figure 66). These 
cells were distributed in dorsal and ventral regions of the brain and particularly dense around 
the aqueduct, in the tectum, tegmentum and around the pontine nuclei (Figure 64). Microglial 
progenitors identified between E 15 and E 16 were closely apposed to the parenchymal wall of 
cerebral blood vessels or positioned at short distances away from vessels (Figure 66 F-K). 
The majority were found within forebrain ventricular and subventricular zones, in the corpus 
callosum, internal capsule, preoptic area, within areas bordering the caudate-putamen, as well 
as within the tectum (superior colliculus), tegmentum and pons. Very rarely were progenitors 
identified within blood vessels. Amoeboid microglia were typically found in transitory white 
matter tracts (corpus callosum and internal capsule) at some distance from blood vessels 
(Figure 66 L-N). Foetal microglia had already begun to differentiate into bipolar and tripolar 
forms (Figure 66 O-Q), progressing to multipolar cells with long and delicate processes. The 
majority of these cells maintained their close relationship with blood vessels. 
The cerebrovasculature had clearly advanced by E17, forming distinguishable networks 
particularly following caudal to rostral and ventral to dorsal gradients (in such areas as the 
medulla- Figure 67) and the ventral diencephalon. Within these highly vascularised regions, 
microglial differentiation was also more at E17 (Figure 67). Amoeboid cells 
anddifferentiating microglia still prevailed within the VZ and SVZ. By E18, amoeboid and a 
few ramifying cells could be found within the hippocampus and dorsal thalamus (Figure 68), 
within the amygdaloid area, hypothalamus, around the aqueduct and basal pons. Microglial 
progenitors and ramified cells could be seen frequently at perivascular sites. Labelled 
progenitors could occasionally be identified within vessels passing through the ventricular 
zone (Figure 68D). Amoeboid and ramifying microglia were further identified within grey 
matter nuclei (caudate and thalamus) as well as in neural tracts. The ramifying variety were 
increasingly difficult to identify using tomato lectin, probably on account of a lower level 
expression of surface (N-acetylglucosamine containing) glycoconjugates with progressive 





















Tomato lectin-positive microglia in the mouse brain at E15 
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FIGURE 66 (continued) 
Tomato lectin-positive microglia in the mouse brain at E15 
Tomato lectin positive vessels and foetal microglia were detected throughout the brain 
(A). Round and amoeboid cells were found around meningeal vessels (B), at the 
juncture between meningeal infolding and the CNS parenchyma (C), and a few cells 
were associated with blood vessels in the ventricular and subventricular zones (D, E). 
Blood vessel-associated progenitors were frequently detected, most of these in the 
vicinity of, or adherent to the parenchymal wall of blood vessels (F, G). The majority of 
these early blood vessel-associated progenitors (H-K) were identified in the forebrain 
ventricular and subventricular zones, corpus callosum and at the boundary between 
these regions and caudate-putamen, the internal capsule, in the preoptic area, tectum, 
tegmentum and pons. Very rarely was a cell detected within a blood vessel (not shown). 
Amoeboid cells at some distance from vessels (L-N) could be seen in the corpus 
callosum (and cingulate cortex) and its extensions, as well as within the internal and 
external capsules bordering the caudate-putamen. A small number of microglia had 
already begun to differentiate at this age to cells with bipolar and tripolar morphologies 
(O-Q). Many of these differentiating cells maintained their close relationship with blood 
vessels (Q). 
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Tomato lectin-positive early ramified microglia in the mouse brain at E17 
Regional development of the cerebral vasculature had clearly advanced (particularly in 
caudal-rostral and ventral to dorsal gradients) by E17, with blood vessels penetrating 
structures such as the medulla (A) and the ventral diencephalon (not shown). With the 
establishment of the vascular network in these regions, microglia clearly also began to 
differentiate and adopt more mature, ramified forms (C-F). Amoeboid cells and early 
ramified cells continued to predominate within the ventricular (B) and subventricular 
zones. 
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FIGURE 68 
Tomato Pectin-positive microglia in the mouse brain at E18 
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FIGURE 68 (continued) 
Tomato lectin-positive microglia in the mouse brain at E18 
A section of the mouse brain at E18, histochemically reacted with tomato lectin and 
showing the thalamus and hippocampus, is indicated in (A). This corresponds 
approximately to section level 13 on Figure 63. Amoeboid and some few ramifying cells 
could be found in the hippocampus and dorsal thalamus at this age, as well as in the 
amygdaloid area, hypothalamus, around the aqueduct of Sylvius and basal pons. These 
areas were highly vascularised. Microglial progenitors were predominantly located at 
perivascular sites (B-D). Occasionally, labelled progenitors could be seen passing 
through vessels in ventricular zones (E). Amoeboid cells (F) and cells with more ramified 
bipolar and tripolar cell morphologies (G-I) could be identified within grey matter nuclei 
(caudate, thalamus) and within white matter tracts. However, these latter variety 
became more difficult to detect using tomato lectin (perhaps on account of 
downregulating surface carbohydrate residues (glycoconjugates containing N- 
acetylglucosmanine) recognised by this lectin (H, I) in the process of differentiation. 
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In contrast to the progressively fewer microglia detected using tomato lectin, RCA- l lectin 
histochernistry continued to identify the ramifying population (in addition to the amoeboid 
microglia) (Figure 65). This may suggest that whereas microglia downregulate certain 
glycoconjugates (e. g. those containing N-acet ylglucosamine) with advancing development in 
utero, others (e. g. those containing lactose and galactose) are maintained or even upregulated 
on differentiated cells. The discrepancy between lectin-positive microglial distribution was 
clearly evident from E19 onwards (Figure 64 and Figure 65). This finding may have some 
relevance related to the function of microglia, for example in adherence to ECM components 
or in their interaction with other cells in the CNS. 
At E19, tomato lectin clearly identified a surge of newly-emergent progenitors and amoeboid 
cells within the cavum septum pellucidum (Figure 69). These cells appeared larger than the 
progenitors identified around vessels at E15, and were found clustered densely within the 
ventricular zone close to the rostral horn of the lateral ventricle, where they were associated 
with thin-walled blood vessels. A small proportion were dispersed in the overlying corpus 
callosum and a few cells had wandered out onto the ependymal surface lining the ventricles. 
Amoeboid cells were particularly notable within the cavum septum pellucidum at E20 (Figure 
70), and now formed a continuous band of cells subjacent to the corpus callosum. Large 
amoeboid cells tended to accumulate within periventricular regions and there were some 
indications that these cells were extravasating within these areas (Figure 70). In newborn 
animals, ramified RCA-1 positive cells could be clearly seen in highly vascularised sites, 
associated with well-differentiated vessels as shown in Figure 71. Far fewer ramified cells 
could be identified with tomato lectin in newborn animals. In the postnatal animals examined, 
amoeboid microglia were found to predominate within the corpus callosum at postnatal day 6 
(P6) (Figure 72 A-C), while ramified cells were already present within the grey matter at this 
age (Figure 72D). The latter variety became progressively more differentiated and had 
downregulated their lectin-binding sites by P19 (Figure 73). As mentioned previously, GSB4 
lectin was not suitable for detecting microglia in the murine CNS according to the protocol 
established in this study for tomato lectin and RCA-1 (Figure 73). 
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Tomato lectin-positive amoeboid cells in the cavum septum pellucidum of 
mouse brain at E19 
At E19, a conspicuous population of lectin-positive cells emerged distinctly within the 
transitory cavum septum pellucidum (corresponding to section level 8) between the two 
rostra) horns of the lateral ventricle (LV) (A-D). These cells were particularly dense 
within the ventricular zone immediately adjacent to the lateral ventricle (C, D), and very 
closely associated with small delicate vessels within these areas. They were larger than 
the microglial progenitors observed around E15, and resembled round macrophages 
more closely. In view of their relationship with the thin-walled capillaries, they appeared 
to have recently emigrated into the cavum from the bloodstream. The majority of cells 
dispersed into the cavum septum pellucidum and were occasionally detected in the 
overlying corpus callosum, while a small number could be seen attached to the 
ventricular surface of the ependymal lining and within the lateral ventricle (not shown), 
suggesting that they had migrated into the ventricle away from their original site of entry. 
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Tomato lectin-positive amoeboid cells in the cavum septum pellucidum and 
subjacent to the corpus callosum in the mouse brain at E20 
At E20, amoeboid cells within the cavum septum pellucidum had migrated along the 
extent of this structure in a linear formation, underlying the corpus callosum (A, 
arrowheads). Blood vessels within this region and the ventricular zone bordering the 
head of the lateral ventricle, had also developed and become more distinguishable 
(C, G). These large amoeboid cells still tended to accumulate at periventricular sites 
(B, D, E, F), and they appeared to be extravasating within these regions (H-J). 
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Lectin-positive microglia and blood vessels in the mouse brain at birth 
In newborn animals, ramifying RCA-1 lectin positive microglia (B-G) were detected at 
highly vascularised sites within the CNS (A, asterisks), particularly associated with well- 
differentiated vessels in the ventral aspect of the brain. The section shown in (A) 














RCA-1 positive microglia and blood vessels in the mouse brain at P6 
.. 
Six days following birth, amoeboid cells were seen within the corpus callosum (A-C) 
whereas ramified forms were located away from these major foci of accumulation. Within 
the grey matter (D), resting microglia which were in a far advanced state of 
differentiation were much fainter and more easily prone to being overlooked (D, 
arrowheads), by comparison to the amoeboid cells in the corpus callosum. 
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FIGURE 73 
RCA-1 and GSB-4 positive histochemistry in the mouse brain at P12 and P19 
Between the 12th and 1911 postnatal days, parenchymal microglia differentiated further 
and were only weakly labelled with the RCA-1 lectin (A-D). This lectin continued to 
detect mature ramified cells at P19 (C-D). By contrast, GSB-4 was not found to be 
suitable for studying the differentiation of microglia using the procedure outlined for 
tomato lectin and RCA-1. As shown in the figure (E-H), GSB4 formed precipitates on the 
tissue section, thus masking any morphological characteristics that could be ascribed to 
microglia. 
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The results presented here have shown a topographical transition in morphology from 
amoeboid to ramified forms of microglia, that takes place around E 17-E 19 and beyond, based 
on lectin histochemical identification of these cells. The ventral aspect of the brain appears to 
be a major site for colonisation by microglia from E15 in the mouse. Cells within these basal 
areas appeared in a more advanced morphological state of differentiation, with several 
processes. These were interspersed between the developing cerebral vasculature. Thus. the 
differentiation of microglia coincided with the regional maturation of blood vessels, and 
progressed in a caudal-rostral gradient overall. 
Of the immunohistochemical markers examined, only F4/80 was detected on populations of 
foetal murine microglia (Figure 74). F4/80 antigen is a 160Kd cell surface glycoprotein 
expressed by certain mononuclear phagocyte populations (McKnight et al. 1996). Molecular 
cloning analysis has shown that F4/80 shows some dgree of homology to two protein 
superfamilies- the extracellular NH2 terminal contains several EGF-like repeats, while the 
final third of the molecule shows homology to members of the 7-transmembrane hormone 
receptor family. Although a definite function has yet to be ascribed to this determinant, it is 
known to be downregulated by IFN-y and in certain types of infection. Furthermore, it is not 
expressed on macrophages within T cell areas of lymph nodes and spleen. 
Immunohistochemistry with the antibody raised against F4/80 demonstrated microglial 
progenitors and amoeboid cells located in the meninges, within the ventricular zone and at 
junctions with the choroid plexus (Figure 74A-E). Expression of this marker was significant 
on amoeboid cells within the corpus callosum, internal and external capsules (bordering the 
caudate-putarnen), and occasionally seen on paired cells which may have recently divided 
(Figure 74G-K). The small vessel-associated progenitor cells that were detected with tomato 
lectin however, could not be detected with F4/80 antigen. Early ramifying cells were 
immunoreactive for F4/80 in the caudate-putamen, preoptic area, dorsomedial and 
ventromedial thalamic nuclei, habenula, and within the VZ and SVZ. Bipolar cells were also 
detected within the marginal zone underlying the meningeal layer. However, expression of 
this marker was downregulated on these ramifying cells from E18 to E20, and they became 
more difficult to identify (Figure 74 L-O). Few of these early ramified cells could be detected 
at E20 or in newborn animals. The results indicated that IF4/80 antigen. initially present on 
both amoeboid and early ramified cells from E15, was gradually downregulated ww ith 
advancing gestational age. These observations support the view introduced earlier, that the 
embryonic period of microglial differentiation occurs between E 17 and E 19. 
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F4/80 immunoreactive microglia in the mouse brain, E15-E18 
Immunoreactivity with F4/80 detected early progenitors surrounding meningeal vessels 
(A), at junctions between the choroid plexus and ventricular lining (B), occasional 
supraependymal cells (C), and within the ventricular zone (D, E). Very rarely, F4/80 
immunoreactivity was also detected on cells attached to blood vessels (F). The small 
progenitor cells identified with tomato lectin however, could not be detected clearly. 
Instead, F4/80 was significantly expressed on amoeboid cells within the corpus 
callosum, internal and external capsules (G-l), where these cells were occasionally seen 
in pairs, having probably recently divided (I). On the whole F4/80 immunoreactivity was 
relatively weak on amoeboid microglia from E15 onwards. These early cells were in the 
process of differentiating (J-K). By E18 different morphologies were present from bipolar 
to multipolar forms (L-O). These were progressively more difficult to visualise as they 
were only faintly immunoreactive for F4/80 antigen. Fewer cells could be detected using 
F4/80 by comparison with lectin histochemical identification of microglia. 
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Expression of adhesion molecules and chemokines 
Of the adhesion molecules examined, none were detected throughout the period of 
development under study. The finding that ICAM-2 was not expressed in the murine CNS was 
surprising, but important, since this may suggest species-specific differences in the 
recruitment of microglia to the CNS, or specialisation during cerebrovascular development. 
Curiously, the expression of MIP-la was also not found within the developing mouse brain, 
which further questions its role in regulating human foetal microglia. However. MCP-1 
expression was indeed noted within the embryonic mouse brain (Figure 75). MCP-1 
expression was particularly evident at E19, and concentrated within the cortical plate 
(superficial aspect), meningeal layer, and the ventricular laver. Interestingly, similar to that 
found in the human foetal CNS, expression of this chemokine was confined to the lateral 
telencephalon and not detected in the frontal or occipital poles. Unlike the human foetal brain, 
MCP-1 was more intensely expressed in superficial cortical layers, rather than within the 
lower cortical plate and subplate. 
Finally, the embryonic mouse brains were screened for the expression of granulocyte- 
monocyte colony stimulating factor (GM-CSF). MCSF and GMCSF are two growth factors 
considered essential for directing the lineage of myeloid cells to macrophages and 
granulocytes. MCSF is present in embryonic CNS and its receptor found on microglia (Chang 
et al. 1994). Recently, it has been found that microglia are still present, albeit reduced in 
numbers, in the brains of mice deficient in MCSF (Blevis and Fedoroff, 1995; Wegiel et al. 
1998; Wiktor-Jedrzejczak and Gordon, 1996). Therefore, GMCSF, which is produced locally 
by astrocytes in the CNS, may in this respect be hypothesised as equally important for the 
differentiation of microglia. Immunohistochemical expression of GMCSF was not found 
within the CNS parenchyma during the embryonic period, and only weak immunoreactivity 
was detected within the meninges at the earlier time points examined (not shown). Therefore, 
further studies are necessary to evaluate expression of this growth factor within the developing 




















MCP-1 expression in the mouse brain at E19 
Expression of MCP-1 was most noticeable in the cortical 
plate (particularly the superficial cortical plate, sc), within 
the meninges, and additionally on the ventricular lining/ 
ventricular zone. Furthermore, immunoreactivity within the 
cortical plate was mainly confined to the lateral neocortex. 
(A) Horizontal section of the brain at E19, showing the 
hippocampus and overlying cortex. Higher magnification of 
neocortex (B), to show immunoreactivity within the cortical 
plate. 
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Chapter IV HUMAN FOETAL MICROGLIA IN TISSUE CULTURE 
In Chapter II, we saw that the distribution and differentiation of microglia within the 
developing human CNS coincided both regionally and spatially. with that for astrocytes 
during the same period. This suggested that a functional interaction may take place between 
these two cell types during the second trimester that may directly influence their proliferation 
and differentiation. It was shown that selective expression of chemokines (notably MCP-1, 
RANTES, MIP-1 a) and chemokine receptors (CCR2. CCR5. CXCR4) within the human 
foetal CNS could be responsible for directing the colonisation and spatial distribution of 
microglia during the second trimester. 
This Chapter will further investigate (i) the dynamic morphological interaction between 
human foetal microglia and astrocytes maintained in tissue cultures, (ii) characterise the 
phenotypical expression of specific chemokines (notably MCP-1, RANTES, MIP-1 a) and 
chemokine receptors (CCR2, CCR5, CXCR4) by these two cell types in co-culture, and (iii) 
assess the response of these cells to select recombinant chemokines. The fundamental 
questions of how ramified microglia develop and maintain their regular spatial distribution 
were also examined in these tissue culture preparations. 
The following questions are addressed: 
0 Is there a direct morphological transition between amoeboid and ramified microglia? 
0 How are microglial morphology and motility influenced by astrocytes in subconfluent 
compared to confluent cultures? 
0 Do human foetal microglia maintain their electrophysiological characteristics by 
demonstrating inward-rectifying K+ channels in vitro, and how does this compare with 
rodent preparations? 
0 Is the expression of certain chemokines in these co-cultures related to cellular interactions 
and the morphological transformation of microglia? 
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MATERIALS & METHODS 
Human material 
Primary human brain cultures, and bone marrow preparations were established from tissues 
obtained from elective pregnancy terminations at King's Healthcare NHS Trust. These were 
collected with approval of the ethical committees of the Bethlem, Maudsley and King's 
Healthcare NHS Trusts. Intact and dissected foetal (13-19 weeks of gestation) brain tissues. 
were collected, placed in holding medium (HM: HBSS (modified). 2mM glutamine, 10mM 
HEPES buffer, 20p. g/ml gentamycin sulphate and transported to the laboratory for culture 
preparation within 2-3 hours after clinical collection. Gestational age (in weeks) was estimated 
according to the following criteria in order of preference: anatomically by crown-to-rump 
length, foot length, hand measurements and calculated from last menstrual period. 
Primary human foetal CNS cultures 
Primary human foetal microglia and astrocyte co-cultures and isolated cultures were 
established as previously described (Rezaie et al. 2002). We and others (Williams et al., 1992) 
have found that adherence properties of foetal and adult human microglial cells contrast those 
of neonatal rodent preparations where microglial cells are less adherent than astrocytes and 
thus can be floated off by rotary shaking. The rotary shaking method of McCarthy and de 
Vellis (1980), although cited on numerous occasions as suitable for rodent material, was found 
to yield too few microglial cells in our human foetal preparations. Human foetal brain 
macrophages/microglia were found to emerge from explant cultures grown on agar for 3-4 
days without a change in medium and proliferated extensively (as described for rodent organ 
`explant' cultures) see Figure 76. The modified technique of holding intact tissue in medium 
for 3 days prior to dissociation was therefore used as a pre-requisite for obtaining higher 
yields of microglia in this investigation. The basal culture medium employed RPMI 1640 
supplemented with IOOU/ml penicillin. 100µg/ml streptomycin, 2mM glutamine and 5% FCS. 
Samples were not pooled between gestational ages. Instead. material from each sample was 
cultured in isolation to maintain homogeneity of cultures. Briefly, tissues were carefully 
dissected on a sterilised gauze, meninges and contaminating blood vessels micro-dissected and 
discarded. The entire intact tissue was then transferred to a 25cm3 sterile plastic tube 
containing culture medium and maintained in an incubator for three days. Cells were obtained 
in the absence of proteolytic enzyme digestion, as this allowed for immunophenoty pic and 
functional characterisation without concomitant alteration in cell surface features associated 
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FIGURE 76 
Human foetal CNS explant culture preparations cultivating microglia 
Phase-contrast microscopic images of mixed glial cultures (A, B), enriched for activated 
(C) and progressively ramified (D) microglial cells. 
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As it was previously found that foetal CNS cultures were sensitive to digestive enzymes. 
repeated mechanical dissociation of cerebral cortical cells was carried out instead, using 
progressively finer fire-polished Pasteur pipettes to obtain isolated cell suspensions. 2x 105 
cells/ml were seeded in 25 or 75cm3 flasks or on circular glass coverslips immersed in 12124 
well plates. Poly-l-lysine, laminin, fibronectin (10µg/ml) and primaera-coated flasks 
(Falcon/Nunclon) and coverslips were used for comparison of culture adherent cells. Cultures 
were maintained in RPMI 1640 medium (Sigma) supplemented with 5% heat-inactivated FCS 
(Sigma), 1% normal human serum (Sigma), 2mM glutamine, 1% penicillin/streptomycin 
solution (10O'[ß/ml penicillin, l 00µg/ml streptomycin) and 2x 10"' M ß-mercaptoethanol, in 
an incubator at 37°C. All solutions were filter-sterilised through a 0.2mm pore filter (which 
excludes the smallest bacterial contaminants -0.8mm) prior to adding to the medium. The use 
of heat-inactivated foetal calf serum was of particular significance, since heat inactivation 
destroys complement, in order to prevent activation of mononuclear phagocytes in culture. 
Essentially, heat-inactivated serum is both antibody-free and complement-free. Likewise, all 
instruments and appliances were autoclaved and rinsed in endotoxin-free water to eliminate 
contamination and activation of cell cultures. The medium was replaced 50% every 3-4 days, 
and cultures maintained for up to six months. 
Seeding density is known to influence cellular proliferation of microglia (Alliot et al. 1991). In 
all preparations a seeding density of 2x 105 cells/ml gave consistent and reproducible 
numbers of microglia. The gestational age of foetal tissue also determined the relative ratio of 
microglia to astrocytes in our hands (i. e higher number of ameboid microglial cells derived 
from 14 weeks or earlier specimens). The above method was found to result in a pure co- 
culture of astrocytes ('95%) and microglia (-5%) over a period of four weeks, without 
contaminating oligodendrocytes or neurons, similar to that previously described in rodent 
CNS preparations (Giulian and Baker, 1986) and human preparations (2% microglia: Lauro et 
al. 1995). More purified (>99%) astrocyte cultures were established with prolonged incubation 
in culture and less frequent change of medium, and by passaging and removal of microglial 
cells by the rotary shaking method (these were harvested for isolated microglial culture 
preparations). 
Characterisation of glial cultures 
In order to define the cell populations isolated, cultures were fixed in situ with methanol and 
characterised immunocytochemically (Table 6) with antibodies to macrophages/microglia 
(CDllb, CD45, CD64, CD68), astrocytes (GFAP), and endothelial cells (PECAM-l. 1: 00 
dilution, Serotec. UK), and glial progenitors (04, A2B5,1: 50-1: 100 dilution, Biogenesis. UK) 
according to standardised protocols (Dako ABC-HRP method and Vector Alkaline- 
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phosphatase protocol). These produced brown-black (DAB). violet (Vector VIP) and red 
(Vector red) reaction products. Where appropriate the DAB chromogen eaction product was 
enhanced using Nickel or Cobalt chloride to give a dense blue-black precipitate. Additional 
immunoreactivity to PCNA (Serotec, UK) and was also assessed. Cytospin preparations were 
also used for cellular identification and characterisation, following dissociation of cells with 
trypsin-EDTA (Sigma, UK). Some samples were frozen in situ in FCS containing 1001"o 
DMSO, and subsequently stored at -70°C. These were used for electrophysiological 
verification (cell recovery 10-20%). Co-cultures were screened for expression of chemokines 
and chemokine receptors Table 7. 
Immunocytochemistry 
Many variations of immunocytochernical protocols are available for demonstrating reactivity 
in situ on frozen or paraffin-embedded sections. Our previous studies in vivo employed a 
modification of the DAKO-ABC-HRP method, described in detail in Chapter 2 (Rezaie et al. 
1997; Simpson et al. 2000), which has now been adapted for cells in culture. Permeabilisation 
of cells (with a detergent such as Tween 20 or Triton X-100) is necessary in order to 
demonstrate detection of intracytoplasmic in addition to surface antigens. The protocol renders 
cells viable for immunoreactivity while preserving microstructure as viewed using 
conventional light microscopy. For negative controls the primary antibody was omitted from 
the procedure and cells were incubated with normal sera alone. Frozen tissue from the CNS of 
two cases diagnosed with multiple sclerosis served as positive controls (Simpson et at. 2000). 
Digitised pictures of cell cultures were captured as *. tif format files and processed using a 
video camera mounted onto a Zeiss Axioplan microscope and OPTIMAS v6.0 image analysis 
software for windows. 
Time lapse video microscopy 
In viable cultures, microglia were identified under phase-contrast microscopy on the basis of 
morphological characteristics (determined from previous immunostained preparations). 
Culture flasks were placed in a temperature (37°C). humidity and CO2 regulated chamber 
mounted onto the stage of a microscope (Zeiss Axiovert 135M) with a gas lamina flow 
attachment. Images were recorded using a CCD videocamera connected to a black and white 
monitor via a time-lapse video cassette recorder (Panasonic AG-6720, recording speed range 
from 0 to 480 hours). Live microglia were identified in culture fields under low magnification 
according to characteristic morphologies. Individual cells or a group of cells in close 
proximity were selected for study at higher magnification. The video recorder was set to 1/160 
speed (i. e. a3 hour tape converted to 480hours) for recording of cultures. Frames were 
simultaneously captured using a conventional camera. Individual sequences of images were 
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subsequently converted to *. tiff files from video tapes using a Windows-based editing 
software (Mirovideo Studio 200 for Windows 95 (video image frame grabber), Video Director 
3.0, Pinnacle Systems Inc. USA). These were used for analysing various parameters. For 
confirmation and to identify the cell types, the same cells that were analysed by video time- 
lapse were immediately fixed by replacing medium with 100% methanol, and processed for 
immunocytochemistry to monocyte/macrophage markers CD1lb/CD45/CD64/CD68 
(microglia) and GFAP immunoreactivity (astrocytes), as previously outlined. 
Analysis of process length, area occupied and motility of microglia 
Measurements of the extent of ramification (total length and number of processes), 2- 
dimensional areas occupied by cells and motility of microglia in the co-cultures were 
investigated using the OPTIMAS programme, version 6.0 (OPTIMAS corporation, USA). The 
software was initially calibrated to the dimensions of the screen image (µm) for subsequent 
frame by frame sequence analysis of area, extent of ramification and velocity. Area 
morphometry was calculated from individual contour images of the cells using a digital 
recording pen. The total length of processes was determined by summation of the lengths 
obtained from a constant central point on the cell to the most distal tips of processes. 
The `analysis of motility/determination of velocity' utility on the OPTIMAS programme 
enabled tracking of objects through a time-sequenced series of images and computed 
direction, distance travelled, position and velocity for each object tracked. The velocity of 
microglia in co-cultures was determined using a correlation-based analysis of contour images 
individually and precisely outlined with a digital recording pen. Contour images were 
computed and compared at defined time intervals. The optimum fit of successive image 
sequences resulted in the localisation of the cell (given as x and y co-ordinates) from which 
the migrated distances (µm) and velocities (µm per hour) were calculated. The overall velocity 
of a given cell was also presented as the mean value for all time points during the experiment. 
Motility was defined as retraction/protraction of processes, or through comparison of 
individual cell bodies at the beginning and end of each experiment, when a cell had migrated a 
distance of at least more than one cell body diameter in any direction. All analyses were 
performed in the absence of growth or additional factors (medium alone). 
Treatment of glial cultures with recombinant human chemokines and bacterial LPS 
Effect of recombinant human MCP-1 and MIP-I a on astrocv ie proliferation 
Tissue samples from human foetal CNS at 19 gestational weeks were cultured for 8-9 weeks 
in 75cm' plastic flasks until astrocytes attained full confluence. Microglia were depleted using 
the rotary shaking method and cells were trvpsinised and passaged onto round glass coverslips 
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coated with poly-l-lysine and inserted in 12 well plates. These were allowed to adhere for 72 
hours, prior to treatment with 0.5.2.5,10 and 50ng/ml of recombinant human chemokines 
(diluted in HBSS containing 0.1%BSA) for 18 hours [rhMIP-l(x (10}ig/ml lyophilised) Sigma 
Chemical Co., Ltd; rhMCP-1(10µg/ml) R&D systems, Europe]. Cells were fixed with 
methanol and stained with Haematoxylin (light microscopy) or Hoechst 33342 (fluorescence 
microscopy), and nuclei were counted in 20 random non-overlapping fields at x200 
magnification, using a 10x10 grid eyepiece graticule. All assays were carried out in duplicate, 
and data given as the mean number of nuclei per 200x field ± SEM. 
Effect of recombinant human chemokines and LPS on foetal CNS cultures 
Samples of CNS material from 13,14 and 15 gestational weeks were processed for tissue 
culture as described. Glial cells were passaged onto coverslips in 12-well plates for seven days 
and treated with 0.5,2.5,10 and 50ngIml recombinant human chemokines or 5,50,500 and 
5,000ng/well LPS for 18 hours. Cells were fixed in methanol and stained 
immunocytochemically for MCP-1 and CCR2. Immunoreactivit}ý from triplicate assays was 
graded, and carried out in direct comparison with baseline expression of MCP-1 and CCR2 in 
unstimulated cultures and in control tissue sections. 
Assessment of the response of human foetal microglia and astrocytes to recombinant 
human chemokines using the Dunn chemotaxis chamber 
Attempts were also made to assess directed migration of human foetal glial cells in response 
to recombinant human MCP-1 and MIP-1 a, using the Dunn chemotaxis chamber (Weber 
Scientific International, Teddington, Middlesex) (Allen et al. 1998; Webb et at. 1996; Zicha et 
al. 1991,1997). This system allows the migration, persistence and directionality of cells to be 
monitored in relation to the direction of the chemoattractive gradient, in more stable and linear 
concentration gradient of chemoattractants than can be achieved using Boyden chambers. The 
Dunn chemotaxis chamber is essentially a modified Helber counting chamber slide. Cells are 
initially cultured onto coverslips that are then inverted onto the slide. Those cells that rest on 
the annular bridge of the chamber (the coverslip is separated by a thin gap of no more than 
-20µm from the slide, due to the continuity of fluid between the outer and inner wells), can be 
observed using phase-contrast and fluorescence microscopy, and their migratory tracks can be 
recorded using automated time-lapse video analysis or frame-by-frame sequence analysis 
under fluorescence optics. The normal procedure to set up gradients. would require both 
concentric wells of the chemotactic chamber to be filled with chemoattractant-free medium, 
and the coverslip seeded with cells inverted onto the chamber in an offset position, allowing 
access to a narrow slit at one edge for refilling the outer well. After firmly seating the 
coverslip, it would be sealed into place using melted dental wax. The medium would next be 
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drained from the outer well and replaced with medium with or without chemoattractant. Cells 
placed in a concentration gradient (for example macrophages responding to MCSF), Nz ill 
polarise and migrate towards the source of chemoattractant. 
The following modifications of this procedure were used in this study: 1.10 and 100ng/ml of 
recombinant human chemokines: MIP-la (Sigma, UK) and MCP-1 (R&D systems, UK) were 
made up in RPMI 1640, and 20µl of each placed in the inner well of separate chemotaxis 
chambers (Figure 77). In the initial attempts 80.. 1 of a fluorescence-labelled cell suspension 
was placed in the outer wells and a round 16mm coverslip overlaid onto the chamber. These 
cells had been dissociated from confluent co-cultures or isolated preparations of human foetal 
microglia and astrocytes, by first washing in HBSS (lacking in calcium and magnesium), 
detached from the flask using trypsin/EDTA, and the cell suspensions spun and washed with 
HBSS (non-modified). They were next labelled in suspension with a weak RCA-1 solution 
(1: 10,000 RCA-1 conjugated to rhodamine (excitation wavelength 570nm. emission 595nm) 
for 30 minutes, Vector Laboratories, UK) or 1: 500 dilution of PG-M 1 conjugated to FITC (for 
30 minutes, Dako UK, excitation wavelength 490nm, emission 520nm), spun down and 
washed twice with HBSS, before being labelled with the cell viability marker calcein AM 
(1: 500 dilution for 30 minutes, Molecular Probes). Calcein AM (excitation wavelength 
495nm, emission 520nm) is among the most reliable indicators of cell viability from a number 
of recognised dyes that label live cells in tissue culture (including carboxy 
fluoresceindiacetate/CFDA, fluoresceindiacetate/FDA, BCECF/AM, acridine orange). It is 
reported to display superior retention by mammalian cells and its green-yellow fluorescence is 
insensitive to pH. Calcein (the hydrolytic product of calcein AM) is a polyanionic fluorescein 
derivative with six negative and two positive charges at pH7. Specifically, unlike the other 
dyes, calcein AM does not interfere with leukocyte chemotaxis, superoxide production, or 
affect lymphocyte conjugation with target cells (Callewaert et al. 1991; DeClerck et al. 1994; 
Denholm and Stankus, 1995; Mandeville et al. 1995; Racliff et al. 1991). The leaching of 
calcein from loaded cells has been used as a measure of membrane permeability in response to 
temperature (Bischoff et al. 1995). cellular damage or assays of cytotoxic T lymphocyte 









ýf chemokine gradient 
chemokine source 
Schematic illustration showing the principle behind the application of the 
Dunn Chemotaxis Chamber 
Cells deposited in a well located around the periphery (a), migrate along a flat, raised 
platform (shaded grey) along a chemotactic gradient towards the central source of a 
chemoattractant (b). Alternatively, isolated microglial cells cultivated on a glass coverslip 
(coated with laminin, fibronectin, poly-L-lysine) or microglia co-cultured with astrocytes 
can be overlaid onto the chamber and the rate of migration towards or away from the 
central source can be estimated from a series of images captured over a set time-frame. 
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Next cells were spun down and washed in HBSS, reconstituted in pure RPMI 1640 medium 
and counted using a haemocytometer to obtain approximately 2x 105 cells ml. In order to 
further substantiate determine the viability of cells, and assist in their tracking, cell nuclei 
were stained with propidium iodide (0.125µg/ml, red fluorescent, excitation wavelength 
530nm, emission, 615), Hoecshst 33342 or Hoechst 33258 (0.25µg/ml UV fluorescent, 
excitation wavelength 355-365nm. emission wavelength 465nm). The Hoechst dyes bind to 
the minor groove of DNA at A-T rich sequences. Hoechst 33342 permeates cells more rapidly 
than Hoechst 33258, and is commonly used for determining the DNA content of viable cells 
without detergent treatment or fixation (Arndt-Jovin and Jovin, 1977; Shapiro, 1989). Data 
obtained with Hoechst 33342 correlates less well with the red fluorescent propidium iodide 
which is a cell-impermeant nucleic acid (DNA/RNA) stain (Myc et al. 1992). Hoechst 33342 
is initially taken up by apoptotic cells, whereas cell-impermeant dyes such as propidium 
iodide and ethidium bromide are excluded. Later stages of apoptosis are accompanied by an 
increase in membrane permeability, which allows propidium iodide to enter cells. Therefore, a 
combination of Hoechst 33342 and propidium iodide can be used for analysing the stages of 
apoptosis and cell cycle distribution (Belloc et al. 1994; Curnow et al. 1994: Ormerod et al. 
1993; Sun et al. 1992) 
In subsequent experiments, the same labelling procedures were used on cells cultured onto 
poly-L-lysine or laminin-coated glass coverslips, and these were overlaid directly onto the 
chemotaxis chamber. All assessments were made at room temperature, in the dark, and in 
triplicate. Photographs of fluorescent cells over defined areas of the platform that formed a 
bridge between the inner and outer wells (shaded grey in Figure 77) were captured manually 
at 15-20 minute intervals over a period of up to 6 hours. At the end of experiments, cells were 
fixed with 1% paraformaldehyde solution for 30 minutes, and coverslips mounted onto a slide 
using fluorescence mounting medium (0.42g glycine, 0.021 g sodium hydroxide, 0.51 g sodium 
chloride, 0.03g sodium azide, dissolved and made up to 30m1 in water, to which was added 
70ml glycerol). 
Electrophysiological recording of glial cells 
Human foetal mnicroglia and astrocytes (prepared from samples at 13 and 17GW) which had 
been previously stored frozen at -70°C were rapidly thawed at 37°C and transferred to a 
universal tube, diluted dropwise in approximately 10ml of RPMI 1640 medium. They were 
spun and washed twice in HBSS, prior to transferring to a culture flask in the presence of 
supplemented RPMI 1640 culture medium (as described, with the exception that 10% heat- 
inactivated foetal calf serum was used for re-culturing these cells). They were cultured for 7-2 
hours and seeded onto glass coverslips for electrophysiological recording. Glial cultures were 
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also prepared from the cerebral cortex of newborn Wistar rats. Cortical tissues were carefully 
freed of meninges and blood vessels, trypsinised for two minutes, and dissociated with a fire- 
polished pipette, and washed twice. Mixed glial cells were cultured for 9-12 day's in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% foetal calf serum and 
antibiotics. Medium was changed every three days. Microglia were separated from underlying 
astrocyte monolayers by gentle rotary shaking (100 rpm) of the flasks for 1 hour in an 
incubator at 37°C. Cells collected in the supernatants were seeded at a density of 4x 104 
cells/well onto glass coverslips. 
Electrophysiological recordings were conducted under the guidance of Drs. Christiane Nolte, 
Carsten Ohlemeyer and Clemens Boucsein in the laboratory of Professor Dr. Helmut 
Kettenmann, Berlin, January 1997. Recordings were made using the conventional patch-clamp 
technique in the whole-cell configuration (Boucsein et al. 2000). Coverslips with cells were 
placed in a chamber which was continuously perfused with bath solution ([134mM] NaCl, 
[2.5mM] KC1, [1.3mM] MgCl2, [2mM] CaCI2. [1.25mM] K2HPO4, [26mM] NaHCO3; 
[10mM] D-Glucose) at a flow rate of 4-6 ml/minute. The electrode solution contained 
[ 130mM] KCI, [2mM] MgC12, [0.5mM] CaCI2, [2mM] Na-ATP, [5mM] EGTA, [ 10mM] 
HEPES. Recordings were made using microelectrodes pulled from borosilicate capillaries 
with filament (6-8Mg). Cells were monitored using live video camera output to a black and 
white monitor, as the pipette was advanced under microscopic view. Pressure was applied to 
the pipette once it was resting on a cell, as indicated by an increment in oscilloscope readout. 
Non-compensated currents were recorded with conventional electronics (EPC9 amplifier, 
HEKA electronics, Germany) at a sampling rate of 3 KHz, and signals filtered at 2.9K-Hz. 
Microglia were clamped close to their membrane potential of -70mV (ranging from -40mV to 
-70mV holding potential, for all glial cell types recorded), for recording membrane currents. 
Membrane currents could be reliably recorded for up to one hour when cells were clamped at 
a holding potential of -40mV for astrocyte/oligodendrocytes and their precursors and -70mV 
for microglia. Membrane currents were activated by stepping of voltage for 50-75 msec to 
depolarising and hyperpolarizing potentials from the holding potential. Nine steps, each with 
an increment of IOmV were performed in each direction (i. e. for microglia, down to -160mV: 




Morphology, electrophysiological properties and phenotype of human foetal 
microglia maintained in culture 
Microglia in isolated preparations were typically found to adopt unipolar, bipolar, amoeboid, 
and less frequently, multipolar morphologies over a period of 1-2 weeks following initial 
cultivation (Figure 78). However, the `amoeboid' variety in isolated cultures tended to be 
more noticeably flattened than rounded in appearance. These cells rarely survived beyond the 
second week without the addition of growth factor supplements to the medium. Isolated 
human foetal microglia adhered to laminin, fibronectin, poly-l-lysine and primaera-coated 
flasks with similar adhesive properties. There was no significant variability in morphology 
associated with substratum. However, microglia in these cultures extended long threadlike 
processes of small diameter. More stable `thorny' projections were emitted at regular intervals 
from pseudopodial extensions or from the cell body area. These were reminiscent of `thorny 
projections' on microglia reported in vivo. All varieties were capable of phagocytosis of 
cellular debris as evidenced by engulfment of particles and accumulating granular vesicles 
within the cytoplasm. However, astrocyte-conditioned medium derived from the supernatant 
of confluent astrocyte cultures failed to promote ramification of isolated microglia in these 
cultures. 
Human foetal microglia and astrocytes derived from material between 13 and 19 weeks gave 
consistent homogeneous cultures. With progressive time in culture, astrocytes formed 
confluent monolayers with motile microglia occupying distinctive areas above or beneath the 
astrocytes. In contrast to the uniformity of confluent astrocytes, microglia were heterogeneous 
in shape (amoeboid, bipolar, ramified). When co-cultured with subconfluent astrocytes, 
microglia tended to preferentially interact and associate with these cells and adopted an 
amoeboid morphology in the initial stages of cell culture (Figure 78 and Figure 79). This 
association occurred between individual cells and there was occasional evidence of cellular 
division as a result of this union (Figure 79F). Nevertheless, microglial cell numbers did not 
vary considerably in these non-stimulated cultures, with only very occasional cells expressing 
PCNA, as a marker of proliferation (S-phase of cell cycle). Attachment to astrocytes involved 
several stages (Figure 79G-L), whereby amoeboid microglia migrated along astrocytic 
processes towards the cell body area where they adopted a perinuclear position overlying the 
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FIGURE 78 
Morphology of human foetal microglia maintained in isolated culture 
preparations (top panel) and in co-culture with foetal astrocytes (lower panel) 
Light microscopic images of CD45: CD68 immunostained microglia in isolated 
preparations (A-N), and in non-confluent astrocyte co-cultures (a-n). 
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Interactions between microglia and astrocytes in culture 
(A-F) Microglia preferentially associated with both type I (e. g. B) and type II (e. g. D) 
astrocytes within the first week in culture This association usually occurred between 
individual cells, and occasionally there was indication of cell division as a result of this 
union (F). Microglia interacted with astrocytes in a stereotypical manner as shown in G- 
L, and underwent progressive ramification with confluency of astrocytes in co-culture (K- 
L). Note the perinuclear position adopted by microglia overlying astrocytes. Scale bar 





Microglia maintained in tissue culture possessed an inward rectifying potassium current, 
irrespective of the morphological state or species derivation (rodent versus human) (Figure 
80A-D). This property is known to differ from macrophages that show an outward current (not 
shown), as well as from glial precursors which typically show a delayed outward rectifying 
current Figure 80E, and from astrocytes and oligodendrocytes. that show large passive inward 
and outward currents Figure 80F. By comparison, neurons have voltage-gated sodium 
channels, not found on microglia (data not shown) 
In more confluent cultures, the morphologies of foetal microglia varied from round/ amoeboid 
forms to bipolar, tripolar and multipolar varieties overlying confluent astrocvtic layers (Figure 
81). Estimates of the number of microglial sub-types were of the order: 75% amoeboid, 12- 
15% bipolar/tripolar and 12-15% multipolar. Microglia could also be identified below the 
layer of astrocytes (Figure 81, see also Figure 89A-F), and these flattened cells roamed 
freely, occasionally extending sheetlike motile projections upwards between astrocytes, as 
viewed by time-lapse video microscopy. Microglia varied in size from 30-50µm in diameter. 
Some amoeboid cells displayed granular vacuolar cytoplasm with numerous lysosomes and 
lipid droplets. 
Astrocytes and microglia displayed considerable heterogeneity in their phenotype, but could 
be consistently identified using antibodies to GFAP and CD68 respectively. A monoclonal 
antibody cocktail against CD 11 b, CD45, CD64 and CD68 was used to detect all 
morphological subtypes (amoeboid, bipolar, ramified) of microglia. The progressive 
ramification of these cells took place over a period of 1-2 months in co-cultures with 
astrocytes and depended on the gestational age of sample material. 04 and A2B5 positivity 
was minimal or absent in these cultures, as was immunoreactivity to PECAM-1, as an intrinsic 
endothelial marker during development. GFAP immunoreactivity varied between astrocytes. 
Generally, large flattened (type I) cells displayed weak/moderate staining whereas the less 
frequent type II cells and glial precursors in earlier cultures (smaller rounded cells with 
delicate processes) were intensely positive. Purified astrocyte cultures occasionally displayed 
parallel arrays of astrocytic processes that resembled radial glia found in situ (not shown) 
These eventually however, gave rise to confluent monolayers of flattened type I astrocytes 



















Electrophysiological recordings characteristic of microglia, oligodendrocyte 
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FIGURE 80 (continued) 
Electrophysiological recordings characteristic of microglia, oligodendrocyte 
precursors and oligodendrocyte/astrocytes in culture preparations 
The panels on the left show the morphology of cells undergoing the procedure, and the 
corresponding membrane currents (nA) versus time (ms) are presented to the right. 
Membrane currents were activated by stepping of voltage for 50-75 msec to depolarising 
and hyperpolarizing potentials from the holding potential. (A-D) Microglia maintained in 
tissue culture possessed an inward rectifying potassium current as indicated, 
irrespective of the morphological state or species derivation (rat versus human). (A, B) 
postnatal rat microglial preparations, (C, D) human foetal microglial preparations. A 
delayed outward rectifying current is a characteristic typical of oligodendrocyte precursor 
cells (E). Differentiated oligodendrocytes/astrocytes (F) display typical large passive 
inward and outward currents. 
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Human foetal microglia and astrocyte co-cultures 
Microglia can be identified both above (A-D) and below (E, F) the confluent layer of 
astrocytes. CD45/68 positive cells overlying astrocytes tend to adopt amoeboid (approx. 
75%), bipolar/tripolar (-12-15%) or multipolar (12-15%) forms, whereas those 
underlying the astrocytic layer appear flattened due to the confined space. These cells 
roam freely below the astrocytes and often extend sheet-like, motile projections 
upwards, between the astrocytes, which can be viewed clearly with time-lapse video 
footage. Occasionally, amoeboid (rounded) microglia can be seen within open spaces 
that occur between astrocytes (D). Cultures were established from samples obtained at 
15 gestational weeks, cultured for 7-8 weeks. Scale bar represents approx. 250µm in A, 
and 20µm in B-F. 
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Motility and ramification of human foetal microglia 
Microglia were in a continuous state of motion, and the morphological and motile states of 
these cells were dictated by the state of confluency of astrocy-tes in co-culture. The remarkably 
motile nature of microglia was best appreciated using time-lapse video microscopy. More than 
50 microglia in a variety of morphological states were recorded, and seven are presented here 
(Figures 82-88). Pseudopods were continuously protracted and retracted as the cells moved 
incessantly within a defined area and underwent a variety of morphological transformations 
(Figure 82). Individual microglial cells in subconfluent cultures underwent a series of 
transitions from ramified to bipolar and ameboid forms associated with migration and 
differentiation of astrocytes in the immediate vicinity, all within a period of 24hours (Figure 
83). For clarity, this has been presented in a schematic form in Figure 84. 
Some cells demonstrated trailing processes very firmly adhered to astrocytes (Figure 82A-F). 
Consequently as microglia progressively moved away, trailing processes became elongated 
further until a point where they were retracted and other processes extended outwards to 
continuously monitor the culture environment (Figure 82i-vii). These could extend up to 
100µm beyond the surface of the cell body and appeared to arise from retraction of the trailing 
edge of the cell at points of strong attachment to the substratum. Fragments of these thread- 
like processes could be frequently observed strewed across the substrate in culture. 
Active phagocytosis by microglia was indicated by the accumulation of phase-bright and 
phase-dark vesicles (to a lesser extent even in ramified forms of microglia). Cytoplasmic 
vesicles diminished with progressive time in culture, as they were cleared by the cell. Vellum- 
like sheets of lamellipodia demonstrated continual exploratory movement both above and 
below the astrocytic layer, clearing cells of debris. Pseudopods were extended at passing 
particles of debris that were subsequently engulfed and internalised. Even in a distinctly 
ramified form, microglia navigated via the cell body and continuous protraction and retraction 
of processes (Figure 86, Figure 87). However, ramified microglia on confluent layers of 
astrocytes were more stable with respect to directional migration, and tended to occupy 
distinct `territories' (Figure 86). Cell bodies of ramified cells varied between 10-20µm in 
diameter. The state of ramification appeared to be temperature-dependent: if the temperature 
of the culture was reduced to ambient room temperature (approximately 21 °C), ramified 
microglia rapidly retracted their processes and adopted amoeboid morphology. 
Occasionally astrocytes were seen to pull away from microglia. These cells displayed different 
motile characteristics from microglia, resembling fibroblasts or epithelial cells in their 
behaviour: they appeared as flattened fan-like cells and advanced with rippling/ruffling 
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membranes and evident cytoplasmic streaming. At the leading margin of the cell, lamellipodia 
were protracted with a smooth fluid motion, pausing occasionally for brief retrograde 
movements. Astrocyte cultures eventually established extensive sheets of flattened cells and 
moved only at their boundaries. In contrast to the rapid astrocytic proliferation, dividing 
microglia were not seen under time-lapse analysis. 
Microglia in sub-confluent cultures displayed highly motile, amoeboid-intermediate ramified 
morphologies, progressively transforming to stabilised, quiescent ramified cells in co-culture 
with confluent astrocytes. Calculations of area, total length of processes and velocity are 
presented graphically (Figure 85 and Figure 87) for the corresponding cells shown in Figure 
83 and Figure 86. Mean velocities (p. m per hour) for individual cells are presented in Figure 
88. The average mean velocity for cells in the intermediate-ramified form was calculated as 
29.4µm per hour (range from 20.2 to 35.0µm per hour), equivalent to approximately 705µm 
per day. The cell with the greatest number of processes was also slowest with respect to 
directional motility (20.2 µm per hour). In contrast, the cell with greatest velocity (82.8 µm 
per hour) displayed the least number of processes. The rate of microglial cell motility also 
varied to some extent with temperature (personal observations), although this requires further 
investigation. Pearson correlation analysis revealed that the area of a cell correlated with the 
total length of its processes (e. g. cell 3: r2=0.5, p<0.01; cell 5 r2=0.24, p=0.016). There was an 
inverse correlation between the maximum length of processes and velocity of a cell (e. g. cell 
4: r2=-0.48, p<0.001; cell 6: r2=-0.25, p=0.016). This confirms the hypothesis that cells lacking 
processes (in the amoeboid state) are capable of more rapid migratory responses compared to 
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FIGURE 82 
Morphological transformations of amoeboid/ramified microglia in co-culture 
with astrocytes (cells 1 and 2). 
(A-F) Time-lapsed images of a ramified microglia and (G-J) an amoeboid/tripolar 
microglial cell overlying astrocytes in cultures established from CNS at 19 gestational 
weeks, maintained for 12 days in vitro. Elapsed time is given in hours: minutes: 
seconds. The cell shown in (F) was fixed in situ at 4 hours and 3 minutes following 
recording and processed for immunocytochemical identification (CD45: 68 positive 
microglia, brown; GFAP-positive astrocytes, red). The morphological transformations of 
the microglial cell shown in A-F are presented pictorially (i-vii), over a period of 4 hours 
in culture. The intersection of processes with astrocytes (overlying or underlying) are 
shown as dotted lines. Note in particular the points of contact of the process emitted 
from the top end of the cell in (iii) and the vellum-like process that scouts below the 
astrocyte layer in (iv-vii). Bar represents approximately 25 µm in A-J. 
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FIGURE 83 
Morphological heterogeneity and motility of an individual microglial cell in 
co-culture with astrocytes, over a 24-hour period (cell 3). 
(A-H) Time-lapsed images of a microglial cell (indicated by arrow in A) to demonstrate 
transformation from a ramified state overlying an astrocyte (A) to bipolar (D, F) and 
amoeboid (H) forms. Morphological transformation was clearly associated with the 
migration and differentiation of astrocytes in the immediate vicinity (E-H). Co-cultures 
were established from CNS obtained at 16 gestational weeks, maintained for 14 days in 
vitro. Elapsed time is given in hours: minutes: seconds. Scale bar represents 
approximately 30 µm. 
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FIGURE 84 
Stages in morphological transitions of human foetal microglia co-cultured 
with astrocytes 
(A-1) Images taken form time-lapsed recordings of the morphological transformation of a 
microglial cell (shown in A), and typical of the interactions that take place between 
microglia and astrocytes maintained in sub-confluent co-cultures. In (A), an amoeboid 
microglia associates with a well-differentiated astrocyte, (B) migrates along an astrocytic 
process, (C) is positioned overlying the astrocyte cell body, (D) ramifies on top of the 
astrocyte, while its vellum-like and finer processes extend and monitor both the 
underlying astrocyte and the local environment. Eventually, (E) the microglia retracts its 
processes (de-ramification), with the exception of a vellum-like extension which 
continues to monitor the immediate environmental milieu via protracted circular motions 
and retraction. (F) The cell disassociates from the astrocyte, adopts (G) amoeboid, (H) 
tripolar, and (I) bipolar morphologies when isolated. An interaction between a migrating 
astrocyte and the bipolar microglial cell is shown to the right of the figure. The microglia 
extends its cell body region towards the ruffled membrane of an astrocyte which 
advances towards it. This astrocyte, subsequently undergoes rapid differentiation and 
settles down, adopting 'resting' characteristics typical of the original astrocyte 
encountered by the microglia (illustrated to the top left of the figure). 
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FIGURE 85 
Morphological heterogeneity and motility of an individual microglial cell in 
co-culture with astrocytes, over a 24-hour period (cell 3). 
The velocity, area occupied, ramification (total length of processes) and number of 
processes of cell 3 (shown in Figure 83), were analysed over a period of 24 hours. Note 
that the velocity and emission of processes correspond with the morphological state of 
the cell. The microglial cell overlying an astrocyte was initially ramified when 
measurements were recorded. Towards the end of recording however (800min+), the 
cell adopted characteristically tripolar, bipolar and amoeboid morphology, with rapid 
alterations in movement and protraction and retraction of cellular processes. Recordings 
for the total process length for the cell represent the summation of the maximum length 
to the distal tip of each process from a constant central reference point on the cell soma. 
Length recordings for the cell in amoeboid configuration represent the maximum 
diameter. 
; uin. e , vZ! ('iýa`R nA ü. - T, 7, r4' 7Arrv0. 'CVA FAjwING CNS page 181 
Time I minutes 
AL. 
00: 00: 00 01: 07: 24 










00: 00: 00 
9 





Ramified microglia overlying confluent astrocyte layer (cells 4-7). 
Time-lapsed images of ramified microglia displaying numerous processes. Co-cultures 
were established from CNS obtained at 16 gestational weeks, maintained for 34 days in 
vitro. Three microglial cells (arrowheads) are shown in (A) and (B) and a single 
multipolar microglia (arrow) is shown in (C-F). These microglia occupied distinct 
'territories' on astrocyte monolayers, with limited directional movement over a period of 
a few hours. However, continuous rapid protraction and retraction of processes was 
characteristic of these cells. In the ramified state, microglia adopted a defined territory 
within the center of the field. Despite the lack of directional movement, active motility of 
these cells could be observed as they continuously protracted and retracted their 
processes in various directions. Elapsed time given in hours: minutes: seconds. Bar 
represents approx. 25 µm. 
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FIGURE 87 
Graphical presentation of microglial velocity and extent of ramification 
compared between ramified cells on confluent astrocytes (cells 4-7). 
The data correspond to cells shown in Figure 86. In their fully ramified state, human 
foetal microglia displayed a more stable baseline motility (left panel) in keeping with their 
morphology. However, there was continuous dynamic retraction and protraction of 
processes even in this 'resting' state (right panel, ramification). The corresponding 
number of processes for cell 7 are shown on the velocity graph (lower left panel). 
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FIGURE 88 
Graphical presentation of the mean velocity of human foetal microglial cells 
observed and recorded in co-cultures 
Data are presented as mean velocity (µm/hour) ± SEM of cells shown in Figures 82 
(cells 1 and 2), 83 (cell 3) and 86 (cells 4-7). n= number of time points used for 
analysis. The morphological states of the cells are indicated on the graph: amoeboid 
(cell 1), amoeboid-ramified (cells 2 and 3), ramified (cels 4-7). Note that the ramified cell 
with the greatest overall length and number of processes (cell 7) also displayed the 
lowest mean velocity. 
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Progression of cultures and detachment of microglia from confluent astrocytes 
Ramified microglia were obvious in older cultures (>I month). These cells possessed a small 
cell soma, many branched processes and lacked cytoplasmic vacuoles. These ramified 
microglia corresponded to a minor population of the total cells in culture (2-5%). 
Occasionally, ramified cells were situated within an open space between astrocytes in culture, 
but more frequently observed overlying the monolayer, and occupying distinct fields. This has 
been noted for rodent co-cultures (Glenn et al. 1989; Jordan and Thomas, 1987). In longer- 
term cultures, isolated and flattened microglia were additionally detected beneath astrocytic 
monolayers (Figure 89A-F). Those overlying the astrocytes eventually detached from these 
confluent cells by first retracting their processes, and adopting bipolar then amoeboid 
morphology prior to detachment (Figure 89G-L). The entire process took place within 
approximately one and a half hours as noted in time-lapse footage (Figure 90). A small 
proportion of the cells underwent a form of controlled cell death within 45-90 minutes, 
whereby the cell first became rounded, showed marked cytoplasmic blebbing, which was 
followed by nuclear rearrangement, fragmentation and rapid cell expansion. So far it has not 
been possible to detect whether this form of cell death is `apoptosis', since TUNEL reactivity 
is negative in cultures. Prior experience from a number of pathological diseases, has shown 
that similar terminal morphological stages of macrophages also occur in situ (Figure 91). 
These cells can be found to accumulate cytoplasmic vesicles, and frequently at sites of 
greatest pathology, they can be found with a distended cell body, where intracellular 
components including the nucleus have been displaced to the periphery, or are altogether 
absent. These presumably defunct cellular `remnants' probably await clearance within the 










Morphology of human foetal microglia maintained in extended co-culture with 
confluent astrocytes 
Light microscopic images of CD45: 68 immunostained microglia in confluent astrocyte 
co-cultures. With prolonged culturing (>2-4 weeks), microglia progressively adopt 
bipolar, tripolar and flattened morphological forms below the confluent layer of 
astrocytes (A-F), whereas cells that overly the astrocyte cultures begin to retract their 
processes, round up and eventually detach from the astrocyte layer into the supernatant 
(G-L). Occasionally, cells that detach also undergo a form of controlled cell death (see 
Figure 90 and Figure 97). 














The process of microglial cell death following detachment from confluent 
astrocytes in co-culture preparations 
Time lapse video microscopic images of solitary microglia (A, G) passing through the 
stages of detachment from the underlying confluent astrocytes and eventually 
undergoing a form of cell death which involves rapid cellular convulsions, blebbing at the 
cell surface, reorganisation of intracellular constituents, and rapid expansion. Note that 
the entire process was complete within an approximate period of 40 minutes to 1 hour, 
at the end of which the phase-dark cell remnant is still bound by a thin membrane at the 
periphery (J-L) (indicating that the cellular contents have been witheld from release, and 
that this may be form of programmed cell death, rather than a result of necrosis). 
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FIGURE 91 
Macrophages within the CNS (A-B, E-G) in Creutzfeldt-Jakob disease and 
within the inner dura mater (C-D) of a case with sub-dural haemorrhage, 
presumed to undergo progressive cell death 
Immunohistochemcal preparations showing various morphological forms of lipid-laden, 
vesicular, CD68 positive brain and dural macrophages, and their cellular remnants at 
the end-stage of disease. Note the weaker staining of membrane and vesicular 
components located at the periphery of defunct cells (arrows in B, C, D). E-G, show 
higher power examples of the proposed stages in the progression of macrophage cell 
death. Figures taken from previously unpublished work by Rezaie and Lantos (A, B, E-G) 
and Rezaie and Al-Sarraj (C, D). 
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Expression of chemokines and chemokine receptors by human foetal astrocytes 
and microglia in culture 
Of all the chemokines tested in these culture preparations (MIP-l(x, MIP-lß, MCP-1, MCP-3, 
RANTES, IL-8, IP-10, SDF-1), only MIP-la and MCP-1 were reproducibly expressed under 
basal conditions (Figure 92, Figure 93). In human foetal astrocyte and microglial co-cultures, 
intense surface and cytoplasmic expression of MIP-la was mainly restricted to microglia 
(Figure 92A, B). Isolated microglia expressing MIP-la usually appeared in pairs (Figure 
92C), a property that resembled MIP-la positive microglia in the intermediate zone of the 
developing human telencephalon. Expression of this chemokine was also found at the surface 
of astrocytes and at borders of contact between astrocytes in longer-term confluent cultures 
(Figure 93B, C). MCP-1 was detected within clusters of sub-confluent foetal astrocytes 
(Figure 93D). However, immunoreactivity was variable between these non-stimulated 
cultures. Variable and weak expression of RANTES was also found, particularly associated 
with cell clusters (data not shown). Importantly, with progressive time, confluent astrocyte 
cultures showed MCP-1 expression at the surface and in distinct intense patches throughout 
cultures (Figure 93E, F), which corresponded closely with overlying intermediate-ramified 
microglia (Figure 94). 
To test whether THP-1 monocytes would selectively adhere to human foetal astrocytes in a 
similar manner to that seen with microglia, and whether MCP- I was important in regulating 
this interaction, isolated sub-confluent astrocytes were co-cultured with THP-1 cells for 24-48 
hours. As can be seen from Figure 95, while many THP-1 cells aggregated on astrocytes that 
expressed MCP-1, this was not an exclusive finding, since a proportion of astrocytes clearly 
expressing this chemokine had very few or no adherent cells. Interestingly, a population of 
isolated THP-1 cells showed some degree of morphological differentiation into large 
microglia-like cells with bipolar or multipolar aspects and spiny or vellum-like processes 
when cultured for up to 48 hours in the presence of 50-100ng/ml recombinant human MCP-1 
(data not shown). Taken together, these findings may suggest that MCP-1 and MIP-1 a act as 
signals not only for the migration, but also the differentiation of microglia. Nevertheless it is 
likely that other factors (diffusible or non-diffusible) are additionally' necessary to mediate the 
interactions between these cells. Clearly however, human foetal microglia did co-localise with 
areas of MCP-1 expression in cultures which attained confluence. as shown in Figure 94. 
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Expression of MIP-1a, CCR2 and CXCR4 in human foetal microglia 
and astrocyte co-cultures. 
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FIGURE 92 (continued) 
Expression of MIP-la, CCR2 and CXCR4 in human foetal microglia 
and astrocyte co-cultures. 
Glial co-cultures derived from human foetal CNS between 13-19 gestational weeks, 
adopted a similar relationship with progressive time in vitro. Microglia in older confluent 
cultures were located both on the uppermost surface and beneath the astrocyte layer 
(A, B). Amoeboid microglia in these cultures demonstrated intense expression of MIP-la 
(A, B, dark brown-black). Similarly, microg'lia in isolated culture preparations were also 
MIP-la positive. However, expression of MIP-1a in these cultures was more intense on 
microglia that occurred in pairs (C, inset: higher magnification of a pair of MIP-1a 
positive microglia). Expression of the ß-chemokine receptor CCR2 (purple-black 
granules) could be detected in GFAP-immunoreactive astrocytes and glial precursors 
(red) maintained in subconfluent cultures (D-F). Expression of this receptor was notably 
confined to vesicular compartments of glial precursors (D, E) and much less was 
detected in type I astrocytes (E, F). Dual-label immunocytochemistry also demonstrated 
CXCR4 expression (brown) by populations of GFAP-positive cells (pale violet) (G-I, K- 
0). Distinct vesicular and perinuclear expression of CXCR4 (brown) was detected in 
astrocytes (G-I, K-N), including type II (K) and type I (L) astrocytes, and in microglia 
overlying astrocytes (J). In addition to cytoplasmic expression, amoeboid microglia 
associated with astrocytes also expressed CXCR4 on their surface (M, N arrows). 
However, surface expression of CXCR4 was more limited in subconfluent astrocytes, 
with only a small proportion of GFAP positive cells (0) demonstrating CXCR4 at the 
surface. Cultures A, B, derived from CNS material at 15 gestational weeks, maintained 
for 25 days in vitro. C: 14 gestational weeks maintained for 32 days in vitro. D-F: 15 
gestational weeks maintained for >30 days in culture, passaged once. G-I, K-0: 19 
gestational weeks maintained for 12 days in culture. L: 19 gestational weeks maintained 
for 12 days in culture, passaged once (maintained for a total of 50 days in vitro). 
Immunoreactivity: A-C: MIP-la, dark brown-black (DAB). D-F: CCR2, violet-black (Vector 
VIP)/ GFAP, red (Vector red). G-O: CXCR4, dark brown-black (DAB)/GFAP, violet 
(Vector VIP). Scale bar approx. 25µm in A, B, D-I, 20µm in C, 7µm in L, 141.1m in K-O. 
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Expression of chemokines MIP-lct and MCP-1 on human foetal astrocytes. 
Immunoreacivity to MIP-1a demonstrated expression of this chemokine on astrocytes 
(B, C) in confluent cultures and particularly at junctions between cells (B). In contrast, 
MCP-1 was expressed specifically within the cytoplasm of differentiating and dividing 
astrocytes in subconfluent cultures (D) and localised to distinct `patches' of astrocytes in 
culture (E, F). These areas coincided with ramified microglia overlying progressively 
confluent astrocyte monolayers (see Figures 81,89 and 94). (A) is a control culture 
where the primary antibodies to MIP-1a and MCP-1 were omitted from the 
immunocytochemical protocol. Scale bars represent approximately 20 µm in A-C and 50 
µm in D-F. 
































MCP-1 expression in human foetal microglia-astrocyte co-cultures 
Immunocytochemistry with CD45: 68 (blue-black: nickel-enhanced DAB), and MCP-1 
(reddish-violet, VIP). Expression of MCP-1 occurs in distinct patches at the centre of 
aggregates of astrocytes in subconfluent cultures (A-D). With progressing confluence of 
cultures, MCP-1 is expressed more diffusely by astrocytes (E-H). At all stages, microglia 
(blue-black) are closely associated with areas of MCP-1 expression. Cultures prepared 
from samples at 14 gestational weeks. 
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FIGURE 95 
Interaction between human THP-1 monocytic cells and astrocytes in vitro 
CD45: 68 immunoreactive THP-1 monocytes (brown-black) cultured with human foetal 
astrocytes tend to aggregate on solitary astrocytes that expressed MCP-1 (red in A-D; 
violet in E, F) (A, B). Various stages in the interaction between THP-1 cells and MCP-1 
positive astrocytes can be detected within 24 hours of co-culture (C-F). THP-1 cells 
typically adhere to the periphery of astrocytes, and are subsequently positioned at 
perinuclear sites on the surface of these cells. THP-1 cell proliferation is evident in some 
instances. However, it is clear from these figures that not all astrocytes expressing MCP- 
1 are bound, which signifies that additional factors are still required for monocytic 
adhesion. 
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Of the chemokine receptors (CCR2, CCR5, CXCRI, CXCR4), only CCR2 and CXCR4 were 
expressed constitutively in astrocytes and microglia (Figure 92D-L). CCR2 was notably 
expressed within vesicular compartments of clusters of glial precursors and occasional type I 
astrocytes in subconfluent cultures (Figure 92D-F). CXCR4 was much more widespread on 
human foetal astrocytes (Figure 92G-I, K-O), and associated microglia (Figure 92J, M, N) and 
specifically on isolated type I astroglia (Figure 92H, I, L). CCR5 expression although not 
detected on human glial cells in vitro, was present on human foetal neurons maintained in 
culture (personal observations). The pattern of intracytoplasmic juxtanuclear 
immunoreactivity for CCR2 and CXCR4 can be attributed to accumulation within the Golgi 
apparatus, as previously noted in other cell types (Halks-Miller et al., 1997; Lore et al., 1998). 
Table 11 lists the estimated percentage of cells in these co-cultures that expressed CXCR4 
under non-activated conditions (basal culture medium). This shows that slightly more than 
half of the cells in culture express CXCR4. Of these approximately half express low 
intracytoplamic levels (<10 granules per cell), and only 10% of the cells demonstrate surface 
expression (the majority of these being microglia, which predominantly show surface 
expression of this receptor). 
Table 11. Expression of CXCR4 in microglia-astrocyte co-cultures 
No expression 
Low cytoplasmic levels 








79.3,14.5` 6.178 b 
[*J Data presented as the mean percentage of cells examined in 100 fields (each field corresponding to an 
area of approximately 0.2mm`) at x200 magnification, assessed in triplicate. Co-cultures were established 
from material obtained at 19GW. 
(e] Out of the total number of astrocytes, 6.17% expressed CXCR4 at the surface 
(ý] Out of the total number of microglia, 79.3% expressed CXCR4 at the surface 
(`] Of the total number of cells expressing CXCR4 at the surface, paired cells 
(microglia/astrocytes) represented 14.5% 
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Effect of recombinant human MCP-1 and MIP-1a on astrocyte proliferation 
Addition of recombinant human chemokines to pure astrocyte cultures produced consistent 
and significant proliferation of these cells above control levels at lOng/ml concentrations, as 
determined by nuclear counts (Figure 96). It is likely that at higher concentrations (>I Ong/ml) 
receptors on these cells become saturated and proliferation is arrested or inhibited. 
Effect of recombinant human chemokines and LPS on foetal CNS cultures 
The effects of chemokines and LPS were next examined on MCP-l, CCR2 and CXCR4 
expression in pure astrocyte cultures (Table 12), and in co-cultures derived from the CNS at 
13,14 and 15 gestational weeks. Basal expression of MCP-1 was noted in clusters of cells in 
these subconfluent preparations (probably proliferating glial progenitors). Treatment of 
cultures with rhMCP-1 did not appreciably alter astrocytic MCP-1 expression in samples 
between 13 and 15 gestational weeks. Although rhMIP-1 cx induced expression of MCP-1 at 
[0.5-50ng/ml] in the 14-week sample, this is inconclusive as this observation could not be 
reproduced in samples derived from 13 and 15 gestational weeks. LPS at 50ng/ml induced 
moderate to widespread upregulation of MCP-l expression in all glial cultures examined. The 
increased expression was related to widespread immunoreactivity in a greater population of 
cells (both astrocytes and microglia) in co-cultures. 
Table 12. Effect of recombinant human chemokines and LPS on the expression of 
MCP-1 and CCR2 by human foetal astrocytes 
MCP-1 
CCR2 
[+1-] weak staining/no appreciable change in immunocytochemical expression 
[+] mild-moderate immunoreactivity 
[+ 41 widespread and intense immunoreactivity 
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Effect of recombinant human chemokines MCP-1 and 
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FIGURE 96 




Effect of recombinant human chemokine treatment on the proliferation of 
human foetal astrocytes. 
Human foetal astrocyte cultures were established from material derived at 19 
gestational weeks, assayed in triplicate. Data represent the mean number of cell counts 
± SEM, from 20 random fields in triplicate. Student's t-test: * very significant difference 
compared with controls (p >_ 0.0), ** highly significant difference compared with controls 
(p? 0.001). 
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The effects of chemokines on expression of the MCP-1 receptor CCR2 was also determined 
(Table 12, lower panel). Treatment of cultures for 18 hours with rhMIP-1 a [2.5-IOng/mil 
induced moderate upregulation of CCR2 receptors expressed intracytoplasmically within 
vesicles as well as on the cell surface. However, rhMCP-1 at a concentration of 50ng/ml 
produced marked and widespread upregulation of the CCR2 receptor including expression in 
Type I astrocytes. By contrast, expression of CXCR4 was not appreciably altered either by 
treatment with LPS or the recombinant chemokines employed. These results demonstrated that 
the expression of CCR2 by human foetal astrocytes could also be upregulated in an autocrine 
manner by astrocytes themselves, which are capable of producing MCP- 1. 
Effect of recombinant human MCP-1 on astrocytes and microglia as determined using 
the Dunn chemotaxis chamber 
Cells previously seeded onto coverslips, or introduced as a suspension directly within the 
outer well of the chemotaxis chamber were readily identified through the use of calcein AM or 
Hoechst 33342 (Figure 97). When rhMCP-l at [10ng/m1] was introduced within the inner 
well, cells in suspension (astrocytes and microglia) began to accumulate at the edge of the 
platform, after a period of exposure lasting between 2 and 6 hours (Figure 97B). 
Occasionally, one or two cells could be detected that were migrating at the edge of the 
platform towards the source of chemoattractant. However, the majority of those that had 
reached the platform were no longer migratory. Microglia co-cultured with astrocytes and 
seeded onto coverslips placed on the chamber, were identified with RCA-1 (shown in red). 
Their viability was assessed through their uptake and retention of calcein (in green), which 
showed that the dilution of lectin used (1: 10,000) was tolerated by the microglia. By contrast, 
live microglia did not tolerate labelling with FITC-conjugated PG-MI (CD68), even at very 
dilute concentrations (up to 1: 5000) (data not shown). Nevertheless, examination of mixed 
glial co-cultures revealed that some of the cells showed signs of damage to DNA 
(fragmentation within the cytoplasm, unravelling and blebbing). This is shown more clearly in 
the higher power figures (Figure 97F-H), one of which is labelled with RCA-I (Figure 97H). 
The lower panel of the figure shows morphologies of individual RCA- I labelled cells exposed 
to rhMCP-1. At [l Ong/ml], rhMCP-1 induced reorientation of microglial cells, and produced 
polarised movement and ruffling of their membrane in the direction of the source of 
chemoattractant (to the right of figure If). within a one-hour period (Figure 97, cell 1). These 
cells were labelled with Hoechst 33342, RCA-1 lectin conjugated to rhodamine. and retained 
calcein AM which confirmed their viability (Figure 97, cell 2, cell 3). However, other than 
their polarisation and membrane ruffling, these microglia did not migrate ans- measurable 
distance in the direction of the chemoattractant. Instead they usually appeared to be in a state 
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of arrest after a period of around four hours. These phenomena could not be reproduced 
following exposure to rhMIP-la under the conditions described. 
When exposed to [l 00ng/ml] rhMCP-1 for a period of up to 6 hours, howevver. RCA-1 
labelled cells began to alter their morphological presentation and progressively die (Figure 
97, cells 4-11). In the initial phases, within 1-2 hours following exposure, labelled cells 
showed more diffuse labelling with Hoechst 33342, and in many instances the nucleus 
appeared distorted and distended. With longer exposures to this concentration of the 
chemokine, these cells clearly began to show signs of nuclear damage, resulting in 
fragmentation at terminal stages. Cells which were undergoing this form of cell death typically 
showed cytoplasmic convulsions (blebbing), with nuclei displaced to the periphery, prior to 
defragmentation. Once again, these alterations could not be demonstrated with rhMIP-1 a or 
IL-8 under the stipulated conditions. These results indicated that human foetal microglia were 
capable of responding to MCP-1 at physiological levels, by reorientation and cytoskeletal 
changes such as membrane ruffling, whereas at higher concentrations, MCP-1 actually 
induced cell death under these experimental conditions. Intriguingly, the initial experiments 
with cell suspensions also suggested that astrocytes as well as microglia could respond to 
MCP-1 (as indicated by the accumulation of cells at the edge of the platform). However, this 




Fluorescent microscopic images of mixed glial cells (A-H) and lectin labelled 
microglia (1-11) subjected to various concentrations of recombinant human 
MCP-1 and assayed in the Dunn Chemotaxis Chamber 
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FIGURE 97 (continued) 
Fluorescent microscopic images of mixed glial cells (A-H) and lectin labelled 
microglia (1-11) subjected to various concentrations of recombinant human 
MCP-1 and assayed in the Dunn Chemotaxis Chamber 
(A) Pale Hoechst 33342-fluorescent cells can be identified on the platform of the 
chemotaxis chamber, located under a glass coverslip previously seeded with isolated 
cells. (B) A cell suspension has been placed within the outer well of the chemotaxis 
chamber, and [10ng/ml] rhMCP-1 located within the inner well. After a period of 
exposure lasting between 2 and 6 hours, cells began to accumulate at the edge of the 
platform, and occasionally, one or two cells could be detected that had reached the 
summit and were positioned on the edge of the platform, directed towards the source of 
chemoattractant. (C-E) Microglia co-cultured with astrocytes and seeded onto coverslips 
placed on the chamber, could be readily detected with RCA-1 (shown in red), and these 
were viable through their uptake of calcein (in green). However, examination of glial co- 
cultures revealed that some cells showed signs of damage to DNA (fragmentation within 
the cytoplasm, unravelling and blebbing). This is shown more clearly in higher power 
figures (F-H). An RCA-1 labelled microglial cell is shown in (H), with an abnormal 
nucleus which has begun to fragment. 
The lower panel shows morphology of individual RCA-1 labelled cells exposed to 
rhMCP-1. (la-f) At [10ng/mi] rhMCP-1 induced reorientation of the microglial cell as 
shown, and produced polarised movement and ruffiling of its membrane in the direction 
of the source of chemoattractant (to the right of figure 1f), within a one-hour period. (2a- 
c) demonstrates one such cell labelled with Hoechst 33342 (2a), RCA-1 lectin 
conjugated to rhodamine (2b), and calcein AM to show cell viability (2c). A second 
example is shown in (3a-b), after a period of exposure for 2 hours. Figures (4-11) are 
examples of individual cells exposed to [100ng/ml] rhMCP-1 for a period of up to 6 
hours. In the initial phases (1-2 hours) following exposure, labelled cells showed more 
diffuse labelling with Hoechst 33342, and in many instances the nucleus appeared 
distorted and distended (4-6). With longer exposures to the chemokine. these cells 
clearly began to show signs of nuclear damage, and at terminal stages, resulting in 
fragmentation (10-11). Cells which were undergoing this form of cell death typically 
showed cytoplasmic convulsions (blebbing), with nuclei displaced to the periphery, prior 
to defragmentation. 
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Chapter V GENERAL DISCUSSION 
Microglia: their origins and relationship with the mononuclear phagocyte system 
We saw in Chapter I, that monocytes and macrophages were originally classified as cells of 
the `reticulo-endothelial system' by Aschoff in 1924. van Furth and colleagues (1972) 
introduced the concept of a `mononuclear phagocyte system' to further define the system of 
monocytes and macrophages. Macrophages, by definition, are any of the diverse forms of 
mononuclear phagocytes found in tissues (Andreesen 1990,1991,1992; Dijkstra and 
Damoiseaux, 1993; Gordon, 1988; Michna 1988; Zwilling and Eisenstein, 1993). It was 
generally held that the development of these cells took place within the bone marrow and 
passed through the following stages: (i) within the bone marrow- stem cell, committed stem 
cell, monoblast, promonocyte, monocyte, (ii) within peripheral blood- monocytes which 
circulate for up to two days, (iii) within tissues- resident macrophages. The differentiation of 
monocytes within the bone marrow proceeds fairly rapidly (1.5-3 days) during which 
cytoplasmic granules are found in monocytes (consisting of non-specific granules containing 
lysosomal enzymes and some lysozyme, and azurophilic granules which appear violet with 
Wright's stain). Following emigration into tissues, monocytes transform into macrophages. 
The morphology of these cells varies among different tissues and between normal and 
pathological states. Most possess a round or indented nucleus, a well-developed Golgi 
apparatus, abundant endocytic vacuoles, lysosomes and phagolysosomes (which they can 
regenerate) and a ruffled plasma membrane covered with microvilli. Several recent articles 
have highlighted the various aspects of the biology of macrophages (Andreesen 1990,1991, 
1992; Dijkstra and Damoiseaux, 1993; Gordon, 1988; Michna 1988; Zwilling and Eisenstein, 
1993). We shall briefly examine the heterogeneity and activation of these cells, outline some 
of their important functions, and address their rate of turnover, before relating these findings 
to the CNS. 
Heterogeneity and activation of macrophages 
The heterogeneity of macrophages is well documented. It has been recognised for some time 
that macrophages isolated from various tissues display diverse phenotypes and functional 
capabilities. Their functions in particular. are related to signals received in their immediate 
environments, unique to different tissues. For example, the anaerobic environment and cellular 
composition of the spleen or peritoneum confers different properties on resident macrophages 
than the aerobic environment of the alveolar macrophage: as a result, although lung 
macrophages are proficient in performing functions that include phagocytosis and secretion of 
nitric oxide, they are somewhat deficient at others such as antigen presentation, when 
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compared with macrophages found within the spleen or peritoneum. The phenotype of 
macrophages, that is, their expression of specific membrane antigens, is usually a reliable 
indicator of their activational states, and related to pathophysiological functions. For this 
reason, antibodies directed against specific membrane antigens have been used to compare 
macrophages from different tissues. 
Generally speaking, resident tissue macrophages are quiescent immunologically-, with low 
levels of oxygen consumption, low constitutive levels of MHC class II gene expression, and 
little or no cytokine secretion. Nevertheless, they retain the ability for chemotaxis and 
phagocytosis, and the capacity to proliferate. There are two stages to macrophage activation: 
the first being a `primed state, in which these cells upregulate expression of MHC class II 
expression, antigen presentation and oxygen consumption, but retain a reduced proliferative 
capacity. Interferons, IL-3, GM-CSF and TNF-a can prime macrophages for selected 
functions. Once primed, macrophages can respond to further stimuli to become fully activated, 
a stage defined by their ability to proliferate, their high oxygen consumption (through NADPH 
oxidase), killing of parasites, tumour cell lysis and maximal secretion of inflammatory 
mediators (TNF-(x, PGE2, IL-I, IL-6, reactive oxygen species and nitric oxide via inducible 
nitric oxide synthase). Bacterial LPS, yeast glucans, GM-CSF and phorbol esters are amongst 
the factors that may provide secondary signals. Nevertheless, a clear distinction between 
primed and fully activated macrophages is usually arbitrary, and depends largely on the 
stimulus and function assessed. Although macrophages may be primed relatively easily in 
response to stimuli, considerably more activation is required to achieve the cytotoxic `fully- 
activated' state. Macrophage activation may therefore be viewed as a multi-step process. 
Functions and turnover of macrophages 
The functions of macrophages include chemotaxis, non-specific phagocytosis and pinocytosis, 
specific phagocytosis of opsonised micro-organisms via Fc and complement receptors, 
proteolytic digestion, processing and presentation of antigens to T and B lymphocytes and the 
secretion of a plethora of products including enzymes (matrix metalloproteinases, lysozyme, 
collagenases, elastase and hydrolases), complement components and coagulation factors, 
prostaglandins and 1eukotrienes and several regulatory cytokines. chemokines and growth 
factors (including PDGF and bFGF). Macrophages are extremely sensitive to hypoxia and are 
triggered to proliferate and signal the recruitment of other mononuclear cells. Inflammation 
triggers resident macrophages to scavenge and eliminate dead tissue. Macrophages also play 
important roles in wound repair and healing, and in angiogenesis. In the process of clearance, 
macrophages secrete by-products that stimulate matrix-producing cells to lay' down complexes 
and scar tissue. Products secreted by macrophages also stimulate the growth of neýN blood 
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vessels, in order to maintain a supply to newly formed tissues. Subsequently. macrophages are 
additionally involved in refining and remodelling the scar. in order to further strengthen and 
support the repaired tissue. This reorganisation within tissues, is brought about by enzymes 
secreted by macrophages, which include hyaluronidase, elastase. collagenase. matrix 
metalloproteinases as well as inhibitors of some of these (antiproteases). regulatory growth 
factors, and so forth. As specific examples, by aluronidase, through degradation of hv-aluronic 
acid (a significant component of the extracellular matrix-ECM). reduces viscosity and permits 
greater spreading of material within tissue spaces. In a similar fashion. elastase and 
collagenase degrade elastin and collagen, which are basic components of the 1: CM. Table 13 
lists some of the effector and regulatory products of macrophages that ha" e been 
characterised. 
Blood monocytes already possess the capacity for migration. chemotaxis. pinoc\ tosis and 
phagocytosis, functions attributed to macrophages and other mononuclear phagocytes, and 
express receptors for IgG Fc domains (FcyR) and complement receptors (e. g. C3bi 
component). Following migration into tissues, monocytes undergo further differentiation 
within a period of 48 hours to become multifunctional tissue macrophages. Under normal 
conditions, the resident population of tissue macrophages can be maintained by the influx of 
monocytes from the circulating blood or by local proliferation. At steady state, the renc« al of 
tissue macrophages occurs mainly through local proliferation of progenitor cells and not via 
influx of monocytes. Although it was originally considered that tissue macrophages %N ere 
long-lived cells, this is not a general rule. The longevity of a macrophage «ill generally 
depend on the tissue in which it resides. More recently, depending on tissue type, estimates of 
their viability is thought to range from one week to several months. For example. splenic 
macrophages circulate into and leave the spleen regularly : the turnover of alp eolar 
macrophages is rapid (within days) due to the high exposure to particulate matter; Kupffer 
cells may remain in the liver for months or more, and the lifespan of microglia is speculated to 
even exceed that for Kupffer cells, with proliferation in situ as the main source for 
supplementing the microglial population. 
'1Ü4 I 
Table 13. Effector and regulatory products of macrophages 
Microbicidal and cytotoxic 
reactive oxygen intermediates superoxide, hydrogen peroxide, hydroxyl radical, chloramines 
reactive nitrogen intermediates nitric oxide, nitrites, nitrates 















hydrogen peroxide, nitric oxide, TNF-a, C3a, proteases, arginase, thymidine 
hydrogen peroxide, TNF-a., nitric oxide, neutral proteases 
IL-1, TNF-a, IL-6 
prostaglandins (PGE2, PGF2a), prostacyclin (PGI2), thromboxanes, leukotrienes 
(LTB4, LTC4, LTD4, LTE4) 
glutathione 
Cl, C2, C3, C4, C5, factors B, D, P, IH 
V, VII, IX, X, prothrombin, plasminogen activator inhibitors 
IL-1, IL-6, IL-8, IL-10, TNF-a, IFN-a/ß, macrophage inflammatory proteins 
(MEP-1, MEP-2, MIP-3), regulatory growth factors (MCSF, GMCSF, GCSF, 
PDGF) 
elastase, collagenase, angiotensin convertase, stromelysin 
a2-macroglobulin, al-proteinase inhibitor, plasmin and collagenase inhibitors, 
plasminogen activator inhibitors 
acid proteases (cathepsin D and L), peptidases, lipases, lysozyme and other 
glycosidases, ribonucleases, phosphatases, sulphatases 
heat shock proteins 
Tissue remodelling elastase, collagenase, hyaluronidase, matrix metal loproteinases, regulatory 
growth factors, fibrobalst growth factor (FGF), transforming growth factors 
(TGF-a, TGF-ß), angiogenic factors 
Miscellaneous Apolipoprotein E (apo-E), IL-I inhibitors, purine and pyrimidine derivatives 
(thymidine, uracil, neopterin) 
Mononuclear phagocytes of the CNS 
There are at least four anatomically (and most likely functionally) distinct mononuclear 
phagocyte populations associated with the CNS, apart from microglia, which reside within the 
CNS parenchyma (Perry 1997; Perry and Gordon 1991,1997). They include meningeal 
macrophages, supraependymal macrophages at the CSF-ependyma border, macrophages of 
the choroid plexus (Kolmer cells), and perivascular macrophages (or 'perivascular cells') that 
are bounded by a basement membrane, lying within blood vessels. This latter population of 
perivascular macrophages has emerged as a group of cells that are located outside the CNS 
parenchyma proper (Graeber et at. 1989,1990). In this respect. they differ from periv, ascular 
microglia that lie close to vessels within the parenchyma, and from pericytes within vessel 
walls that are believed to derive from smooth muscle precursors Figure 98. Perivascular cells 
are long spindle-shaped, or flattened ovoid cells lacking direct contact with neural cellular 
elements. They constitutively express several mvelomonocytic antigens that are absent from 
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resting microglia. They express MHC class II antigens and are capable of synthesising T cell 
co-stimulatory molecules such as B-7. 
Are microglia a component of the mononuclear phagocyte system? 
There are several lines of evidence (including phenotypic and functional characteristics) to 
support the concept that microglia belong to the system of mononuclear phagocytes (Aloisi; 
2001, Berry and Butt, 1996; Bruce-Keller, 1999; Gehrmann et al. 1995; Kreutzberg et at. 
1996; Ling et al. 2001; Stoll and Jander, 1995; Streit, 1995; Streit et al. 1988). Activated 
microglia have a high content of hydrolytic enzymes (Ling and Wong, 1993: Williams et al. 
1994). They behave in much the same manner as other tissue macrophages, and their 
activation is characterised by transformation into motile phagocytic cells that secrete 
proteases, cytokines, reactive oxygen species and nitric oxide. They are capable of 
phagocytosing dead or dying neurons (neuronophagia) and of 'stripping' synapses from 
certain neuronal populations (e. g. facial motor neurons), whereby they interpose processes 
between afferent synaptic terminals and the neuronal surface. The reorganisation (stripping) of 
synaptic inputs to injured neurons contributes towards aiding recovery (Blinzinger and 
Kreutzberg, 1968). In vitro, their phagocytic activity has been associated with expression of 
receptors for complement and Fc receptors for lgG (Ulvestad et al. 1994). Furthermore, 
cellular activation and morphological transformation of foetal microglia can be stimulated by 
factors known to influence and activate macrophages including lipopolysaccharide (Hetier et 
al. 1988; Suzumura et al. 1991), colony-stimulating factors (Sawada et at. 1990; Suzumura et 
at. 1990), and IFN-y (Frei et al. 1987; Suzumura et al. 1987). 
Activation of microglia is also associated with a marked upregulation of surface markers 
including MHC class II antigen, CD11b, CD64 and CD68. Microglia-derived TNF-a can 
produce bystander damage to oligodendrocytes during demyelination. Free oxygen radicals 
released by microglia exert neurotoxic effects in co-cultures of neurons and microglia. These 
cytotoxic properties of microglia can be modulated by cytokines and neurotransmitters. For 
example, cytokines such as IFN-y can prime microglia to become activated. Others like TGF- 
ß or IL-4 downmodulate the cytotoxic and phagocytic potential of microglia. Noradrenaline 
has been shown to reduce IL-1 and free radical production in macrophages and ß-adrenergic 





Schematic illustration to show the distinction between perivascular cell types: 
pericytes, perivascular cells and perivascular (parenchymal) microglia 
Note the anatomical distinctions between pericyte (PE), perivascular cells (PC) 
(macrophages) and perivascular (CNS parenchymal) microglia (PM). Annotations: 
[1], [2], [3] represent the capillary, pericytal, and glia limitans basal laminae respectively; 
GL: glial limitans; CL: capillary lumen, PVS: perivascular space; AST: astrocyte. 
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In addition to their cytotoxic and phagocytic roles, microglia can process and present antigens 
that they have internalised (Hickey and Kimura, 1988). In situ, human microglia express low 
levels of MHC class II molecules, but widely upregulate these molecules and important T cell 
costimulatory molecules CD80 and CD86, following damage or during immune reactions 
(Williams et al. 1994). Although they have the capacit`, to present antigens and induce T cell 
proliferation in vitro (Frei et al. 1987), the level of T cell activation is only partial in vivo. 
probably due to the general immuno-suppressive environment of the CNS. T cell proliferation 
in the CNS is very limited, even though the activation of these cells does occur, as judged by 
the production of T-cell cytokines. Finally, microglia may also promote tissue repair, neunte 
outgrowth (by secreting substances such as plasminogen, bFGF, NGF), regulate cell migration 
and synaptogenesis (through degrading ECM components), and participate in tissue 
remodelling (as evidenced in the regeneration of optic nerve in fish and amphibians and 
segments of the spinal cord in rodents). As a result, microglial activation, like that of 
macrophages, has been considered as a `double-edged' response. 
Nevertheless, a property that sets microglia apart from other mononuclear phagocytes is their 
expression of an inward-rectifying potassium channel, and lack of outward current channels 
(Kettenmann et al. 1993; McLarnon et al. 1997). This property, which is retained across 
species (rodent and human), renders microglia very sensitive to depolarising events, since 
relatively small changes in membrane potentials trigger large inward currents, a phenomenon 
that is directly related to their capability for a rapid response to pathological stimuli. 
Microglial ion channels may be linked to P2 purinoceptors that become activated by ATP 
released from damaged cells. Microglial activation may therefore be triggered by pronounced 
depolarisation in response to tissue damage, during normal wear and tear, and after traumatic 
or ischaemic injury. Microglia share this inward rectifying channel with a population of 
precursor cells within the bone marrow, a fording that has direct bearing on the possibility of 
microglial progenitors being derived from the bone marrow. 
Where do microglia originate from? 
Developmentally, microglia have been considered to derive principally from four separate 
sources: (i) bone marrow progenitors, circulating in the blood, (ii) intrinsic bipotential 
mesodermal progenitors within the nervous system, seeded early during embryonic 
development, (iii) mesenchymal progenitors located around the nervous system, which 
penetrate the brain parenchyma, (iv) from neuroectodermal progenitors in the ventricular zone 
that give rise to glial and neuronal cell populations. The meningeal (pial) origin for microglia 
first proposed by del Rio-Hortega, has received support from several studies (Boya et al. 1979; 
Cammermeyer 1070, Dougherty 1944). In the last decade, Boya and colleagues (1991) 
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reported that meningeal macrophages (of mesodermal origin) invade the brain parenchyma 
and transform into ramified microglia. However, other authors have held the contrary opinion, 
that microglia like astrocytes and oligodendrocytes, arise from neuroectoderm-derived 
glioblastic progenitors (Fujita et al. 1981: Hao et al. 1991; Kurtz and Christ, 1998; Lewis 
1968; Metz and Spatz 1924; Richardson et al. 1993; Pruijs 1927; Rydberg 1932: Schaffer 
1926; Schelper and Adrian 1986). Alliot and co-workers (1991) postulated that the central 
nervous system contains and intrinsic pool of pluripotent haematopoietic-related stem cells, 
whereas yet others have hypothesised dual lineage and time courses for microglial 
development (Chugani et al. 1991; Eglitis and Mezey, 1997). 
Although these alternative hypotheses cannot be entirely dismissed, evidence accumulated 
over the past two decades, has placed microglia within the unifying hypothesis of the 
mononuclear phagocyte system of van Furth and colleagues. The majority of these 
independent studies have offered support for the bone-marrow progenitor hypothesis (Ling 
and Wong, 1993). The reasons for this are as follows. In the 1980s, it was confirmed mainly 
through immunohistochemical studies, that microglia share epitopes with blood monocytes, 
lymphocytes and tissue macrophages, which are not present on astrocytes or oligodendrocytes. 
Prior to this, initial experiments with carbon-labelled blood monocytes prepared from adult 
donor Lewis rats, showed these cells to be subsequently located in the corpus callosum of 
postnatal recipient animals, following injection into the circulation of the recipient animals. 
The labelled cells progressively transformed to amoeboid cells (Ling and Tan, 1974). Other 
studies using transfected cells, bone marrow chimaeras and transplantation experiments have 
further shown cells which are derived from the bone marrow to enter the newborn and adult 
CNS in rodents, where they take up residence predominantly around blood vessels (in the 
perivascular space), as well as within the choroid plexus and the meninges (DeGroot et al., 
1992; Flügel et al. 2001; Hickey and Kimura, 1988; Hickey et al. 1992; Krall et al. 1994). 
Mononuclear phagocytes within the meninges and perivascular macrophages in particular, 
possess a relatively rapid turnover, and within a few months, large numbers of donor cells are 
located in these compartments (Hickey et al. 1992). By contrast, adult `resting' microglia 
bearing donor markers are extremely rare. This evidence, together with the observation that 
there is no perivascular infiltration of mononuclear cells in rodents following transection of 
facial motor neurons (Graeber et al. 1988) suggested that the intrinsic adult microglia have a 
very low turnover in comparison with perivascular cells (Perry and Gordon. 1991). From their 
studies, using immunohistochemistry combined with autoradiography in mice, LaýNson and 
colleagues (1992) came to the conclusion that the microglial population is maintained through 
slow turnover by an equal share of division of resident cells in situ, and b\ infiltration of 
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monocytes. They estimated that it would take the lifetime of the mouse for the entire 
microglial population in the steady state to be replaced by immigration of monocytes alone. In 
a separate investigation, Yeager et al. (1992) noted that after 8 months in the mouse. many of 
the host cells were of donor origin. Therefore, in the adult, it is mainly the perivascular cell 
population, rather than parenchymal microglia, which are continually renewed from 
circulating bone marrow precursors. Indeed, the aforementioned bone marrow chimaera 
studies have shown resident microglia to have a very low turnover with bone marrow 
precursor cells (less than 1%), whereas the percentage of macrophages is considerably higher 
in the leptomeninges (60%), and for perivascular cells (30%) (DeGroot et al. 1992; Flügel et 
al. 2001; Hickey and Kimura, 1988; Hickey et al. 1992: Krall et al. 1994). 
The only comparative studies of the renewal of microglia in humans have emerged following 
bone marrow transplantation (Krivit et al. 1995; Unger et al. 1993). Unger and colleagues 
(1993) were able to histologically identify the Y-chromosome in microglia within the CNS of 
female patients who had received bone marrow transplants from male donors. Their study 
demonstrated enhanced immunoreactivity predominantly for perivascular microglia with an 
antibody to CD45, without perturbance of the blood-brain barrier. These authors were able to 
detect CD45/Y-chromosome positive cells in the medulla and inferior olive of five females 
who had received male bone marrow transplants. Krivit and co-workers (1995,1998) further 
investigated five patients with globoid cell leukodystrophy, who had been treated with 
allogeneic haematopoietic stem cells. The rationale behind this course of treatment was that 
donor leukocytes would enter the CNS to correct the enzyme deficiency associated with the 
disease. These authors noted that a difference between results of transplantation in patients 
with late-onset, compared to those with onset during early infancy may be due to the different 
rates of entry of donor-derived mononuclear leukocytes to form perivascular cells or 
microglial cell populations within the CNS. The course would be slow and would be expected 
to occur over a period of months to a year after engraftment. In their later study, Krivit and 
colleagues (1998) demonstrated the reversal of symptoms of enzyme-deficiency in a two-and- 
a-half years old infant given umbilical cord blood. This particular evidence implied the 
existence of a microglial progenitor population in human umbilical blood. These experiments 
lent further support to the concept that resident microglia are long-lived cells, with a very slow 
turnover, that are able to repopulate their numbers through intrinsic proliferation (Hickey et al. 
1992, Perry and Gordon, 1988,1991). Although these cells are capable of division, this 
property is arrested once they populate the parenchyma and differentiate into mature process- 
bearing forms. 
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A credible explanation for these conclusions would be to consider that the main influx of 
microglial progenitors takes place within a brief perinatal window in time, whereby microglial 
progenitors populate the nervous system, and that following the developmental maturation of 
the blood-brain barrier, such recruitment no longer operates, or is highly restricted. Any 
subsequent increase in the adult microglial population would be a result of the proliferation of 
pre-existing parenchymal microglia. An alternative and equally plausible explanation for these 
findings would be related to a difference in the ontogeny of resident microglia from meningeal 
macrophages, perivascular macrophages or even perivascular parenchymal microglia. 
Evidence for this proposal derives from recent emerging evidence on the origin of 
macrophages that suggests a divergent origin between foetal macrophages during development 
and bone marrow-derived macrophages of the adult (Morioka et al. 1994; Naito 1993: Naito et 
al. 1996; Shepard and Zon, 2000; Takahashi 1994; Takahashi et al. 1996). Primitive and foetal 
macrophages are derived from the yolk sac and liver. The liver in particular, progressively 
becomes the major site of haematopoiesis until shortly before birth when the bone marrow 
takes over this task. Hence, for the major part of development, these two principal tissues, the 
yolk sac and the liver, are predominant sources for primitive macrophages. Foetal 
macrophages differentiate from primitive macrophages before the development of monocytes 
and prior to the circulation of blood within vessels. These early macrophages are migratory 
and distribute throughout the mesenchyme surrounding tissues (including the CNS), and 
progressively colonise these tissues to be retained as resident macrophages (Takahashi et al. 
1996). Later, following the establishment of the blood circulatory network, newly generated 
monocyte-derived macrophages can supplement the tissue-residing population. 
Morphology and distribution of microglia in the developing human nervous system 
In the present work we have seen that mononuclear phagocytes of the human foetal cerebrum 
can derive from two principal sources: (i) from cells located in the mesenchyme and 
leptomeninges which populate the marginal layer, lower cortical plate and subplate of the 
telencephalic neocortex during the initial period of the second trimester (12-14GW) and (ii) 
from vascular-derived progenitors and macrophages which begin to enter via blood vessels 
within the internal capsule, germinal layers, and at the boundary between deep grey structures 
such as the caudate and thalamus, around the same period in development. While the first type 
of progenitors display different morphological and phenotypic characteristics (small round 
cells, RCA-1+ TL+ CDI lb- CD45- CD64- CD68-), and clearly differentiate earlier within the 
subplate of the human foetal telencephalon, the latter variety (RCA-l+ TL+ CD68+ CDI 1b+ 
CD45+1- CD64"-) has the tendency to adopt amoeboid macrophage-like forms, and associate 
with neuronal and glial fibers and certain blood vessels and migrates long distances 
(tangentially and radially) along white matter tracts. Nevertheless, these cells progressively 
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disperse throughout the nervous system, and can be seen to divide within the intermediate 
zone of the telencephalon and in the germinal layers. as they differentiate into more ramified 
cells and downregulate their phenotype. The phases of colonisation are best seen within the 
neocortex, where the initial phase of migration inwards from the meninges is met during the 
latter half of the second trimester by an advancing population of foetal microglia migrating 
outwards from the germinal layers (ventricular and subventricular zones). Within other areas, 
foetal microglia maintained their prevalence within tracts bordering nuclear grey matter (for 
example basal ganglia, caudate, thalamus) and rarely penetrated the cortical grey matter. 
Colonisation of these grey matter areas will likely proceed during the third trimester, and will 
be the subject of separate ongoing investigations. The marked heterogeneity in phenotype of 
these foetal microglia likely reflected their state of differentiation and/or specialised functions, 
regionally within the human foetal brain. 
At all stages in human foetal development spanning the second trimester, microglial 
colonisation was found to associate with blood vessels, vimentin-positive radial glia and later 
with differentiating GFAP positive astrocytes. Initially, between 12-14GW the infiltration of 
progenitor cells could be followed from the pial mesenchyme, and these RCA-1 positive cells 
populated the subplate, lower cortical plate and intermediate zone, where they began to 
differentiate into ramified cells. A small proportion of these cells, located to the subplate, 
demonstrated more robust morphologies, more typical with macrophages and expressed 
CD68. However, by far the majority of the microglial progenitors were negative for 
monocyte/macrophage markers employed in this study. At later stages (15-16GW onwards), 
there was clear indication of additional infiltration of newly arrived progenitors within the 
ventricular zone of the telencephalon, and these appeared to have traversed the walls of blood 
vessels. Colonisation was in progress at 16GW and proceeded in a co-ordinated manner, and 
by 22GW, microglia had distributed widely throughout the developing human foetal brain and 
began to take on the immature forms of resident ramified cells, probably constituting a merger 
of the two populations of progenitor cells. However, amoeboid microglia still prevailed within 
the ventricular zone, subventricular zone and corpus callosum and at boundaries between deep 
grey nuclei (basal ganglia and thalamus) even up to the beginning of the third trimester. The 
foetal microglia located beneath the cortical plate (within the subplate) were noted to display a 
more ramified morphology and downregulated phenotype, on account of their advanced stage 
of differentiation compared to the newly-recruited progenitors arriving via vessels. This was 
reflected in their respective phenotypes, as CD68 and RCA-1 appeared to label different 
populations of foetal microglia, emphasised by their apparent uneven distribution at 19GW 
and 22GW. Although the lectin additionally identified blood vessels, the thickness of sections 
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employed in these studies clear enabled morphological discrimination between microglia and 
blood vessels when viewed under the light microscope. 
It has been shown in this study and by others (Gould and Howard, 1987: Larroche. 1982) that 
the germinal layer is characterised by many thin-walled blood vessels, which lie in the densely 
compacted cell mass with little support from surrounding tissue, and this is a frequent site of 
haemorrhage in the preterm infant (Rezaie and Dean, 2002). These vessels are therefore 
relatively weak although they are at least partially invested by filial elements by the 1O week 
(Gould and Howard, 1987). In this study. GFAP positive astrocytic investment of vessels 
within these regions was clearly evident from 19GW, and may indicate the commencement of 
regional barrier formation between the blood and brain. As the capillaries within the germinal 
layer offer perhaps the least resistance to migration, this appears to be a logical portal of entry 
into the nervous system. Microglial progenitors identified within the germinal layer can be 
seen within or surrounding capillaries and can be identified by microglial markers in this study 
and by others (Choi, 1981; Peudenier et al. 1991: Wierzba-Bobrowicz et al. 1997; Zecevic et 
al. 1998). As gestation continues, microglia are increasingly detected at sites distant from the 
germinal layer, as they disseminate and differentiate throughout the nervous system. 
This study has shown that by 22GW, most foetal microglia in the intermediate zone of the 
telencephalon have differentiated into bipolar, tripolar and multipolar cells, and their 
immunophenotype was greatly reduced in comparison with the amoeboid forms found within 
the germinal layers. Microglia maintained their territorial fields and were found to be in a 
morphologically more advanced state of differentiation in the subplate, beneath the more 
dense, primitive neurons of the cortical plate. The migration and maturation of microglia, 
known to be influenced by factors derived from astrocytes, coincided with the development of 
radial glia and the maturation of astrocytes within the respective brain areas. Postnatally, at six 
weeks and three months, some RCA-1 positive microglia still prevailed within the corpus 
callosum, whereas resting adult forms were distributed elsewhere in the cerebrum. Human 
foetal macrophages were also noted within the optic tract, at the infero-lateral edge of the 
germinal matrix, around the margins of the anterior commissure and within the white matter 
of the developing temporal lobe between 16 and 18GW, in accordance with the report by 
Gould and Howard (1991). 
Mononuclear phagocytes in the spinal cord were identifiable by 9GW, at which stage they 
were predominantly amoeboid in morphology and preferentially located around the neural 
crest (ependymal zone). These cells expressed CD45 and CD68 and were few in numbers: 
between 10 and 20 immunolabelled cells could be identified per longitudinal 60µm thick 
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section of the spinal cord. These cells also co-localised with PECAM-positive blood vessels in 
the subependymal region, similar to periventricular 'nests' seen in the cerebrum. They were 
closely associated with GFAP positive radial glia, which were already established at this time. 
Between 9 and 16GW, microglia appeared as a heterogeneous population, with subsets 
identifiable using CD I1b, CD64, CD68, RCA-1 and less intense expression of CD45. CD68 
in particular, consistently identified the majority of amoeboid and ramified microglia within 
the spinal cord throughout this period. RCA- i detected cells with more ramified morphologies 
(2-3 short, fine processes) with advancing gestation. These were morphologically comparable 
to those detected within the cerebrum. With advancing gestational age, and close to 16GW. 
there was a marked influx of cells from the meninges/connective tissue (external limiting 
membrane) into the marginal layer (developing white matter) surrounding the spinal cord. By 
16GW GFAP immunoreactivity was largely confined to the marginal layer. associated with 
microglial influx, which was more prevalent dorsal and ventral to the neural cavity 
(corresponding to the roof plate and floor plate) with highest densities of microglia (40-50 
cells/mm2). Other regions of the spinal cord (dorso-lateral, medial, ventro-lateral) totalled 
between 5-30 CD68 immunoreactive cells/mm2 by 16GW. GFAP immunoreactivity is absent 
in the neural tube at 7GW, and vimentin is first detected on ventricular cells and radial fibers 
at 9GW in the spinal cord. Between 12-15GW, GFAP was specifically detected on radial 
fibers of the anterior and posterior fissures, as well as on short processes within the mantle and 
marginal zones. The major influx of microglia into the human foetal cord as shown, occurred 
along the routes of the anterior and posterior fissures and is directed inwards from the 
mesenchymal tissue/meninges between 14-16GW. As in the telencephalon therefore, 
colonisation followed the course of radial glia and suggested that cell migration partly follows 
these tracts (radial migration). In the developing cerebrum, a wave of proliferation and/or 
migration occurs between weeks 16 and 23, which seemingly supplements the developing 
cortex with new complement of microglia. As these cells migrate across the intermediate 
zone, there is evidence for division, since numerous pairs of cells expressing microglial 
markers and proliferating cell nuclear antigen (PCNA) can be readily identified. This 
proliferative activity of amoeboid microglia has been documented within the CNS of a 
number of other species during development (Dalmau et al. 1997: Imamoto and Leblond, 
1978; Kaur and Ling, 1991; Kitamura et al. 1984; Ling and Tan, 1974; Ling and Wong, 1993; 
Marin-Teva et al. 1999; Schnitzer, 1989; Vela-Hernandez et al. 1997). Figure 99 briefly 
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Anatomy of the human foetal spinal cord 9-16GW, and cerebrum 22GW 
Top: Spinal cord at 9GW. There are a few amoeboid microglia within and overlying the 
ependymal layer at this stage. However, mononuclear phagocytes are abundant within 
the meninges/connective tissue surrounding the cord. GFAP positive radial glial fibers (a) 
course in parallel arrangement from the ependyma to the marginal layer Spinal cord at 
16GW. The dorsal and ventral fissures are major sites of inwardly-directed microglial 
influx in the spinal cord. Note that radial glial fibers (GFAP-positive) are now redistributed 
to the marginal layer (a). ICAM-2 positive blood vessels (b) coincide with areas of 
microglial influx. There are a few transitional forms of microglia within the grey mantle 
layer. Lower: coronal section of one cerebral hemisphere 20-22GW, at the level of the 
basal ganglia. (I) microglia in the germinal layer, projections of the corpus callosum (CC) 
and the boundary between the caudate and putamen are amoeboid, whereas those 
distributed throughout the intermediate zone (II) are transforming early ramified forms in 
the second trimester. Note the arrangement of radiating cortical vessels, radial glial 
astrocytes and migrating cells within the intermediate zone. 
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The work presented here, and in several recent published articles, has helped to paint a clearer 
picture of the morphology, phenotype and distribution of human foetal microglia in the CNS 
and retina during development. Morphological accounts of microglia within the human CNS 
indicate that these cells are already present in limited numbers within the brain between 5 and 
8 GW, and appear as round or oval 'globose' cells (Andjelkovic et al. 1998: Choi. 1981: 
Fujimoto et al. 1989; Geny et al. 1995; Soloveva and Orlovskaia, 1979; Z. eUvi6 et al. 1998). 
These earliest forms of microglia (CD68+, MHC II+ cells) occur in low numbers and appear 
to be inefficient at presenting antigens (Geny et at. 1995). CD68 positive cells have been 
located in the ventricular and marginal zones between 5 to 7 weeks (Zecevic et al. 1998). 
Other cells within the nervous tissue are typical of macrophages, and these occur at or near 
walls of blood vessels. The following section summarises findings related to the regional 
distribution of microglia in the developing human brain: 
Spinal cord: Random haematogenous cells have been noted prior to 10GW in the human 
foetal spinal cord (Choi, 1981), and populations of CD68 or RCA-1 positive microglia have 
been detected within the ventricular zone and overlying marginal zone between 5 and 7 weeks 
(Zecevic et al. 1998). Amoeboid microglia are sparsely distributed within the human foetal 
spinal cord from 9-10 weeks of gestation, mainly located within the ependymal layer 
(Hutchins et al. 1992; Rezaie et al. 1999; Weidenheim et al. 1994; Wierzba-Bobrowicz et al. 
2001). Microglia within the cord predominate within regions of developing white matter 
where they coincide with vimentin and GFAP-positive radial glia, and increase in numbers 
between 10 and 20 GW (Rezaie et al. 1999; Weidenheim et at. 1994; Wierzba-Bobrowicz et 
at. 2001). Ramified cells with delicate, elongated processes can be detected by 16GW within 
the grey matter (Weidenheim et al. 1994). Aggregates of microglial progenitors are also 
situated beneath the pial surface of foetal spinal cords (Rezaie et at. 1999; Weidenheim et al. 
1994). Whereas astrocytes and oligodendrocytes appear to differentiate along rostral to caudal 
gradients within the foetal spinal cord, such a relationship is less clear for differentiating 
RCA-1 positive microglia (Weidenheim et al. 1994). Furthermore, immunoreactivity for 
GFAP and myelin basic protein (oligodendrocyte marker) is more intense in anterior and 
antero-lateral funiculi than in the dorsal and posterolateral funiculi. This suggests a physical 
temporo-spatial relationship between astrocytes and oligodendrocytes, and these two cell 
types may be responding to similar growth and differentiation factors (Weidenheim et al. 
1994). Alternatively, a mutual influence may exist that drives the correct differentiation of 
these glial lineages. The same is perhaps true for microglial cells, which coincide within the 
same localities as macroglia, demonstrated in this study. Intriguingly, synaptophysin reactivity 
(a synaptic marker) manifests more strongly in the anterior aspects of the spinal cord 
(Wietzba-Bobrowicz et al. 2001), and could possibly be related to microglial colonisation. 
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Myelination of the human spinal cord begins from 11 to 16G W (Choi, 1981; Hutchins et al. 
1992; Zecevic et al. 1998), and double immunofluorescence labelling has indicated that some 
of the early haematogenous cells also express myelin basic protein (MBP) before 
oligodendrocytes have differentiated. The significance of this finding remains to be 
ascertained. 
Cerebellum: Within the cerebellum, amoeboid microglia surround the fourth ventricle and 
localise in the vicinity of blood vessels within the germinal matrix by I1GW (Wierzba- 
Bobrowicz et at. 1998,2000). By 14GW, round, ferritin-immunoreactive microglia are found 
within the periventricular germinal matrix and at the boundary of the dentate nucleus 
(Maslinska et at. 1998). These cells progressively proliferate and develop into ramified cells in 
subcortical areas, reaching densities of --6 cells/mm2 by 22GW (Wierzba-Bobrowicz et al. 
1998). By 20GW, ramified cells have begun to invade the inner aspect of the cerebellar 
granular layer, and progressively colonise the outer aspect between 24 and 28GW. Following 
this period, microglia invade the Purkinje cell layer (primarily in the vermis, subsequently in 
cerebellar hemispheres) and downregulate their phenotypic markers, as they settle down and 
adopt mature `resting' forms (Maslinska et al. 1998). Postnatally, ramified cells can 
occasionally be detected in the cerebellar white matter. 
Mesencephalon: RCA-1 positive cells can be observed in the mesencephalon around 8GW. 
These mainly occur as isolated amoeboid cells positioned close to the cerebral aqueduct, 
around the germinal matrix, close to the parenchymal (ablumenal) wall of blood vessels, and 
in the leptomeninges (Wierzba-Bobrowicz et al. 1995,1998). A large proportion of lectin- 
positive cells are preferentially located around the wall of vessels, adherent in rows or clusters. 
Morphologically, they possess oval or spindle shapes with a foamy cytoplasm full of vesicular 
material (Wierzba-Bobrowicz et al. 1995). These cells progressively emit short pseudopodal 
processes at locations associated with the matrix within mesencephalic tectum and 
tegmentum, and ramify mainly from 16 to 40GW (Wierzba-Bobrowicz et al. 1995,1997). 
Telencephalon and diencephalon: In the frontal, temporal and occipital lobes, ramifying 
microglia are evident between 11 and 22GW in the expanding intermediate zone (future white 
matter) (Gould and Howard, 1999; Hutchins et al. 1990; Rezaie and Male, 1997,1999; 
Wierzba-Bobrowicz et al. 1998,2000). These cells are spatially interspersed and occasional 
microglia may also be detected within the marginal layer (Wierzba-Bobrowicz et at. 1998). 
Immunoreactivity to MHC class II antigen is confined to cells located in the meninges, 
choroid plexus, and associated with blood vessels within the periventricular germinal layer 
and subependymal zone during this period (Esiri et al. 1991; Rezaie et al. 1997; Wierzba- 
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Bobrowicz et al. 2000). Importantly, mononuclear phagocytes in these locations have been 
regarded to operate in `immune surveillance' of the adult CNS (Wekerle et al. 1986). 
Throughout the second trimester, microglial progenitors (amoeboid migratory cells) are 
abundant in white matter tracts bordering nucleated structures such as the basal ganglia and 
thalamus. They subsequently invade these grey matter nuclei at later stages of development 
(Kershman, 1939; Maslinska et al. 1998; Rezaie et al. 1997). Well-differentiated microglia can 
be detected throughout the CNS after 35GW (Esiri et al. 1991). 
Retina: Colonisation of the retina by microglia also bears mentioning here, since this 
developmental event corresponds closely with that which takes place within the CNS proper. 
In the human foetal retina, MHC class I, class II and CD45 immunoreactive microglia are 
present from 10GW (prevascularisation) and express macrophage S22 antigen from 14GW 
(postvascularisation). The earlier progenitors enter the retina from the peripheral retinal 
margin and optic disc, whereas the latter population (which comprise at least 40% of the MHC 
and CD45-positive cells) appear in association with the retinal vasculature and enter via the 
optic disc after 14GW (Diaz-Araya et al. 1995). Subpopulations of human foetal microglia in 
the retina, termed `paravascular' microglia, accompany the developing vasculature (Diaz- 
Araya et al. 1995; Penfold et at. 1990; Provis et at. 1996,1997). Thus two waves of microglial 
migration also appear to take place within the retina: the first via the ciliary margin prior to 
retinal vascularisation (these are considered to represent the ramified, non-vessel-associated 
microglia of the adult retina), and a second wave of macrophage-like MHC class II positive 
cells that enter via the optic disc, coinciding with the development of retinal vasculature (these 
cells are thought to become established as vessel-associated para- and perivascular microglia, 
active in phagocytosing the remnants of eliminated endothelial cells during vascular 
remodelling (Provis et al. 1996,1997). 
From the above accounts, the main focus for microglial progenitors entering the CNS, has 
been regarded to occur within and around the germinal layers: ventricular and subventricular 
zones. Foetal microglia are also distributed within the corpus callosum, thalamus, internal 
capsule, putamen, caudate, septum pellucidum, anterior commissure, tectum and tegmentum 
of the mesencephalon, and within the retina throughout the second trimester. A striking 
similarity in all these investigations is the characteristic 'pattern of differentiation' associated 
with the progressive outward migration and ramification of microglia from their original 
portals of entry which, in the telencephalon, has been widely accepted as located within the 
periventricular germinal layer (see Rezaie and Male, 1999). It has however, emerged from this 
study that at the earlier time points examined between 1? and 14GW, microglial progenitors 
are intimately associated with the parenchymal wall of penetrating radial blood vessels, and 
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appear to invade the CNS parenchyma from the surrounding mesenchyme and align within the 
subplate region and intermediate zone of the developing telencephalon. At later stages of 
development (16GW onwards), there is additional supplementary infiltration of progenitors 
via blood vessels in the ventricular and subventricular zones. This is in keeping with studies 
carried out in lower vertebrates and mammals (Alliot et at. 1999; Herbomel et al. 2001: Kaur 
et al. 2001; Sorokin et al. 1992), which indicate that early foetal macrophages first colonise 
the cephalic mesenchyme from whence they invade the brain, prior to commencement of 
vascularisation of this organ. Subsequently, these cells penetrate the CNS parenchyma in 
association with the invading vessels. The existence of a dual lineage for microglia (cells 
derived from foetal macrophages versus bone marrow progenitors) is a topic that is currently 
under debate (Alliot et al. 1999; Andjelkovic et al. 1998; Kaur et al. 2001; Provis et al. 1996, 
1997; Rezaie and Male 1999,2002; Rezaie et al. 1997), and will be discussed later in this 
section. 
By comparison with normal foetal development, the study of microglia in developmental 
disorders has been rather neglected. There is some circumstantial evidence from ultrastructural 
studies that microglia are in a morphologically more activated state (rod-shaped, vesicle- 
laden) in the CNS of foetuses from mothers diagnosed with schizophrenia (Soloveva and 
Orlovskaia, 1979). Although not demonstrable in the three cases investigated in the present 
study, the density of lectin-positive ramified cells in Down's syndrome is reported to be 
elevated during the second trimester, and microglia appear more prominent when compared to 
normal foetal CNS (Becher et at. 1991; Wierzba-Bobrowicz et at. 1999). Whether this finding 
reflects a more activated phenotype of resident microglia (in the sense that they upregulate 
glycoconjugate residues on their cell surface and thus become more readily detectable) or 
whether there is an actual increase in cell numbers per se, is not clear. Since there is believed 
to be an inherent disturbance in synaptogenesis in Down's syndrome that takes place 
essentially beyond the second trimester, it is tempting to speculate that microglia are in some 
way associated with such events. Whereas no differences have been noted between MHC class 
II expression by microglia in spinal cords from normal foetuses and those with genetic 
disorders of Down's syndrome (trisomy 21), Nori's syndrome, mucoviscidosis, or 
mucopolysaccharidoses, again the numbers of CD68 and RCA-I lectin positive cells appear to 
be greater in these disorders (Wierzba-Bobrowicz et al. 2001). Intriguingly, the genes 
encoding ß-subunits for a number of cytokine receptors including IL-3, IL-4, IL-5, IL-9, M- 
CSF and GM-CSF receptors, are also located in the vicinity of the genetic disturbances 
affecting mucopolysaccharidoses (Wierzba-Bobrowicz et at. 2001). Whether these are related 
or merely coincidental remains to be established. 
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Preferential accumulation and differentiation of microglia within the subplate zone 
It is noteworthy that mature forms of microglia are aligned within the subplate at the boundarýbetween 
the intermediate zone and cortical plate with progressive development. Foetal 
microglia also form boundaries around the basal ganglia. Presumably these densely cellular 
sites (grey areas) lack either necessary matrix components or signalling molecules required for 
colonisation during the early second trimester. Although this distribution pattern can be taken 
to signify specific stages in the process of colonisation, it is also possible that microglia 
perform specific roles at these sites, for example in the development of a blood brain barrier 
(Mato et al. 1996). It has also been considered that colonisation is a response to programmed 
neuronal death or axonal degeneration. Despite this, other studies, including the present one, 
have failed to correlate microglia solely with cell death during foetal development, and this 
idea is not consistent with the overall distribution of microglial progenitors. Therefore, it 
appears likely that the process of CNS colonisation by microglia is primarily a 
developmentally regulated step rather than a response to cell death in a simplistic sense. What 
therefore, preferentially attracts microglial progenitors to the subplate during the initial period 
of the second trimester? 
In order to address this question, we should first consider the development of this region of the 
telencephalon in more depth. It is well established that neurons are generated in ventricular 
zones of the cortical wall and ganglionic eminence and reach their destinations by radial and 
tangential migration (Meyer et al. 2000). The cortical plate of the human neocortex emerges 
around the seventh week of gestation, prior to which it differentiates from the preplate and 
exists as two components, namely Cajal-Retzius (CR) cells in the marginal zone, and subplate 
cells below the cortical plate. Within the cortical plate, neuronal lamination forms in an 
`inside-out' manner (lower layers formed initially and superceded by subsequent layers), and 
this patterning is governed by proteins released from CR cells (such as reelin or presenilin), 
and the rudimentary sub-pial granular layer overlying the marginal zone (which harbours 
tangentially migrating reelin positive neurons) (Meyer et al. 2000; H. Uylings, personal 
communication). Pioneering neurons within the marginal zone and subplate contribute the first 
efferent fibers to the internal capsule via the intermediate zone. 
The development of the human subplate is a protracted process that extends over several 
months (Kostovic and Rakic, 1990). Between 13 and 36GW, this transient structure serves as 
a `waiting area' for unsettled thalamocortical, corticostriatal and associative and commissural 
pathways. Furthermore, the subplate acts as a reservoir for subplate neurons that may also 
exert influence on the laminar arrangement of the cortical plate (Kostovie and Judas, 2002). In 
particular, plasticity of these subplate neurons appears essential in aiding functional recovery 
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following perinatal brain injury. Subplate neurons (a proportion of which are nitrinergic). are 
thought to be involved in the development of connections between the thalamus and the 
cerebral cortex, Specification of cortical areas and formation of ocular dominance columns. 
These subplate neurons are involved in the early stages of synaptogenesis of the cerebral 
cortex. Synapses received by these neurons (many of which are transient) are important for 
transmitting early afferent input to neurons of the cortical plate. A proportion of the subplate 
neurons will also die, although the timing and mechanisms underlying this have not been 
confirmed (Kostovic and Judas, 2002; Rakic and Zecevic, 2000). Furthermore, cells within this 
region display less vulnerability to hypoxia compared to the intermediate zone and 
periventricular areas (Kostovic and Juda§, 2002; Rezaie and Dean, 2002), a property that may 
either reflect the variation of cerebrovascular architecture to these regions, or intrinsic cellular 
capabilities. 
Thalamocortical fibers predominantly accumulate within the subplate between 13 and 24GW, 
and these are likely to be involved in area specification of the cortex, participating in the 
induction of a new area. As a result this region is highly plastic. The subplate zone is 
characterised by large extracellular space that is rich in extracellular matrix components, 
particularly of the chondroitin sulphate family, laminin, fibronectin, tenascin, as well as 
growth-promoting molecules, contains early maturing neurons, neurotransmitters and 
synapses (prior to their detection within the cortical plate). The abundance of extracellular 
matrix, attractant and repellant components within this area is also central to its role, as 
changes in the gradients of molecules between the subplate zone and the cortical plate 
(Hübener et al. 1995; Pearlman and Sheppard, 1996), can promote their relocation from the 
subplate into the cortical plate (Bicknese et al. 1994; Miller et al. 1995). Hunter and 
colleagues (1992) found that laminin and s-laminin (the homologues of the B-subunit of 
laminin, which signals the outgrowth of motor neurons) were transiently present in the 
subplate of the developing rat, and disappeared with progress in development. Both 
fibronectin and chondroitin sulphate proteoglycan are prominent in the marginal zone and 
subplate of the murine CNS between E13 and EK and immunolabelling of fibronectin is 
closely associated with radial glial processes, whereas that for chondroitin is more diffuse 
(Sheppard et al. 1991; Stewart and Pearlman, 1987). As the cortical plate itself matures, the 
expression of these two ECM components decline (by E18-E19), and that for another 
component of the ECM, tenascin appears in the marginal zone. subplate and eventually 
widespread throughout the cortex and subcortical white matter. In man, the rich extracellular 
matrix environment subsides from the 28th week of gestation (Kostovic and Judag, 2002). 
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It is known that macrophages and microglia are capable of synthesising and responding to 
several proteoglycans including keratan, chondroitin and dermatan sulphate proteoglycans 
under physiological and pathological conditions (Edwards et at. 1990; Jander et al. 2000; 
Jones et al. 2002; Jones and Tuszynski, 2002; Moon et al. 2002). Evidence from studies 
looking at the effects of ECM components on neunte outgrowth, suggests that keratan 
sulphate and chondroitin sulphate proteoglycans are required to establish boundaries for 
axonal growth, by potentially inhibiting neunte outgrowth in the developing brain and spinal 
cord (Jones et al. 2002; Jones and Tuszynski, 2002). By contrast, heparan sulphate 
proteoglycans may support neuronal outgrowth and promote survival of neurons (Moon et al. 
2002). Keratan sulphate is known to be present on microglia, when these have differentiated 
and show a ramified morphology, but is absent on amoeboid cells and macrophages 
(Bertolotto et al. 1995; Wilms et al. 1999). Kappler and colleagues (1997) found chondroitin 
sulphate, expressed in the subplate of the developing neocortex, to enhance neunte outgrowth. 
Specifically, enzymatic removal of chondroitin sulphate from slices of the brain, has been 
noted to interfere with neunte adherence and outgrowth in tissue culture preparations 
(Emerling and Lander, 1996). These experiments strongly suggest that the repellant/anti- 
adhesive properties of the cortical plate and the attractantlneurite-promoting properties of the 
subplate and intermediate zone, are reliant on specific and differential expression of bound 
proteoglycans (Bicknese et al. 1994; Emerling and Lander, 1996). Likewise, cytokine and 
growth factors that are bound to specific sulphated proteoglycans can promote the migration 
of mononuclear phagocytes (Hayashi et al. 2001). Factors produced by microglia, such as 
tissue plasminogen activator may additionally be involved in facilitating neunte outgrowth 
and pathfinding (Tsirka, 2002). possibly through the processing of ECM components. The 
proteolytic activity of this system may also establish chemoattractant gradients for microglia. 
Thus, it would appear that the developing subplate (and intermediate zone) is not only a site 
which promotes the recruitment of microglial progenitors, but also contributes towards their 
early differentiation. These hypotheses are further supported in this investigation through (i) 
the characteristic binding of THP-1 monocytes to the subplate and sub-pial granular layer on 
sections from the neocortex between 16 and 22GW. (ii) the specific pattern of expression of 
the chemokine MCP-1 (and to a lesser extent, RANTES). confined to the subplate and lower 
cortical plate during this period. We shall discuss the latter subject further during the course of 
this discussion. 
Morphologically and phenotypically distinct subpopulations of microglia 
Another important finding that is emphasised by this study is the heterogeneity inherent in the 
phenotype of foetal microglia. The fact that microglia are a heterogeneous population of cells 
is not, in itself, a new finding (Becher and Antei, 1996; deGroot et al. 1992; Hutchins et al. 
222 
1990; Lawson et al. 1990; Ogawa et al. 1993). The heterogeneous phenotype of microglia has 
conferred difficulty in attempts to distinguish the intrinsic population of microglia from 
invading monocytes or macrophages in the adult. One proposed discriminatory criteria relates 
to expression levels of multiple surface markers. For example, rodent microglia constitutively 
express low levels of CD45 and negligible CDI lb, detected by flow cytometry (Sedgwick et 
al. 1991). These are designated CD 11 b"/CD45'°w, whereas monocytes and macrophages are 
typically CDllb+/CD45high 
. Becher and Antel (1996) further demonstrated that immediately' 
ex vivo human cultured microglia displayed a CDI Ib`7CD45" phenotype and undetectable 
levels of CD14 (Peterson et al. 1995). A more recent attempt at multiple characterisation of 
phenotype for human microglia has been reported by Dick et al. (1997), whereby freshly 
isolated resident human microglia could be defined by the following flow cytometric 
phenotype: CD45": CD4-: CD1lb+: CDllc"8h: MHC Il+: CD26-: CD14-. Upon activation, 
microglia adopted the following phenotype: CD45b°`""6 : CD4: CD ll b+: CD Il ch'": 
MHC II +': CD26-: CD14-. The lack of reliable and specific markers for microglia continues 
to confound attempts to distinguish between transient populations, incoming cells and resident 
microglia of the brain. 
On the basis of morphology and phenotypic expression, microglia within the normal CNS 
have been further subdivided into two distinct populations, namely amoeboid and ramified 
cells. From studies in rodents, it is recognised that rounded or amoeboid macrophages are 
widely distributed throughout embryonic and neonatal rodent brains, where they 
predominantly occur close to blood vessels, within the white matter, and become increasingly 
ramified as they differentiate into microglia (Kaur and Ling, 1991; Perry et at. 1995). Similar 
findings are also documented in this work, both in human and murine development. 
Amoeboid cells may represent the precursors of ramified microglia (Imamoto and Leblond, 
1978), and during development, a rise in the number of ramified cells parallels a decline in the 
number of amoeboid cells (Ling and Tan, 1974). Data presented herein, both from work 
carried out in situ in the developing brain, and in tissue culture supports the view that 
microglia may derive from cells with amoeboid morphology. However, it is not yet clear at 
this stage, how many of the invading cells actually differentiate into amoeboid microglia in 
situ. Studies to date, have yet to resolve this issue, and are mainly hampered by difficulties in 
tracking the phenotypically heterogeneous population of cells in development. Certainly, not 
all amoeboid microglia in the foetus and neonate will survive into adulthood and many 
undergo apoptosis (Perry 1996), although this is another topic that 
has come into debate 
(Wang et at. 2002). Therefore, the exact percentage of microglial progenitors that persist and 
differentiate to form amoeboid and then ramified microglia are as yet unknown. 
Nevertheless, 
estimates have placed this figure somewhere in the region of 
30% in rodents. 
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Although microglia share a broad antigenic profile with blood monoc,, tes. lymphocytes and 
macrophages (Fujita et al. 1981), data from this study and others have shown that antibodies 
directed at macrophage-specific antigens, possess differing degrees of specificity for foetal 
microglia at different stages of development (Hutchins et al. 1990,1992: Sasaki et al. 1988. 
Sorokin et al. 1994). Macrophage-specific markers frequently localise to cells in the meninges 
and choroid plexus, without detecting differentiating parenchymal microglia. This is 
consistent with the knowledge that many surface antigens are downregulated or 'lost' in the 
process of `maturation' of amoeboid cells during development, to the adult ramified form, 
reappearing when the cells are activated (Hume et al. 1983; Oehmichen et al. 1979; 
Tsuchihashi et al. 1981; Wood et al. 1979). This is illustrated for human microglia in Table 
14. Table 15 summarises the phenotypic markers that have been characterised on human 
foetal microglia in situ or in isolated cell cultures. A schematic illustration of the 
differentiation and associated phenotpye of microglia during human foetal intrauterine 
development, is presented in Figure 100. 
Table 14. Phenotypic markers of human microglia 
Immunocytochemistry Amochoid Ramified Reacti%e 
C D4 + +%- ++ 
CDI Ib (Mac-l, C3 bi) ++ +! - 
CD45 (leukocyte common antigen) ++ +/- ++ 
CD64 (FcyRI) - 
CD68 (PG-MI, KP-I, EBM-1 1) ++ - +-+ 
MHC class I antigen + +/- + 
MHC class II antigen + +/- ++ 
Leetin Hiato chemistry 
Ricinus communis agglutinin-1 (RCA-I) ++ +/- + 
Gritlimea simplicifolia bandeira (GSB-4) + - + 
Enzyme hh tochemistry 
nonspecific esterase ++ - ++ 
thiamine pyrophosphatase + + 
Miscellaneous 
keratan sulphate +- +/- 
acetylated LDI. receptor ++ - ++ 
silier carbonate impregnation ++ ++ 
(J not expressed. p/-] some expression. [I ýNeak to rm icratc c\ pre,,, ion, 
[--*]sign iticant ly upregulated expression 
ti: i 
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Table 15. Phenotype of human foetal microglia 
Antigenic determinant 
CDI lb/CD18 (Mac-], C3bi receptor, u,, 102 integrin) 
CDI I c/CD18 (CR4 receptor, p150.95 antigen, ctxo: integrin) 
CD36 (class B scavenger receptor) 
CD45 (leukocyte common antigen) 
CD64 (Fey receptor type 1) 
CD68 (PG-M 1, KP-1, EBM-1 1) 
CD86 (B7-2) 







Ricinus communis agglutinin-I (RCA-1) 
Lycopersicon escuulenlum (tomato lectin) 
Arachis hvpugeu 
Triricrmr vul c iris 
Reference 
Hassan et al. 1991, Lee et al. 2002 
Pouly et al. 1999 
Coraci et at, 2002: 
Diaz-Arava et al. 1995; 
Rezaie et at. 1997,1999.2002 
Rezaie et at. 1997,1999.2002; 
Andjelkovic et al. 1998; Esiri et at. 1991; 
Hutchins et at. 1992: Lee et al. 1992.2002; 
Pouly et al. 1999; Rezaie et al. 1997,1999, 
2002. Wierzba-Bobrowicz et al. 1999; 
Zec evic et at. 1998 
Lee et at. 2002 
Esiri et al. eta]. 1991; 
Lauro et al. 1995: Lee et al. 21002: Wierzba- 
Bobrovv icz et al. 1997,1999,2000.2001 
Rezaie et at. 1997; 
Wierzba-Bobro%%icz et al. 1998; 1999 
Gould and Howard. 1991 
Maslinska et at. 1998; 
Wierzba-Bobro w icz et at. 1995,1998,1999 
Gould and Howard, 1991 
Fujimoto et at. 1989 
Andjeiko%is et al. 1998,1{urchins et al. 1990, 
1992, Maslinska et al. 1998, Rezak et at. 
1997,1999; Weidenheim et al. 1994; 
Wierzba-Bobro%%icz et at. 1995,1997,1998; 
Zec evic et at. 1998 
Andjelkovic et al. 1998; 
Wierzba-Hobro, k icz et al. 1999 
Wierzba-Bobro%k icz et at. 1999 
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FIGURE 100 
The different stages of microglial development 
ºMIFIED 
Adapted from original descriptions by Del Rio-Hortega, 1932. The prevailing view has held microglia 
to be derived from circulating blood progenitors They have also been considered to be denved from 
bone marrow precursors, circulating blood monocytes, mesodermal pial elements (meningeal), from 
intrinsic mesodermal elements, blood vessel adventitia, histiocytes or connective tissue elements 
Microglia progressively downregulate surface antigenic markers with maturation TM1 first tnmester, 
predominantly amoeboid microglia, TM2 second tnmester, amoeboid and intermediate stages 
(transitional, early ramified microglia), TM3: third trimester, predominantly early ramified microglia In 
the adult, ramified microglia may be further classified according to their location (I) neuronal satellites 
project a number of branches around the nerve cell forming a basket structure, and are more or less 
flattened against the neuron which they partially surround, or have processes which run in parallel 
direction to those of the neuron, (II) neuroglial satellites placed near astrocytes or rows of 
oligodendroglia, and may arborise with branches of the neuroglia, (III) perivascular satellites 
accompany vessels more frequently in the grey areas, mainly in superficial regions and along larger 
vessels up to the point where they branch. Capillanes have microglia arranged along their course in 
most cases, microglia in contact with vessels are multipolar elements that either run across the vessel 
walls or are parallel to the latter, in which case their wavy projections extend along the vessels 
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Specifically, microglia have been characterised by their expression of CD 11 b/CD 18, CD45, 
CD64 and CD68 antigens. The 265Kd leukocyte integrin aMß2 (CD11b/CD18). also referred 
to as Mac-1 or type 3 complement receptor, mediates monocyte adherence to endothelium and 
subsequent extravasation and chemotaxis to sites of inflammation. It is additionally involved 
in phagocytosis of C3bi complement-coated or IgG-coated particles via CRI and 
immunoglobulin Fc receptors. A calcium-dependent conformational change allows the 
distinction to be made between adhesive and phagocytic properties of this molecule. Ligands 
for Mac-1 include ICAM-1 /2, fibrinogen, and C3bi (Albelda and Buck, 1990. Larson and 
Springer, 1990). CD45 (leukocyte common antigen) is a protein tyrosine phosphatase 
predominant on leukocyte plasma membranes, but also expressed typically at high levels on 
all haematopoietic cells. Post-translational modification of CD45 results in three different 
isoforms of CD45 (exons 4,5 and 6), which encode A, B, and C-determinants respectively. 
The 220Kd isoform has all three determinants, the 21OKd isoform has A and B, or B and C, 
and the 200Kd contains only the B determinant. Macrophages and dendritic cells express the 
B determinant (designated CD45RB) as well as the I8OKd isoform, which lacks the A, B and 
C determinants (designated CD45RO). Substrates for CD45 include galectin-1, CD2, CD3, 
and CD4. CD64 (Fcy receptor I) is a 72Kd receptor expressed on monocytes, macrophages 
and subsets of blood dendritic cell. It is involved in phagocytosis (receptor-mediated 
endocytosis of IgG-antigen complexes) and antigen capture for presentation to T cells. Human 
CD64 binds IgG3>IgGI>IgG4»>IgG2. Murine CD64 binds murine IgG3>IgG2a»> 
IgG 1 /IgG2b. Expression of CD64 can be induced by IFN-y and IL-10, and downregulated by 
IL-4 and glucocorticoids. CD64 is also involved in antibody-dependent cellular cytotoxicity 
and ligation results in the release of cytokines and reactive oxygen intermediate species. CD68 
(macrosialin, gp110) is a 110Kd sialomucin (type I transmembrane glycoprotein) and member 
of the host defence scavenger receptor superfamily (SR-D class). It is expressed intracellularly 
in cytoplasmic granules and on the surface of monocytes, macrophages, dermal dendritic cells, 
Langerhans cells, myeloid progenitor cells and a subset of CD34+ haematopoietic bone 
marrow progenitor cells. In mice, this receptor has been shown to bind to oxidatively- 
modified low density lipoprotein (LDL). 
A battery of these macrophage-specific markers were employed in the present investigation 
and have clearly shown the variability in antigenic profile of subpopulations of microglia in 
the human foetal brain during the second trimester. Within the ventricular and subventricular 
pones and the corpus callosum, foetal microglia expressed higher levels of all these markers. 
and assumed morphologies more characteristic of phagocytic cells Bithin these regions. In 
disseminating from these sites, foetal macrophages downregulated their expression of CD64 
and CD68. Morphologically. these isolated cells (mainly encountered within the intermediate 
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zone and subplate) adopted bipolar and multipolar forms. Lectin histochemistry identified a 
similar progressive pattern of downregulated phenotype. Surprisingly, a minor population of 
CD68 positive cells also expressed the selectin CD62-P on their cell body. which has not been 
reported in the developing CNS. These cells were randomly distributed throughout the foetal 
cortex and not usually placed close to vessels. Most were round or angular in morphology. and 
a few appeared to be phagocytic, displaying similar morphology to amoeboid microglia. 
Although the expression of CD62-P has not been reported on microglia, a previous study 
showed CD62-P mRNA to be induced in Kupffer cells of the liver, following activation 
(Essani et al. 1995). 
What determines the phenotypic heterogeneity of microglia? 
Put simply, the phenotype of microglia depends on their location, state of differentiation and 
potential physiological functions. The altered immunophenotype of microglia in the brain 
appears to correlate with cells in particular localities, and may reflect functional specialisation 
of microglia in response to local environmental cues. For example, cells which are located in 
transitory white matter (intermediate zone), and which co-localise with radial glial astrocytes 
as shown here and in the study by Hutchins et al. (1990), appear to downregulate expression 
of CD68 and CD64 (phagocyte markers) and become more ramified. Radial glia are 
demonstrable by the 8`h week of gestation in the spinal cord and by the 10`" week in the 
cerebrum (Choi, 1981; Rakic, 1981). Penfold and co-workers (1991) have also reported 
subpopulations of CD68 and CD45 positive microglia in the human foetal retina. The 
substrate to which microglia adhere has an important influence on their phenotype both in 
vitro (Giulian et al. 1995), and in situ, as discussed previously with reference to the subplate. 
By comparison, phenotypic heterogeneity is a phenomenon that is seen in other populations of 
mononuclear phagocyte within foetal tissues, that also reflects the localisation and associated 
specialised function of these cells. Examples are the spleen (Takeya and Takahashi, 1992; 
Wijffels et al. 1994), foetal rat lungs (Higashi et al. 1992), and foetal liver (Bardadin et al. 
1995; Naito et al. 1990). In these tissues, there is similar uncertainty whether heterogeneity 
reflects variation within a single cell population, or identifies the coexistence of several 
distinct populations of macrophages. 
The foetal brain represents a distinctive environment for the differentiation of mononuclear 
phagocytes. Astrocytes may be partly responsible in controlling this process through cell/cell 
interactions and via cytokines, particularly M-CSF and GM-CSF. which can modulate cell 
morphology, function and metabolism (Naito et al. 1996). Studies in M-CSF deficient mice 
however, have shown only partial loss of microglia (which are reduced in numbers by 
approximately 30-40° 0) without significant alterations in their distribution (E3levins and 
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Fedoroff 1995), despite severe depletion of mononuclear phagocytes in liver, spleen and 
thymus (Wiktor-Jedrzejczak et al. 1991). These studies have shown that the development of 
mononuclear phagocytes which is considered to depend on M-CSF during foetal and neonatal 
life, actually varies from tissue to tissue (Blevins and Fedoroff, 1995; Cecchini et at 1994: 
Wijffels et al. 1994). In the brain, the production of GM-CSF. IL-3 and IL-6 by astrocytes, 
endothelium or even neurons, may partly compensate for the lack of M-CSF (Blevins and 
Fedoroff, 1995). 
The blood-brain barrier (BBB) is also known to influence microglial phenotype (Becher and 
Antel, 1996). In the adult CNS, microglia express higher levels of phenotypic markers at sites 
lacking a BBB, and this also occurs in aged CNS where presumably limited barrier breakdown 
occurs, allowing leakage of plasma proteins. A full barrier forms relatively late in 
development, long after the majority of neurons have formed their connections (Davis et al. 
1994). However, cerebral endothelial cells have an intrinsic ability to form -tight junctions' 
when they first invade the brain during development (Saunders 1992), and naturally-occurring 
plasma proteins have not been found to leak across even the most immature cerebral vessels, 
although the 'BBB' of the foetus and newborn is much more permeable to smaller molecules. 
Hence microglia in different locations will be in contact with different levels of serum 
molecules, which is partly related to their distance from the blood vessels and the ependymal 
barrier. Moreover, different areas of the brain may develop their barrier properties at different 
times. In the mouse, a `mature barrier' is lacking prior to embryonic day 15 (Engelhardt and 
Risau, 1995). A barrier first forms in the spinal cord and finally in the telencephlon. There 
appears to be an ependymal-cortical gradient in barrier formation, since injected proteins are 
still visible in subependymal layers at embryonic day 16 (Engelhardt and Risau, 1995). The 
morphology and immunophenotype of foetal microglia may therefore relate partly to the 
timing and extent of barrier development in each region of the brain. 
The mechanisms of entry and dispersion of microglial progenitors in the developing CNS 
While this work has painted an unambiguous picture of the timing and phases of colonisation 
for microglia in the developing CNS, the mechanisms governing entry. dissemination and 
differentiation of microglial progenitors are only partially clear. Astrocytes appear to be 
important and partly responsible for these events, and some potential signals have been 
discussed extensively elsewhere (Rezaie and Male, 2002), outlined in Figure 101. Briefly, 
factors that have been proposed to drive colonisation of these cells, include the growth factors 
M-CSF! GM-CSF, chemokines, the onset of synaptogenesis, programmed cell death and 
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Factors associated with the ramification, differentiation and apoptosis of microglia 
As f)(1,, 230 
Data accrued from this investigation suggest that the adhesion molecule ICAM-2 and 
chemokine MCP-1 in particular, may be associated with directing microglial colonisation in 
the human foetal CNS. A separate group (Schwab et al. 2001) have proposed developmental 
expression of IL-16 as a key factor in this process. Neurons may additionally influence the 
differentiation of microglia and promote either a 'quiescent' ramified phenotype or an 
`activated' amoeboid phenotype through release of neurotransmitters/neuromodulators, 
adenosine triphosphate, purines and pyrimidines, hormones, growth factors (TGFßz, NGF. 
NTs) and a number of cytokines (IL-3, IL-6, M-CSF/GM-CSF, MCP-1, MIF) into the 
extracellular space. By contrast, serum components in the vicinity of newly formed blood 
vessels lacking a blood-brain-barrier, probably maintain microglia in more activated states 
(i. e. perivascular versus cortical/parenchymal cells (Tanaka et al. 1998)). The precise nature of 
these stimuli on developing microglia will have to be explored further. The following section 
will focus on three aspects governing dissemination and differentiation of these progenitors: 
(i) the influence of, and interaction with astrocytes, (ii) the relationship of microglial 
progenitors with cerebral blood vessels, and developmental expression of the adhesion 
molecule ICAM-2, and (iii) potential roles for chemokines in directing cell migration within 
the developing CNS. 
The relationship between astrocytes and microglia in the second trimester 
In all regions of the CNS discussed so far, and with particular reference to the telencephalon, 
the differentiation and proliferation of microglia increases in parallel with a rise in the number 
of astrocytes. The differentiation of these two cell types further coincides within the same 
regions, although astrocytes have been estimated to outnumber microglia 4-5 fold during this 
developmental period (second trimester) (Wierzba-Bobrowicz et al. 1998). In the present 
study, we have seen that microglia co-localise with differentiating astrocytes in the germinal 
layers (VZ and SVZ), corpus callosum, cavum septum pellucidum and within neural tracts, 
particularly surrounding deep grey structures such as the striatum and thalamus. Furthermore, 
they appear to disperse throughout the intermediate zone and adopt more mature 
morphologies, prior to and concomitant with the differentiation of GFAP-positive astrocytes 
within this region, which takes place around 19-23GW. Curiously astrocytic 
differentiation 
within the intermediate zone follows a similar spatially interspersed pattern as seen 
for foetal 
microglia. Immediately before and during this period, foetal microglia can 
be seen to 
specifically associate with vimentin-immunoreactive radial glial fibers that span the neocortex 
and are particularly rich within the subplate. A similar pattern of events appears to take place 
within the spinal cord between 9 and 16GW. These observations suggest that the 
differentiation of microglia precedes that of astrocy-tes. although it remains to 
be seen whether 
factors released by microglia may influence astrocyte differentiation in situ. 
This is 
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particularly intriguing, since an overwhelming number of studies have focussed on the 
contrary relationship, that is to say. the influence of astrocvtes on microglial differentiation. 
How do these findings relate to our present knowledge of the differentiation of astrocytes in 
situ during development? The intermediate filament protein vimentin, which is 
developmentally expressed in proliferating neuroepithelial cells, is among the first markers for 
immature and differentiating astrocytes and their progenitors. GFAP on the other hand has 
long been recognised as specifically restricted in its expression to astrocytes that have gone (or 
are undergoing) differentiation to mature forms, and subsequently lose expression of v imentin 
(Bignami and Dahl, 1974; Bignami et al. 1980; Eng et al. 1971: Wilkinson et al. 1990). The 
appearance of GFAP positive cells has been reported to correlate with myelination in rodents 
(Bignami et al. 1980 Jacque et al. 1980), and in humans (Takashima and Becker, 1983). 
However, the timing of proliferation and differentiation of astrocytes, which occurs from the 
second trimester onwards, is at odds with this hypothesis, since myelination occurs mainly, 
within the third trimester and after birth (Reske-Nielsen et al. 1987b). Notwithstanding, the 
relationship between differentiating astrocytes, microglia and maturing oligodendrocytes is 
one that will require further analysis during this period. 
Expression of GFAP has been identified on human foetal radial glia as early as 9GW 
(Wilkinson et al. 1990) and on more mature, process-bearing foetal astrocytes between 14- 
15GW (Roessmann and Gambetti, 1986a; Wilkinson et al. 1990), although at this age, there is 
very little expression (Aquino et al. 1996). Aquino and colleagues (1996), like Borit and 
McIntosh (1981) before them, observed GFAP positive tanycytes and many small 
immunoreactive cells in the ventricular and subventricular zones at 16GW. Throughout the 
second trimester, bipolar cells and radial glia are evident in the cerebral hemispheres (Borit 
and McIntosh, 1981). In their study, Roessmann and Gambetti (1986a) noted GFAP positive 
astrocytes to form aggregates at the borders between large white matter bundles/fiber tracts 
and neighbouring grey areas, lining the cavum septum pellucidum, and over the surfaces of 
the fornices and optic tract. These initial findings have been verified convincingly in the 
present work. Astrocytes have been found in many developing fiber tracts including the 
internal capsule, cortico-spinal and medullary tracts, where they begin to differentiate from 
19-20GW onwards (Roessmann and Gambetti, 1986a; Wilkinson et al. 1990). Differentiated 
astrocytes populate the CNS in a systematic way and are more widespread and readily 
discerned by the end of the second trimester (Reske-Nielsen et al. 1987a; Wilkinson et at. 
1990). By 22GW, GFAP positive cells have been noted by Aquino and colleagues (1996) 
within the marginal layer. a few cells identified in the subplate region, and continuing 
expression widely distributed in paraventricular areas. These authors also 
found a striking 
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increase in the content of GFAP within the prefrontal cortex from 16-24GW. and the rapid 
increase towards the late second trimester was thought to correlate with the active 
proliferation of GFAP positive cells. The overall increase in levels of GFAP was along a 
caudal-rostral gradient, consistent with the maturation of the CNS during the foetal period. 
Therefore the findings presented in this work correspond well with previous reports. and 
indicate that the differentiation (and dissemination) of astrocytes parallels that for microglia 
during the second trimester. 
Three additional and separate points also surfaced from this study. These relate to (i) the 
timing of ensheathment of cerebral blood vessels by astrocytic endfeet, as a precursor to 
establishment of blood-brain barrier properties, (ii) expression of GFAP by specialised cells, 
termed tanycytes, that line the ventricles, and (iii) the pathology of foetal astrocytes in 
response to hypoxic-ischaemic injury. With regards to the first point, a clear finding from the 
present study was the region-specific investment of radial cortical blood vessels and germinal 
layer vessels, with endfeet derived from differentiating astrocytes, detected from 19GW 
onwards. There appeared to be a gradient for ensheathment of cortical vessels, with those in 
more dorsal and medial aspects of the telencephalon preferentially targeted. This may bear 
some significance with respect to the development of properties associated with the blood- 
brain barrier, that are region-specific (i. e. some areas develop these properties in advance to 
others). Partial ensheathment of blood vessels by astrocytes has been detected by electron 
microscopy from 10GW (Povlishock et al. 1977). GFAP positive endfeet (considered to derive 
from type I astrocytes: Miller et al. 1985), have also been noted around vessels from 14GW in 
the brainstem and cerebrum, and from 17GW in the ganglionic eminence (Wilkinson et al. 
1990). Studies in vitro indicate that type II astrocytes are prevalent prior to the second 
trimester, whereas type I astrocytes predominate around 16GW. From these, one can speculate 
that the differentiating GFAP positive astrocytes that are detected around these vessels 
correspond to type I astrocytes, and certainly in vitro studies, have shown these cell types to 
influence microglial morphology, phenotype and functional properties. Thus type I astrocytes 
may potentially emerge in situ, within the human cerebrum towards the end of the second 
trimester and further influence microglial activity and differentiation beyond this period. 
The second point very briefly addresses tanycytes, which are specialised epithelial cells that 
may also give rise to astrocytes. Expression of GFAP by tanv cotes has been reported 
previously (Aquino et al. 1996; Gould and Howard, 1987; Gould et al. 1990, Roessmann et al. 
1980), and is known to diminish at later gestational stages (Sarnat. 1992). Their densith has 
been detailed to be highest around the third ventricle and adjacent areas of the lateral 
ventricles. These findings correspond closely with that seen in the present stud. where 
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tanycytes expressing GFAP were not continuous around the ventricular lining, but found 
regionally, and more frequently around the ventral aspects of the ventricles. This may suggest 
differential patterns for the differentiation of these cells to astrocytes, or relate perhaps to 
functional specialisation of these cells. In accordance with the previous studies, the numbers 
of GFAP-expressing tanycytes were found to reduce considerably, towards the end of the 
second trimester. 
The third point concerns the rather remarkable pathological forms of astrocvtes that were 
prevalent in the foetal case with hypoxic-ischaemic injury. It has been noted that a variety of 
cases with perinatal brain injury (ranging from subependymal haemorrhage, ponto-subicular 
necrosis, through to periventricular leukomalacia), show typical pathological alterations 
within the white matter, and specifically the periventricular white matter (Rezaie and Dean, 
2002a, 2002b). Immature GFAP positive astrocytes are capable of a reactive response from as 
early as 20GW. Changes such as axonal injury or damage to oligodendrocyte precursors, that 
may be the result of hypoxic-ischaemic injury, or bacterial infection, are often accompanied 
by such glial activation (Roessmann and Gambetti, 1986b). The morphology of reactive 
`gemistocytic' astrocytes in the case with hypoxic-ischaemic injury presented here was 
comparable to that previously described in perinatal brain injury (Roessman and Gambetti, 
1986a), in methylmercury poisoning in utero (Choi et al. 1978), in tuberous sclerosis 
(Stefansson and Wollmann, 1980), cerebellar neuroecto-mesenchymoma (Akimoto et al. 
1994), as well as in hypoxic-ischaemic brain lesions (Nakamura et al. 1986). These cells have 
been considered to react in response to pathological changes particularly involving hypoxic- 
ischaemic white matter injury (Brand and Bignami, 1969: Gilles and Murphy, 1969; 
Nakamura et al. 1986; Simpson et al. 1987). Specifically, the response shown in the case with 
hypoxic-ischaemic injury was diffuse and widespread within white as well as grey areas, 
particularly affecting cells in perivascular positions, which is within reason given the nature of 
the pathological insult. 
Gemistocytic astrocytes have been described more extensively in studies on human gliomas, 
where they are considered to represent a `benign' secondary. and `biologically harmless' 
component (Hoshino et al. 1975; Liberski, 1998; van der Meulen et al. 1978). These cells. 
which typically show marked hypertrophy, rounded morphology. with circular arrangement of 
bundles of glial filaments, are mainly detected from mid-intrauterine development onwards. 
They have also been described to accompany abnormal neuronal migration and deranged 
cerebral cortical organisation following foetal methyl mercury intoxication (Choi et al. 1978). 
The presence of large numbers of these types of astrocytes therefore indicates some form of 
ongoing destructive process that most likely interferes with correct neuronal migration and 
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positioning, and can be indicative of a long-standing reaction. However, it is intriguing that 
these gemistocytic astrocytes are not usually associated with reactive microglia or 
macrophages in these disorders. Furthermore, there is debate as to whether in this immature 
reactive state, these cells are capable of some non-specific phagocytic activity. Focal 
accumulation of gemistocytic astrocytes (for example at subependymal locations) may 
alternatively suggest a disturbance in their function that incapacitates their own migration. A 
separate hypothesis that needs to be addressed is whether these gemistocytic cells reflect an 
abnormal differentiation of glial (oligodendrocyte and astrocyte) progenitors, which may be 
arrested at a stage prior to differentiating into mature astrocytes. Gemistocytic astrocytes 
frequently have a dense eosinophilic cytoplasm, with the nucleus located at the periphery, and 
are densely filled with a mixture of vimentin and GFAP immunoreactive fibers, and other 
components (Akimoto et al. 1994; Liberski, 1998). These attest to an immature or abnormally 
differentiated state. In this context, one should also consider the so-called `bouquet' cells, 
which express GFAP in the normal foetal brain, but resemble gemistocytic astrocytes to some 
extent, in their immature morphology (Borit and McIntosh, 1981). This particular observation 
may be significant, since these `bouquet' cells are especially numerous in areas of neural 
tracts, immediately prior to myelination, and decrease in numbers once myelination is 
established (Borit and McIntosh, 1981). 
The interaction between astrocytes and microglia in tissue culture 
Interactions between human foetal microglia and astrocytes were clearly evident from the 
studies carried out in tissue culture preparations, presented in Chapter IV. Following isolation, 
human foetal microglia adopted an amoeboid morphology that transformed into 
morphologically heterogeneous microglia bearing processes when co-cultured with astrocytes. 
Microglia maintained in these co-cultures were noted to alter their morphology continuously 
with constant extension and retraction of cellular processes. Migration of these cells appeared 
random overall, but was confined to a localised `territory' that was actively scavenged and 
cleared of debris. However, both the morphology and motility of these cells was reliant on the 
state of activity and confluency of astrocytes in vitro: microglia were highly motile in 
subconfluent cultures, where astrocytes were differentiating and proliferating markedly . and 
progressively more stable, and ramified cells when astrocytes had differentiated and attained 
confluency. Using time-lapse video imaging, human foetal microglia were found to be capable 
of migration not only in the amoeboid, but also in the ramified state overlying confluent 
astrocv, tes, albeit more slowly. Thus, the behaviour of microglia appeared to be goy erred to a 
considerable extent by the state of differentiation of astrocytes in vitro. Frequently. one could 
also detect some direct interaction between solitary microglial cells and differentiating 
astrocytes in these preparations, which may reflect that which occurs in situ. 
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Direct interactions between astrocytes and microglia may of course, be mediated via 
cytokines, and microglia may influence the proliferation of astrocytes through release of 
cytokines such as IL-1 (Table 16). However, cultured astrocytes have also been shown to 
respond to microglia-conditioned medium by upregulating ECM molecules such as tenascin 
on their surface by as much as two-and-a-half fold. The synergistic effect of TGF-ß released 
from microglia and bFGF from astrocytes are believed to account for this upregulation (Smith 
and Hale, 1997). TGF-ß itself inhibits astrocytic proliferation, and can suppress the mitotic 
effects of EGF and FGF on astrocytes (Lindholm et al. 1992; Rozovsky et al. 1998), and 
downregulates ICAM-1 expression on astrocytes (Xiao et al. 1996). Microglia themselves 
have been shown to express receptors for all three isoforms of TGF-ß, but it is unclear 
whether they respond to this cytokine by proliferation (Dobbertin et al. 1997), or whether 
proliferation is inhibited (Jones et al. 1998). In the former study, the effect of TGF-ß was 
synergistic with M-CSF produced by astrocytes. Therefore it is plain that factors released from 
microglia can influence the capacity of astrocytes to proliferate as well as regulate their 
expression of adhesion molecules and ECM components. These effects are of course mutual, 
and numerous studies have defined the proliferative influence of astrocytes on microglia 
maintained in culture. 
The differentiation of mononuclear phagocytes outside the CNS is known to be driven by 
sequential actions of different cytokines, such as stem cell factor (SCF), IL-3, M-CSF and 
GM-CSF (Nicola, 1989). Different studies have addressed the question whether these 
cytokines are present in the developing brain, and whether microglia respond to them in 
culture. Genes for a number of cytokines (SCF, IL-3, IL-7, IL-9, CSFs) have been detected 
early in the developing nervous system (Merrill and Jonakait, 1995). SCF is present in discrete 
cell clusters in the floor plate of the neural tube, in the early embryonic thalamus and olfactory 
epithelium. Studies on rodent brains demonstrated that IL-7, IL-9 and M-CSF are expressed as 
early as E13, and receptors for these factors are co-expressed in the same brain regions, and 
sometimes on the same cell. Various studies indicate that M-CSF, GM-CSF, IL-3 (produced 
by foetal astrocytes and microglia) (Blevins and Fedoroff, 1995; Giulian and Ingemann 1988; 
Lee et al. 199?, 1994; Liu et al. 1994, Malipiero et al. 1990; Mizuno et al. 1994: Raivich et al. 
1994, Sawada et al. 1990; Schlichter et al. 1996; Tanaka and Maeda, 1996) or adenosine 
(Gebicke-Haerter et al. 1996) may act as possible signals for microglial division, whereas 
deprivation may lead to apoptosis. More specifically, in vitro studies indicate that either GM- 
CSF (Lee et al. 1994) or GM-CSF like peptides in rodents (Giulian et al. 1991). are 
responsible for microglial proliferation during embryogenesis. GM-CSF has further been 
shown to inhibit MIIC class II expression on microglia,, and may keep these cells in an 
immunologically quiescent state, favouring their differentiation (Hayashi et al. 1993). 
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Table 16. Functional biochemistry of human foetal microglia 
Biological Component 
Cytokines and growth factors 







Tumour necrosis factor-alpha (TNF-(x) 
Hu et al. 1999, Lee et al. 1993,1994,2002, Sebire et al. 1993 
Chao et al. 1994; Lafortune et al 1996; Lee et al- 1993,1994,2002, 
Sebire et al. 1993, Sheng et al- 1995 
Ehrlich et al. 1998, Janabi et al. 1999; Lee et al. 2002, Lipovsk) et a1 1998 
Lee et al. 2002, Sheng et al. 1995 
Lee et at 2002 
Lee et al. 1996,2002 
Schwab et al. 2001 
Chao eta]. 1995; Deguchi et al. 1996; Fine et aL 1999; Lafortune et al. 1996; 
Lee et al. 1993,2002; Liu et al. 1996; Sheng et al. 1995 
Chemokines 
Macrophage inflammatory protein-I a (MIP-1 (x) 
Macrophage inflammatory protein-I 0 (MIP-l ß) 
Macrophage chemotactic protein-I (MCP-1) 
RANTES* 
Interferon-gamma inducible protein-10 (IP-I 0) 
Growth-related oncogene alpha (GRO-a) 
1-309 
Growth factors 
basic fibrobaist growth factor (bFGF) 
macrophage colony-stimulating factor (M-CSF/CSF-1) 
granulocyte-monocyte colony-stimulating factor (GM-CSF) 
platelet avtivating factor (PAF) 




inducible nitric oxide synthase (NOS) 
matrix metalloproteinases 1,2,3,9 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 
complex components (e. g. gp91-phox) 
Receptors 
IL-1111, IL-IRII, IL-5R, IL-6R, IL-8, IL-10R, 
IL-12R, IL-13R, IL-15R 
FGF receptors(1-4) 
Complement 5a receptor (C5aR, CD88) 
CDI4 (LPS receptor) 





orphan opioid receptor (OR) 
substance P receptor (neurokinin-1) 
a-chemokine receptor: CXCR4 
ß-chemokine receptors: CCR2, CCR3, CCR5 
]on Channels 
inward K+ channel, outward calcium-dependent K+ channel 
transiently activated anion channel 
Miscellaneous 
substance P 
NG2 chondroitin sulphate 
Hua and Lee, 2000, Lee et al. 2002, Janabi et al. 1999, McManus et at 1998, 
2000; Peterson et al. 2000; Rezaje et al. 2002, Si et al. 1996 
DiPucchio et al. 1996; Hua and Lee, 2000, Janabi et al 1999; Lee et al 2002, 
McManus et al. 1998,2000; Peterson et al. 1997; Si et al. 1996 
Hua and Lee, 2002, McManus et al 1998,2000; Peterson et al 1997, 
DiPucchio et al. 1996, Hu et al- 1999. Hua and Lee 2000, 
McManus et al. 2000, Si et al. 1996, 
Hua and Lee, 2000 
Janabi et al 1999 
Hua and Lee 2000 
DiPucchio et a9.1996, Presta et a0 199 5 
Lee et al. 1993 
Lee et aL 1994 
Jaranowska et al. 1995 
Colasanti et at. 1995, Ding et al 1997, Peterson et al. 1994 
Espey eta]. 1997 
Colasanti et al. 1995, Ding et al. 1997 
Cross and Woodroofe 1999, Ghorpade et al. 2001 
Green et al. 2001 
Lee et al 2002 
Balaci et al 1994, Presta e ta ) 1995 
Gasque eta]. 1997 
Peterson et al. 1995 
Coraci et aL 2002 
Liu et al, 1994 
Jaranowska et al. 1995 
Chao eta]. 1996 
Chao ei al. 1997, Lipovsky et al. 1998, Peterson et al. 1995 
Chao et al. 1998 
Lai et al. 2000 
Gabuzda et at 1998, He et al. 1997, Rezaie and Male, 1999, Rezaie et al. 
2002, Va1{at et aL 1998 
Cross and Woodroofe, 1999, Gabuzda et al 1998, He et al. 1997, Hegg et al. 
2000, Kitai et al, 2000; Rezaie and Male, 1999, Rezaie et al 2002, 
Vallat et al. 1998 
McLamon et al. 1997 
Lai et al 2000.2002 
Poul\ et al 1 UIN 
'" Abbreviation for: 'regulated on activation, normal T cell-expressed and secreted' 
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M-CSF appears to affect both the survival and differentiation of microglia. Tomozawa and co- 
workers (1996) found that 1 ng/ml of recombinant human M-CSF enhanced the survival rate of 
rodent microglia in culture. They also found that 5ng/ml rhM-CSF or ing/ml recombinant 
murine GM-CSF caused division in the microglia, and these cells differentiated in response to 
50ng/ml rhM-CSF. All of these factors are produced at least in part, by astrocytes. and it has 
therefore been proposed that CSFs regulate the number of microglia in the developing CNS. 
The work in vitro must be interpreted with caution since many studies have used inflammatory 
stimuli to activate astrocytes. Nevertheless, several key cytokines including M-CSF and GM- 
CSF have now been found in situ within the normal developing brain (Chang et al. 1994: 
Thery et al. 1990). 
Other than direct interactions with astrocytes and their migratory response, further 
characteristic patterns of behaviour for human foetal microglia emerged from the co-culture 
studies presented in Chapter IV: when cultured microglia encountered debris, they emitted 
pseudopods that encircled, engulfed and ultimately assimilated the particles. Multipolar 
microglia whose lamellipodia projected in several directions appeared to explore the 
surrounding environment to orientate their movement. In addition, intermediate morphologies 
between multipolar, bipolar and unipolar types were observed in the same cell, indicative of 
interchangeable morphological states. Microglia were found to occupy distinct `territories' 
and very rarely did they make contact. These observations further indicated that the patterns of 
microglia distribution and differentiation could be mimicked in culture. This is contrary to 
other cell types found in the CNS, and raises the possibility that microglia themselves can 
secrete factors that initiate interconversion and regulate their spatial distribution, both in vitro 
and in vivo. Which then, are the signals that can initiate the patterns of differentiation and 
migration of microglia that we can detect in situ in the developing brain? 
Factors regulating microglial ramification: A number of factors are known to be associated 
with or induce microglial ramification (Figure 101). As noted, chief amongst these is the 
influence exerted by astrocytes. Both soluble (M-CSF: Hao et al. 1990: Liu et al. 1994; 
Sawada et al. 1990; GM-CSF: Fujita et al. 1996) and insoluble factors (Tanaka and Maeda, 
1996) secreted from astrocytes have been known to cause microglial ramification and 
proliferation. Moreover, amoeboid microglia ramify on fixed or freshly cultured astrocyte 
monolayers (Lee et al. 1992; Tanaka and Maeda, 1996). This implies that a component or 
substrate (such as integrins) derived from the extracellular matrix and present on astrocytes is 
required for contact-mediated ramification of microglia (Giulian et al. 1995). Fibronectin, 
vitronectin, laminin, thrombospondin and tenascin have all been suggested as mediators 
(Chamak and Mallat, 1991; Smith and Hale, 1997; Tanaka and Maeda, 1996). Several studies 
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have supported this hypothesis: astrocyte-derived ECM components including laminin and 
fibronectin (as well as serum-free medium) can induce microglia to ramify- (Fujita et al. 1996. 
Tanaka et al. 1998.1999), although laminin may also promote the amoeboid form of 
microglia (Giulian et al. 1995). Similarly, blood monocytes and tissue macrophages ramif on 
astrocyte monolayers, but not on acellular substrates or on fibroblasts (Sievers et al. 1994), or 
on mesenchymal/epithelial cells (Wilms et al. 1997). These cells downregulate their antigenic 
markers and display ion channel properties similar to those of microglia (Schmidtmaver et al. 
1994). 
As shown in this study, the ramification and motility of microglia depend on the state of 
confluency of astrocytes in culture. Microglia tended to adopt more stable morphological 
states and motility in progressively confluent cultures of astrocytes. Therefore the density of 
astrocytes in culture exerts a separate influence on microglial numbers and ramification (a 
plating density of less 8,000 cells/cm3 inhibits the growth of microglia, which appear as 
isolated cells: Richardson et al. 1993; Sievers et al. 1994). According to another study, a 
plating density of less than 10,000 microglial cells per 24-well plate was found necessary for 
microglia to ramify (Heppner et al. 1998). Secretory products released by astrocytes clearly 
affect microglial morphology. As we have seen, GM-CSF and M-CSF produced by astrocytes 
in vitro, are not only potent stimulators of microglial proliferation and survival, but are also 
required for their morphological differentiation (Aloisi et al. 1992; Ganter et al. 1992; Giulian 
et al 1995; Giulian and Ingemann 1988; Lee et al. 1992.1993,1994; Liu et al. 1994; 
Malipiero et al. 1990; Suzumura et al. 1990,1991). Liu and colleagues (1994) reported that an 
antibody to the M-CSF receptor effectively inhibited the ramification of microglia co-cultured 
with astrocytes. Microglia may be induced to ramify in serum-free medium supplemented 
with 2ng/ml GM-CSF (Fujita et al. 1996). 
Serum supplements may also influence microglial morphology (Fujita et al. 1996). 
Constituent proteins within foetal calf serum (e. g. progesterone, insulin, casein) as well as 
high glucose concentrations can inhibit GM-CSF-induced ramification of microglia, whereas 
microglia that are cultured in media devoid of glycine and serine display a ramified 
morphology (Tanaka et al. 1998; Yao et al. 1990). Microglia cultured in serum-free medium 
on poly-L-lysine coated coverslips or in long-term tissue culture slice preparations likewise 
exhibit a ramified morphology (Czapiga and Colton, 1999; Mertsch et al. 2001; Sudo et al. 
1998), and their macrophage-associated activities are suppressed, as indicated by a reduction 
in superoxide ions produced. Other factors such as thyroid hormones exert proliferative and 
differentiating effects that promote ramification of microglia in rodents (Lima et at. 2000). 
Therefore, certain constituents within serum can maintain microglia in an activated state. This 
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may be of particular relevance during early stages of development, when the blood-brain 
barrier is not completely formed, and amoeboid microglia could be maintained in their 
activated states at these sites through exposure to serum components. For comparison. in the 
adult, microglia also adopt a more activated state in areas of the CNS that lack a complete 
blood-brain barrier (Perry and Gordon, 1991). 
A number of other determinants known to induce microglia to ramify have been reported. 
Treatment with antioxidants such as a-tocopherol and ascorbic acid, initiate microglial 
ramification within 48 hours with accompanying downregulation of surface antigens (LFA-1, 
VLA-4 and ICAM-1) and increased survival (Heppner et al. 1998). Thapsigarin, a calcium- 
ATPase inhibitor of endoplasmic reticulum has been reported to promote ramification in vitro 
(Yagi et al. 1999). Agents known to accelerate the differentiation of CNS precursor cells (e. g. 
retinoic acid and dimethylsulphoxide) also stimulate the formation of processes by microglia 
in vitro, of up to 700µm in length (Giulian and Baker, 1986; Yao et al. 1990). Nanogram 
amounts of bacterial lipopolysaccharide (LPS), reportedly also induces ramification although 
this usually predisposes microglia to activation and their associated amoeboid forms (Mertsch 
et at. 2001). Finally, an alteration in the levels of free radicals available to microglia may be 
influential. Scavenging of free radicals is a property that has been noted in microglia (Noble et 
al. 1994), and free radicals have the potential to activate and maintain microglial activation, 
particularly in isolated cultures devoid of other cell types that could act in some buffering 
capacity. Low serum levels (5% foetal calf serum, 1% normal human serum) in addition to 
mercaptoethanol (which inhibits superoxide and free radical) in this study may have 
contributed towards the progressive ramification of microglia in co-culture. Nonetheless, the 
most convincing requirement for microglial ramification appeared to be direct contact with 
astrocytes. On the whole, it is therefore likely that the ramification of microglia will depend 
on a combination of factors and on the level of contribution of each of these that are present in 
the milieu of the normal developing CNS. 
Factors regulating microglial motility: Migratory cells respond to mutiple directory cues in 
a co-ordinated manner. To accomplish this, adhesion receptors such as integrins and cadherins 
that are expressed at the surface of cells, mediate interactions between the cell and ECM as 
well as direct cell-cell interactions necessary for migration (Huttenlocher et al. 1998). Within 
cells, the actin cytoskeleton provides the extension and contractile forces required for cellular 
movements (phagocytocis, cytokinesis, crawling and contraction) including migration using 
lamellipodia or pseudopodia (Stössel, 1993). This takes place through a combination of actin 
polymerisation. depolymerisation, cross-linking and interaction with myosin (Allen et al. 
1998, Bray 1992). In macrophages, the regulation of these activities is partly governed h\ the 
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Rho family of GTPases: Rho, Rac, and cdc42 which activate the M-CSF tyrosine kinase 
receptor (Allen et al. 1998; Webb et al. 1996). These actin-regulatory proteins modulate cell 
migration during chemotaxis of macrophages in vitro. The dynamic protrusion and retraction 
of processes by microglia, movements of the cell body and internal structures noted in this 
study and by others, all indicate a flexible cytoplasm characteristic of macrophages, that can 
be inhibited by blocking actin polymerisation (Brockhaus et al. 1996). Examining slice 
cultures of corpus callosum from postnatal murine CNS, Brockhaus and colleagues noted that 
microglia within the slices retracted their processes and migrated at velocities of 0.5- 
1 p.. mlminute (30-60prnlhour) to the surface of the slice where they projected vellum-like 
processes in a rotary motion. This compared well with speeds of around 25 to 75µm per hour 
recorded for human foetal microglia in this study. Rapid movement of these processes 
preceded the generation of phagocytic and pinocytic vesicles. In their investigation, migration 
followed a direct route or occurred indirectly after traversing several micrometers parallel to 
the surface. Pseudopods of these activated cells were involved in phagocytosis of dead or 
dying cells at the surface, and their movement could be inhibited by treatment with 
cytochalasin B (an inhibitor of actin). The motility of microglia can also be directly affected 
by changes in the extracellular pH: acidification reduces motility through bundling of f-actin 
and formation of stress fibers (Faff and Nolte, 2000). 
It is also recognised that cells are further guided by the substratum over which they move. 
Insoluble guidance molecules promote or inhibit migration, and physical contours are also 
important. For example, when a cell encounters as fibre or filament, the ruffled membranes 
follow the fiber and pull the cells into a bipolar shape (Bray, 1992). Thicker fibers exert more 
powerful contact guidance than thin fibers: the shape of cells can be controlled by abundance 
of thicker fibers. Substratum guidance is particularly important for the migration of cells in 
developing embryos, where ECM components are known to regulate cell motility. For 
example laminin, a prominent ECM component of the CNS, has been shown to promote the 
migration of neuronal and oligodendrocyte precursors (Schmidt et al. 1997). Microglia 
preferentially associate with and migrate on astrocytic substrates, and laminin promotes their 
amoeboid `migratory' phenotype in culture (Chamak and Mallat, 1991). Furthermore, 
microglia constitutively express the ß2 integrins CD 1l a/LFA-1, CD l1 b/Mac-1 /CR3. 
CD 1l c/CR4, and CD 18 (Akiyama and McGeer, 1990), which are involved in interactions 
with ECM components and adhesion molecules within the CNS. These can be modulated in 
i'ivo and in culture and are associated with the morphological transformation and migratory 
response of microglia (Kloss et al. 2001). 
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In order for cells to migrate, the ECM has to be degraded enzymatically. In this regard, matrix 
metalloproteinases (MMPs) and other ECM-degrading enzymes are also of great significance, 
not only in migration, but also for the remodelling of tissues which is part of the process of 
maturation of the nervous system. Human microglia have been shown by others to express 
MMPs 1,2,3 and 9 in the adult brain (Maeda and Sobel, 1996), membrane-type MMP. an 
activator of MMP-2 (gelatinase-A) in the white matter (Yamada et al. 1995). as well as the 
receptor for urokinase plasminogen activator (an active cell surface protease) in cell culture 
(Washington et al. 1996). Migration is further directed by chemical cues 4 ithin the 
environment of a cell (Haapaniemi et al. 1995). Microglia have been shown to respond by 
chemotaxis and migration to a variety of chemoattractive stimuli in the brain (Graeber et al. 
1993; Nolte et al. 1996). These include ß-amyloid peptide (Davis et al. 1992; Fiala et al. 1998; 
Maeda et al. 1997; Nakai et al. 1998), complement 5a (Faff and Nolte, 2000; Nolte et al. 1996: 
Yao et al. 1990); TGF-ß (Yao et al. 1990), NGF (Glad and Gilad, 1995). LPS (Yang et al. 
1996), neuronal platelet activating factor (Aihara et al. 2000), leukaemia inhibitory factor 
(Sugira et al. 2000), epidermal growth factor (Heppner et al. 1998; Nolte et al. 1997), neuronal 
M-CSF (duYan et al 1997), substance P (Maeda et al. 1997), zymosan-activated serum 
(Czapiga and Colton, 1999) and chemokines: C 10 (Asensio et al. 1999), RANTES (Cross and 
Woodroofe, 1999; Hu et al. 2000), the beta chemokines MIP-Ia, MIP-1' , 
MCP-1 (Cross and 
Woodroofe, 1999; Peterson et al. 1997), as well as IL-8, IP-10 (Hu et al. 2000), and neuronal 
fractalkine (Harrison et al. 1998; Pan et al. 1997). In particular, microglia can respond rapidly 
by migration to a site of injury or inflammation, where many of these stimuli accumulate. In 
contrast to astrocytes, microglia display a marked migratory response to the chemokines, 
particularly MCP-1 (Calvo et al. 1996; Hayashi et al. 1995), which in turn can induce the 
production of IL-1 and IL-6 in mononuclear cells (Jiang et al. 1992). Therefore these studies 
all suggest that a chemotactic gradient if present focally, can amplify the recruitment of 
microglia. 
Microglial motility in situ: Colonisation of the CNS by microglia necessitates long distance 
migration of progenitors. This migration is brought about partly through the association with 
radial glia (Rakic 1981). For example, amoeboid microglia in the avascular embryonic retina 
migrate tangentially along Müller radial glia (Cuadros and Navascues. 1998; Navascues et al. 
1996). This model is useful as it precludes complications of precursor influx from vessels. 
"Tangential migration occurs along a tortuous pathway with cell movements in various 
directions. Amoeboid cells adhere strongly to Müller cell endfeet and processes at focal 
contacts and appear to migrate along these. Vellum-like lamellipodia have been noted to 
emerge from the cell body, from short and thick, or long and delicate processes. Although 
these lamellipodia from neighbouring cells do occasionally make contact, they do not o-vcrlap. 
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which suggests that contact-inhibitory factors are at play (Bershadsky and Vasiliev. 1988). 
Microglia are oriented along and generally migrate from central (optic disc) regions to the 
periphery of the retina, although migration is not entirely unidirectional. Again, this behaviour 
appears to be similar to that of cells migrating along a gradient of chemoattractant (Yao et al. 
1990). 
Axonal tracts are the preferred sites for migration of glial progenitors. For example, during 
development, 02A progenitor cells specifically invade and associate with axonal tracts, where 
they differentiate into oligodendrocytes, extending their processes between fascicles and 
synthesise myelin. The corpus callosum is a major axonal tract that developmentally contains 
both microglia and oligodendrocyte precursors. Microglia accumulate in great numbers at the 
surface of tissue slice preparations, and in some cases, migrate parallel to the fibers of the 
corpus callosum (Brockhaus et al. 1993). However, the direction of most motile cells is 
towards the cortex, with more than 80% of motile cells traversing parallel fiber tracks of the 
corpus callosum (Cuadros and Navascues, 1998). Similarly, amoeboid microglia appear to 
migrate along axon fascicles within the developing optic nerve (Moujahid et al. 1997), and 
cerebellar white matter (Navascues et al. 1996; Cuadros et al. 1997). Myelinated tracts appear 
to be a favoured site for the migration of other cell types including transplanted cells (for 
example xenogeneic astrocytes, Booss et al. 1991) in the absence of an inflammatory 
response. Mechanical guidance through adhesion molecules, such as NCAM, laminin, or 
heparan sulphate proteoglycan are likely to be involved in this type of migration. Both the 
depth and interspacing of fascicles may influence the degree of alignment of cells, as 
demonstrated by parallel alignment of cells on a corrugated surface in culture (Bray, 1992). In 
a similar fashion grooves between fascicles may therefore provide highways for neuronal 
growth cones and associated microglia. 
Factors regulating microglial proliferation and apoptosis: The behaviour of astrocytes in 
long-term cultures can be explained partially by observations of the behaviour of other cell 
types, where cells that are proliferating will come into collision more frequently, and cell 
migration between contacts is shorter. Eventually, when confluence is reached, cell movement 
stops. It' cells are not subject to contact inhibition, they will often overly others in culture 
(Bray, 1992). This is typical of human foetal astrocytes in culture. However, evidence 
suggests that the upper surface of confluent cells exposed to the medium, does not provide a 
sufficiently, adhesive surface for other cells to migrate over. Instead, the layering results from 
one cell crawling under another (Bray 1992). This phenomenon is typical of microglia in long- 
term co-cultures with astrocytes, where these cells can be seen to roam under the confluent 
layer of astroc) tes. Early studies with cultured microglia showed that 'epithelioid cells' 
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(astrocytes) eventually dominated the culture and thereafter. microglia rapidly died (Dunning 
and Furth, 1935). In Chapter IV we also saw that microglia overlying astrocvies in long-term 
co-cultures progressively detached and subsequently underwent a form of cellular death. 
These processes are likely to be elicited either due to factors that accumulate within the 
supernatant (Mattion et al. 1995), or as a result of the non-permissive nature of astrocytes once 
they have established contacts and formed confluent sheets. In this respect, a lack of growth or 
related factors may be partly responsible for microglial detachment. Colony-stimulating 
factors such as G-CSF, GM-CSF, M-CSF and IL-3 are recognised as growth promoters for 
cells of the mononuclear phagocyte lineage (Metcalf, 1985; Nicola, 1989). GM-CSF and M- 
CSF are also growth factors for amoeboid microglia (Blevins and Fedoroff, 1995; Giulian and 
Ingemann, 1988; Lee et al. 1994; Sawada et al. 1990), and are produced by astrocytes (Lee et 
al. 1993; Malipiero et al. 1990; Ohno et al. 1990; Thery et al. 1990) and neurons (Nohava et 
al. 1992). Withdrawal of these mitogens in vitro leads to an elevated rate of microglial cells 
death via DNA fragmentation (Gehrmann, 1995). For example, microglia undergo apoptosis 
characterised by the shrinkage of cytoplasm, nuclear condensation and/or fragmentation, 
forming apoptotic bodies when M-CSF is deprived from the culture medium (Tomozawa et al. 
1996), and this can be detected by in situ nick-end labelling of fragmented DNA (Gavrielli et 
al. 1992). Contrary to astrocytes, human foetal microglia (and neurons) readily undergo 
apoptosis in tissue culture, when exposed to the opiate receptor agonist morphine (Hu et al. 
2002). This property is also consistent with studies of apoptosis following the exposure of 
rodent peritoneal macrophages and human blood monocytes to morphine (Singhal et al. 1998, 
2000). In Chapter IV, it was further noted that human foetal microglia (and astrocytes) 
exposed to recombinant MCP-1 at [100ng/ml] for several hours, also showed nuclear 
alterations characteristic of cells undergoing apoptosis, with fragmentation of DNA evident 
towards terminal stages. TUNEL labelling could not be reliably performed on these cultures, 
since the majority of these cells were disrupted morphologically upon fixation. Therefore this 
seemingly important finding, that long exposure to high concentrations of MCP-l may 
actually induce apoptosis in human foetal microglia and astrocytes, will have to be verified in 
independent studies. 
Although microglial proliferation has been extensively studied in disease states, following 
trauma, or injury to the CNS, less attention has been directed towards the developing brain 
(Giulian et al. 1991; Lee et al. 1994). Many of the macrophages within the developing CNS 
are believed to undergo apoptosis and will not survive to adulthood, while others are capable 
of proliferating prior to differentiation. Here, using dual-label immunohistochemistr} with 
CD45: CD68 and PCNA, it has been estimated that up to one third of microglia within the 
intermediate zones are undergoing division during the second trimester. Notably, despite the 
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abundant cell division noted at various sites in the cerebrum (including the ventricular zone 
and choroid plexus), only microglia appeared to express PCNA within the intermediate zone. 
Microglial proliferation therefore contributes to the process of colonisation of the developing 
nervous system 
Various studies indicate that M-CSF, GM-CSF, IL-3 produced by foetal astrocytes and 
microglia (Blevins and Fedoroff, 1995; Giulian and Ingemann 1988; Lee et al. 1992.1994: 
Liu et al. 1994; Raivich et al. 1994; Sawada et al. 1990; Schlichter et al. 1996; Tanaka and 
Maeda, 1996) or adenosine (Gebicke-Haerter et al. 1996) may act as possible signals for 
microglial division, whereas deprivation may lead to apoptosis. More specifically, in vitro 
studies indicate that either GM-CSF (Lee et al. 1994) or GM-CSF like peptides in rodents 
(Giulian et al. 1991), are responsible for microglial proliferation during embryogenesis, 
whereas the role of M-CSF is more controversial. All of these factors are produced at least in 
part, by astrocytes, and it has therefore been proposed that CSFs regulate the number of 
microglia in the developing CNS. Several key cytokines including M-CSF have been found 
within the normal developing mouse brain (Thery et al. 1990). Chang and colleagues (1994) 
showed that M-CSF (but not GM-CSF or IL-3) mRNA was constitutively synthesised from 
E13, with particularly high levels from E17 to postnatal day 15, and diminishing thereon 
through to adulthood. This corresponds to the period when microglia are proliferating and 
differentiating to ramified forms in the mouse brain, as shown in Chapter III, following which 
amoeboid cells are noted to decline in numbers. M-CSF appears to affect both the survival and 
differentiation of microglia. Tomozawa and co-workers (1996) found that I ng/ml of 
recombinant human M-CSF enhanced the survival rate of rodent microglia in culture. They 
also found that 5ng/ml rhM-CSF or Ing/ml recombinant murine GM-CSF caused division in 
the microglia, and these cells differentiated in response to 50ng/ml rhM-CSF. Furthermore, 
microglia underwent apoptosis associated with extensive nuclear condensation and 
fragmentation, within 48 hours following deprivation of M-CSF. These authors correlated 
their findings with the disappearance of a large proportion of amoeboid cells by about the 15`'' 
postnatal day in rodents, following the completion of synaptogenesis. In mice genetically 
deficient in M-CSF (osteopetrotic mutants), although microglia are present within the CNS in 
appreciable numbers (60-70% compared to wild-type animals), their proliferative capacity is 
reduced by as much as 90% as assessed by the facial nerve transection model (Blevins and 
Fedoroff, 1995: Wegiel et al. 1998; Wiktor-Jedrzejczak et al. 1991; 1996; Witmer-Pack et al. 
1993). These studies highlight the importance of both M-CSF and GM-CSF on the correct 
proliferation and differentiation of microglia during the foetal period. 
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Electrophysiological properties specific to microglia 
This study further showed that the electrophysiological property of microglia in vitro, was not 
altered by the length of cultivation (as opposed to freshly isolated cells). was independent of 
the morphological state of microglia, and consistent between species (rodent and human). 
Rodent and human microglia possessed membrane potentials around -70 to -8OmV. If 
clamped at -70mV, they showed no currents when subjected to a hyperpolarising voltage step, 
but for depolarising voltage steps, a large inward-rectifying current was detected. Potassium 
channel blocking agents (such as TEA, 4-AP and barium) are known to block this inwardly 
rectifying current. The lack of outward currents is believed to render microglia sensitive to 
depolarising events, which are long-lasting and may allow the transition of microglia from one 
morphological state to another. This depolarisation can be induced by exposure to ATP. 
Recently, Boucsein et al. (2000) have confirmed that the inward-rectifying K+channel is also 
a marker for activation and possibly triggering of microglia in vivo. 
However, this property seen in activated microglia is not inherent in resting ramified cells in 
situ. Within organotypic tissue slice preparations of the rodent CNS, ramified (perivascular) 
microglia are instead characterised by little if any inward voltage-gated membrane currents, 
and very low membrane potentials (their resting potential is closer to -20mV rather than - 
70mV). Microglia in these slices, exhibit larger, passive conductance over the entire stepping 
voltage range, and it is likely that their resting conductance is due to non-specific cationic 
conductance (Boucsein et al. 2000). Despite this characteristic, once these cells are activated 
(as in the facial nucleus, following transection), their activation parallels an increase in 
membrane area and a shift to a more negative potential, due to an increase in K+ conductance 
compared with non-specific cationic conductance. That is, they resemble isolated and cultured 
microglia. Furthermore, the inward current appears to be a transient phenomenon, since it can 
be identified within 12 hours following axotomy (in the facial nerve transection model). 
Within 24 hours, microglia express a prominent outward current (usually seen following LPS- 
activation of microglia in vitro), and by one week following the lesion, their `resting' 
electrophysiological properties have been regained, in parallel with the morphological 
transformations and with the ensuing reparative processes that are underway within the tissue 
at this time. 
Thus the inward rectifying potassium current can be taken as an early marker (or trigger) for 
microglial activation in vivo. It remains to be seen whether ramified human microglia 
overlying confluent astrocytes, and amoeboid and early ramified microglia in situ in the 
developing human CNS, will adopt the electrophysiological characteristics typified of rodent 
microglia seen under these experimental conditions. The specific question would be whether 
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amoeboid microglia similarly downmodulate their potassium currents upon differentiation to 
early ramified forms. Likewise, it would be important to determine whether potential 
populations of microglial progenitors residing in cord blood or within foetal haematopoietic 
tissues (yolk sac, spleen and liver), could be identified by these electrophysiological 
characteristics, and how these properties are affected if these progenitors are stimulated to 
differentiate to form microglia, for example by co-culture with human foetal astrocytes. 
Cerebrovascular development and expression of adhesion molecules 
Cerebrovascular development and differentiation begin with the formation of the neural tube 
and progress throughout gestation. By the end of the 4thweek, the human embryo has a well- 
developed vascular system and its heart is beating. Vessels arise from mesodermal cells 
independently in the yolk sac, the chorion and the embryo. These three systems of vessels 
later unite to establish the complete circulation. Vascularisation of the CNS commences at 5 
weeks near the leptomeningeal side of the neural plate and between the 5`i' and 6th weeks, 
numerous yolk sac-derived blood cells occur within and outside blood vessels in human 
embryos (Choi, 1981; Kershman 1939). Within the mature CNS, endothelial cells are 
characterised by continuous `tight junctions' resulting in a high electrical resistance which 
contributes to the blood-brain barrier. This is induced in the CNS by the neural environment 
during development, and principally by astrocytic contact as already outlined. From studies 
conducted in rodent and chick embryos, the timing of barrier formation (based on 
impermeability to inert tracers) is known to depend on the anatomical location of blood 
vessels: a barrier in the spinal cord forms earlier than in the telencephalon and probably 
commences around E13 in the chick and E16 in rodent embryos. Although the precise timing 
of formation of the blood-brain barrier has not been determined in humans, indirect evidence 
suggests that tight junctions develop from the 7`' to the 20" gestational weeks (Mollgard and 
Saunders, 1986). 
Figure 102 shows a general schema for the development of blood vessels in the cortical plate 
of the telencephalic neocortex. From the earliest time points examined, microglia displayed a 
close relationship with the development and maturation of the cerebrovasculature. The 
appearance of microglial progenitors coincided with vascularisation of a particular region. In 
particular, human foetal microglia and their potential (amoeboid) progenitors were closely and 
preferentially associated with certain radiating cortical vessels in the telencephalon, capillaries 
within the germinal layers and corpus callosum, and with blood vessels in the internal capsule 
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The finding that foetal microglia preferentially associated with certain large-diameter blood 
vessels (for example within the internal capsule) is intriguing. It raises the possibility whether 
they can use such vessels for migration to various sites. Certainly, time-lapse video 
microscopic studies on slice preparations from the CNS of postnatal rodents, have found that 
perivascular microglia can indeed migrate along cerebral vessels during development 
(Grossmann et al. 2002). Alternatively, it is possible, although not confirmed, that factors 
associated with the walls of these microglia-adherent blood vessels, stimulate these 
progenitors to divide, and in so doing, may add to the local population of foetal microglia. 
Nevertheless, in many of the regions displaying microglial progenitors (particularly, amoeboid 
cells), there was evidence for circulating cells having recently gained entry into the CNS via 
blood vessels. The expression of adhesion molecules ICAM-1 (CD54), VCAM-1 (CD106), 
ICAM-2 (CD 102), E- and P-selectin, and PECAM (CD31) were examined between 16 and 
23GW in the human foetal cerebrum and spinal cord, in order to identify whether microglial 
infiltration into the CNS was regulated by regional vascular expression of these molecules. 
In the adult, trans-endothelial migration of mononuclear phagocytes occurs via specific 
binding to adhesion molecules expressed on the surface of vascular endothelium. Observations 
on the migration of monocytes to inflammatory sites have indicated the importance of 
interactions between ICAM-1 on the endothelium and LFA-1 (aL(32 integrin, CD 11 a/CD 18) 
and/or CR3 ((XMß2 integrin, CD ll b/CD 18), on monocytes and macrophages. VCAM-l 
mediates adhesion to leukocytes via a4 integrins (e. g. (x4ß1 and (x407) (Shimizu et al. 1992) 
and has been shown to facilitate cell-cell interaction during development (Gurtner et al. 1995). 
However, studies on human embryogenesis have shown that VCAM-1 is not expressed on 
most derivatives of the neural crest (Sheppard et al. 1994). Instead, VCAM-1 is selectively 
expressed on haematopoietically-active foetal tissues such as the spleen, liver and bone 
marrow (Schweitzer et al. 1996). Moreover, VCAM-1 is not readily inducible on CNS 
endothelium in comparison with non-CNS endothelium (dos Santos et al. 1996). Although 
ICAM-1 is expressed at low levels on most vessels, endothelial cells do not express VCAM-1 
under normal circumstances. This is desirable in order to limit the trafficking of leukocytes 
into tissues. Induced expression of VCAM-1 is more readily detected in postcapillary venules, 
a site of prominent leakage and leukocyte extravasation during inflammation, though VCAM- 
I can also be encountered on capillary endothelium and arterioles at sites of inflammation 
(Pober and Cotran, 1991). Both ICAM-1 and VCAM-1 are inducible by inflammatory 
cytokines such as IL-1. IFN-y and TNF-a (Bell and Perry, 1995). 
In the present study, VCAM-1 was not expressed by cerebral vascular endothelium between 
16 and 23GW at a time when microglia are colonising the CNS. This therefore precludes the 
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use of VCAM-I for recruitment of these cells. Similarly, the expression of ICAM-1 was 
largely absent in normal foetal brains, as reported for the adult brain (Kupner et al. 1990). 
ICAM-1 was found to be expressed sparsely by foetal cerebral vessels in this study. The 
intensity of the stain was weak and the distribution did not correlate with zones of microglial 
influx. Furthermore, there was no evidence for the expression of VCAM-1 or ICAM-1 in the 
human foetal spinal cord. The finding that ICAM-1 and VCAM-1 were similarly not 
expressed in the murine foetal CNS contradicts the findings of Dalmau and colleagues (1997). 
who found expression of ICAM-1 in the developing rat brain and postulated that it may 
contribute to recruitment of microglial progenitors. However, it does make sense from the 
viewpoint that events, which occur during embryonic and foetal development, are quite 
distinct from those that preside in inflammation (Heyward et al. 1995). In this respect. P- 
selectin and E-selectin, known to be important contributors to the interaction of monoc\ tes 
with venular endothelium during inflammation (Bevilacqua 1993), were also found to be 
largely lacking from the developing CNS in this study. 
An alternative ligand for LFA-1 (and probably also for Mac-1) is ICAM-2, and this adhesion 
molecule is non-inducible by inflammatory cytokines (Acevedo et al. 1993; Holness et al. 
1995; Nortamo et al. 1991; Staunton et al. 1989), but does seem to be specifically expressed 
on endothelium at varying levels in different tissues (Ebnet et al. 1996). For example, low 
levels of ICAM-2 are constitutively expressed by human brain microvessel endothelium 
isolated in culture (Brayton et al. 1998), and on a human bone marrow endothelial cell line 
(Schweitzer et al. 1997). Similarly, the levels of ICAM-2 expression on adult brain 
endothelium are reportedly low (Navratil et al. 1997), which may partly explain why 
lymphocyte trafficking into the CNS is limited under normal circumstances. Current opinion 
regards the expression of ICAM-2 on endothelium as necessary but not sufficient to induce 
monocyte migration. Additional signalling molecules (such as MCP-1) are also required. 
Unexpectedly, this investigation showed a relationship between vascular ICAM-2 expression 
and highly vascularised areas of the human brain colonised by microglia, particularly within 
the corpus callosum at 16GW and more widespread on radiating cortical vessels by 22GW. 
Similarly, ICAM-2 was present on the vasculature in the connective tissues surrounding the 
spinal cord between 9 and 16GW, and these areas correlated with macrophage entry. Within 
the cord, ICAM-2 positive vessels were first detected around 12 weeks and more prominently 
by 16 weeks. The majority of these vessels were located in the dorsal and ventral funiculi, 
extending into the mantle layer, which corresponded to the pattern of migration for foetal 
microglia that took place from 14-16GW, and was directed inwards from the connective tissue 
surrounding the spinal cord both dorsally and ventrally. These findings suggest that an 
interaction between LFA-1 /Mac-1 and ICAM-2 is at least partially required for the migration 
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of microglial progenitors. This would seem sensible from the point of view that ICAM-2 is 
developmentally expressed and subsequently downregulated on adult CNS endothelium. The 
finding that ICAM-2 was not expressed in the murine CNS between Ely and birth may 
suggest a species-specific and/or functional specialisation in the developmental expression of 
this vascular adhesion molecule. Nevertheless, the expression of ICAM-2, although necessary 
is probably not sufficient to induce the migration and recruitment of monocytes alone. 
In the present study, both PECAM-1 and laminin were highly expressed on the majority of 
foetal cerebral vessels irrespective of localisation with microglia, including on capillaries 
within the germinal layers between 16 and 22GW, and within the spinal cord between 9 and 
16GW. The expression of subunits of laminin on cerebral blood vessels has been associated 
with their development. For example in rodents, S-laminin has been detected specifically on 
developing cerebral vessels during the perinatal period, and coincides with the maturation of 
the blood-brain barrier, whereas laminin is constitutively present on the walls of vessels 
throughout development and in the adult (Hunter et al. 1992). In the developing spinal cord of 
rats, Hunter and colleagues (1992) further found laminin to be present throughout the pia, 
whereas s-laminin was concentrated specifically on the pia that overlay the floor plate. This 
region has been proposed to provide extracellular cues for guidance of growing axons, and as 
shown by the present study, also accumulates microglial progenitors. It should therefore be 
determined whether microglial progenitors specifically interact with specific subunits or 
isoforms of laminin and whether these molecules are developmentally expressed in a region- 
specific manner within the human foetal CNS. 
PECAM-1 (CD31), a 120-13OKd membrane glycoprotein expressed on endothelial cells, 
platelets and a variety of mature haematopoietic cells including monocytes, neutrophils and 
subsets of T cells (Watt et at. 1995), mediates transendothelial migration of leukocytes by 
heterophilic (glycosaminoglycan-dependent) or homophilic (glycosaminoglycan-independent) 
mechanisms (Baldwin et al. 1994; Yan et al. 1995). It is abundantly expressed on endothelium 
both in vivo and in culture (Muller et al. 1989). In the adult, PECAM-1 is constitutively 
expressed on endothelial cells and preferentially localised at sites of cell-cell contact. This 
restricted pattern of expression is considered to contribute towards interactions that limit 
vascular permeability. This is also particularly significant to cell migration since antibodies 
raised against CD31 block normal cell-cell contact and disrupt cell migration (Schimmenti et 
al. 1992). Experiments also suggest that homophilic interaction between leukocyte and 
endothelial CD _3 molecules result 
in signal transduction that consequently increases adhesion 
mediated by ßl and 02 integrins (or in other words. via CDII'CD18 or (x4ß1 dependent 
mechanisms) (Bevilacqua 1993). PECAM-1 can potentially induce integrin-modulated 
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adhesion at high endothelial venules (Shimizu et al. 1992). PECAM-1 has also been suggested 
as a useful marker for following vascular formation in mammalian embryos. It has been 
localised to early endothelial precursors within the yolk sac and subsequently in all organs and 
tissues within the embryo (Baldwin et al. 1994; Vecchi et al. 1994), and is expressed at high 
levels on all early myeloid cells (Lund and Terstappen, 1993). The immunoglobulin domains 
of PECAM-1 (domains 1 and 2) are known to be involved in distinct processes of diapedesis 
and migration of cells through the extracellular domain (domain 6) (Liao et al. 1995). In 
addition, PECAM may contribute to endothelial barrier function in vivo, disruption leading to 
leakage of hepatic and renal blood vessels in mice (Ferrero et al. 1995). The constitutively 
high expression of PECAM between 16 and 22GW may therefore reflect a dual role for 
PECAM during development, namely a contribution to the migration of microglial progenitors 
into the parenchyma and the formation of a preliminary barrier. 
Therefore, the expression of ICAM-2 on cerebral endothelium during the second trimester, 
associated most closely with the influx and distribution of foetal microglia. ICAM-2 is 
normally expressed at low levels in the adult brain and is not induced by inflammatory 
cytokines. Therefore, its association with microglial colonisation suggests tissue-specific 
control of this process, mediated by the endothelium. These findings can be placed in 
perspective when considering stages in development of the vascular system and of 
mononuclear phagocytes. In the early phases, mesodermal (phagocytic) cells gain access to 
the CNS prior to vascularisation. Following this, blood vessels develop within this tissue, and 
express ICAM-2 at certain distinct locations. Shortly afterwards, progenitor cells develop that 
have the capacity to interact with ICAM-2 and migrate into vascularised sites. 
Expression of chemokines and chemokine receptors in the foetal brain and spinal cord 
Cells of the human CNS are known to express or can be induced to express an expanding 
number of chemokines and their receptors. Table 17 provides a summary of chemokines 
produced by human astrocytes, neurons and mononuclear phagocytes. Table 18 lists the 
expression of chemokine receptors characterised in cells from the human nervous system. 
Certain chemokines may regulate neuronal functions such as synaptic transmission, enhance 
neuronal survival, and possibly contribute towards neuronal repair following injury,. with 
additional support derived from glial cells (Araujo and Cotman, 1993; Bacon and Harrison. 
2000; Brenneman et al. 1999: Giovanelli et al. 1998; Meucci et al. 1998; Ragozzino et al. 
1998). Furthermore, neurons have been shown to express specific chemokine receptors (e. e. 
CCR2. CCR 3, CXCR2, CXCR3, CXCR4) (Hesselgesser et al. 1997; Horuk et al. 1997. Zhang 
et al. 1998), and chemokines have been proposed to act as signalling molecules for neurons 
within specific 'chemokinergic' pathways such as that within the hypothalarno- 
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neurohypophyseal axis (Lira 1996; Sakamoto et al. 1996; Tani et al. 1996). Several lines of 
evidence have further shown chemokines to be important in directing neuronal migration both 
in vivo (Bagri et al. 2002; Hesselgesser et al. 1998; Horuk 1998; Klein et al. 2001: Ma et al. 
1998; Zou et al. 1998) and in vitro (Bolin et al. 1998; Hesselgesser et al. 1997; Lazarini et al. 
2000). Some studies have shown that chemokines may act as proliferating signals and 
migrational cues for glial progenitors (Dorf et al. 2000). Chemokines such as MIP-1 a. MIP- 
10, MCP-1, RANTES, IL-8, IP-10, SDF-1 and fractalkine are potent chemoattractants for 
microglia in vitro (Cross and Woodroofe, 1999; Harrison et al. 1998; Heesen et al. 1996: Hu 
et al. 2000; McManus et al. 2000; Pan et al. 1997; Peterson et al. 1997; Tanabe et at. 1997). 
and MIP-la has some chemotactic effect on astrocyte progenitors (Tanabe et at. 1997). 
Microglia in particular display marked migratory responses to MCP- 1, which can be produced 
by both cell types in situ (Calvo et al. 1996; Hayashi et al. 1995). Based partly on these 
previous findings, it was proposed that the migration of microglial progenitors in the CNS 
during development, was likely to be initiated by the establishment of intracerebral gradients 
of chemotactic agents such as chemokines. 
In order to ascertain which chemokines were present in the developing human brain during the 
second trimester, the patterns of expression for the ß-chemokines MCP-1, MCP-3, MIP-1 a, 
MIP-10, RANTES, the a-chemokines IL-8, IP-10 SDF-1, and the CX3C chemokine 
fractalkine, were examined in the developing brain. It was found that MCP-I localised to the 
subplate and lower cortical plate of the telencephalon, to projections of the corpus callosum, 
within the matrix of the ventricular and subventricular zones, and was additionally found in 
the choroid plexus. Importantly, the expression of MCP-1 was limited to the lateral regions of 
the cerebrum, and co-localised with accumulation of differentiating microglia in the subplate. 
Although astrocytes are known to produce MCP-1 from tissue culture studies, expression of 
this chemokine did not appear to co-localise with GFAP, but was more likely to be neuronal. 
Expression of MCP-1 in the cortex can be induced in hypoxic-ischaemia (for example after 
transient middle cerebral artery occlusion) (Wang et al. 1995). However, the fact that none of 
the normal human foetal tissues analysed showed pathological signs of hypoxic-ischaemic 
injury, coupled to the developmentally-restricted pattern of expression for MCP-1 found 
within the CNS, precluded expression of this chemokine to be the result of secondary 
phenomena. The expression of RANTES was more widespread on cells within the 
intermediate zone, progressing toward the cortical plate, whereas IL-8 was associated with 
radial cortical vessels of the frontal cortex (these were previously characterised to 
be PECAM 
and ICAM-2 positive), and to some extent within the meninges overlying the cortical plate. 
Unlike MCP-l, MIP-la was not expressed within the cortical plate. Instead, this chemokine 
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Double-labelling with an antibody to CD68 revealed that MIP- Ia positive cells in the 
intermediate zone were microglia. Notably, these cells commonly appeared in pairs. Paired 
microglial cells within this region also expressed PCNA, implying recent division. It is likely 
that within the ventricular zone, both MIP- la and MCP- I additionally labelled blood vessels. 
In situ hybridisation analysis also detected the mRNA for MIP-1 a and MCP-1 confined to the 
ventricular zone, germinal matrix of the ganglionic eminence and more diffusely within the 
cortical plate. Taken together, these observations indicate that microglial progenitors could 
respond to differentially expressed chemokine gradients (MCP- I and RANTES) by, migrating 
away from the germinal layers towards the cortical plate. In addition, frectalkine was 
expressed by cells within the corpus callosum, on cell clusters within the germinal layers and 
in the intermediate zone, and diffusely on radiating cerebral vessels within the telencephalon. 
Thus, regional expression of fractalkine may also contribute to the patterns of colonisation 
seen during the second trimester. This is particularly significant since most recently, 
fractalkine produced by human astrocytes and neurons in culture, has been shown to bind to 
human foetal microglia and neurons which express CX3CRI receptors, and specifically 
induces microglial proliferation up to 3-fold (Hatori et al. 2002). Therefore it is possible that 
fractalkine expression within areas densely populated by microglial progenitors may also 
stimulate their proliferation in situ. By comparison, there was no detectable expression of 
SDF-1 or MIP-l ß, and only minimal levels of MCP-3 or IP-10 in the cerebrum during the 
second trimester. The expression of chemokines within the human foetal spinal cord (9- 
16GW) differed from that described for the cerebrum between 16-23GW. None of the 
chemokines examined were found in the spinal cord during the period under examination. 
This may suggest that different mechanisms operate within the spinal cord and cerebrum for 
the recruitment of microglial progenitors, which may also reflect differences in the patterns of 
colonisation seen within these respective sites. 
Within the human foetal cerebrum, the chemokine receptors CCR5 and CXCR4 were 
expressed in ventricular and subventricular zones and projections of the corpus callosum, 
CXCRI expression was lacking, and CCR2, although present on microglia in the intermediate 
zone and subplate between 17 and 22GW. progressively demonstrated widespread expression 
on cellular profiles within the lower cortical plate, subplate and intermediate zone, as well as 
within the ventricular zone towards the end of the second trimester. 
The sheer numerical 
density of cells expressing this chemokine receptor far outweighed the number of microglia 
located within these regions, and whereas CXCR4 expression was 
found to co-localise to a 
large extent with microglia on double-immunolabelling, 
CCR? expression became more 
widespread within the same regions and not solely restricted to microglia. 
Whereas both 
CCR5 and CXCR4 were specifically expressed within 
localised areas of the spinal cord, 
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particularly at 9GW, neither CCR2 nor CXCR1 were found in human foetal spinal cord 
samples examined between 9 and 16GW. CCR5 and CXCR4 expressed within the spinal cord 
at around 9GW may have been related to directing the migration of neuroglial progenitors, 
since few microglia were present within the ependymal zone at this age. These observations 
further supported the concept that different cues directed migration of microglial (and 
neuroglial) progenitors within the cerebrum to that seen in the spinal cord during 
development. The finding that CCR2 is widely expressed by a variety of cells within the 
developing brain may be significant from the perspective of correct migration of neuronal and 
(astro-)glial progenitors, as well as microglia in response to the chemotactic gradient 
established by MCP-1. This hypothesis is supported by findings that cultured human foetal 
neurons and a clonally-derived human neuronal cell line (NT2. N) are able to express CCR2, 
CXCR4 and that NT2. N cells can also produce MCP-1 (Coughlan et at. 2000). 
There is a distinct paucity of studies looking at the expression of chemokines and their 
receptors in situ within the developing nervous system, with which to compare the above 
findings. Nevertheless, two other studies have looked at the developmental expression of 
CCR3, CCR5, CXCR3 and CXCR4 (van der Meer et al. 2001; Westmoreland et al. 2002). 
CCR5 and CXCR4 were found in cortical neurons of the rhesus macaque, commonly co- 
expressed at the cell membrane and in the cytoplasm of hippocampal CAI-4 neurons, Purkinje 
cells, subcortical nuclei and neocortical pyramidal neurons of layers III, V and VI 
(Westmoreland et al. 2002). Microglia were the predominant glial cell type that expressed 
CCR5 and CXCR4, and the expression of these chemokine receptors increased significantly 
from birth, within the first nine postnatal months. mRNA expression for CCR5 and CXCR4 
however, was variable or showed a slight decrease. Such a lack of correlation between mRNA 
and protein levels has been found under some experimental conditions (Fields, 2001; 
Westmoreland et al. 2002), and may partly relate to differences in the stability of mRNA, the 
translation of message or to the post-translational modification of proteins. In the case of 
chemokine receptors, these can recycle or redistribute to the cell surface from intracellular 
stores (Andjekovic and Pachter, 2000). By contrast, a recent study reported limited or no 
expression of CCR3 and CXCR4 in the human foetal brain, while CXCR3 was found from 
26GW on glial cells, endothelial cells and at term in Purkinje cells of the cerebellum (van der 
Meer et al. 2001). Surprisingly, these authors found that the expression of CXCR4 in their 
samples commenced between 3 to 4 years of infancy. This report contradicts the present 
findings in the human foetal brain, and that of Westmoreland and colleagues (2002) who 
noted in the rhesus macaque. that moderate neuronal and glial expression of CXCR4 (and 
CCR5) began within the second trimester, and increased with developmental age beyond birth, 
as detected immunohistochemically and by flow cytometry. Therefore. a discrepancy in the 
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timing of CXCR4 expression between these studies may be due to technical differences in the 
detection of this receptor, namely immunohistochemical detection on snap-frozen sections of 
human foetal CNS used in the present study, compared to formalin-fixed paraffin-embedded 
archival material that was used in the study by van der Meer and colleagues. These 
observations will therefore require careful further analysis. 
Cultures derived from human foetal CNS between 13 and 19 weeks of gestation were also 
screened for chemokines and receptors previously demonstrated in situ in the developing 
CNS. Of all the chemokines examined, constitutive expression of MIP- Ia on microglia, and 
variable low levels of MCP-1, MIP-la and RANTES were found on human foetal astrocytes 
under basal conditions in vitro. In these non-stimulated culture systems, foetal astrocyte- 
microglial co-cultures did not express MIP-1 ß, MCP-3, IL-8, IP-10 or SDF-1 at the protein 
level as detected by immunocytochemistry. This seeming lack of expression may be 
attributable to a number of factors including the culture conditions, but appropriately reflects 
the equally apparent absence of expression of these particular chemokines in astrocytes and 
microglia in the normal human foetal CNS in situ, as shown above. By contrast, inflammatory 
cytokine such as TNF-a, IL-10 and IFN-y can induce expression of IP- 10, IL-8, MCP-1 and 
RANTES by human astrocytes (Oh et al. 1999). In the present culture system, following 
treatment of with LPS, only MCP-1 was significantly upregulated by glial cells. Human foetal 
astrocytes have been shown to express a number of chemokine receptors including CCR1, 
CCR3, CCR5, CXCR2 and CXCR4 (Dorf et al., 2000). Of the chemokine receptors examined, 
CCR2 expression was localised to clusters of astroglial precursors and less frequently in 
astrocytes, but could be upregulated by treatment of cultures with recombinant MCP-1. The 
expression of CCR2 by human foetal astrocytes maintained in tissue culture has now been 
confirmed by an independent group (Andjelkovic et al. 2002). CXCR4 was widely expressed 
by glial cells under basal conditions and was not appreciably altered by LPS treatment. CCR5 
and CXCRI could not be detected immunochemically on human foetal astrocytes or microglia 
in non-stimulated cultures. 
Recombinant human chemokines MCP-1 and MIP-la further acted as proliferative cues for 
second trimester human foetal astrocytes in a dose-response manner. This response was likely 
to be elicited via CCR2 receptors with MCP-1, or via the newly described CCR11 receptor 
(Murphy et al., 2000). The expression of CCR5 (a receptor for MIP- l a) has been noted on 
human foetal astrocytes (Klein et al., 1999; McManus et al., 2000b; Sabri et al., 1999). and 
RANTES, an alternative ligand for this receptor, promotes the proliferation of astrocyyte 
progenitors derived from 5 and 10 week old human foetal CNS (Bakhiet et al., 2001). 
However, as expression of CCR5 could not be detected in non-stimulated glial cultures, it is 
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instead proposed that the effects of MIP-1a occur through interaction with CCR1 on 
astrocytes (Han et al., 2000; Tanabe et al., 1997). The possibility of 'cross-talk' between 
chemokine receptors however, cannot be entirely eliminated. 
MIP-1 a labelled microglia in subconfluent cultures and was diffusely expressed at the surface 
of astrocytes and at junctions between astrocytes once these cells had attained confluence. 
However, in contrast to other studies (Janabi et al., 1999; Miyamoto and Kim, 1999). human 
foetal astrocytes in these cultures did not express consistent levels of MIP-1 a under basal 
conditions. Microglia, therefore represented the principal source of this chemokine in vitro as 
previously noted (McManus et al. 1998). Microglia co-cultured with astrocytes or purified and 
maintained in vitro, demonstrated expression of MIP-1 a. Nevertheless, not all microglia in 
these isolated preparations were immunoreactive. Instead, this chemokine localised mainly to 
the surface and was apparent on paired cells, which implied recent division, similar to the 
observations recorded in situ in the developing CNS. By comparison, in a separate study using 
human foetal microglia, Peterson et at. (1997) found minimal expression of MIP- Ia in the 
supernatant of isolated cultures maintained for 18-48 hours, as detected by ELISA (although 
production of this chemokine was evident when microglia were cultured in medium 
supplemented with LPS or recombinant IL-lß /TNF-(x). It was not stated whether MIP- la 
was also detected in situ on cells in culture. Therefore the apparent differences between the 
basal expression of MIP-la by human foetal microglia can be explained by [i] different 
culture conditions (long-term co-culture with astrocytes and isolated preparations in the 
present investigation versus short-term isolated cultures), or [ii] the methods of detection of 
the chemokine: in situ on microglia as shown here versus release into the supernatant. 
It is possible that co-culture with astrocytes regulates expression of MIP-1 a by human foetal 
microglia. Furthermore basal expression of MIP-1 a appears to be restricted to the surface of 
microglia (perhaps 'bound' to surface glycosaminoglycans) whereas further stimulation of 
these cells (with LPS or recombinant cytokines IL-10 or TNF-a) promotes release into the 
supernatant. Clarification of these issues certainly warrants further investigation. This 
particular chemokine is known to inhibit the proliferation of myeloid progenitors (Graham and 
Pragnell, 1992), is mainly produced by activated cells of myeloid or lymphoid origin 
including macrophages of the hone marrow (Graham et al. 1990), and is chemotactic for 
monocytes (Wang et at., 1993). It inhibits stem cell proliferation, but enhances committed 
GM-CSF and M-CSF induced colony formation (Broxmeyer et at., 1989; Graham et at., 1990; 
1992; Keller et at., 1994). Murine MIP- la enhances the myelopoietic effects of GM-CSF in 
culture (Broxmever et at. 1989). and exerts an autocrine effect on macrophage proliferation, 
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reported to induce TNF-a production in these cells (Fahey et al. 1992). The concentrations of 
MIP-la required to elicit an inflammatory response are at least three orders of magnitude 
higher than that required for its inhibitory effects. It is at present unknown whether expression 
of IMP-la by microglia and astrocytes regulates microglial proliferation in a similar manner 
to the effects observed on myeloid stem cells, and whether MIP-la maintains these cells in a 
differentiated state. 
Traditionally astrocytes have been regarded as a cellular source of MCP-1 (Andjelkovic et at., 
2000; Barna et al., 1994; Barnes et al., 1996; Glabinski et al., 1996; Gourmala et al.. 1997; 
Hayashi et al., 1995; Hurwitz et al., 1995; McManus et al., 2000; Weiss et al., 1998). 
Recently, neurons are also potential candidates for MCP-1 production (Coughlan et al., 2000: 
Meng et al., 1999). The expression of MCP-1 in this study was confined to clusters of 
astrocytes in subconfluent cultures, where this chemokine was predominantly located within 
intracytoplasmic vesicles. Importantly, with progressive confluence, astrocyte cultures showed 
MCP-1 expression at the surface and in distinct intense patches throughout cultures, which 
coincided with overlying, progressively ramified microglia. THP-1 monocytes were also noted 
to bind to isolated astrocytes that expressed MCP-1 in co-cultures, albeit not exclusively. The 
results presented here correspond well with the report by Andjelkovic and colleagues (2000). 
These authors found that while neither astrocytes nor monocytes alone produce detectable 
levels of MCP-1, co-culture of these two cell types led to time-dependent production of this 
chemokine. Specifically, the production of MCP-1 was dependent on physical contact 
between monocytes and astrocytes and involved the engagement of cell adhesion molecules 
ICAM-1 and VCAM-1, possibly mediated via release of IL-1ß and TNF-a (Andjelkovic et at. 
2000). In the developing human CNS, expression of this chemokine within the subplate 
similarly coincided with the accumulation of progressively more ramified microglia. Low 
levels of MCP-1 may therefore help to confine cells to distinct areas, and promote their 
differentiation. Although recombinant human chemokines exerted variable effects on MCP-1 
expression between samples, treatment with LPS significantly upregulated expression of this 
chemokine by human foetal astrocytes in a reproducible manner. 
MCP-I, also known as monocyte chemotactic and activating factor (MCAF), wN-as initially 
purified by two independent groups based on its ability to chemoattract monocytes. 
Subsequent cloning and sequencing of MCP-1 showed this protein to be identical to the 
product of the murine PDGF-inducible JE gene (originally identified in mouse fibroblasts) 
(Cochran et at. 1983). Human MCP-1 cDNA encodes a 99-amino acid residue precursor 
protein with 23-residue hydrophobic signal peptide that is cleaved to generate a 76 residue 
mature protein. MCP-1 is heterogeneous in size due to addition of O-linked carbohydrates and 
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sialic acid residues. It can be expressed constitutively or following stimulation in a number of 
cells including fibroblasts, tumour cells, smooth muscle cells, endothelial cells and 
mononuclear phagocytes. MCP-1 appears particularly important since it has been 
demonstrated to specifically induce chemotaxis of microglia and recruit monocytes to the 
CNS (Bell et al., 1996; Hayashi et al., 1995). Furthermore, transgenic mice overexpressing 
MCP-1 (linked to a myelin basic protein promoter) have higher numbers of mononuclear 
phagocytes in the CNS (Fuentes et al., 1995). The amino terminal domain is specifically 
responsible for chemotaxis of monocytes (van Damme et al. 1992). This chemotactic response 
to MCP-1 is elicited via the CCR2 receptor G-protein (the major receptor for MCP-1). 1 inked 
to cytoplasmic activation of mitogen-associated protein kinase (MAPK) (Yen et al., 1997). 
The existence of binding sites for ß-chemokines (MCP-1, MCP-3, MIP-(x and MIP-10) on 
human foetal astrocytes has been suggested from binding assays (Andjelkovic et al., 1999). 
CCR3 (Simpson et al., 2000) and CCR5 (Klein et al., 1999: Rottman et al., 1997; Sabri et al., 
1999) have previously been identified on human astrocytes. Constitutive expression of CCR2, 
the receptor for MCP-1 was found in human foetal astrocytes and astrocyte progenitors 
maintained under basal culture conditions. This appears to be associated with the state of 
differentiation and activity of astrocytes, since higher levels of CCR2 expression were noted 
on motile precursor cells and much lower levels in differentiated type 1 astrocytes. 
Furthermore, treatment with recombinant human MCP-1 specifically upregulated CCR2 
expression in human foetal astrocytes over an 18-hour period in vitro. Expression of this 
receptor by certain populations of human foetal microglia has now been confirmed by an 
independent group (Andjelkovic et al. 2002). The chemotaxis of astrocytes and astroglial 
progenitors towards cytokines and classical chemoattractants is recognised from previous 
studies in culture (Armstrong et al., 1990,1991; Bressler et al., 1985; Rowen and Glaser, 
1985; Senior et al., 1986; Tanabe et al. 997). It is therefore possible that MCP-1 also acts as a 
functional and chemotactic signal for human foetal glial progenitors in the developing central 
nervous system. 
The data regarding CXCR4 expression by human foetal microglia and astrocytes is in 
agreement with other studies (Albright et al., 1999; Gabuzda and Wang, 1999; He et al.. 1997: 
Klein et al., 1999; Sabri et al., 1999; Shieh et al.. 1998; Vallat et al., 1998). As previously 
noted, the pattern of `perinuclear' intracytoplasmic immunoreactivity for both CCR2 and 
CXCR4 in this study can be attributed to accumulation within the Golgi apparatus, an 
observation previously noted in other cell types (Halks-Miller et al., 1997; Lore et al., 1998). 
Presumably, the intracytoplasmic expression of these receptors is a preliminary step towards 
expression at the surface of the cell and requires further triggering signal(s) for this purpose, 
present only on certain cells (including microglia and dividing astrocytes). For example, in 
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rodents type I astrocytes and microglia expressing CXCR4 respond to SDF-1 by mobilising 
intracellular calcium (Bajetto et al., 1999; Tanabe et al., 1997) 
CXCR4 is constitutively expressed in a wide range of tissues including brain, heart, kidney. 
liver, lung and spleen (Ma et al., 1998). During early development, CXCR4 is expressed in 
both haematopoietic organs and proliferative areas of the brain (Jazin et al.. 1997: Zou et al., 
1998): migrating cells (mesoderm and definitive ectoderm) contain CXCR4 mRNA while the 
ligand for this receptor, SDF-l, is expressed by embryonic ectoderm (McGrath et al., 1999). 
Temporo-spatial interaction between this receptor and its ligand(s) appear to be critical in 
correct neuronal patterning of the cerebellum during development in the mouse, and deletion 
of the respective genes is embryologically lethal (Ma et al., 1998; Zou et al., 1998). Since 
ligation of CXCR4 has been shown to induce apoptosis in human neurons, it has been 
proposed that correct neuronal patterning results from the apoptotic elimination of cells that 
have migrated incorrectly (Hesselgesser et al., 1998; Horuk, 1998; Zheng et at. 1999). 
However, this study failed to detect expression of SDF-1, the ligand for CXCR4, either in 
culture in this investigation or in situ in the human foetal cerebrum. It is possible that 
additional as yet unidentified ligand(s) for CXCR4 exist within the CNS. Alternatively, it is 
possible that expression of this chemokine is developmentally regulated and absent or minimal 
during the period of development under study. Similar to the report in rodents (Ohtani et al., 
1998), the levels of CXCR4 expression on human foetal glial cells were not appreciably 
altered by stimulation of cultures with bacterial LPS (or the recombinant human MCP-1 and 
MIP-1 (x) in this study. 
To summarise, the colonisation of the CNS by microglia in situ necessitates long-distance 
migration of progenitors from specific sites to reach their target locations. Within the 
neocortex, this migration is brought about in part through association with radial glial 
elements, as well as axonal tracts. This behaviour appears similar to that of cells migrating 
along a gradient of chemoattractant. The temporo-spatial expression of MCP-1, MIP-la, 
RANTES, IL-8 and fractalkine in situ in the human foetal CNS supports a role for these 
chemokines in directing the colonisation of microglial progenitors. A summary figure of the 
signals associated with the colonisation of microglial progenitors in the human foetal 
telencephalon is presented pictographically in Figure 103. The distinct expression patterns for 
chemokines such as MCP-1 (Meng et al. 1999; Pousset 1994), as shown in this study may also 
suggest additional specific roles for these factors at different stages of development, related to 
the cytoarchitectural organisation of the CNS. For example, related to (i) chemoattraction of 
filial precursors from ventricular and subventricular layers, (ii) promoting initial, random 
















Summary diagram to show the distribution and colonisation of 
human cerebral cortex by microglia, 16-22GW 
Microglia arising from the germinal layer associate with radiating cortical vessels and 
specifically with radial glial fibers as they migrate towards the cortical plate, and 
progressively increasing concentrations of the chemokines MCP-1 and RANTES. 
Foetal microglia adopt transitional morphologies in advancing through the intermediate 
zone. They are aligned below, but do not penetrate the cortical plate prior to 22GW. 
Abbreviations: (vz) ventricular zone, (svz) subventricular zone, (iz) intermediate zone, (cp) 
cortical plate, (m) meninges, (rcv) radiating cortical vessel, (n) neuronal progenitors, (rg) radial 
glial astrocytes. Arrow indicates the direction of microglial colonisation/differentiation along 
chemokine gradients towards higher concentrations of RANTES and MCP-1. 
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This is supported by studies in vitro that have shown neuronal progenitors to migrate towards 
MCP-l (Bolin et al. 1998; Hesselgesser et al. 1997; Lazarini et al. 2000), as well as towards 
other chemokines such as IL-8, RANTES and SDF-1. The above findings suggest that 
chemokines such as MCP-1, MIP-la, RANTES and fractalkine may not only act as signals 
for the migration and differentiation of microglia, but could additionally be employed during 
development to direct the migration, proliferation and perhaps differentiation of glial and 
neuronal progenitors during development (Bakhiet et at. 2001; Hatori et al. 2002; Rezaie et al. 
2002). Ontogenic differences between astrocytes, microglia and neurons and their 
differentiation states may contribute towards their responses towards chemokines. In this 
respect, the generation of knockout and transgenic animals will continue to be useful in order 
to differentiate between causation and mere association of chemokines with developmental 
responses, and in determining the functionality of chemokine receptors expressed by cells of 
the nervous system. In this investigation, the relationship demonstrated in vitro between MCP- 
I and expression of its receptor, CCR2 in human foetal astrocytes and the proliferative effects 
of recombinant human chemokines on these cells, support a functional and/or chemotactic role 
for this chemokine/chemokine receptor pairing in the developing nervous system. 
Colonisation of other tissues by mononuclear phagocytes during the second trimester 
Does colonisation of other foetal tissues follow the same time-frame as for microglial 
colonisation of the CNS, and do the progenitors for resident mononuclear phagocytes use a 
similar array of cues to gain access to developing tissues? By comparison with the CNS, there 
is little information on the precise mechanisms by which mononuclear phagocytes enter other 
developing tissues, and these important questions remain for the most part unanswered at 
present. Nevertheless, studies carried out on the developing skin, another tissue also derived 
from embryonic ectoderm, have been promising. The epidermis contains specialised 
monocyte-derived dendritic cells called Langerhans cells (LCs). These function as antigen 
presenting cells, and can migrate from the skin via dermal lymphatics to regional lymph nodes 
where they present antigen to T cells and initiate primary immune responses against antigens 
encountered in the skin (Wang et al. 1999). To this effect, LCs first dissociate from 
keratinocytes, traverse the basement membrane of the dermal-epidermal junction and proceed 
via afferent lymphatics to draining lymph nodes. The interaction of cytokines and chemokines 
with appropriate receptors by LCs orchestrates their mobilisation from the epidermis and 
correct positioning within the paracortex of lymph nodes (Kimber et al. 2000; Wang et al. 
1999). It has been proposed that bone marrow-derived, myeloid LC precursors traffic . is the 
peripheral blood, through the dermis to the overlying epidermis (Stroebel et al. 1997). 
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In man, foetal LCs migrate to the skin during the first and second trimesters (Fujita et al. 
1991). By 17-18GW, these cells begin to mature phenotypically (expressing CD 1a and Lag 
antigens). Regional variations in the development of Langerhans cells have also been noted: 
epidermal cells of the palms of the hands and soles of the feet reach a peak in numbers in the 
first trimester, but are rarely detected after 18GW, whereas in other regions, their numbers 
increases with gestational age. Similarly, Gibran and colleagues (1996) found that dermal DCs 
expressing factor XIIIa (a coagulation transglutaminase) populated the dermis from about 
6GW onwards and attained an adult-like distribution by 22GW. Factor XIIIa positive DCs 
were evident in the embryonic skin prior to the onset of bone marrow haematopoiesis and the 
majority expressed CD68 antigen (Gibran et al. 1996). 
By comparison, in the rat primitive mononuclear phagocytes have been shown to migrate into 
the epidermis of the foetal rat at E17 and express an antigenic determinant (RED-1) that is 
present on LCs, dendritic cells, monocytes and macrophages in various organs and tissues in 
adult rodents (Mizoguchi et al. 1992). These RED-1 positive cells proliferate, express la 
antigen at E18, and differentiate into dendritic cells and LCs within a few days after birth. A 
separate group has found that foetal mouse skin is colonised by myeloid precursors that 
possess a macrophage/immature DC-like phenotype (H-2d, b+, I-Ad, B+, 2.4G2+, 2F8+, Sca- 
2+, CD I1 b+, CD 11 c+, F4/80+, B7.2+, CD44+, CD54+), and these cells can be stimulated to 
proliferate with GM-CSF, but not M-CSF (Girolomoni et al. 1995). 
The timing of colonisation of the skin and differentiation of these epidermal monocyte-derived 
cells found in both man and rodents, correlate well with the period of colonisation of the CNS 
by microglial progenitors and their subsequent differentiation. The question that emerges is 
whether any similarities can be found in the expression of signals within these two `ectoderm- 
derived tissues', that would preferentially recruit mononuclear phagocytes to their respective 
sites. Recent studies have provided exciting data particularly relating to the controlled 
expression of the chemokine MCP-1 in the skin. Nakamura and colleagues (1995) have show n 
that transgenic mice overexpressing MCP-1 in the basal layer of epidermis display a dramatic 
increase and redistribution of CD45+, Ia+ cells that assume dendritic morphology in situ, 
including a subset that expressed markers characteristic of LCs. MCP- 1, produced mainly by 
keratinocytes, was specifically upregulated in the basal layer of the epidermis. Strikingly, the 
recruitment of these cells occurred in the absence of inflammation. Normal adult skin shows 
minimal levels of MCP-1. but this is upregulated in diseased skin, and increased MCP-1 
expression is associated with increased numbers of CD68+ dendritic epidermal cells in various 
diseases of the skin (Nakamura et al. 1998). In transgenic mice. MCP-1 has been shown to 
specifically recruit these CD68+ cells, which represent a subpopulation of the CDla-- 
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Langerhans cells (Nakamura et al. 1995). Most recently. Merad and colleagues (2002) showed 
that resident Langerhans cells of the skin were long-lived cells with low turnover from the 
bone marrow. They showed that in lethally radiated mice, dendritic cells were almost 
completely replaced by cells of donor origin, whereas LCs of host origin remained for at least 
18 months. Significantly, these authors demonstrated that under UV-light, LCs rapidly 
disappeared and were replaced by circulating precursors within a fortnight, and further that the 
recruitment of these newly-derived cells was dependent on their expression of CCR2 and on 
the release of chemokines targeting this receptor from the tissue. Based on these observations, 
when taken together with the findings presented in this work, and recent characteri sat ions that 
suggest LCs are derived from monocytes, these data support a role for MCP-1 in directing 
progenitors of tissue-resident mononuclear phagocytes to the skin and the CNS during 
development. Other than MCP-1, additional factors that are involved in the specific 
constitutive recruitment of LCs to the skin include MIP-3a and TGF-ß (Charbonnier et al. 
1999; Godefroy et al. 2001; Larregina et al. 2001; Nakamura et al. 1999). The selective 
recruitment of LCs into the dermis can also be induced in the adult by intradermal injection of 
recombinant GM-CSF (Kaplan et al. 1992). However, one should still exercise caution with 
respect to exactly which type of cell is recruited to the skin in these studies, since normal 
human skin contains several different populations of cells with dendritic morphology (Nestle 
and Nickoloff, 1995), and the relationship between dermal dendritic cells and epidermal LCs 
is still unclear. It remains to be seen whether these same factors are expressed in the 
developing human CNS and if so, whether they are involved in the recruitment of microglial 
progenitors to this tissue. 
Microglia in the developing mouse brain 
Studies that have investigated microglia in the developing rodent brain have focused mainly 
around the perinatal and more intensively on the postnatal periods of development, since these 
are the times when an abundant, yet transient population of amoeboid cells can be identified 
using conventional methods, in addition to the emerging population of ramified cells (Chamak 
et al. 1995; DeGroot et al., 1992; Miyake et al. 1984; Perry et al. 1985: Wang et al., 1996; Wu 
et al., 1992,1993). Although these periods of microglial colonisation in the mouse appear to 
differ from the observations in man, which occurs predominantly during the second trimester 
as shown in Chapter 11, the timing is in fact comparable in relation to the developmental stages 
in humans and rodents. In humans, the onset of bone marrox\ formation in the humerus 
(embryos of 30mm crown-rump length) has been adopted by the Carnegie staging s} stem as 
one of the criteria for distinguishing between the embryonic period and commencement of the 
foetal period of prenatal life (8 or more weeks of gestation). In the mouse. this corresponds 
approximately to 14-15 days of gestation (Theiler stage 23) (Theiler 1989). Further 
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extrapolation determines that a gestational age of 14-20 weeks in man corresponds to 
postnatal days 6-12 in rodents. These are periods when microglial colonisation is prevalent in 
both species. 
It is clear from this investigation that microglial progenitors, amoeboid microglia and 
differentiating cells are already present at E15 in the mouse brain. Furthermore, the 
differentiation of microglia from amoeboid to early ramified cells is already underway during 
the latter half of the embryonic period, from E15 onwards. Microglial progenitors closely 
adherent to the parenchymal wall of cerebral vessels could be identified clearly using lectin 
histochemistry with lycopersicon esculentum and RCA-1, whereas these cells did not express 
markers of mononuclear phagocytes (CD 11 b, CD45, MOMA) and a smaller population 
expressed F4/80 antigen (a marker found on differentiated macrophages and monocyte- 
derived dendritic cells). RCA-1 in particular, clearly identified all populations of microglia in 
the embryonic CNS, and showed that the early ramifying cell types increase progressively in 
numbers. Furthermore, the period of differentiation from amoeboid to early ramified microglia 
was identified between E 17 to E 19, coincident with the progressive downregulation of binding 
sites for tomato lectin and F4/80 antigen on ramifying cells. This morphological 
differentiation also coincided with the regional maturation of cerebral blood vessels according 
to caudal-rostral and ventral-dorsal axes. Differences between microglia colonisation of the 
marine CNS from that in man may further reflect the differences in the timing and structural 
organisation of the nervous system (particularly related to neuronal and vascular organisation). 
The topographical distribution of microglia in the murine CNS is in line with previous studies 
(Chamak et at. 1995; Dalmau et al. 1997; Earle and Mitrofanis, 1997; Ling 1979; Milligan et 
al., 1991; Miyake et al., 1984; Perry et al. 1985; Wang et al., 1996; Wu et al., 1992,1993). For 
example, Perry and colleagues (1985) demonstrated early microglia/macrophages in the white 
matter of the developing cortex, the corpus callosum, with many cells detected within the 
choroid plexus and widely distributed in the pia at E16. In this study. amoeboid cells were 
generally more abundant in developing white matter tracts such as the corpus callosum, 
internal and external capsules, whereas ramifying cells were more frequently distributed 
additionally within grey areas (such as the caudate and thalamus). with the exception of the 
developing cortical plate which lacked these cells up to birth. This supports a white to grey 
axis for the migration and differentiation of microglial progenitors, much like that seen in the 
human foetal nervous system. A striking feature during murine development however, was the 
transient population of amoeboid cells evident between E19-E20 in the cavum septum 
pellucidum. Once again, this observation was in keeping with other reports (Tseng et al.. 
1982, I. i et al., 1997). 
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The timing of differentiation for microglial progenitors also corresponds well with the reports 
by Chugani and colleagues (1991) and Alliot and co-workers (1991). Chugani et al. (1991) 
demonstrated that vaults (ribonucleoprotein particles) that were highly enriched in 
mononuclear phagocytes, were differentially expressed on microglial populations during 
development. They found between E 15 and E 18., a population of ramified cells that were ED I 
and OX-42 negative, but could be detected by GSB4 isolectin and by vault immunoreactivity. 
Postnatally, vault immunofluorescence was also present on amoeboid cells, which expressed 
high levels ED I antigen, as well as on ramified microglia, and both of these markers "v ere 
downregulated by P14. These authors also noted that early ramifying cells could be detected 
earlier in the parenchyma than the influx of amoeboid cells detected postnatally. Thus the first 
component of the microglial population was made up differentiating cells between F15 and 
E18, and a second migration occurred in the first postnatal week, when amoeboid microglia 
appeared in the corpus callosum and other large fiber tracts, these cells likely to be derived 
from circulating monocytes. In a separate study, Alliot and co-workers (1991) found that 
CD I1b (Mac- l) labelled cells were located in the brain parenchyma from E 16 in the mouse, 
and the numbers of CD I1 b+ F4/80+ cells increased between E 16 and E 19. In culture, these 
progenitors appeared to be CDI l b+ F4/80-. Based on the phenotype of these cells and their 
capacity to proliferate in vitro, giving rise to clones of CD1lb+, Fc receptor+ F4/80+ cells 
(much like progenitors found in the bone marrow), these authors proposed that the initial 
progenitors of microglia could represent cells of the CFU-GM type that could give rise to 
granulocytes or monocytes depending on appropriate cytokine stimulation. 
The finding that the differentiation of microglia coincided with the regional maturation of 
blood vessels in both rodents and human development, raises the question whether the same 
signals within the CNS drive the maturation of microglia and endothelial cells, or whether 
these two cell types can mutually influence each other's differentiation. Since microglia are 
still present in considerable numbers in mice deficient in M-CSF, the embryonic mouse brains 
were screened for expression of GM-CSF, to determine whether this cytokine was present 
within the developing brain. The results showed a lack of expression within the brain 
parenchyma between E15 and birth, consistent with a previous report (Chang et al. 1994). 
Nevertheless, the importance of GM-CSF in regulating microglial differentiation would be 
more suitably addressed by investigating embryonic brains from GM-CSF knockout or 
combined M-CSF/GM-CSF knockout mice. 
Environmental factors that maintain microglia in the resting state in situ, also remain unclear. 
By comparison, a , side spectrum of factors are known to induce ramification of microglia in 
tissue culture. as outlined previously (Figure 101). However, recent evidence from studies on 
268 
CD200 knockout mice indicate that this membrane protein enriched on neurons. may exert 
inhibitory control on the activation and morphology of macrophages and microglia, through 
interaction with the corresponding CD200 receptor restricted to cells of the myeloid lineage 
(Barclay et at. 2002; Hoek et at. 2000; Wright et al. 2000,2001). The expression patterns for 
this molecule and its receptor within the developing brain will certainly prove informative 
from the perspective of microglial differentiation. Brown and Perry (1998) further noted the 
preferential adhesion of murine macrophages and microglia to neurons in a modified in situ 
adhesion assay, on sections of the adult mouse brain. Adhesion of macrophages to neurons in 
the mouse may partially involve interaction with an l1OKd protein (recognised by the 
monoclonal antibody HB1) on macrophages (Brown et al. 1998). This same protein is 
recognised by the lectin GSB4 (Brown et al. 1998). It remains to be seen whether different 
populations of neurons could express or secrete factors (including chemokines and adhesion 
molecules) that attract microglial progenitors and/or influence their differentiation to ramified 
cells in the embryonic environment. 
Thus far, we have gained a comprehensive impression of the timing, phases and potential 
signals recruiting microglial progenitors to the developing nervous system. Two further topics 
related to this work will also require examination. The first concerns functional roles for 
microglia during development. The second addresses the important question of the origin of 
these cells in the context of newly revised concepts regarding the system of mononuclear 
phagocytes. 
Functional roles of microglia during development 
Microglia have been regarded as a component of the mononuclear phagocyte system, in 
accord with their functional and phenotypic characteristics. From the above discussions, it is 
clear that selective expression of particular markers by microglia at various stages of 
development, may reflect functional specialisation of these cells in response to local 
environmental cues, particularly derived from astrocytes (Giulian et al. 1995; Sievers et al. 
1994; Tanaka and Maeda, 1996). We have ascertained that microglia colonise the human 
foetal CNS during the second trimester, and establish their territorial 'domains' by the start of 
the third trimester. This period coincides with that which encompasses the greatest activity 
within the foetal CNS, a time when neuronal migration to the cortical plate is complete and 
synaptogenesis and neuronal differentiation have commenced (Chan et al. 2002). It is 
reasonable to assume therefore, that the infiltration of microglia within this period of 
heightened structural organisation serves a fundamental purpose. The exact nature of this 
purpose however, remains speculative at present. Nevertheless, it is necessar\ to e' aluate the 
potential contribution of microglia towards CNS histogenesis and tissue modelling during 
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development. In order to place such hypotheses into context, mention must first be made of 
the developmental processes that abound during the second trimester. 
The remarkably complex organisation of the cerebrum follows a series of highly co-ordinated 
temporally and spatially-regulated sequence of events, which are heightened during the second 
trimester. These involve the generation, migration and maturation of neurons destined for the 
cortical plate and glial cells within germinal layers, as we have already seen (Choi, 1988). 
During this period, post-mitotic neurons migrate in highly restricted fields along fibers of 
radial glia, which span the thickness of the telencephalon extending from the ependyma to the 
leptomeninges (Choi, 1988; Gould and Howard, 1987; Hatten, 1990: Rakic 1981; Sasaki et al. 
1988; Wilkinson et al. 1990). The marginal zone (Layer I) develops early on, following the 
establishment of the pia-glial barrier. Migration and maturation of Cajal-Retzius neurons to 
this layer appears critical in determining the subsequent growth and layerwise arrangement of 
the cortical plate (Chan et al. 2002). Cortical plate neurons that arrive first, are destined for 
deeper layers, and successive waves of neurons arriving at the same location, populate more 
superficial layers in an inside-out fashion (Choi, 1988). This developmental process raises two 
important points for discussion. The first concerns radial glial tracts that are established for the 
migration of neuronal progenitors and glial precursors to the developing cortical plate. There 
is undoubtedly a close association between foetal microglia and vimentin+/GFAP+ radial glia 
and astrocytes both in situ and in tissue culture, as shown in this investigation, to the extent 
that microglia are absent from areas devoid of radial glial projections within the intermediate 
zone in situ, and migrate on astrocytes in vitro. By reason of this relationship it is possible that 
microglia use the same structural highways (although not exclusively) as neuronal/glial 
progenitors in colonising the CNS. 
The second matter involves signals used for triggering migration. The specific distribution of 
chemokines MCP-1, RANTES and fractalkine in the second trimester not only identifies 
signals triggering the migration, proliferation and perhaps differentiation of foetal microglia 
but may also be responsible for signalling specific neuronal and glial migration, neuronal 
patterning and neuronal-microglial interaction, as discussed previously. Evidence supporting 
these last hypotheses has only recently emerged. Primary sensory neurons have been shown to 
migrate in response to RANTES expressed in situ, in embryonic mice (Bolin et al. 1998). 
CXCR2 is widely expressed in the human CNS, particularly on subsets of projecting neurons 
in the hippocampus, dentate nuclei, pontine nuclei, locus coeruleus, paraventricular nucleus, 
as well as in the anterior horn. antero-mediolateral cell column. and Clarke's column of the 
spinal cord. Fibres expressing CXCR2 are located in the superior cerebellar peduncle. 
substantia gelatinosa and other sites of the adult nervous system (Hesselgesser et al. 1997; 
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Horuk et al. 1997). The importance of chemokines in the developing CNS is further realised 
since transgenic mice deficient in CXCR4 or SDF- l die perinatally with severely 
compromised immune development, and abnormal cerebellar organisation (Ma et al. 1998). 
CCR3, CCR5 and CXCR4 have been detected in the human brain in a 'variety of cell tý pes 
including microglia, astrocytes, neurons and vascular endothelium (Lavi et al. 1997: Rottman 
et al. 1997; Vallat et al. 1998). This study has shown that the expression of CCR2 in the 
human foetal CNS is not exclusive to microglia. In culture, astrocytes and their progenitors 
also express this chemokine receptor. Moreover, astrocytes have been shown to migrate 
towards certain chemokines, including MIP-la (Tanabe et al. 1997). A human neuronal cell 
line which expresses CCR1, CCR5, CXCR2 and CXCR4 receptors, responds to a- and ß- 
chemokines by migrating in the differentiated (but not undifferentiated) state (Hesselgesser et 
al. 1997). The idea of signalling between neurons and microglia is supported by Nishiyori et 
al. (1998) who demonstrated the expression of fractalkine mRNA in rat neurons, and 
dominant expression of its CX3CR1 receptor mRNA in microglia in vitro, but not on 
astrocytes or neurons. Human foetal astrocytes and neurons likewise produce fractalkine in 
culture, the receptor for which is present on human foetal microglia (and on neurons 
themselves) (Hatori et al. 2002). A separate report by Hesselgesser and colleagues (1998) 
highlighted a different role for chemokines within the nervous system, namely the induction of 
neuronal apoptosis by SDF-1 acting via CXCR4. This is intriguing since this study has shown 
a pattern of CXCR4 expression within the germinal layers of the human cerebrum and spinal 
cord, which coincided with TUNEL-detection of apoptosis. 
Programmed cell death is an important feature of the developing nervous system, and 
macrophages can be found engulfing pyknotic nuclei (Ashwell, 1991; Hume et al. 1983). 
Naturally occurring cell death or `apoptosis' associated with the development of many organs, 
may act as a contributing stimulus for recruitment of macrophage populations (Ferrer et al. 
1990; Raff et al. 1993). However, the relationship between microglial distribution and 
apoptotic events in the developing nervous system remains controversial. There have been 
reports associating the distribution of microglial progenitors with cell death (Perry et at. 1985: 
Perry and Gordon, 1988; Rakic and Zecevic, 2000). Macrophages have also been noted at 
various sites in developing tissues before neuronal death is prominent, and are not necessarily 
associated with foci of cell death (Ashwell 1990,1991; Diaz-Araya et al. 1995; Gould and 
Howard, 1991; Milligan et al. 1991; Upender and Naegele. 1999; Sorokin et al. 1994). The 
fact that microglia are not exclusively associated with pyknotic cells. implies that dN ing 
neurons are not the sole determinants of the distribution of these cells, but may play an 
important role (Perry et al. 1985). Using TUNEL labelling to identify the extent of apoptosis 
and CD68 immunohistochemistny on the developing cortex. this study has also noted that 
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although microglia appear to be associated with dying cells in the ventricular and 
subventricular zones, they are equally present in neighbouring areas that lack dead cells. 
Foetal microglia may therefore regulate earlier (or later) events, in addition to their function in 
removing cellular debris (Davis et al. 1994). Nevertheless, the process of colonisation of the 
CNS by microglia proceeds in a cohesive and orchestrated manner, which hints primarily of a 
development-regulated response (i. e. to a specific set of temporo-spatial cues or signalling 
factors). Their topographical distribution patterns correspond to specific stages in the 
structural organisation of the CNS (i. e. they predominate in white matter and invade grey 
matter only when these areas are at a more advanced stage of development structurally and 
functionally). Their colonisation during the mid-to-late foetal period coincides with neuronal 
differentiation, synaptogenesis and the development of axonal-target connections (Chan et al. 
2002). The early emergence of microglial progenitors within the subplate (and intermediate 
zone) of the telencephalon may be important from the viewpoint that this region is known to 
harbour thalamocortical projections with a high degree of synaptogenesis (Chan et al. 2002), 
in addition to possessing the highest index of apoptosis in the developing CNS (Rakic and 
Zecevic, 2000). 
Like their macrophage counterparts in other tissue compartments, microglia have 
demonstrated the potential to produce factors (bFGF, TGF J, IL-1p, IL-8) that are associated 
with angiogenesis (the formation of new capillaries from pre-existing blood vessels) and tissue 
repair (Aldskogius, 2001; Giulian et al. 1988). Studies on neovascularisation of allografts 
(Pennell and Streit, 1997) and in the human foetal retina between 15 and 22GW (Provis et al. 
1997) have shown microglia to be positioned in advance of ingrowing blood vessels, as well 
as intimately associated with vascular endothelium and vascular sprouts. At all stages of 
development examined in this study, microglia were noted to closely associate with vessels. 
During development, the formation of new blood vessels from angioblasts is referred to as 
vasculogenesis. Histological examination of tissue sections with ongoing angiogenesis (for 
example in tumours), emphasise the importance of granulocytes and macrophages as 
prerequisite for neovascularisation. Experimental depletion of either cell type suppresses the 
formation of new vessels (although the angiogenic capacity of granulocytes is inferior to that 
of macrophages). Macrophages release several proteases (including plasminogen activator and 
elastase) that may yield angiogenic fragments from ECM molecules. Several soluble factors 
are stored in the ECM through binding to heparin-like glycosaminoglycans (e. g. bl GF, TGF- 
ß, GM-CSF). Enzymatic release from these 'reservoirs' would render them available to 
endothelial cells. For instance, macrophages can degrade heparan sulphate and release ECM- 
bound bFGF through expression of urokinase-type plasminogen activator. Among the 
cytokines produced by macrophages, TGF-ß modulates the expression of fibronectin or Type I 
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collagen and incorporation of these molecules into the ECM, angiotropin, PDGF. and IL-6 
exert modulatory roles in angiogenesis, bFGF which has been shown to stimulate the directed 
migration and proliferation of cultured endothelial cells and promotes the formation of 
differentiated capillary tubes in vitro, and human angiogenic factor initiates neovascularisation 
by inducing migration of endothelial cells to form sprouts without proliferating. Macrophages 
also control the extent of development of new vascular networks and promote their 
differentiation of vascular sprouts into functionally-mature capillaries through the release of 
several factors that inhibit mitosis or migration of endothelial cells: monocYte- derived 
endothelial cell inhibitory factor (MECIF), macrophage-derived endothelial cell inhibitor 
(MD-ECI), thrombospondin-1, and IFN-a. These factors promote the differentiating effects of 
otherwise chemotactic and mitogenic factors such as angiotropin. bFGF, GM-CSF or M-CSF. 
The accumulation of microglia within the CNS at sites where considerable vascular 
reorganisation, collateral sprouting and maturation is prevalent (for example within the 
germinal layers, corpus callosum, and subplate) may therefore indicate their involvement in 
modelling of the cerebral vasculature. In order to examine this further, one could look at the 
direct interaction between human foetal microglia and endothelial cells in vitro, and check 
expression of certain of these angiogenic-associated elements (including aV ß3/CD51 /CD61, 
angiogenic cytokines such as VEGF and FGF) in cerebrovascular development in relation to 
microglia. The maturation of blood vessels may be followed by investigating expression of 
specific molecules including laminin, which is constitutively expressed on developing vessels, 
fibronectin, which is a developmental marker and factor VIII, a marker for the progressive 
maturation of blood vessels. 
The reasons for the preferential location of amoeboid microglia within the white matter of the 
developing nervous system are certainly intriguing. These observations beg such questions as 
whether microglia in these localities are simply phagocytes eliminating debris and aberrant 
projecting axons as suggested, or whether they exert a more specific role in directing the 
growth and differentiation of myelinating oligodendrocytes, astrocyte proliferation and 
differentiation, or indeed the spatial regulation and modelling of axonal tracts. It is equally 
possible that amoeboid microglia are directed through the CNS by signals that accompany the 
formation of these tracts. As has been emphasised, amoeboid microglia that are abundant 
within the developing brain, closely resemble macrophages in terms of morphology. 
phenotype and function. In the rodent CNS, these cells are believed to phagocytose 
debris. 
which occurs as a result of naturally-occurring cell death in the late embryonic and early 
postnatal stages of development (Ferrer et al. 1990). and to eliminate certain axonal 
projections and synapses as part of the normal structural organisation of the 
CNS (flume et al. 
1983, Innocenti et al. 1983; Perry et al. 1985). Innocenti and co-workers (1983) 
in particular. 
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noted the capacity of amoeboid microglia to selectively eliminate non-connected cortico- 
cortical axons without affecting neighbouring fibers and cells. With progressive 
transformation to adult forms, this phagocytic capacity gradually subsides. Amoeboid cells 
isolated in vitro from the rodent CNS have been shown to secrete a variety of cytokines 
(including bFGF, NGF, IL-3) that may participate in gliogenesis. regulate neuronal migration 
and differentiation, direct axonal projections/sprouting and synaptogenesis, and even regulate 
myelin synthesis (Hamilton and Rome, 1994). Amoeboid microglia can also be stimulated to 
produce a variety of inflammatory mediators including TNF-a, IL-Iß and IL-6, chemokines 
and free radicals, all of which are potentially damaging to the vulnerable cellular environment. 
However, it should be stressed that events occurring during normal development are disparate 
from those associated with an inflammatory response that is initiated in the adult nervous 
system. It is more likely that these factors, if produced in the developing CNS, are strictly 
controlled and exert specific effects at physiological levels. Table 16 lists the main factors 
known to be expressed by or released from human foetal microglia. 
Tissue culture studies indicate that microglia not only produce factors that may in essence 
promote neuronal survival, regeneration and plasticity, but may also influence the 
differentiation of particular subsets of neurons (for example GABAergic or cholinergic 
neurons (Mazzoni and Kenigsberg, 1997), mesencephalic neurons (Nagata et al. 1993), and 
promote neunte outgrowth (Nakajima et al. 1993)). Moreover, there is indirect in vivo 
evidence of a physical role for microglia in neuronal regeneration through the process of 
`synaptic stripping' or `pruning' of presynaptic terminals that abut onto a traumatised neuron. 
This, combined with astrocytic aid, affords the afflicted neuron the opportunity to recuperate 
and regenerate (Aldskogius, 2001). Experiments in vitro have shown that microglia- 
conditioned medium is neurotrophic to primary neurons, and significantly enhances the 
survival of cortical and mesencephalic neurons and their neunte extensions in rodents (Nagata 
et al. 1993). Microglia-conditioned medium also elevates dopamine uptake by dopaminergic 
neurons (Nakajima and Kohsaka, 1993). NGF, known to be synthesised by microglia, does not 
mediate this effect. It is possible that IL-1 (Giulian et al. 1986, Yao et al. 1992), IL-3, bFGF 
(Araujo and Cotman, 1992; Presta et al. 1995; Shimojo et al. 1991), and plasminogen also 
produced by microglia, may serve as neurotrophic factors promoting the survival of neurons. 
Platelet activating factor (PAF) produced by human foetal microglia (Jaranowska et at. 1995) 
has a putative role in neuronal differentiation, and signal transduction, since binding sites to 
PAF have been localised to synaptosomes and specific brain areas. In addition to its 
recognised roles in stimulating neunte outgrowth and exerting trophic influence on neurons in 
culture and in situ, bFGF is also a proliferative factor for astrocytes, oligodendrocytes. and a 
differentiation and proliferation factor promoting phagocytosis in microglia (DiPucchio et al. 
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1996). Human recombinant bFGF can induce proliferation of glioblasts in human foetal brain 
cultures. Microglial bFGF could in theory. prevent naturally-occurring neuronal death or exert 
a mitogenic effect on neuroblasts and glioblasts, since bFGF receptors are also present on 
immature neurons and glia in rodents and man (Presta et al. 1995). 
These observations indicate a physiological significance for microglia in regulating neuronal 
growth, function and regeneration. Further evidence supporting a role for microglia and 
macrophages in promoting neunte outgrowth (collateral sprouting) is obtained from grafting 
studies in the peripheral nervous system, where these cells can promote the regeneration of 
sensory axons (Lazar et al. 1999; Prewitt et al. 1997; Rabchevsky and Streit, 1997). Although 
blood-derived macrophages have been shown to modify the properties of adult mammalian 
CNS white matter near mechanical lesions, and convert a non-permissive state to promoting 
axonal growth (David et al. 1990), to date the majority of studies addressing the central 
nervous system, do not favour a supportive function for these cells under traumatic conditions 
in the adult (Aldskogius, 2001). So, it still remains to be seen whether microglia could indeed 
exert effects favouring neunte outgrowth and neuronal differentiation in situ within the 
developing nervous system. 
So far, the heterogeneity inherent in the morphology and functional biochemistry of microglia 
has been the cause for conflicting views on the roles of these cells during development. The 
source (rodent versus human tissues) and processing of material (isolated cell preparations, 
organotypic cultures, or paraffin-embedded versus frozen tissue sections) have additionally 
presented as confounding variables. Despite this, the functions currently proposed for 
microglia in the developing brain, are generally in keeping with their topographical 
distribution, phenotype and behaviours determined in situ, and in culture experiments (Streit, 
2001): cells located preferentially within white matter tracts may carry out functional roles 
related to phagocytosis of aberrant axons, or they may adopt additional roles, for example in 
tissue and vascular remodelling, or promoting the growth of axons and neurites (for example, 
through the production of extracellular matrix components such as thrombospondin and 
growth factors including NGF and bFGF). Overall the findings highlighted above suggest a 
supportive role for microglia in histogenesis and modelling of the CNS during development. 
Which are the progenitor cells for microglia? 
In attempting to answer the question regarding the origin and nature of microglia, we first 
have to consider the differentiation of myeloid cells, and their respective phenotypic and 
functional characteristics. In the first instance, we are confronted with the necessity ion 
distinguish events that occur during haematopoiesis in development, from that which 
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predominates in the adult. First, we shall examine the ontogeny and development of 
mononuclear phagocytes and dendritic cells. According to the classical hypothesis of the 
mononuclear phagocyte system, macrophages are the progeny of bone marrow-derived 
monocytes (van Furth et al. 1972). Mononuclear phagocytes are widely distributed throughout 
the body and include precursors in haematopoietic tissues, peripheral blood monocytes and 
free and fixed macrophages in tissues, organs and cavities. Stem cells give rise to committed 
progenitors along specialised cell lineages. Among these, myeloid progenitors differentiate 
into precursor cells including granulocyte-macrophage forming cells. The bipotential 
granulocyte-macrophage progenitor [CFU-GM] further differentiates to granulocytes [CFU- 
G] and macrophage-forming [CFU-M] cells. The monoblast (or immature macrophage) 
differentiates to form promonocytes, the immediate precursor of monocytes. The latter 
circulate in the blood and penetrate various tissues via blood vessels, where they differentiate 
into resident macrophages. Haematopoiesis is controlled by a system of more than eleven 
growth factors, and at least three glycoproteins initiate the differentiation of macrophages 
from uni- and bi-potential progenitor cells. The progression from a pluripotent stem cell to a 
myeloid-restricted progenitor is driven by IL-3 (a cytokine that generates differentiated 
progeny of all myeloid lineages). With differentiation, IL-3 responsive progenitors, become 
responsive towards M-CSF and GM-CSF (and to some extent TNF-a), the principal growth 
factors giving rise to monocyte/macrophage-restricted cell lineages. It is well known that M- 
CSF, GM-CSF and stem cell factor promote the differentiation of macrophages precursors 
into mature macrophages, and are important for their growth and survival (Sorokin et at. 1992, 
1996). Specifically, in the past, the growth factor M-CSF was considered to specifically 
promote differentiation of myeloid progenitors to form macrophages. Following lineage 
commitment, the cells are dependent on these factors for proliferation and viability. 
Ultrastructurally, M-CSF-treated macrophages retain a mature appearance whereas GM-CSF- 
treated cells become less differentiated. Haematopoietic differentiation is therefore supported 
by the environmental milieu within specific organs. For example foetal rat lungs have high 
levels of GM-CSF, M-CSF and IL-10 (but not TNF-a) supportive of macrophage 
differentiation early in development (Sorokin et al. 1997). The phenotypic profile of rodent 
and human myeloid cells and the markers of differentiation of mononuclear phagocytes are 
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Dendritic cells (DCs) on the other hand, have been considered for many years as representing 
a lineage distinct from monocytes and macrophages (Steinman, 1991). These cells form a 
network of highly efficient antigen-presenting cells whose function is predominantly 
concerned with surveillance of tissues for pathogens. Their 'sentinel' functions are primed 
through exposure to immune or inflammatory stimuli. Following the capture of antigen in 
peripheral tissues, DCs undergo a process of 'maturation' that enables them to migrate to 
lymphoid organs and present antigen to naive T cells (Lane and Brocker, 1999). Immature 
DCs are highly motile, but cease migration after they differentiate. After having gained entry 
to lymphatic organs, maturing DCs pass into the subcapsular sinus of lymph nodes and 
migrate to T cell areas, where they are referred to as 'interdigitating cells'. Chemokines have 
emerged as important regulators of the migration of DCs and their homing to lymphoid organs 
(Allavena et al. 1999; Caux et al. 2002; Dieu-Nosjean et at, 1999. Rescigno et al. 1999. 
Sozzani et al. 1999). In particular, DCs have been shown to express the chemokine receptors 
CCR-1, -2, -3, -5 and CXCR-1, -2, -4 (Sato et al. 1999; Sozzani et al. 1997), and can respond 
by migration to several CC chemokines and SDF-1 (Dieu et at. 1998; Lin et at,, 1998: 
McWilliams et al. 1996; Vecchi et al. 1999; Xu et al. 1996). Recently. experiments mainly 
gathered from tissue culture experiments have identified a population of dendritic cells that 
are derived from the same haematopoietic CD34+ precursors as monocytes and tissue 
macrophages (Nicod and Dayer, 1999). This newly identified population of cells is referred to 
as `monocyte-derived dendritic cells', to distinguish them from lymphoid follicular dendritic 
cells. The concept has now emerged that monocytes represent an abundant source of 
precursors that can develop into dendritic cells or macrophages depending on external stimuli 
(Figure 105). In vitro, this polarisation can be driven by the addition of appropriate cytokines: 
GM-CSF, IL-4 and TNF-a, or M-CSF. 
DCs can be generated from haematopoietic progenitors in the bone marrow, CD34+ cord 
blood cells, precursor cells in the peripheral blood and blood monocytes through appropriate 
culturing conditions with combinations of these cytokines (Hashimoto et al. 1999). For 
example, CD34+ haematopoietic progenitors from human cord blood generate a mixed cell 
population containing different types of dendritic cells when cultured with GM-CSF and TNF- 
a. After a few days in culture, two types of dendritic cell precursors can be identified by 
mutually exclusive expression of CD1a (a marker found on dendritic cells and Langerhans 
cells) and CD14 antigens. Within 1-2 weeks, CDIa precursors generate cells that express 
Birbeck granules (cytoplasmsic organelles), lymphocyte activation gene antigen, and E- 
cadherin- markers characteristic of epidermal Langerhans cells. In contrast, CD 14+ precursors 
mature into CD 14+/CD 1 a- dendritic cells which express CD2. CD9, CD68 and coagulation 
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These same CD14+ precursors (but not the CDla precursors) are able to differentiate into 
macrophages in response to M-CSF. Dendritic cells can also develop from CD14+ peripheral 
blood monocytes cultured with GM-CSF and IL-4. Under these conditions, monocytes 
develop into a homogeneous population of immature dendritic cells, in which maturation can 
be further induced through exposure to inflammatory stimuli such as TNF-a, IL-l, bacterial 
LPS, or by monocyte-conditioned medium and IL-13. Immature dendritic cells generated from 
monocytes retain expression of the M-CSF receptor, but lose it after maturation. Therefore it 
is becoming increasingly more evident that multiple cell types with distinct developmental 
pathways and functional properties constitute the system of DCs. 
Mononuclear phagocytes arise from haematopoietic stem cells during embryonic. foetal and 
adult life. It has been thought for some time, that macrophages are the exclusive progeny of 
bone-marrow-derived monocytes. However, there is now accumulating evidence for 
differences in ontogeny between foetal and adult macrophages (Shepard and Zon, 2000). 
Embryonic or foetal macrophages in particular, do not necessarily follow the monocytic 
pathway. Studies in a variety of species indicate that foetal macrophages instead differentiate 
from yolk sac and hepatic-derived primitive macrophage precursors prior to the onset of 
development of `adult' monocytes. As far back as 1908, Dantschakoff noted the existence of 
macrophages in the yolk sac prior to the initiation of bone marrow haematopoiesis. This was 
later confirmed by Moore and Metcalf in 1970, and Cline and Moore in 1972. 
In the mouse, the first haematopoietic cells arise in the yolk sac around day 7.5 of mouse 
development and migrate to the foetal liver by Ell. The foetal liver remains the major 
haematopoietic site during mid-to-late gestational ages, until about the first postnatal week 
(Ikuta et al. 1992). Haematopoietic cells later populate the spleen after day 15 and eventually 
the bone marrow, which remains the major definitive haematopoietic organ throughout adult 
life (Ikuta et al. 1992; Kee and Paige, 1995). In yolk sac and early hepatic haematopoiesis, 
primitive/foetal macrophages develop from haematopoietic stem cells bypassing the stage of 
monocytic cells (monoblasts, promonocytes and monocytes) (Takahashi et al. 1996). They 
differentiate into tissue macrophages in late ontogeny. Monocytes develop in hepatic 
haematopoiesis following the development of primitive/foetal macrophages. The bone marrow 
adopts the function of haematopoiesis later in development. In adult life. the macrophage 
precursors (immature myeloid cells) and monoc\tes are released from the bone marro into 
peripheral blood. These precursors also migrate into tissues and differentiate into resident 
macrophages or related cells in response to differentiation and growth factors such as M-CSF 
and GM-CSF. By comparison, in man the first formation of blood cells takes place in blood 
islands in the wall of the yolk sac, and after the 6" ýw eek, blood formation takes place chiefl\ 
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in the liver, but also in the spleen and other tissues (including connective tissues). Late in the 
third month haematopoiesis commences in the bone marrow, and progressively, these other 
sites become effete. 
In rodents, macrophages first appear in the blood island of the yolk sac on the ninth day and 
mature into foetal macrophages by day 10 (Takahashi et al. 1989: Takahashi and Naito. 1993). 
They leave the blood island and enter mesenchymal layer and extra-embryonic coelom before 
colonising various tissues via blood vessels, where they are retained as resident macrophages 
(Takahashi et al. 1996). These foetal macrophages possess a high proliferative capacity. 
typically lacking in adult macrophages. They display phagocytic capability and can be 
identified by immunocytochemistry to F4/80 antigen. Foetal macrophages arise from primitive 
macrophages prior to development of monocytes. Data from studies carried out in vertebrates 
and invertebrate species supports the existence of these two separate macrophage lineages: 
foetal and adult/monocytic (Shepard and Zon, 2000 for references). In avian species, yolk sac 
chimaera studies have shown macrophage-like cells of yolk sac origin with phagocytic 
capacity, particularly in the developing CNS associated with areas of cell death. In the 
zebrafish macrophages originate from the lateral mesoderm located at the anterior end of the 
embryo. Primitive macrophage precursors first appear in the yolk sac and migrate to the 
mesenchyme of the head and circulating blood. These are present before the appearance of 
other leukocytes, and display proliferative potential and capacity for phagocytosis. In 
Xenopus, creation of head-body chimaeras demonstrates that early macrophages originate 
from mesenchyme of the head portion of embryos. Similarly, in insects macrophages 
(haemocytes) derived from mesoderm of the head migrate throughout the embryonic larvae 
where they develop into phagocytic macrophages. In rodents, primitive macrophages can be 
identified in the connective tissue surrounding the brain at E 12, prior to vascularisation of this 
organ (Sorokin et al. 1992). The predominant functions of these primitive macrophages are 
thought to concern removal of apoptotic cells during embryogenesis and development 
(Hopkinson-Woolley et al. 1994) and modelling of tissues. From these studies, it appears that 
foetal macrophages originate from a separate lineage of cells than rnonocvte-derived 
macrophages, and that various tissues are colonised by two `waves' of macrophages: yolk- 
sac/mesenchyme-derived population of foetal macrophages that initially surround organs and 
later in development by blood-borne monocyte-derived mononuclear phagocytes. This 
distinction may partly reflect different functional requirements of foetal macrophages (such as 
tissue modelling) during early embryogenesis. There are also differences in the cytokine 
responsiveness of progenitor cells isolated from foetal liver, cord blood and adult bone 
marrow (Weekx et al. 1998). A summar' of the proposed origins for myeloid-derived 
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In man, the first cells with ultrastructural characteristics of macrophages appear in the yolk sac 
and mesenchyme in the fourth week of gestation, and in pre-haematopoietic liver by the fifth 
week. Muramidase and Mac-387 positive cells have been detected in human foetal liver as 
early as 7 weeks, mainly in connective tissue and occasionally within hepatic sinusoids 
(Bardadin et al. 1991). Consistent with the knowledge in rodents. that the liver and spleen are 
the major sites of haematopoiesis during early foetal development (Morioka et al.. 1994. 
Moris et al. 1991; Naito et al. 1990; Roth and Stanley, 1995), in humans, the liver is the 
principal haematopoietic organ of the embryo and foetus between 5 and 22 gestational weeks, 
with granulomonocytic precursor cell activity greatly enhanced in the liver between 16 and 22 
weeks (Torubarova et al. 1995). In keeping with its central role in haematopoiesis, the highest 
levels of M-CSF are detected in the liver of second trimester human foetuses (Roth and 
Stanley, 1995). Furthermore, second trimester foetal blood contains much higher levels of 
progenitor cells and mononuclear cells than are present postnatally (Jones et at. 1994). 
Following this, there is a gradual increase of `mature' foetal macrophages in various tissues, 
with increasing gestational age (Morioka et al. 1994; Naito et al. 1996). 
The findings presented above, namely that a population of dendritic cells are derived from 
monocytes or CD34+ progenitors derived from cord blood, and foetal (primitive or immature) 
macrophages differ in their origins (derived from the yolk sac, liver and spleen) and 
phenotype, from mature adult macrophages (which derive mainly from progenitors in the bone 
marrow), have called for a revision to our concepts of the mononuclear phagocyte system: 
Questions: Where exactly do microglial progenitors fall into place in the new scheme of 
myeloid lineage commitment? Could microglia belong to a family of monocyte-derived 
dendritic cells, or do they derive from foetal macrophages originating from the yolk sac and 
liver? 
Over the past few years, it has clearly emerged that circulating blood monocytes are 
themselves a heterogeneous population of cells, some of which give rise to cells which 
demonstrate features common to dendritic cells (Grage-Griebenow et al. 2001), as already 
summarised (refer to Figure 105). Whilst the evidence for duality in lineage commitment of 
CD34+ cord blood progenitors and circulating CD14+ monocytes appears convincing from 
tissue culture studies highlighted above, there is rather less certainty of the extrapolation of 
this system to events that occur during the development of tissue-resident mononuclear 
phagocytes. Based on their phenotypic and functional characteristics, it is almost certain that 
microglia derive from progenitors of the myeloid lineage. However. like dendritic cells. 
microglia downregulate their phenotype and are present within the CNS as `immature' forms 
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which can be stimulated to 'mature' and adopt many functional and phenotypic characteristics 
normally attributed to macrophages. Therefore, the possibility that microglia are derived from 
immature bipotential progenitors with the ability to differentiate into, and adopt characteristics 
of macrophages and/or dendritic cells, remains to be explored (Flaris et at. 1993). 
There have been several attempts to identify microglia-specific phenotypic markers, but these 
have been largely unsuccessful. With few exceptions (Graeber et at. 1989. Kida et at. 1993: 
Lassmann et al. 1993; Yokoo et al. 1998) antibodies raised against the mononuclear phagocyte 
population are generally present also on microglia, and identify these cells particularly when 
activated. From these studies, it would appear that parenchymal microglia exist in an 
`immunologically immature' state, but do possess the potential to become fully differentiated 
phagocytic and antigen-presenting cells. This phenomenon, taken together with the restricted 
expression of CD45 and macrophage-related markers on microglia, has led some authors to 
the conclusion that microglia are derived from separate precursors to other populations of 
tissue-resident mononuclear phagocytes (Walker 1999). Several authors have noted that 
microglia possess functional and phenotypic similarities with professional antigen presenting 
dendritic cells (Fischer and Reichmann, 2001, Lowe et al. 1989, Penfold et al. 1993. 
Santambrogio et at. 2001, Ulvestad et at. 1994). Among these are their ability to process and 
present antigens, their expression patterns of `empty' MHC class II molecules (Santambrogio 
et al. 2001), and B7 molecules (B7.2 is constitutively expressed by human microglia, and B7.1 
can be expressed upon activation) (Becher and Antel, 1996), their profile of cysteine proteases 
(Santambrogio et at. 2001), their maturation upon exposure to T cells (Becher and Antel, 
1996), expression of CD 11 c (Fischer and Reichmann, 2001), and reportedly, expression of 
dendritic markers CD1 (Lowe et al. 1989) and RFDI (Ulvestad et al. 1994). Finally, 
osteopetrotic mice deficient in M-CSF, considered to be critical for driving the lineage of 
myeloid progenitors towards macrophages, still possess substantial numbers of mononuclear 
phagocytes within the brain (as well as in the lungs and liver) (Blevins and Fedoroff, 1995. 
Wegiel et al. 1998; Wiktor-Jedrzejczak et al. 1991; 1996; Witmer-Pack et al. 1993). 
Likewise the possibility that parenchymal microglia represent a heterogeneous population of 
cells derived during development from foetal macrophages originating in the yolk sac and 
liver (and later from bone marrow-derived progenitors), warrants further investigation (Alliot 
et at. 1999; Shepard and Zon, 2000). Thus, foetal macrophage populations, derived from the 
yolk sac, liver and spleen, in the earlier stages of development which give rise to the resident 
microglial population, may differ in all likelihood from populations at later stages of 
development, and in the adult, that are mainly derived from bone marrow. This particular 
hypothesis is more compelling, given the nature of the colonisation of the developing human 
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and murine CNS by microglia during the period in development which corresponds to that 
when the liver is the principal haematopoietic organ (between 16-22GW in man, Torubarova 
et al. 1995). It would also explain differences between the initial wave of lectin positive 
(immunophenotype negative) progenitors that penetrate the CNS (particularly from the 
surrounding mesenchyme) and progressively differentiate into ramified microglia. and 
amoeboid cells which are derived concomitantly and at later periods from within blood 
vessels. These hypotheses remain to be established. 
Concluding remarks 
The present work has clearly defined the phasing and regional colonisation of the developing 
human and murine nervous systems by microglia. Colonisation of the developing human 
nervous system by microglia is an orchestrated response, related to the maturation of the 
nervous system, coincides with vascularisation of the CNS, is associated with radial glia, and 
correlates with the differentiation of astrocytes, neuronal migration and myelination, all of 
which are events that occur predominantly in the fourth and fifth months of life, and beyond. 
The sites of entry into the nervous system appear initially to derive from mesenchymal tissues 
(mesodermal progenitors/ foetal macrophages) that envelop the brain and spinal cord, and 
subsequently, at local vessels (within the corpus callosum and internal capsule for example, or 
in regions of the brain where apoptosis occurs), and from `reservoirs' within the germinal 
layers, where large numbers of amoeboid microglia tend to accumulate. There are at least 
three successive stages in microglial colonisation of the human nervous system. First and 
foremost, progenitor cells migrate from the meninges/mesenchymal tissue surrounding the 
CNS and later, via blood vessels into the primary sites of colonisation: the intermediate zone 
and subplate, internal capsule, corpus callosum, ventricular and subventricular zones. Second, 
cells migrate tangentially along the germinal layers, within the corpus callosum, and radially 
along the direction of radial glial tracts spanning the intermediate zone (developing white 
matters) towards the cortical plate. Finally, microglia distribute ubiquitously throughout the 
CNS in non-overlapping fields. Colonisation of the spinal cord in man begins around 9GW, 
with the major influx of microglial progenitors commencing between 14-16GW. In the 
cerebrum, colonisation is well underway during the second trimester. Although the patterns of 
colonisation may appear to differ between the spinal cord and cerebrum, the route of traffic for 
these cells is the same: from white matter to developing grey areas. In the mouse, microglial 
progenitors begin to colonise the CNS around embryonic day 15, and these cells begin to 
differentiate to ramified forms from day 17 to day 19 onwards. The gradient of colonisation 
follows a caudal to rostral axis, in keeping with the general development of the nervous 
system, and the differentiation of these cells accompanies highlyy vascularised regions of the 
CTN. 
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The distribution of these cells is likely to be co-ordinated by regional and differential 
expression of chemokines such as MCP-1 (acting via CCR2), MIP-1 a, RANTES. IL-8 and 
fractalkine in the cerebrum and by ICAM-2, PECAM and laminin on cerebral blood vessels 
and on capillaries within the germinal layer, as well as by regional apoptotic cell death (for 
example in the ventricular and subventricular zones). Developmentally regulated expression 
of ICAM-2 on vessels is significant, since this adhesion molecule is not inducible in 
inflammation and very low levels can be detected in the normal adult brain. A population of 
foetal microglia are actively dividing with the intermediate zone, and paired cells within this 
region express MIP-1 a. Moreover, data from tissue culture experiments indicate that 
chemokines (such as MCP-1 and MIP-1 (x) may not only direct the migration of microglia and 
their progenitors, but may also influence the proliferation of developing astrocytes. The 
morphological status and motility of microglial progenitors are clearly influenced by the 
activity of astrocytes in vitro, and foetal microglia are closely associated with GFAP-positive 
radial glial cells, differentiating astrocytes and their processes in situ during the second 
trimester. 
With new insights into the heterogeneity between foetal and adult macrophages, it is proposed 
that the initial phase of colonisation of the nervous system consists of foetal macrophages or 
their precursors that originate from the yolk sac and liver. This is followed by a secondary 
wave of colonisation by circulating progenitors derived from the foetal liver and subsequently 
bone marrow following the development of the vascular network and blood circulation. 
Therefore, amoeboid microglia may not represent the sole source for ramified microglia, and 
the precise nature of the earlier progenitors will require identification. At the end of this 
process, by the end of the second trimester (24GW) foetal microglia have established their 
territories, begin to downregulate many of their surface molecules and progressively lose their 
migratory capacity, amoeboid shape and transform to ramified microglia. Amoeboid microglia 
may be associated with modelling of the CNS architecture, similar to mononuclear phagocytes 
in other tissues (for example modelling of bone by osteoclasts during development). 
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Future directions 
There is now considerable knowledge regarding the activation and involvement of microglia 
in the pathology of the CNS. By comparison, circumstances surrounding the origin. 
development, and normal resting state of these cells are less apparent. It is evident that 
microglial colonisation of the CNS and subsequent differentiation require specific temporo- 
spatial cues derived from their environment. Although astrocytes appear central to this 
process, there are indications that neurons also influence this behaviour. Chemokines as well 
as growth factors have emerged as important regulators driving the directed migration of 
microglia. However, the precise nature and roles of these and other factor during development 
will require confirmation. Likewise, the mechanisms governing the differentiation of 
microglia and their territorial phenomena await systematic investigation. 
Future work should focus on the physico-anatomical relationship of microglial progenitors 
with regards to synaptogenesis and the development of the cerebrovasculature and 
leptomeninges (the meninges are indicated at 6GW, the choroid plexus appears around 7GW, 
and the dura mater and pia arachnoid are distinct from 8GW in man (Arey, 1965)). Most 
importantly, the concept of a dual origin for microglia (from mesenchymal progenitors/foetal 
macrophages, and subsequently from circulating blood progenitors or possibly derived from 
perivascular cells) will have to be addressed primarily in studies on developing rodents during 
the foetal as well as postnatal periods (for example in mice lacking the myeloid differentiation 
transcription factors PU. I and CEBPa. (Iwama et al. 1998, Tenen, 2001; Zhang et al. 1997), or 
in combined M-CSF/GM-CSF knockout animals (Lieschke et al. 1994, Seymour et al. 1997) 
which are deficient in or lack certain populations of mononuclear phagocytes, as well as 
through experimental manipulation of haematopoietic tissue sources). Furthermore, the focus 
for such investigations should be directed towards progenitors derived from the foetal liver. 
rather than the bone marrow, since this latter organ adopts the principal role of haematopoiesis 
from mid-trimester, when microglial progenitors are already disseminated throughout the 
nervous system. The use of knockout animals (e. g. osteopetrotic/M-CSF-/-, MCP-11CCR2-/- 
and CDl lb-/- mice: Jeetle et al. 2002) as well as transgenic mice (e. g. mice that overexpress 
MCP-1: Fuentes et al. 1995) will continue to present valuable tools to determine the signals 
driving the recruitment of microglial progenitors. The possible functions of developing 
microglia may be addressed further by examining non-inflammatory developmental 
disorders 
and malformation of the CNS, including those related to neuronal migration and enzymatic or 
lysosomal storage disorders. 
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The underlying purpose of this investigation was to understand the ternporo-spatial phasing 
and mechanisms by which the nervous system is colonised by microglial progenitors. These 
data are of particular application to potential therapies for a number of paediatric disorders 
affecting the brain, including hereditary lipidoses (Niemann-Pick disease, Gaucher"s disease, 
Krabbe disease and metachromatic leukodystrophy) (Scriver et al. 1989), which are caused by 
single enzyme deficiencies that may lead to the accumulation of lipids within mononuclear 
phagocytes and subsequently to progressive neuropathological damage of variable severity. 
These defects may be partly corrected by transplantation of normal bone marrow or cord 
blood (rich in haematopoietic progenitors). The use of microglial progenitors as a tool for 
gene therapy targeting the CNS in such disorders is now conceivable. This study has shown 
that an effective window for such therapy exists during the second trimester of intra-uterine 
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"I have endeavoured to show the reader the position in which our knowledge...... stood about the 
middle of the present year, and I trust that my book may enable many who have not yet attempted, but 
who are nevertheless anxious, to do something to advance this work a little nearer to its great 
therapeutic ends, to understand where to begin. If it be thought to fail in these objects, it may perhaps 
yet succeed indirectly, on the principle that a man who publicly upholds erroneous views often 
advances truth by the amount of opposition and discussion which he arouses. If even in this way, our 
knowledge 
....... is in some small measure increased, the 
labour I have expanded upon this work may 
not have been altogether in vain. " 
W Ford Robertson, Edinburgh, 22"d October, 1900 
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